Protein Separations’ Handbook Collection Antibody Purification
The Recombinant Protein Handbook
GST Gene Fusion System...
170 downloads
1855 Views
15MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Protein Separations’ Handbook Collection Antibody Purification
The Recombinant Protein Handbook
GST Gene Fusion System
Handbook
Protein Amplification and Simple Purification
Handbook
Protein Purification
Ion Exchange Chromatography
Affinity Chromatography
Principles and Methods
Principles and Methods
Hydrophobic Interaction Chromatography
PRINCIPLES AND METHODS
Handbook
18-1037-46
18-1142-75
18-1157-58
18-1132-29
18-1114-21
18-1022-29
Edition AB
Edition AB
Edition AA
Edition AB
Edition AA
Edition AC
Antibody Purification
The Recombinant Protein Handbook
GST Gene Fusion System
Protein Purification
Ion Exchange Chromatography
Reversed Phase Chromatography
Microcarrier cell culture
Percoll
Ficoll-Paque PLUS
Principles and Methods
Principles and Methods
principles & methods
Methodology and Applications
For in vitro isolation of lymphocytes
18-1134-16 Edition AB
Edition AI
Gel Filtration
Reversed Phase Chromatography
Updated July 2002 – Keep updated with new updates of the included handbooks.
18-1140-62 Edition AA
18-1152-69 18-1115-69
Edition AB
Edition AC
Microcarrier Cell Culture
Percoll
Edition AB
Affinity Chromatography
Gel Filtration
18-1022-18
18-1020-90
Ficoll-Paque PLUS
Hydrophobic Interaction Chromatography
Choose a handbook by clicking on it
Hydrophobic Interaction Chromatography
PRINCIPLES
AND
METHODS
Back to Collection
18-1020-90 Edition AB 1
to order: Asia Pacific Tel: +852 2811 8693 Fax: +852 2811 5251 Australasia Tel: +61 2 9894 5152 Fax: +61 2 9899 7511 Austria Tel: 01 576 0616 20 Fax: 01 576 0616 2 7 Belgium Tel: 0800 73 888 Fax: 03 272 1637 Canada Tel: 1 800 463 5800 Fax: 1 800 567 1008 Central, East, South East Europe Tel: +43 1 982 3826 Fax: +43 1 985 8327 Denmark Tel: 45 16 2400 Fax: 45 16 2424 Finland Tel: 09 512 3940 Fax: 09 512 1710 France Tel: 0169 35 67 00 Fax: 0169 41 9677 Germany Tel: 0761 4903 401 Fax: 0761 4903 405 Italy Tel: 02 27322 1 Fax: 02 27302 212 Japan Tel: 81 3 5331 9336 Fax: 81 3 5331 9370 Latin America Tel: +55 11 3667 5700 Fax: +55 11 3667 87 99 Middle East and Africa Tel: +30 (1) 96 00 687 Fax: +30 (1) 96 00 693 Netherlands Tel: 0165 580 410 Fax: 0165 580 401 Norway Tel: 2318 5800 Fax: 2318 6800 Portugal Tel: 01 417 7035 Fax: 01 417 3184 Russian Federation Tel: +7 (095) 232 0250,956 1137 Fax: +7 (095) 230 6377 South East Asia Tel: 60 3 724 2080 Fax: 60 3 724 2090 Spain Tel: 93 594 49 50 Fax: 93 594 49 55 Sweden Tel: 018 612 19 00 Fax: 018 612 19 10 Switzerland Tel: 01 802 81 50 Fax: 01 802 81 5 1 UK Tel: 0800 616 928 Fax: 0800 616 927 USA Tel: +1 800 526 3593 Fax: +1 877 295 8102
Sephadex, Sepharose, Superose, BioProcess, FPLC, SMART, Mono Q, SOURCE, HiTrap, HiLoad, BPG, Superloop, Superdex, Ultroscan, PhastSystem, and RESOURCE are trademarks of Amersham Pharmacia Biotech Limited or its subsidiaries. Amersham is a trademark of Nycomed Amersham plc. Pharmacia and Drop Design are trademarks of Pharmacia & Upjohn. Amersham Pharmacia Biotech AB Björkgatan 30, SE-751 84 Uppsala, Sweden. Amersham Pharmacia Biotech UK Limited Amersham Place, Little Chalfont, Buckinghamshire HP7 9NA, England. Amersham Pharmacia Biotech Inc 800 Centennial Avenue, PO Box 1327, Piscataway, NJ 08855 USA. Amersham Pharmacia Biotech Europe GmbH Munzinger Strasse 9, D-79111 Freiburg, Germany. Amersham Pharmacia Biotech K.K. Sanken Building, 3-25-1, Hyakunincho, Shinjuku-ku, Tokyo 169-0073, Japan. All goods and services are sold subject to the terms and conditions of sale of the company within the Amersham Pharmacia Biotech group that supplies them. A copy of these terms and conditions is available on request. © Amersham Pharmacia Biotech AB 2000 – All rights reserved.
Hydrophobic Interaction Chromatography PRINCIPLES AND METHODS
ISBN 91-970490-4-2
Foreword Many biotechnologists began their careers in chromatography reading Gel Filtration: Theory and Practice. First published in 1966, this monograph has had over 250,000 copies printed in five languages. It was soon followed by another helpful monograph from Amersham Pharmacia Biotech on ion exchange. About 15 years ago, Affinity Chromatography: Principles and Methods was published describing the emergence of this powerful separating method for macromolecules. In some ways this monograph series has defined the critical methods in the field at the time of publication and has been both good business and a public service for over 25 years. With the rise of the modern biotechnology industry and its requirement for highly purified pharmaceutical proteins, a further emphasis has been placed on entire processes with respect to their economy, capacity and resultant product quality. Often the extent of separation power required is defined by the need to resolve the product not only from the background impurities derived from the fermentation but also from degradation products and analogues of the drug itself. For many cases, hydrophobic interaction chromatography (HIC) is an ideal separation method. In my experience, HIC is finding dramatically increased use both in laboratory and production processes. Since the molecular mechanism of HIC relies on unique structural features, it serves as an orthogonal method to ion exchange, gel filtration and affinity chromatography. It is very generic, yet capable of powerful resolution. Usually media have high capacity and are economical and stable. Adsorption takes place in high salt and desorption in low salt concentrations. These special properties make HIC very useful in whole processes for bridging or transitioning between other steps in addition to the separation which is effected. This book can serve as an excellent introduction to the subject of HIC for those new to this method of separation. More experienced chromatographers can also benefit from the useful review. Topics include the molecular mechanism of separation by HIC in contrast to reversed phase chromatography, a helpful section on strategies for rapid method development, as well as a wide selection of examples. Practical aspects such as packing, use and sanitization of columns are discussed. There are many tricks, techniques and insights to be gained in a complete reading. I recommend it be read and kept handy on your personal book shelf and I predict that you will find HIC a surprisingly helpful technique both alone and especially in combination with other modes of separation.
Stuart E. Builder So. San Francisco January 15, 1993
Contents 1. Introduction to HIC................................................... 9 2. Principles of HIC.................................................... 11 Theory .............................................................................11 HIC vs RPC .....................................................................12 Factors affecting HIC .......................................................13 Type of ligand .......................................................13 Degree of substitution ..........................................14 Type of base matrix ..............................................14 Type and concentration of salt .............................15 Effect of pH ...........................................................16 Effect of temperature ............................................17 Additives ...............................................................18
3. Product Guide ........................................................ 19 BioProcess Media ...........................................................20 Base matrices .......................................................20 Coupling ...............................................................21 Chemical stability .................................................21 Physical stability ...................................................22 Binding capacity ...................................................22 Phenyl Sepharose 6 Fast Flow (low sub) and Phenyl Sepharose 6 Fast Flow (high sub) .......................23 Butyl Sepharose 4 Fast Flow ...........................................24 Phenyl Sepharose High Performance .............................25 Custom Designed HIC Media ..........................................26 HIC Media Test Kit ..........................................................26
Contents Phenyl Sepharose CL-4B and Octyl Sepharose CL-4B ...................................................27 Phenyl Superose and Alkyl Superose ..............................27
4. Experimental Design ............................................. 29 Hydrophobicity of proteins .............................................29 Multivariate mapping ......................................................29 Strategic considerations .................................................30 Choice of HIC media .......................................................31 General considerations .........................................31 Screening experiments .........................................32 Optimizing a HIC step .....................................................39 The solute .............................................................39 The solvent ...........................................................41 Elution ..................................................................42 Sample load and flow rate ....................................45 Regeneration ........................................................45 Process considerations ...................................................46 Method optimization in process ............................... chromatography ...................................................46 Scaleability ...........................................................49 Regulatory considerations ....................................50
5. Experimental Technique ........................................ 53 Choice of column ............................................................53 Column dimensions..............................................53 Packing the column ........................................................53 Packing Sepharose Fast Flow based HIC gels ......54 Packing Phenyl Sepharose High Performance .....55 Packing Sepharose CL-4B based HIC gels ...........55
Contents Use of an adaptor .................................................55 Checking the packed bed ......................................56 Prepacked HIC media ...........................................58 Sample preparation .........................................................59 Sample composition .............................................59 Sample volume .....................................................59 Sample viscosity ...................................................60 Particle content .....................................................60 Sample application ..........................................................61 Sample reservoir ..................................................61 Sample applicators ...............................................61 Sample loops with valves LV-4 or SRV-4 .............62 Sample loops or Superloop with valves V-7 or MV-7 ...............................................62 Batch separation .............................................................63 Cleaning, sanitization and sterilization procedures .........63 Storage of gels and columns ..........................................65 Prevention of microbial growth ............................65 Antimicrobial agents .............................................65 Storage of unused media ......................................67 Storage of used media ..........................................67 Storage of packed columns ..................................67 Process considerations ...................................................68 Selecting a column ...............................................68 Aspects of column design ....................................69 Packing large scale columns ................................71 Scale-up ...............................................................74
Contents 6. Applications ........................................................... 77 Preparative and analytical HIC applications in the research laboratory ...........................77 HIC in combination with ammonium sulphate precipitation ..........................................................77 HIC in combination with ion exchange chromatography ...................................................78 HIC in combination with gel filtration ................... 80 HIC as a ”single step” purification technique ........81 Analysis of conformational changes with HIC....... 84 Other HIC application areas in the research laboratory .............................................................84 Preparative, large scale applications ............................... 85 Purification of a monoclonal antibody for clinical studies of passive immunotherapy of HIV-1 ...................................................85 Purification of recombinant human Epidermal Growth Factor (h-EGF) from yeast ....... 87 Purification of a monoclonal antibody for in vitro diagnostic use .......................................... 90 Purification of a recombinant Pseudomonas aeruginosa exotoxin, produced in E. Coli ..............92
7. References ............................................................ 97 Order from................................................................ 102
10
1 Introduction to HIC In a classical paper published in 1948 and entitled: ‘‘Adsorption Separation by Salting Out’’, Tiselius [1] laid down the foundation for a separation method which is now popularly known as hydrophobic interaction chromatography (HIC). He noted that, ‘‘...proteins and other substances which are precipitated at high concentrations of neutral salts (salting out), often are adsorbed quite strongly already in salt solutions of lower concentration than is required for their precipitation, and that some adsorbents which in salt-free solutions show no or only slight affinity for proteins, at moderately high salt concentrations become excellent adsorbents”. Since then, great strides have been made in developing almost ideal stationary phases for chromatography (such as cellulose, cross-linked dextran (Sephadex™), cross-linked agarose (Sepharose™ CL, Sepharose High Performance and Sepharose Fast Flow), and in developing coupling methods for immobilizing ligands of choice [2,3] to such matrices. It was a combination of these two events which, in the beginning of 1970's, led to the synthesis of a variety of hydrophobic adsorbents for biopolymer separations based on this previously rarely exploited principle. The first attempt at synthesizing such adsorbents was made by Yon [4] followed by Er-el et al. [5], Hofstee [6] and Shaltiel & Er-el [7]. Characteristically, these early adsorbents showed a mixed ionic-hydrophobic character [8]. Despite this, Halperin et al. [9] claimed that protein binding to such adsorbents was predominantly of a hydrophobic character. Porath et al. [10] and Hjertén et al. [11] later synthesized charge-free hydrophobic adsorbents and demonstrated that the binding of proteins was enhanced by high concentrations of neutral salts, as previously observed by Tiselius [1], and that elution of the bound proteins was achieved simply by washing the column with salt-free buffer or by decreasing the polarity of the eluent [6, 10, 11]. Amersham Pharmacia Biotech was first in producing commercial HIC adsorbents (Phenyl and Octyl Sepharose CL-4B [12]) of the charge-free type and has continuously followed this up with new developments in agarose matrix design by introducing new stable HIC media based on Superose™, Sepharose Fast Flow and Sepharose High Performance, meeting various demands on chromatographic productivity, selectivity and efficiency.
11
The commercial availability of well-characterized HIC adsorbents opened new possibilities for purifying a variety of biomolecules such as serum proteins [12, 13], membrane-bound proteins [14], nuclear proteins [15], receptors [16], cells [17], and recombinant proteins [18, 19] in research and industrial laboratories. These adsorbents were also used for the reversible immobilization of enzymes [20] and liposomes [21]. The principle for protein adsorption to HIC media is complementary to ion exchange chromatography and gel filtration. HIC is even sensitive enough to be influenced by non-polar groups normally buried within the tertiary structure of proteins but exposed if the polypeptide chain is incorrectly folded or damaged (e.g. by proteases). This sensitivity can be useful for separating the pure native protein from other forms. Altogether this makes HIC a versatile liquid chromatography technique, being a logical part of any rational purification strategy, often in combination with ion exchange chromatography and gel filtration. HIC has also found use as an analytical tool to detect protein conformational changes. HIC requires a minimum of sample pre-treatment and can thus be used effectively in combination with traditional protein precipitation techniques. Protein binding to HIC adsorbents is promoted by moderately high concentrations of anti-chaotropic salts, which also have a stabilizing influence on protein structure. Elution is achieved by a linear or stepwise decrease in the concentration of salt in the adsorption buffer. Recoveries are often very satisfactory. A number of mechanisms have been proposed for HIC over the years and factors that affect the binding of proteins to such adsorbents have been investigated. These aspects will be briefly outlined in this handbook. Greater emphasis has been given to practical considerations on how to make optimal use of Amersham Pharmacia Biotech range of HIC products.
12
2 Principles of HIC Theory The discussions that follow in this chapter will be limited to the non-charged type of HIC adsorbents. The many theories that have been proposed for HIC are essentially based upon those derived for interactions between hydrophobic solutes and water (22,23), but none of them has enjoyed universal acceptance. What is common to all is the central role played by the structure-forming salts and the effects they exert on the individual components (i.e., solute, solvent and adsorbent) of the chromatographic system to bring about the binding of solute to adsorbent. In view of this, Porath (24) proposed ‘‘salt-promoted adsorption’’ as a general concept for HIC and other types of solute-adsorbent interactions occuring in the presence of moderately high concentrations of neutral salts. Hofstee (6) and later Shaltiel (7) proposed ‘‘hydrophobic chromatography’’ with the implicit assumption that the mode of interaction between proteins and the immobilized hydrophobic ligands is similar to the self association of small aliphatic organic molecules in water. Porath et al. (10) suggested a salting-out effect in hydrophobic adsorption, thus extending the earlier observations of Tiselius (1). They also suggested that ‘‘. . .the driving force is the entropy gain arising from structure changes in the water surrounding the interacting hydrophobic groups’’. This concept was later extended and formalized by Hjertén (25) who based his theory on the well known thermodynamic relationship: DG = DH - TDS. He proposed that the displacement of the ordered water molecules surrounding the hydrophobic ligands and the proteins leads to an increase in entropy (DS) resulting in a negative value for the change in free energy (DG) of the system. This implies that the hydrophobic ligand-protein interaction is thermodynamically favourable, as is illustrated in Fig. 1. An alternative theory is based on the parallelism between the effect of neutral salts in salting out (precipitation) and HIC (26,27). According to Melander and Horvath (27), hydrophobic interaction is accounted for by increase in the surface tension of water arising from the structure – forming salts dissolved in it. In fact, a combination of these two mechanisms seems to be an obvious extension and has been exploited long
13
L
+
H
S
L H
S +
P P=Polymer matrix S=Solute molecule L=Ligand attached to polymer matrix H=Hydrophobic patch on surface of solute molecule W=Water molecules in the bulk solution
W
Fig. 1. Close to the surface of the hydrophobic ligand and solute (L and H), the water molecules are more highly ordered than in the bulk water and appear to ‘‘shield off’’ the hydrophobic ligand and solute molecules. Added salt interacts strongly with the water molecules leaving less water available for the ‘‘shielding off’’ effect, which is the driving force for L and H to interact with each other.
before HIC adsorbents were synthesized (28). Finally, Srinivasan and Ruckenstein (29) have proposed that HIC is due to van der Waals attraction forces between proteins and immobilized ligands. The basis for this theory is that the van der Waals attraction forces between protein and ligand increase as the ordered structure of water increases in the presence of salting out salts.
HIC vs RPC In theory, HIC and reverse-phase chromatography (RPC) are closely related LC techniques. Both are based upon interactions between solvent-accessible non-polar groups (hydrophobic patches) on the surface of biomolecules and the hydrophobic ligands (alkyl or aryl groups) covalently attached to the gel matrix. In practice, however, they are different. Adsorbents for RPC are more highly substituted with hydrophobic ligands than HIC adsorbents. The degree of substitution of HIC adsorbents is usually in the range of 10–50 mmoles/ ml gel of C2–C8 alkyl or simple aryl ligands, compared with several hundred mmoles/ml gel of C4–C18 alkyl ligands usually used for RPC adsorbents. Consequently, protein binding to RPC adsorbents is usually very strong, which requires the use of non-polar solvents for their elution. RPC has found extensive applications in analytical and preparative separations of mainly peptides and low molecular weight proteins that are stable in aqueous-organic solvents. In summary, HIC is an alternative way of exploiting the hydrophobic properties of proteins, working in a more polar and less denaturing environment. Compared with RPC, the polarity of the complete system of HIC is increased by decreased ligand density on the stationary phase and by adding salt to the mobile phase.
14
Factors affecting HIC The main parameters to consider when selecting HIC media and optimizing separation processes on HIC media are: • Ligand type and degree of substitution • Type of base matrix • Type and concentration of salt • pH • Temperature • Additives
Type of ligand
Fig. 2. The effect of alkyl chain length and degree of substitution on binding capacity in HIC. In Fig. 2A it is assumed that the degree of substitution is the same for each alkyl chain length shown.
Binding capacity (mg protein/ml gel)
The type of immobilized ligand (alkyl or aryl) determines primarily the protein adsorption selectivity of the HIC adsorbent (6,7,30). In general, straight chain alkyl (hydrocarbon) ligands show ‘‘pure’’ hydrophobic character while aryl ligands show a mixed mode behaviour where both aromatic and hydrophobic interactions are possible (30). It is also established that, at a constant degree of substitution, the protein binding capacities of HIC adsorbents increase with increased alkyl chain length (Fig. 2A) (30,31). The charged type HIC adsorbents (6,7) show an additional mode of interaction, which will not be discussed here. The choice between alkyl or aryl ligands is empirical and must be established by screening experiments for each individual separation problem.
B
A
C4
C6
C8
n-Alkyl chain length
10
20
30
Degree of substitution (µmol ligand/ml gel)
15
HIC media shown in Fig. 3 are all based on the glycidyl ether coupling procedure, which produces gels that are charge free and that should thus only have hydrophobic interactions with proteins. The phenyl group shown in Fig. 3-C also has a potential for þ-þ interactions. The glycidyl-ether coupling technique will introduce a short spacer but the effect of this will be very limited since the short hydrophobic chain is ‘‘neutralized’’ with the hydrophilic OH-group.
–
OH
A
–O–CH2–CH–CH2–O–(CH2)3–CH3 Butyl Sepharose 4 Fast Flow
Fig. 3. Different hydrophobic ligands coupled to cross-linked agarose matrices.
–
OH B
–O–CH2–CH–CH2–O–(CH2)7–CH3 Octyl Sepharose CL-4B
–
OH C
–O–CH2–CH–CH2–O– Phenyl Superose Phenyl Sepharose High Performance Phenyl Sepharose CL-4B Phenyl Sepharose 6 Fast Flow (low sub) Phenyl Sepharose 6 Fast Flow (high sub)
–
OH D
–O–CH2–CH–CH2–O–CH2–C(CH3)3 Alkyl Superose
Degree of substitution The protein binding capacities of HIC adsorbents increase with increased degree of substitution of immobilized ligand. At a sufficiently high degree of ligand substitution, the apparent binding capacity of the adsorbent remains constant (plateau is reached) but the strength of the interaction increases (31–33, 35) (Fig. 2B). Solutes bound under such circumstances are difficult to elute due to multi-point attachment (34).
Type of base matrix It is important not to overlook the contribution of the base matrix. The two most widely used types of support are strongly hydrophilic carbohydrates, e.g. cross-linked agarose, or synthetic copolymer materials. The selectivity of a copolymer support will not be exactly the same as for an agarose based support substituted with the same type of ligand. To achieve the same type of results on an agarose-based matrix as on a copolymer support, it may be necessary to modify adsorption and elution conditions.
16
Type and concentration of salt The addition of various structure-forming (‘‘salting out’’) salts to the equilibration buffer and sample solution promotes ligand-protein interactions in HIC (10, 12, 36, 65, 66). As the concentration of such salts is increased, the amount of proteins bound also increases almost linearly up to a specific salt concentration and continues to increase in an exponential manner at still higher concentrations.
Fig. 4. Protein binding capacity on Phenyl Sepharose High Performance as a function of salt concentration in the column equilibration buffer (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
Protein capacity mg/ml packed bed
This latter phenomenon is demonstrated in Fig. 4 where total binding capacity of Phenyl Sepharose High Performance for a-chymotrypsinogen and RNAse was examined at gradually increasing salt concentrations.
80
α-chymotrypsinogen RNA se
60
40
20
1
2
3
4
Initial salt concentration M (NH4)2 SO4
In this experiment, the column was first equilibrated with buffer containing varying concentrations of salt as indicated in the Figure. The sample was dissolved in buffer including this initial salt concentration prior to application to the column. However, in those experiments where the protein begins to precipitate at high salt concentration (1.3 M and 2.3 M ammonium sulphate for a-chymotrypsinogen and RNAse respectively) the sample was dissolved at a slightly lower salt concentration. The samples were loaded on the column until breakthrough could be observed at the column outlet. Then start buffer with initial salt concentration was run through the column until UV-absorption in the eluent returned to the baseline. Finally, the bound proteins were eluted with a decreasing salt gradient. A significant increase in adsorption capacity can be seen when the salt concentration is increased above the precipitation point.
17
This phenomenon is probably due to the precipitation of proteins on the column. It has a concomitant negative effect on the selectivity of the HIC adsorbent.
t
The effects of salts in HIC can be accounted for by reference to the Hofmeister series for the precipitation of proteins or for their positive influence in increasing the molal surface tension of water (for extensive review, see refs. 27,29). These effects are summarized in Tables 1 and 2.
Increasing precipitation (‘‘salting -out’’) effect
Anions: PO43–, SO42–, CH3 • COO–, Cl–, Br–, NO3–, CLO4–, I–, SCN– Cations: NH4+, Rb+, K+, Na+, Cs+, Li+, Mg2+, Ca2+, Ba2+
Na2SO4>K2SO4>(NH4)2SO4>Na2HPO4>NaCl>LiCl. . . >KSCN
t
Increasing chaotropic (‘‘salting-in’’) effect
Table 1. The Hofmeister series on the effect of some anions and cations in precipitating proteins.
Table 2. Relative effects of some salts on the molal surface tension of water.
In both instances, sodium, potassium or ammonium sulphates produce relatively higher ‘‘salting-out’’ (precipitation) or molal surface tension increment effects. It is also these salts that effectively promote ligand-protein interactions in HIC. Most of the bound proteins are effectively desorbed by simply washing the HIC adsorbent with water or dilute buffer solutions at near neutral pH.
Effect of pH The effect of pH in HIC is also not straightforward. In general, an increase in pH weakens hydrophobic interactions (10,41), probably as a result of increased titration of charged groups, thereby leading to an increase in the hydrophilicity of the proteins. On the other hand, a decrease in pH results in an apparent increase in hydrophobic interactions. Thus, proteins which do not bind to a HIC adsorbent at neutral pH bind at acidic pH (9). Hjertén et al. (42) found that the retention of proteins changed more drastically at pH values above 8.5 and/or below 5 than in the range pH 5–8.5 (Fig 5). These findings suggest that pH is an important separation parameter in the optimization of hydrophobic interaction chromatography and it is advisable to check the applicability of these observations to the particular separation problem at hand.
18
Fig. 5. The pH dependence of the interaction between proteins and an octyl agarose gel expressed as Ve/VT (Ve is the elution volume of the different proteins and VT is the elution volume of a non-retarded solute). Elution was by a negative linear gradient of salt. The model proteins used were STI=soy trypsin inhibitor, A=human serum albumin, L=lysozyme, T=transferrin, E=enolase, O=ovalbumin, R=ribonuclease, ETI=egg trypsin inhibitor and C=cytochrome c. (Reproduced with permission, from ref. 42).
Effect of temperature Based on theories developed for the interaction of hydrophobic solutes in water (22,37), Hjertén (38) proposed that the binding of proteins to HIC adsorbents is entropy driven [ ÐG = (ÐH-TÐS) ~ -TÐS], which implies that the interaction increases with an increase in temperature. Experimental evidence to this effect has been presented by Hjertén (25) and Jennissen (34). It is interesting to note that the van der Waals attraction forces, which operate in hydrophobic interactions (29), also increase with increase in temperature (39). However, an opposite effect was reported by Visser & Strating (40) indicating that the role of temperature in HIC is of a complex nature. This apparent discrepancy is probably due to the differential effects exerted by temperature on the conformational state of different proteins and their solubilities in aqueous solutions. In practical terms, one should thus be aware that a downstream purification process developed at room temperature might not be reproduced in the cold room, or vice versa. 19
Additives Low concentrations of water-miscible alcohols, detergents and aqueous solutions of chaotropic (‘‘salting-in’’) salts result in a weakening of the protein-ligand interactions in HIC leading to the desorption of the bound solutes. The non-polar parts of alcohols and detergents compete effectively with the bound proteins for the adsorption sites on the HIC media resulting in the displacement of the latter. Chaotropic salts affect the ordered structure of water and/or that of the bound proteins. Both types of additives also decrease the surface tension of water (see Table 3) thus weakening the hydrophobic interactions to give a subsequent dissociation of the ligand-solute complex. Although additives can be used in the elution buffer to affect selectivity during desorption, there is a risk that proteins could be denatured or inactivated by exposure to high concentrations of such chemicals. However, additives can be very effective in cleaning up HIC columns that have strongly hydrophobic proteins bound to the gel medium.
Solvent Water Ethylene glycol Dimethyl Sulphoxide Dimethyl Formamide n-propanol
20
Viscosity (centipoise) 0.89 16.90 1.96 0.796 2.00
Dielectric constant 78.3 40.7 46.7 36.71 20.33
Surface tension (dynes/cm) 72.00 46.70 43.54 36.76 23.71
Table 3. Physical properties of some solvents used in HIC (data at 25 oC).
3 Product Guide Amersham Pharmacia Biotech manufactures a wide range of HIC media suitable for analytical, small scale preparative and process scale applications. The HIC product range is summarized in Table 4.
a e di ™ s M e from c e srformacnacle-upctohnical o r e s P n p gh ll te ices
BioQualityrcah throkued bypfuort serv . ac ea up res tion. B tory s rmacia ha ula duc pro nd reg from P a
B
dia ™ Me m fro e ss ance p to al rocn perfogrmh scalell-utechnicices P a u io rv y fu b se ality thro Qu earch acked pport . u res tion. B tory s rmacia ha ula duc pro nd reg from P a
Table 4. HIC products available from Amersham Pharmacia Biotech.
Phenyl Sepharose 6 Fast Flow (low sub) Phenyl Sepharose 6 Fast Flow (high sub) Butyl Sepharose 4 Fast Flow Octyl Sepharose 4 Fast Flow*
Suitable for all initial and intermediate step purifications. Available in laboratory pack sizes and bulk quantities.
Phenyl Sepharose High Performance
Suitable for all high resolution purifications. Available in laboratory pack sizes, bulk quantities and as prepacked columns.
Phenyl Sepharose CL-4B Octyl Sepharose CL-4B
Traditional medium for all applications. Available in laboratory pack sizes and bulk quantities.
Alkyl Superose and Phenyl Superose
For analytical and small scale preparative applications. Available as prepacked columns.
HIC Media Test Kit
For screening different types of ligands and for method development work at small scale. Five different HIC media as prepacked 1 ml columns.
* Octyl Sepharose 4 Fast Flow is currently (December 1992) only available as a CDM product (see p. 17), but will later be available as a standard catalogue product.
21
Pr
a e dmi ™ fro s M s nce -up to al e a oc orm le nic
h a perf gh sc ll tec ices an u by fu erv ality thro ts Qu earch acked ppor . u res tion. B tory s rmacia ha ula duc pro nd reg from P a
Bio
BioProcess Media BioProcess™ Media form a full range of separation media especially designed to meet the demands of today’s industrial production of biomolecules.
Productive:
High flow rates, high capacity and high recovery lead to good process economy.
Validated:
Manufactured according to fully validated process with strict quality standards and complete documentation.
Scaleable:
Work equally well in laboratory and pilot production systems as well as in industrial operation.
Cleanable:
Very high chemical stability enables thorough cleaning and sanitization treatments that reduce the risk of contamination of the end product and increase the media lifetime.
Documented:
Regulatory Support Files give full details of approval support data such as performance, stability (including leakage data), extractable compounds and analytical methods. A Regulatory Support File is an invaluable starting point, especially for pharmaceutical process validations.
Guaranteed supply: Large production capacity and guaranteed future supply.
Base matrices The BioProcess HIC media range is based on the highly cross-linked beaded agarose matrices Sepharose Fast Flow and Sepharose High Performance. Their macrostructures containing polysaccharide chains arranged in bundles (Fig. 6) are further strengthened by different degrees of inter-chain cross-linking. The resulting macroporous structures combine good capacities for molecules up to 4x106 (6% agarose) and 2.7x107 (4% agarose) in molecular mass with excellent flow properties and high physical and chemical stability. Fig. 6. Structure of cross-linked agarose gels.
22
All Sepharose based matrices have virtually no non-specific adsorption properties and are also resistant to microbial degradation due to the presence of the unusual sugar 3,6-anhydro-L-galactose.
Coupling The HIC ligands are coupled to the monosaccharide units by stable ether linkages. The structures of the coupled ligands are shown in Fig. 3.
Chemical stability BioProcess HIC Media are stable in all commonly used aqueous buffers and solvents in the pH range 2-14. When these media were challenged by storage for 7 days at 40oC in the solutions listed in Table 5, no significant change in chromatographic function was seen. Of special interest is their stability in alkaline solutions, as cleaning and sanitization with NaOH solutions are preferred in process applications. The functional stability and recommended pH ranges are summarized in Table 6. The ligand leakage of BioProcess HIC Media at different pH values has been tested and generally found to be extremely low (43). The pH range 2–14 can be used for cleaning-in-place (CIP) and sanitization-in-place (SIP), see ‘‘Cleaning, sanitization and sterilization procedures’’, page 63. BioProcess HIC Media are stable at high temperatures and can be sterilized by autoclaving at 120oC for 20 min. Table 5. Chemical stability test of BioProcess HIC Media. Tested media
Test solutions 1 M NaOH
1 M acetic acid
1 mM HCL
3M (NH4)2SO4
70% ethanol
30% isopropanol 6 M GuHCl 8 M Urea
Phenyl Sepharose 6 Fast Flow (low sub)
X
(n. t.)
(n. t.)
X
X
X
X
X
Phenyl Sepharose 6 Fast Flow (high sub)
X
(n. t.)
(n. t.)
X
X
X
X
X
Butyl Sepharose 4 Fast Flow
X
(n. t.)
X
(n. t.)
X
X
X
(n. t.)
Phenyl Sepharose High Performance
X
X
(n. t.)
(n. t.)
X
X
X
X
X = Functionally stable when tested for 7 days at +40°C (n. t.) = Not tested
Table 6. Stability and recommended pH ranges for BioProcess HIC Media.
Long term stability and recommended working pH range: Short term stability and recommended CIP and SIP pH range: Recommended long term storage:
3–13 2–14 0.01 M NaOH or 20% ethanol.
23
Physical stability The highly cross-linked structures of Sepharose Fast Flow and Sepharose High Performance matrices are physically stable resulting in very good flow properties. This is illustrated by the pressure-flow rate curves for Phenyl Sepharose 6 Fast Flow shown in Fig. 7. In columns with 5 cm inner diameter and a bed height of 15 cm, flow rates up to 500 cm/h can be used without exceeding a back pressure of 1 bar. The optimal working flow rate during elution is normally 50–150 cm/h but during equilibration, regeneration, and also often during sample application, higher flow rates of 200– 300 cm/h can be used. These higher flow rates reduce cycle times. Fig. 7. Typical pressure/flow rate curves for Phenyl Sepharose 6 Fast Flow (low sub) and Phenyl Sepharose 6 Fast Flow (high sub) in an XK 50/30 Column, bed height 15 cm, mobile phase 0.1 M NaCl. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
Flow rate (cm/h) 700 600 500 400 high sub low sub
300 200 100 0.0
0.2
0.4
0.6
0.8
1.0
1.2
Pressure (bar)
Binding capacity One of the major features of BioProcess HIC Media is the high binding capacity, which results in high throughput and productivity even at relatively low salt concentrations. Fig. 8 shows the total dynamic binding capacities of human serum albumin and human IgG at different concentrations of ammonium sulphate as determined by frontal analysis. Phenyl Sepharose 6 Fast Flow (high sub) showed the highest capacities for both hIgG and HSA. Phenyl Sepharose High Performance had higher capacity for hIgG compared with HSA while Butyl Sepharose 4 Fast Flow showed the reverse, indicating the difference in selectivity. The protein recoveries when eluting with low salt buffer were all 80% or more. The dynamic binding capacity will decrease with increasing linear flow rates. This is especially important to consider when optimizing initial separation steps where large volumes need to be processed. Productivity may be higher at high flow rates even though the binding capacity is decreased.
24
Adsorption capacity (mg h IgG/ml gel) Adsorption capacity (mg HSA/ml gel)
Fig. 8. Total adsorption capacities of Phenyl and Butyl Sepharose media for human IgG and HSA as a function of the concentration of ammonium sulphate in the equilibration buffer. 1=Phenyl Sepharose 6 Fast Flow (high sub), 2=Phenyl Sepharose High Performance, 3=Phenyl Sepharose 6 Fast Flow (low sub), 4=Butyl Sepharose 4 Fast Flow. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
30
hIgG
1 ▲
20 2 ▲
10
3 4
0.39
0.45 0.57 0.68 Concn. of ammonium sulphate (M) ▲
HSA 30 1 ▲
20
4 ▲
10
BioQualityrcah throkued bypfuort serv . ac ea up res tion. B tory s rmacia ha ula duc pro nd reg from P a
23
▲
0.6
a e di ™ s M e from c e srformacnacle-upctohnical o r P n pe gh s ll te ices
▲
0.9 1.2 1.5 Concn. of ammonium sulphate (M)
Phenyl Sepharose 6 Fast Flow (low sub) Phenyl Sepharose 6 Fast Flow (high sub)
Phenyl Sepharose 6 Fast Flow (low sub) and Phenyl Sepharose 6 Fast Flow (high sub) are based on highly cross-linked 6% agarose with phenyl ligands coupled via stable ether linkages. The media characteristics are summarized in Table 7. Phenyl Sepharose 6 Fast Flow (low sub) and Phenyl Sepharose 6 Fast Flow (high sub) were initially developed and tested in cooperation with leading pharmaceutical manufacturers. They are ideal for initial or intermediate step purification of proteins Table 7. Characteristics of Phenyl Sepharose 6 Fast Flow (low sub) and Phenyl Sepharose 6 Fast Flow (high sub).
Bead structure Mean particle size Particle size range Degree of substitution
cross-linked agarose, 6%, spherical 90 µm 45–165 µm approx. 20 (low sub) and 40 (high sub) µmol phenyl groups/ml gel
Further information is available in Data File 2040 (Code No. 18-1020-53).
25
and peptides with a low to medium degree of hydrophobicity. The availability of two degrees of substitution increases the possibility of finding the best selectivity and capacity for a given application. Phenyl Sepharose 6 Fast Flow (high sub) has been used as an effective capture step in methods for the purification of recombinant human Epidermal Growth Factor (h-EGF) and recombinant Pseudomonas aeruginosa exotoxin. These applications are presented in chapter 6, pages 87 and 92 respectively.
Product availability Phenyl Sepharose 6 Fast Flow (low sub) and Phenyl Sepharose 6 Fast Flow (high sub) are supplied as suspensions in 20% ethanol in packs of 200 ml, 1 litre and 5 litres.
a e dmi ™ fro s M s nce -up to al e a oc orm le nic
Pr perf h sca ll tech es BioQualityrcahn throkuegd bypfuort servic . ac ea up res tion. B tory s rmacia ha ula duc pro nd reg from P a
Butyl Sepharose 4 Fast Flow
Butyl Sepharose 4 Fast Flow is based on highly cross-linked 4% agarose with butyl ligands coupled via stable ether linkages. The characteristics of this medium are summarized in Table 8.
Bead structure Mean particle size Particle size range Degree of substitution
cross-linked agarose, 4%, spherical 90 µm 45–165 µm approx. 50 µmol butyl groups/ml gel
Table 8. Characteristics of Butyl Sepharose 4 Fast Flow.
Further information is available in Data File 3300 (Code No. 18-1020-70).
Butyl Sepharose 4 Fast Flow was initially developed and tested in cooperation with leading pharmaceutical manufacturers. It is intended for the initial or intermediate step purification of proteins and peptides with a low to medium degree of hydrophobicity and often works efficiently with rather low salt concentrations. For the butyl ligand, the mechanism of adsorption and desorption is different than for the phenyl ligand, which gives a difference in selectivity. This was illustrated in an application where recombinant human Annexin V, expressed in E. coli, was purified using HIC after an initial capture step on a cation exchanger. A comparison of the chromatograms in Fig. 9 shows that the elution position of Annexin V and the main impurities interchanged when changing from Butyl Sepharose 4 Fast Flow to Phenyl Sepharose 6 Fast Flow (high sub).
Product availability Butyl Sepharose 4 Fast Flow is supplied as suspension in 20% ethanol in packs of 200 ml, 500 ml and 5 litres. 26
A280 nm
Medium: Butyl Sepharose 4 Fast Flow Column: XK 16/20 Buffer A: 20 mM sodium phosphate pH 7.0 + 1.0 M ammonium sulphate Buffer B: 20 mM sodium phosphate pH 7.0 Sample: Partially purified Annexin V expressed in E. Coli Sample volume: 5 ml Flow rate: 100 cm/h Gradient: 0–100% B, 10 column volumes
A280 nm
Medium: Phenyl Sepharose 6 Fast Flow (high sub.) Column: XK 16/20 Buffer A: 20 mM sodium phosphate pH 7.0 + 1.0 M ammonium sulphate Buffer B: 20 mM sodium phosphate pH 7.0 Sample: Partially purified Annexin V expressed in E. Coli Sample volume: 5 ml Flow rate: 100 cm/h Gradient: 0–100% B, 10 column volumes
Annexin V
Annexin V
0
60
Time (min)
0
60
Time (min)
Fig. 9. Purification of Annexin V on Butyl Sepharose 4 Fast Flow and Phenyl Sepharose 6 Fast Flow (high sub). (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
dia ™ Me m ss ance -ufrop to al e c m ro rfor cale chnic
pe h s ll te P es BioQualityrcahn throkuegd bypfuort servic . ac ea up res tion. B tory s rmacia ha ula duc pro nd reg from P a
Phenyl Sepharose High Performance
Phenyl Sepharose High Performance is based on very highly crossed-linked 6% agarose with phenyl ligands coupled via stable ether linkages. The characteristics of this medium are summarized in Table 9. Table 9. Characteristics of Phenyl Sepharose High Performance.
Bead structure Mean particle size Particle size range Degree of substitution
cross-linked agarose, 6%, spherical 34 µm 24–44 µm approx. 25 µmol phenyl/ml gel
Further information is available in Data File 2050 (Code No. 18-1020-56).
Phenyl Sepharose High Performance is ideal for laboratory and process scale intermediate step purifications where high resolution is needed. The separation of slightly modified variants, clipped forms etc., of a recombinant protein from the native protein is a typical application example. It has also proven to be very efficient for the purification of monoclonal antibodies. Two large scale applications on monoclonal 27
antibodies, one for the purification of anti-gp120, which is in clinical trials for treatment of AIDS, the other for the purification of an antibody used in diagnostic tests, are presented in Chapter 6, pages 85 and 90 respectively. Product availability Phenyl Sepharose High Performance is supplied as a suspension in 20% ethanol in packs of 75 ml, 1 litre and 5 litres and prepacked in HiLoad™ 16/10 and 26/10 columns.
Custom Designed HIC Media Custom Designed Media (CDM) meet the needs of specific industrial process separations where chromatography media from our standard range are not suitable. CDM can be made to meet BioProcess Media specifications if required. The CDM group at Amersham Pharmacia Biotech works in close collaboration with the customer to design, manufacture, test and deliver media for specialized separation requirements. Several CDM products are also available to the general market. Some HIC media first produced as Custom Designed Media have proven so successful that they have subsequently been introduced as standard products, e.g. Phenyl Sepharose 6 Fast Flow (low sub), Phenyl Sepharose 6 Fast Flow (high sub) and Butyl Sepharose 4 Fast Flow. Product availability Please contact your local Amersham Pharmacia Biotech representative for further details of CDM products and services.
HIC Media Test Kit HIC Media Test Kit consists of five ready-to-use 1 ml plastic columns for screening different types of ligands and for method development work at small scale. The kit contains the following HIC media: • Phenyl Sepharose High Performance • Phenyl Sepharose 6 Fast Flow (low sub) • Phenyl Sepharose 6 Fast Flow (high sub) • Butyl Sepharose 4 Fast Flow • Octyl Sepharose 4 Fast Flow Product availability Please contact your local Amersham Pharmacia Biotech representative for further information. 28
Phenyl Sepharose CL-4B and Octyl Sepharose CL-4B Phenyl Sepharose CL-4B and Octyl Sepharose CL-4B are produced in large quantities with high and consistent quality. Their performance has been demonstrated in hundreds of applications and they have been approved by regulatory authorities for use in many pharmaceutical production processes. Phenyl Sepharose CL-4B and Octyl Sepharose CL-4B are based on cross-linked 4% agarose matrices with ligands coupled via stable ether linkages. The media characteristics are summarized in Table 10.
Table 10. Characteristics of Phenyl Sepharose CL-4B and Octyl Sepharose CL-4B.
Bead structure Mean particle size Paricle size range Degree of substitution
cross-linked agarose, 4%, spherical 90 µm 45-165 µm approx. 40 µmol phenyl or octyl groups/ml gel
Phenyl Sepharose CL-4B and Octyl Sepharose CL-4B are stable in all commonly used aqueous buffers. Long term stability and recommended working pH range is 3–12. 1 M NaOH can be used for short term exposure in cleaning and sanitization procedures, see ‘‘Cleaning, sanitization and sterilization procedures’’, page 63. Short term stability and recommended CIP and SIP pH range is 2–14. Maximum flow rate for a laboratory-scale column with an internal diameter of up to 5 cm and a bed height of up to 15 cm is 150 cm/h.
Product availability Phenyl Sepharose CL-4B and Octyl Sepharose CL-4B are supplied as suspensions in 20% ethanol in packs of 50 ml, 200 ml and 10 litres.
Phenyl Superose and Alkyl Superose Phenyl Superose and Alkyl Superose are media for high performance HIC, available in prepacked columns for use in FPLC™, SMART™ System (Phenyl Superose only) or HPLC systems. Phenyl and neopentyl groups respectively are attached to the matrix via a stable ether linkage. The characteristics of these media and columns are summarized in Table 11.
29
Bead structure Mean particle size Column sizes
cross-linked agarose, 12%, spherical 13 µm 5x50 mm (HR 5/5) 10x100 mm (HR 10/10) 1.6x50 mm (Phenyl Superose, PC 1.6/5 for SMART System)
Table 11. Characteristics of Phenyl Superose and Alkyl Superose.
Further information is available in Data File for prepacked HR columns (Code No. 18-1009-26) and in Data File for prepacked PC columns (Code No. 18-1009-02).
Phenyl Superose and Alkyl Superose are stable in all commonly used aqueous buffers. Long term stability and recommended working pH range is 2–13. 1 M NaOH can be used for cleaning and sanitization, see ‘‘Cleaning, sanitization and sterilization procedures’’, page 63. Short term stability and recommended CIP and SIP pH range is 2–14. The columns are typically used in laboratory scale protein purification schemes or as an analytical tool, as a complement to e.g. ion exchange chromatography and gel filtration. Examples of applications are shown in chapter 6, page 79–83. Suitable protein loads are in the mg range (HR columns) or, for micropurification, in the ngµg range (Phenyl Superose, PC 1.6/5). Alkyl Superose is less hydrophobic than Phenyl Superose and is therefore particularly suitable for high performance HIC with retained biological activities of labile proteins and of proteins which bind very tightly to media with higher hydrophobicities.
30
4 Experimental Design This chapter will deal with experimental methods of HIC which are applicable in the majority of cases. Since the factors which influence HIC are numerous, the relevant chromatographic parameters that lead to the selective purification of the protein(s) of interest should be optimized on a case to case basis.
Hydrophobicity of proteins It is estimated that as much as 40–50% of the accessible surface area of proteins is non-polar (44, 45). These areas are responsible for the binding of proteins to HIC adsorbents in the presence of moderate to high concentrations of salting-out salts. The strength of this salt-promoted interaction may be predicted from the close relationship between precipitation data for proteins and their relative retention on HIC adsorbents (27). Since such retention data are not readily available for the large majority of proteins, they must be established from case to case for the protein(s) of interest in a biological sample.
Multivariate mapping This is a useful method for: i. Characterizing hydrophobic media on the basis of their selectivity (46). ii. Choosing the most suitable medium for the optimum resolution of two closely related proteins. iii. Determining the adsorption behaviour of proteins on HIC media and thereby establishing a ‘‘practical hydrophobic scale’’ for the proteins in question.
31
The results obtained in our laboratories (46) suggest that: i. The adsorption selectivity of Octyl Sepharose CL-4B is related to the fraction of hydrophobic amino acids in the model proteins examined. ii. The retention of proteins on alkyl Superose and Pyridine sulphide-Sepharose 6 Fast Flow is proportional to a parameter best described as ‘‘absence of surface charge’’ on the sample molecules. iii. The phenyl- and butyl-based media separated proteins according to a combination of the above two mechanisms. iv. Different hydrophobicity coefficients co-variate with the retention data established for the various hydrophobic media examined. Multivariate analysis thus opens new possibilities in the design of HIC and other chromatography-based separations by using a minimum number of experimental data.
Strategic considerations One of the most important aspects of developing a complete purification scheme is to keep the number of unit operations to a minimum. A logical approach to reach the highest possible purity with the smallest number of individual chromatographic steps is to combine techniques based on different principles and thus exploit different surface properties of the substances to be separated. However, the sequence in which the chosen techniques are used must be carefully planned. In many applications HIC is useful especially in combination with techniques such as ion exchange chromatography and gel filtration. As an example, hydrophobic interaction chromatography is a logical choice when the sample already has a high ionic strength. The conductivity of most biological starting materials is typically in the range of 15–30 mS/cm, which makes HIC an attractive alternative to ion exchange chromatography (IEX) in the first step of a downstream purification scheme. High conductivity in the starting material will reduce the binding capacity of ion exchange media and some type of conditioning such as desalting, diafiltration or dilution has to be included before an ion exchange step. In contrast, the only conditioning needed if HIC is used, is to add enough salt to promote the proper binding to the medium. Used in the first step HIC, like IEX and other adsorption techniques, will serve as an effective means of concentrating a dilute sample. Other typical points in a purification scheme where HIC fits in naturally are after an ammonium sulphate precipitation, which often comes in the beginning of a downstream process, and after an ion exchange step where the sample is eluted with a rather high ionic strength. The further addition of salt that might be needed to retard the components in a desired way on the HIC medium is thus a very simple linking step. In a similar way, a sample eluted from a HIC step in a low ionic strength buffer can often be directly applied to an ion exchange column without an extra dialysis or desalting step.
32
Choice of HIC media The type of immobilized ligand, the degree of substitution and the type and concentration of salt and pH used during the adsorption stage have a profound effect on the overall performance (i.e., selectivity and capacity) of a HIC medium [see Chapter 2]. Moreover, the type of matrix used and the coupling chemistry can also influence to a variable degree the binding and elution behaviour of many proteins. The practical implications of these effects are that different HIC media must be compared much more rigorously than ion exchange or affinity media, especially when the HIC step is part of a downstream purification process intended for an industrial scale operation.
General considerations i. The HIC medium should bind the protein of interest at a reasonably low concentration of salt. This is often dependent on the type of salt chosen, e.g. up to four times higher concentration of NaCl might be necessary to obtain a binding effect comparable to that obtained with ammonium or sodium sulphate. The salt concentration should be below the concentration that causes precipitation of different proteins in the crude feed stock. 1 M ammonium sulphate is a good starting point for screening experiments. If the substance does not bind in e.g. 1 M ammonium sulphate, then choose a more hydrophobic medium. The right choice of a suitable HIC medium can often lead to a lower consumption of salt in the binding buffer. This in turn has a direct bearing on the economic and environmental aspects of the purification process, especially for large-scale HIC applications. ii. The bound protein should be eluted from the column with salt-free buffer and with high recovery (75% or higher). If non-polar solvents are required for its elution, try a less hydrophobic medium. iii. The pH of the start buffer and the type of salt to use are both parameters that can be exploited to maximize selectivity during the adsorption phase. This is done by checking the adsorption properties of the media at different pH-values and with different types of salts during the screening of different ligands. iv. Since hydrophobic interaction is dependent on temperature, it is important that method development work is performed at the intended final working temperature.
33
Screening experiments This section outlines a general procedure for performing HIC screening experiments where emphasis is laid on optimizing selectivity by proper choice of HIC medium and by roughly defining the most critical experimental parameters. It also presents some typical elution profiles that could be obtained in a variety of situations followed by relevant discussions of the results and recommendations for further experimental work. i. Pack the media in suitable columns according to our packing recommendations (a bed volume of 1–10 ml is adequate) or use the HIC Media Test Kit from Amersham Pharmacia Biotech. The HIC Media Test Kit consists of five 1 ml plastic columns prepacked with BioProcess HIC media. For more information about the HIC Media Test Kit, see Chapter 3, Selection Guide. ii. Equilibrate the column with 2 bed volumes of the equilibration Buffer A (50 mM sodium phosphate, 1.0 M ammonium sulphate, pH 7.0). Use a constant flow rate throughout (e.g. 100 cm/h). iii. Apply a suitable amount of sample, also containing 1.0 M ammonium sulphate (pH adjusted to 7.0), to the column and wash with 2–3 column volumes of Buffer A, or until the UV-trace of the effluent returns to near baseline. iv. Elute the bound fraction using a linear and descending salt gradient from 0 to 100% Buffer B (50 mM sodium phosphate buffer, pH 7.0). A total gradient volume of 10 bed volumes is usually sufficient.
34
Evaluation of results Figs. 10 to 15 show some typical elution profiles that could be obtained from screening experiments. The shaded area shows the elution position of the protein of interest. Each chromatogram is accompanied by a general discussion of the results and suggestions for further experiments to optimize the separation of the protein of interest.
Rel. Abs
Fig. 10.
Elution volume
Result:
Product is eluted early in gradient. Resolution is not satisfactory.
Discussion:
Not much can be gained in this situation by changing salt concentration. Decreasing the salt concentration will decrease the binding capacity of the protein of interest and might even lead to its elution together with the unbound fraction. Increasing the salt concentration might lead to the co-adsorption of unwanted impurities and thereby lead to a decrease in the selectivity of the adsorbent for the protein of interest. Changing the pH of the equilibration buffer might result in stronger binding and higher selectivity for the protein of interest. The effect of pH is variable for different proteins and usually a lowering of the pH leads to increased binding of proteins. Increasing the pH usually leads to a decreased binding of proteins, which, in this particular case, might result in the elution of the protein of interest together with the unbound fraction.
Next step:
Repeat the experiment at a lower and a higher pH. If no improvement in selectivity is obtained – TRY A MEDIUM WITH A DIFFERENT LIGAND or, if available, A MEDIUM WITH A HIGHER DEGREE OF LIGAND SUBSTITUTION. 35
Rel. Abs
Fig. 11.
Elution volume
36
Result:
Product is eluted near the end of the gradient. Resolution is not satisfactory
Discussion:
A decrease of the salt concentration will weaken the strength of binding resulting in the earlier elution of the protein of interest. It may also have a positive effect on selectivity since more of the less hydrophobic substances will be eluted together with the unbound fraction. However, the effect of this approach on the resolution is marginal since the contaminants are eluted very close to the protein of interest, both before and after. Changing the pH of the equilibration buffer may have a positive effect on resolution and should be tried.
Next step:
Repeat the experiment at a higher and a lower pH of the equilibration buffer. If no improvement in resolution is obtained – TRY A MEDIUM WITH A DIFFERENT LIGAND or, if available, A MEDIUM WITH A LOWER DEGREE OF LIGAND SUBSTITUTION.
Rel. Abs
Fig. 12.
Elution volume
Result:
Product is eluted in the middle of the gradient. Resolution is not satisfactory.
Discussion:
Changing the concentration of salt in the equilibration buffer will have a limited effect on resolution. However, a change of pH of the equilibration buffer (both lower and higher pH values) might have a favourable effect.
Next step:
Repeat the experiment at a higher and a lower pH value. If no improvement in resolution is obtained – TRY A MEDIUM WITH A DIFFERENT LIGAND or, if available, A MEDIUM WITH A HIGHER DEGREE OF LIGAND SUBSTITUTION.
37
Rel. Abs
Fig. 13.
Elution volume
Result:
Product is eluted early in gradient. Resolution is satisfactory.
Discussion:
In principle, this can be a good choice of medium. However, the fact that the protein of interest is eluted very early in the gradient indicates that the binding capacity may be low. This might be compensated for, if necessary, by a moderate increase of the salt in the equilibration buffer. This in turn may lead to a decrease in the selectivity of the adsorbent since some of the unbound proteins might be adsorbed together with the protein of interest. Another negative effect of increased salt concentration may be a decrease in resolution caused by the increase in gradient slope if the total gradient volume, or the cycle time, is kept constant. Increased salt concentration will also give increased costs which may be of importance if the HIC step is to be a part of a manufacturing process. Finally, not much can be gained by changing the pH of the equilibration buffer since the resolution obtained was considered to be satisfactory.
Next step:
Continue with method development as outlined under ‘‘Optimizing a HIC step’’. If low binding capacity is a problem and problems with increased salt concentration as outlined above are encountered – TRY A MEDIUM WITH A DIFFERENT LIGAND or, if available, A MEDIUM WITH A HIGHER DEGREE OF LIGAND SUBSTITUTION.
38
Rel. Abs
Fig. 14.
Elution volume
Result:
Product is eluted near the end of the gradient. Resolution is satisfactory.
Discussion:
This can also be a good choice of medium. Decreasing the concentration of salt in the equilibration buffer will give earlier elution of the protein of interest, reduced cycle time and decreased cost for salt. A disadvantage in this situation might be that some of the most hydrophobic contaminating substances bind so strongly that some organic solvent or chaotropic agent has to be used for their removal. Not much can be gained by changing pH since the selectivity is already good.
Next step:
Continue with method development as outlined under ‘‘Optimizing a HIC step’’. If problems with very strong binding of hydrophobic contaminants are encountered – TRY A MEDIUM WITH A DIFFERENT LIGAND or, if available, A MEDIUMWITH A LOWER DEGREE OF LIGAND SUBSTITUTION.
39
Rel. Abs
Fig. 15.
Elution volume
Result:
Product is eluted in the middle of the gradient. Resolution is satisfactory.
Discussion:
The choice of ligand is very good and there is less risk of strong binding of the most hydrophobic contaminants.
Next step:
Continue with method development as outlined under ‘‘Optimizing a HIC step’’.
The examples presented above do not cover two extreme cases that may arise, i.e. the situation in which the protein of interest is either not bound to the HIC medium or that it binds so strongly that it is difficult to elute it without using denaturing solvents. In both instances, one should try to use a different HIC medium or use another medium which operates on a different separation principle. In some of the examples above it is assumed that resolution is inadequate. The requirements for resolution in any particular chromatographic step must be stipulated on a case-by-case basis. What sometimes seems to be fairly bad resolution can often be good enough if it is an initial capture step where the main objective is reduction of volume, removal of critical contaminants and preparation for higher resolution chromatography.
40
Optimizing a HIC step The main purpose of optimizing a chromatographic step is to reach the pre-defined purity level with highest possible recovery by choosing the most suitable combination of the critical chromatographic parameters. In process applications there is also a need to reach the highest possible throughput. The screening experiments outlined previously will mainly help in establishing the most suitable medium to use. The sections below will deal with some important guidelines for optimizing the critical operational parameters which affect the maximum utilization of the HIC step. These parameters include: type of buffer salt, salt concentration, buffer pH, temperature, bed height, flow rate, gradient shape and gradient slope.
The solute As in other adsorption chromatography techniques, the way HIC is used depends on the size of the solute molecule. Small molecules such as small peptides interact with the medium by single point attachment. Their migration velocity depends directly on the binding constant of a single bond and can vary over a wide interval depending on the ionic strength of the mobile phase. Larger molecules such as proteins and nucleic acids interact with the medium by multi-point attachment. Their migration velocity depends on the sum of several bonds. Thus their velocity is extremely low at all ionic strengths over a certain value. The protein is more or less stuck to the column. Below this ionic strength, the protein is practically not retarded at all (47). The interval of eluting strength where a large molecule is partly retarded on the column is thus much smaller than for a small molecule. This means that purifying large molecules on HIC is a typical on-off technique where the difference in retention for the molecules to be separated can be substantial at any specific ionic strength. In other words, separation of large molecules on HIC is a high selectivity technique. The separation should be optimized by manipulating the parameters affecting the selectivity of the system, i.e. optimizing the chemistry of the system by means of salt concentration, type of salt, pH, gradient slopes or stepwise elution schemes. By effecting relatively small changes in selectivity, large changes in resolution can occur. When purifying small molecules on the other hand, the selectivity of the system is usually much lower and the requirements for purity might not be met by working on the selectivity alone. The efficiency parameters such as bed height, bead size, theoretical plates, linear flow rate and sample volume may also have to be optimized. In this handbook however, the focus will be on large molecules such as proteins and large peptides.
41
In conclusion, when purifying large molecules such as proteins, relatively short columns can be used if the selectivity of the adsorbent is exploited in an optimal way. The linear flow rate should, if required, be sufficiently reduced in order to optimize the kinetics of the adsorption and desorption process. This can also be further enhanced by choosing a smaller bead size. Smaller beads will also provide the necessary increace in efficiency when more difficult separation problems are encountered.
The solvent This is one of the most important parameters to have a significant influence on the binding capacity and selectivity of a HIC medium. In general, the adsorption process is often more selective than the desorption process and it is therefore important to optimize the starting ‘‘binding’’ buffer conditions with respect to critical parameters such as pH, type of salt, concentration of salt and temperature. The combination of salt and pH can be manipulated to give optimum selectivity during purification by HIC. Optimal conditions differ from application to application and are best established by running linear gradients and varying the parameters in a controlled way (for example by using Factorial design). Changes of temperature and pH are sometimes restricted by the stability of the substance of interest or by system constraints etc. but may often be of interest to evaluate. The Hofmeister series (Table 1) gives important guidelines in choosing the type of salt to use. The most efficient salts are normally ammonium sulphate and sodium sulphate but also ‘‘weaker’’ salts such as sodium chloride should be considered. In an ideal situation, the correct choice of salt and salt concentration will result in the selective binding of the protein of interest while the majority of the impurities pass through the column unretarded. If the protein of interest binds weakly to the column, an alternative approach is to choose the starting buffer conditions which will result in the maximum binding of a large proportion of the contaminating proteins but allowing the protein of interest to pass through unretarded. An extension of this strategy is to increase the salt concentration in the unbound fraction to such an extent that the protein of interest binds to the same column in a second run while most of the impurities pass through the column unretarded. The effect of varying the concentration of salt in the binding buffer on the purification of a monoclonal antibody (IgG1) from mouse ascites fluid is shown in Fig. 16. The column of Alkyl Superose was equilibrated with varying concentrations of ammonium sulphate (2 M to 0.8 M) and its selectivity for the IgG1 investigated. The results show that high selectivity for IgG1 is obtained using 1 M ammonium sulphate in the binding buffer. It should be pointed out that the higher the salt concentration in the equilibration buffer, the greater the risk that some of the proteins in the sample will precipitate. Since such precipitates can clog tubings and column filters, the sample must be filtered or centrifuged. This extra step can be avoided by equilibrating the sample in a lower salt concentration than is required for its precipitation and then applying it to a column which is equilibrated with a higher salt concentration (48). Some of the proteins will precipitate on the column (zone precipitation) but they redissolve upon reduction of the salt concentration during stepwise or gradient elution. 42
a)
b)
IgG
IgG
Albumin Albumin
c)
d)
IgG
IgG
Fig. 16. The effect of starting conditions in HIC. Sample, 100 µl anti-CEA MAB (-IgG1) from mouse ascites fluid in 0.8 M (NH4)2SO4 (corresponding to 20 µl ascites); column. Alkyl Superose HR 5/5; flow rate, 0.5 ml min -1; buffer A, 0.1 M sodium phosphate, pH 7.0, (NH4)2SO4). (a) Sample applied in 2 M (NH4)2SO4: both albumin and IgG are absorbed. (b) Sample applied in 1.5 M (NH4)2SO4: less albumin binds and IgG elutes earlier in the gradient. (c) Sample applied in 1.0 M (NH4)2SO4: albumin does not bind and, therefore, the column has a greater capacity for binding IgG. (d) Sample applied in 0.8 M (NH4)2SO4: albumin does not bind; IgG is retarded, but elutes in a broad peak. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
43
0.25
I
2.0
conc. (NH4 )2 SO4 (M)
b A 280 nm 0.5
I
I
2.0
conc. (NH4 ) 2 SO4 (M)
a A 280 nm 0.5
0
I
I
20
40
I
60 Time (min)
0 0
I
I
I
20
40
60
0 Time (min)
Fig. 17. The effect of loading conditions in HIC. Column, Alkyl Superose HR 5/5; flow rate, 0.5 ml min-1; buffer A, 0.1 M sodium phosphate, pH 7.0, 2 M (NH4)2SO4. (a) Sample (500 µl anti-CEA MAB (IgG1) from mouse ascites fluid in 0.9 M (NH4)2SO4 (corresponding to 115 µl ascites) applied in one injection. (b) Sample as (a) applied in five 100 µl injections with 1.3 ml 2.0 M (NH4)2SO4 after each portion. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
When sample is applied at a salt concentration lower than that used for equilibration of the column, the sample volume becomes important. This is demonstrated in Fig. 17. When a 500 ml sample of ascites fluid was applied to a 1 ml column of Alkyl Superose, albumin, the weakest interacting substance, started to elute during sample application (Fig. 17 a). Dividing the sample into portions, e.g. five 100 ml samples and adding equilibration buffer (1.3 ml) after each sample application to enhance the hydrophobic interaction prevented early elution of albumin (Fig. 17 b).
Elution This can be achieved by: i. A linear or step-wise decrease of the concentration of salt. ii. Adding various proportions of organic solvents to the elution buffer (see Chapter 2) provided that the protein of interest is stable upon exposure to such solvents. These additives decrease the polarity or surface tension of the eluent resulting in a reduction in the binding strength and the elution of the bound proteins from the column. Usually, 40% ethylene glycol or 30% iso-propanol, dissolved in salt-free buffer, is used. In some applications, it can be advantageous to linearly increase the concentration of such additives as the salt concentration of the elution buffer is simultaneously decreased by a linear gradient. The latter procedure can sometimes lead to increased resolution of the bound proteins. 44
iii. Adding neutral detergents (usually 1%) to the elution buffer. However, some detergents are bound so strongly that they are difficult to wash out completely with common organic solvents (e.g. ethanol). In the worst case, this might lead to a decrease in the capacity of the HIC medium for subsequent applications. These additives must therefore be used with care. The preferred method of elution is a linear or step-wise decrease of the salt concentation in the elution buffer. Some typical examples are presented below.
Gradient elution Simple linear gradients are the first choice for screening experiments, but when more experience is at hand it might be advantageous to make a gradient more shallow in areas where resolution is inadequate. Consequently, areas where resolution is good can be covered by a steep gradient (Fig. 18). Such complex gradients offer maximum flexibility in terms of combining resolution with speed during the same separation.
Rel. Abs
Rel. Abs
By increasing the total gradient volume (i.e. decreasing gradient slope) of a linear gradient, resolution will be improved in all parts of the chromatogram (Fig. 19). This is usually not the best approach in preparative mode where the prime issue is not to resolve as many peaks as possible but to separate the compound of interest from the rest of the compounds in the feed material. Increased gradient volume will also give increased cycle time and the separated fractions will also be more diluted.
Elution volume
Elution volume
Fig. 18. Effect of a complex gradient on resolution.
45
Rel. Abs
Rel. Abs
Elution volume
Elution volume
Rel. Abs
Rel. Abs
Fig. 19. Effect of gradient slope on resolution.
Elution volume
Fig. 20. Switching from a continuous gradient to step-wise elution.
46
Elution volume
Step-wise elution Step-wise elution is often preferred in large scale preparative applications since it is technically more simple and reproducible than gradient elution. Step-wise elution can sometimes be advantageous also in small scale applications since the compound of interest can be eluted in a more concentrated form if the eluting strength of the buffer can be kept high enough without causing co-elution of more strongly bound compounds. The principle of step-wise elution is to increase resolution in the area where the peak of interest elutes. Fig. 20 illustrates how a three step increase in eluting strength can be used to obtain maximum resolution of the fraction of interest (shaded peak). In the first step, the strength and the volume of the elution buffer is optimized to elute all compounds binding less strongly to the gel than the compound of interest. The elution strength and volume of buffer should be large enough to elute these contaminating weaker binding substances, but it must not exceed that level where the peak of interest starts to co-elute with the contaminating compounds. In the second step the elution strength is increased to the point where the compound of interest elutes. The elution strength should be large enough to elute the compound of interest without excessive dilution, but must be kept below the level where the more strongly bound contaminating compounds start to co-elute. In the final step, the elution strength is further increased to elute all of the remaining contaminating compounds. This step can be a very short one with high elution strength. When step-wise elution is applied, one has to keep in mind the danger of getting artefact peaks when a subsequent step is administered too early after a tailing peak. For this reason it is recommended to use continuous gradients in the initial experi-ments to characterize the sample and its chromatographic behaviour.
Sample load and flow rate The through-put of the method can be increased by increasing sample load and flow rate. However, this has to be traded off against decreased resolution (efficiency). The effects of sample load and flow rate are further discussed below under ‘‘Process considerations’’.
Regeneration After each cycle, bound substances must be washed out from the column to restore the original function of the medium. HIC adsorbents can normally be regenerated by washing with distilled water after each run. To prevent a slow build up of contaminants on the column over time, more rigorous cleaning protocols may have to be applied on a regular basis. (See page 63, ‘‘Cleaning, sanitization and sterilization procedures’’).
47
Process considerations In contrast to analytical chromatography or small scale preparative chromatography in research and development, process chromatography is used as part of a manufacturing process. Method development work has to focus on purifying the product of interest to the highest yield and the required purity as quickly, cheaply and easily as possible, i. e. to find the conditions that give the highest possible productivity (amount of product produced per volume of media and unit time) and process economy.
Method optimization in process chromatography Firstly, selectivity for the substance of interest is maximized by choosing the proper type of media, pH, type of salt, salt concentration and temperature, as has already been outlined above. In HIC, as for most other adsorption techniques, there are then basically two alternative routes to follow: i. If HIC is used in an intermediate or final step where the need for resolution is high in order to meet purity requirements for the final product, the resolution is maximized by working on the eluting conditions such as gradient shape, gradient slope or concentration and volume of steps in a step-wise elution procedure. Resolution should be the highest possible while still keeping separation time reasonably short and avoiding excessive dilution of eluted product. From this point, flow rate and sample load are optimized to find highest possible productivity where resolution is still high enough to meet the predefined purity requirements. In HIC, as in ion exchange chromatography, sample load, flow rate and gradient volume are interrelated. Increased flow rate will give a decrease in resolution, but this decrease will not be very significant at high sample loadings. This means that under process conditions, where maximum sample load is applied to achieve maximum throughput, the flow rate is limited primarily by the rigidity of chromatography media and by system constraints. The effect on resolution of increased gradient volume is usually more significant than the effect of flow rate. This means that when increasing gradient volume to increase resolution, flow rate can also be increased accordingly to compensate for loss in separation speed. The result is an increase in resolution that may be traded off for increased sample loading and thereby increased productivity. In other words, in process chromatography the best result will be obtained by using the maximum flow with the gradient volume that provides the best resolution, which is demonstrated in Fig. 21 for a model experiment on Phenyl Sepharose High Performance. The flow rate in each experiment is shown in the bottom square. The largest increase in resolution was seen when going diagonally from A to C, i.e. increasing gradient volume at a constant flow rate. Even when going from AD to BC, i.e. increasing gradient volume and flow rate in the same order and thereby keeping a 48
Fig. 21. The effect of gradient volume and flow rate on resolution and cycle time. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden.)
Rs 6 5 4
tim
3 2 0
e (m
0.8
00
in) 1
0.4
200 0.0
300
3
0
1 l) × m ( . vol
B
A
200
200 100
100 50
200
50 100
100 cm/h
C
50
25 25 12.5
D
constant separation time, an increase in resolution could be observed. Going diagonally from D to B, i.e. increasing the gradient volume 2-fold while increasing the flow rate 4-fold, demonstrates how the separation time can be cut without losing resolution. As the resolution increases with increased gradient volume, however, dilution of each peak occurs, which also has to be taken into consideration. ii. If HIC, on the other hand, is used as an initial product capture step where the major concern is to remove critical contaminants and reduce volume, selectivity during desorption is not a prime issue. After having washed out the non-bound substances, the compound of interest is eluted with a single-step procedure. In this mode, the entire bed volume is utilized for sample binding and the prime consideration when optimizing for highest possible productivity is to find the highest possible sample load over the shortest possible sample application time with acceptable loss in yield. In this situation, more emphasis should be given to the binding strength of the compound of interest than to selectivity during sample application. This means that the salt concentration during sample application should not be too low since this will have a negative effect on dynamic binding capacity. Note also that less hydrophobic contaminating substances will not have any dramatic effect on the binding capacity for the compound of interest since they will be displaced by the latter. 49
C/Co 1
Fig. 22. Breakthrough curves for determination of dynamic capacity.
a)
Equilibrium bed capacity
Adsorbate not adsorbed by bed
0
Time
C/Co 1
b)
‘‘useful’’ capacity
0
Time
The dynamic binding capacity for the protein of interest should be determined by frontal analysis using real process feedstock. PAGE, ELISA or other appropriate techniques are used for the determination of the breakthrough profile of the actual protein (Fig. 22). The curve in Fig. 22 a) and b) shows the ratio of the concentration of product at the outlet of the bed (C) to the concentration of product at the inlet (Co) as more and more sample is applied to the column. When the ratio has risen to 1, the bed is at equilibrium with the inlet stream and no further adsorbtion occurs. Fig. 22 a)
Here the equilibrium bed capacity is reached only after a considerable amount of adsorbate has passed through the bed without being adsorbed.
Fig. 22 b) This shows the ‘‘useful’’ binding capacity of the bed if the loading is terminated when breakthrough of the protein of interest is detected. The actual loading capacity may have to be reduced even further to compensate for the unbound fraction still being present in the void volume of the column when breakthrough is detected. Since the dynamic capacity of a chromatographic adsorbent is a function of the linear flow rate used during sample application, sample loading capacity must be checked at different flow rates to reveal the optimum level that gives highest productivity without excessive leakage of product at the column outlet. 50
Significant increase in flow rate during sample application will always give a decrease in dynamic binding capacity. Even if dynamic capacity will be significantly lower at a higher flow rate it can still be advantageous from a productivity point of view to use a higher flow rate. To process a specific batch size, the process can be run in a cycling mode with a lower sample loading at a higher flow rate. The lower sample loading capacity per cycle may be compensated for by the decrease in cycle time caused by decreased sample volume and increased flow rate. The usefulness of this approach depends on how many cycles have to be run for a specific batch size and on how large the sample application time is in relation to the rest of the cycle time.
Scaleability Scaling-up a chromatographic process is discussed in Chapter 5, ‘‘Experimental Technique’’. Scaling-up is usually not a major concern if scaleability has been considered from the very beginning and built into the process during the method development stage. One important aspect of scaleability common to all types of chromatography is selection of chromatographic media. Important properties of media that should be considered during the initial media screening phase are physical and chemical stability. Physical stability (rigidity) is important in reaching the same high flow rates in the large production column as were achieved in the small column during method development. When column diameter is increased, the support from the column wall is decreased and if the media are not rigid enough bed compression will occur. This compression will increase back pressure and reduce flow rate. Chemical stability of the media is important for applying efficient regeneration, cleaning-in-place and sanitization-in-place protocols. Cleaning and sanitization are a vital part of any chromatographic process.They assure product integrity and maximize media life time. Often harsh chemicals, e.g. 1 M NaOH, are used in such procedures and the chromatographic media have to withstand exposure to such conditions without their chromatographic properties being adversely affected. Recommendations for cleaning, sanitization, and sterilization procedures are given in Chapter 5, ‘‘Experimental Technique’’. Another aspect of media selection and scaleability is bead size. Smaller beads give less peak broadening (higher efficiency) due to decreased diffusion distances (reducing non-equilibrium zone broadening) and decrease of eddy diffusion. However, smaller beads also give increased backpressure and more problems with fouling of the chromatographic bed, especially when crude feed material is applied to the column in the first chromatographic step.
51
As has been discussed earlier, HIC is a high selectivity technique where efficiency usually is of minor importance for the resolution achieved. In consequence, a moderate bead size (e.g. 90 µm) should always be used in initial steps. In intermediate and final steps, smaller beads (e.g. 34 µm) can be used if requirements for resolution cannot be met by selectivity alone. In addition, the type of salt used, salt concentration and gradient volume are all important aspects of scaleability which have to be considered early in the method development stage. Different types of salt, as well as the amount of salt consumed in the process, offer different degrees of environmental and waste disposal problems, and will also affect the overall cost of the process. Such problems can be overcome by minimizing initial salt concentration as discussed earlier in this chapter under ‘‘Choice of HIC media’’ and ‘‘Optimizing a HIC step’’. The effect of excessive gradient volumes on the consumption of salt should also be considered. The waste water treatment cost varies between different countries but according to Swedish conditions, where legislation in this area is very rigorous, the cost for ammonium sulphate (1 M) is approximately 300 USD per 1000 l and for sodium suphate (1 M) approximately 200 USD per 1000 l (December 1992). Sodium chloride (4 M) has to be diluted 50 times before it can be fed into the municipal sewage system.
Regulatory considerations Regulatory considerations are often as critical to the successful development and implementation of a chromatographic process as the purification scheme itself. This is particularly true when producing biologicals to be used as therapeutics. Licensing authorities look upon chromatography media as raw material used in the process. New batches of chromatography media have to be placed in quarantine and can be released for production only when they have been tested and found to be in compliance with established acceptance criteria. Generally, identity tests also have to be performed on each new lot to be brought into production. When selecting media for development of a production process, it is therefore of utmost importance that documentation needed to set up analytical test procedures is available from the media vendor. Part of the testing needed for acceptance of new batches of media, such as particle size distribution, total capacity, flow properties and microbial contamination, is normally provided by the vendor through a Certificate of Analysis. Some of the tests may have to be repeated as part of the acceptance routines at the production site and analytical methods and identity tests provided by the vendor can then be of great help. Besides the documentation needed for setting up acceptance criteria, extensive documentation about the chemical stability of the medium is also needed to define optimal conditions for regeneration, cleaning, sanitization and storage.
52
Another important aspect that has to be investigated during process development is whether any extractable compounds or leakage products from the medium can be potential contaminants in the end product. To be able to test for absence of such compounds, information should be available from the vendor on possible extractable compounds and leakage products and on the kind of methods to use to quantify these compounds in the column eluate. In this connection, it must be made clear that there is no such thing as ‘‘leakage-free’’ chromatography media. Whether leakage in the eluent stream will be detected or not is solely a question of the detection limit of the analytical method used. The leakage levels in product stream that may be accepted by different licensing authorities will be stipulated on a case-by-case basis depending on the application area of the final product, the form of administration, the life time dosage and the toxicity of the leakage product. A regulatory concern specific for HIC is the different additives such as chaotropic substances, organic solvents and detergents that can be used to modulate the separation behaviour. Such additives also may have to be proved absent from the final product.
53
54
5 Experimental Technique Choice of column The material of a chromatographic column should be chosen to prevent denaturation of labile biological substances and minimize non-specific binding to exposed surfaces. The nets or frits used to retain the media should be easily exchangeable to restore column performance whenever contamination and/or blockage in the column occurs. It is also important that all dead volumes, i.e. the volume of the distribution system and tubing, is kept to a minimum to prevent band spreading through dilution or remixing. The pressure specification of the column has to match the back pressure generated in the packed bed when run at optimal flow rate. This is particularly important when using high performance media with small bead sizes. Amersham Pharmacia Biotech has developed a series of standard laboratory chromatography columns (XK columns) suitable for HIC. Further information on the full range of laboratory chromatography columns can be found in the Amersham Pharmacia Biotech catalogue which is available upon request.
Column dimensions As for most adsorptive, high selectivity techniques, HIC is normally carried out in short columns. A typical HIC column is packed to a bed height of 5-15 cm. Once the separation parameters have been determined, scale-up is easily achieved by increasing the column diameter.
Packing the column As with any other chromatographic technique, packing is a very important step in a HIC experiment. A poorly packed column gives rise to poor and uneven flow, zone broadening, and loss of resolution. Packing a HIC column with a modern, highly crosslinked agarose-based gel such as Sepharose Fast Flow is however easier than packing a gel filtration column since the bed height required is much smaller. 55
Packing Sepharose Fast Flow based HIC gels Preparation of the gel The gel is supplied pre-swollen in 20% ethanol. Prepare a slurry by decanting the 20% ethanol solution and replace it with packing solution in a ratio of 50–70% settled gel to 50–30% packing solution. The packing solution should not contain agents which significantly increase the viscosity. Distilled water or a low ionic strength buffer are suitable packing solutions.
Packing 1. Equilibrate all materials to the temperature at which the chromatography will be performed. 2. De-gas the gel slurry to minimize the risk of air bubbles in the packed bed. 3. Eliminate air from the column dead spaces by flushing the end pieces with packing solution (or 20% ethanol). Make sure no air has been trapped under the column net. Close the column outlet. Leave a few centimeters of packing solution remaining in the column. 4. Pour the slurry into the column in one continuous motion. Pouring the slurry down a glass rod held against the wall of the column will minimize the introduction of air bubbles. 5. Immediately fill the remainder of the column with packing solution, mount the column top piece onto the column and connect the column to a pump. 6. Open the bottom outlet of the column and set the pump to run at the desired flow rate. Ideally, Sepharose 6 Fast Flow matrices are packed at a constant pressure of 0.15 MPa (1.5 bar) and Sepharose 4 Fast Flow matrices at a constant pressure of 0.10 MPa (1.0 bar). If the packing equipment does not include a pressure gauge, use a packing flow rate of 400 cm/h (15 cm bed height, 25°C, low viscosity buffer). If the recommended pressure or flow rate cannot be obtained, use the maximum flow rate the pump can deliver. This should also give a reasonably well-packed bed. Note: Do not exceed 70% of the packing flow rate in subsequent chromatographic procedures. 7. Maintain the packing flow rate for 3 bed volumes after a constant bed height is reached. 8. After packing is completed, the level of the packed bed is marked on the column tube before the pump is stopped. Next, the outlet is closed, the pump is stopped and the inlet tubing is disconnected from the pump. Then the adaptor O-ring is slackened and the adaptor is lowered down until it reaches the surface of the packed bed. The O-ring is then tightened sufficiently for the adaptor to slide when pushed. Finally, the adaptor is lowered down until it is 3 mm below the mark on the column tube.
56
Packing Phenyl Sepharose High Performance Preparation of the gel The gel is prepared in the same way as has been described previously for Sepharose Fast Flow based HIC gels.
Packing Sepharose High Performance media are packed by a two-step technique using a low settling flow rate in the first step and then compressing the bed with a high constant back pressure in the second step. STEP 1: Pack with a flow rate of 10–30 cm/h for 20–60 min or until the packed bed has reached a constant height. STEP 2: Lower the adaptor to approximately 1 cm above the surface of the bed. Increase the flow rate until a pressure of 5.0 bar is reached and maintain this pressure for 30–60 minutes. Points 1–5 and point 8 in the packing instruction for Sepharose Fast Flow based HIC gels also apply to the packing of Sepharose High Performance based gels. Note:
There could be some resistance from the packed bed when pushing the adaptor down the last 3 mm, but it is important to fix the adaptor at this level. The packing procedure described above has been developed for the XK 16 and XK 26 columns.
Packing Sepharose CL-4B based HIC gels Sepharose CL-4B based HIC gels are packed using a procedure similar to the method for Sepharose Fast Flow media. The maximum flow rate for a laboratory scale column with an internal diameter of up to 5 cm and a bed height of up to 15 cm is 150 cm/h. Do not exceed a maximum back pressure of 0.04 MPa (0.4 bar).
Use of an adaptor If an adaptor has not been used during column packing it should be fitted as follows: 1.
After the gel has been packed as described above, close the column outlet and remove the top piece from the column. Carefully fill the rest of the column with buffer to form an upward meniscus at the top.
2.
Slacken the adaptor tightening mechanism and insert the adaptor at an angle into the column, ensuring that no air is trapped under the net.
57
3.
Adjust the tightening mechanism to give a sliding seal between the column wall and the O-ring. Screw the adaptor end-piece on to the column.
4.
Make all tubing connections at this stage. There must be a bubble-free liquid connection between the column and the pump and the column and the sample application system.
5.
Slide the plunger slowly down the column so that the air above the net and in the capillary tubing is displaced by eluent. Valves on the inlet side of the column should be turned in all directions during this step to ensure that all air is removed.
6.
Lock the adaptor in position with the tightening mechanism, open the column outlet and start the eluent flow. Pass eluent through the column at the packing flow rate until the gel bed is stable.
7.
Mark the column tube at the level of the packed bed before the pump is stopped.
8.
Close the outlet, stop the pump and disconnect the inlet tubing from the pump.
9.
Slacken the adaptor O-ring and push the adaptor down until it reaches the surface of the packed bed.
10. Tighten the O-ring so the adaptor is still able to slide and push the adaptor down until it is 3–5 mm below the mark on the column tube.
Checking the packed bed Testing the bed is easily done by injecting a test substance on the column and calculating the number of theoretical plates (N) or the height equivalent to a theoretical plate (HETP). Choose a test substance which shows no interaction with the media and which has a low molecular weight to give full access to the interior of the beads. Acetone at a concentration of 1% (v/v) can be used with all kinds of chromatographic media and is easily detected by UV-absorption. Keep the sample volume small to have a narrow zone when the sample enters the top of the column. For optimal results, the sample volume should be - 0.5% of the column volume for a column packed with a medium of approximately 30 µm bead diameter, and - 2% of the column volume for a column packed with a medium of approximately 100 µm bead diameter. Keep the linear flow rate low to reduce that part of the zone spreading which is an effect of non-equilibrium at the front and rear of the zone. For 30 µm media the flow rate should be between 30–60 cm/h and for 100 µm media, 15–30 cm/h. Use the following equations to calculate the number of theoretical plates (N) and HETP.
N = 5.54
58
( ) Ve
W1/2
2
HETP =
L N
where, Ve is the volume eluted from the start of sample application to the peak maximum and W1/2 is the peak width measured as the width of the recorded peak at half of the peak height (see Fig. 23). L is the height of the packed bed. Measurements of Ve and W1/2 can be taken in distance (mm) or volume (ml). The plate count will be the same as the resulting ratio is dimensionless. The unit of measurement should be the most convenient available but both parameters must be expressed in the same units. Fig. 23.
Ve
W1/2
h 1/2 h
As a general rule of thumb, a good HETP value is about two to three times the mean bead diameter of the gel being packed. For a 90 mm particle packing, this means an HETP value of 0.018–0.027 cm. Another useful parameter for testing the packed bed is the Asymmetry factor (Af). b Af = a where, a = 1st half peak width at 10% of peak height b = 2nd half peak width at 10% at peak height (see Fig. 24)
59
Fig. 24.
Ve
h
a b 10% h
Af should be as close as possible to 1. A reasonable Af value for a short column such as a HIC column is 0.80–1.80. (For longer gel filtration columns it will probably fall within 0.70–1.30). An extensive leading edge is usually a sign of the gel being packed too tightly and extensive tailing is usually a sign of the gel being packed too loosely.
Prepacked HIC Media Sepharose High Performance and Superose based HIC media are available in prepacked HiLoad, HR or PC columns. (See Product Guide, Chapter 3). After connecting the column to the chromatography system, column preparation simply consists of washing out the 20% ethanol solution with start buffer and bringing the column to equilibrium. Details of the installation and use of these columns are available in their respective instructions.
60
Sample preparation Sample composition HIC requires a minimum of sample preparation work. Since adsorption is carried out at high salt concentration, it is not necessary to change the buffer of a sample before applying it to a HIC column. The only action to be taken is to add sufficient salt and adjust the pH if necessary to ensure that the component of interest binds. If the salt is added in solid form, some precipitation may occur due to high local salt concentration. This can be avoided if the salt is added as a high concentration stock solution. If chaotropic agents such as guanidine hydrochloride and urea are present in the start material, they have to be removed prior to sample application since their influence on binding to the HIC medium will be opposite to that of the salt used for promoting hydrophobic interaction. Sometimes lipids or other very hydrophobic substances are present in the sample. These may interact very strongly with a HIC column, blocking capacity and being very difficult to remove from the column after the purification cycle. In such cases, using a slightly less hydrophobic column as a pre-column can prove to be very efficient in removing such substances before the sample enters the actual chromatographic column. The pre-column should be chosen to bind the most hydrophobic material and allow the substance of interest to pass through under equilibration conditions.
Sample volume HIC is an adsorption technique and starting conditions are normally chosen so that all important substances are adsorbed at the top of the bed. As such, sample mass applied is of far greater importance than the sample volume. This means that large volumes of dilute solutions, such as cell culture supernatants, can be applied directly to a HIC column without prior concentration. HIC thus serves as a useful means of concentrating a sample, in addition to fractionating it. However, sample volume becomes important when the salt concentration in the sample is lower than in the buffer used for equilibration. This can be the case if the salt concentration in the sample has to be decreased to avoid precipitation as has been discussed in Chapter 4, ‘‘Experimental Design’’. When a large sample volume is applied under such conditions, the weakest interacting substances may start to elute during sample application. This can be avoided by dividing the sample into portions and adding equilibration buffer between each sample application to enhance the hydrophobic interaction and prevent early elution (see Fig. 17).
61
Sample viscosity The viscosity may limit the quantity of sample that can be applied to a column. A high sample viscosity causes instability of the zone and an irregular flow pattern. High viscosity can also create problems with high back pressure, in particular if the medium used has a small bead size, e.g. 10 or 34 µm. A rule of thumb is to use 4 cP (centipoise) as the maximum sample viscosity. This corresponds to a protein concentration of approximately 5% in water. Approximate relative viscosities can be quickly estimated by comparing emptying times from a pipette. If the sample is too viscous due to high solute concentration, it can be diluted with start buffer. High viscosity due to nucleic acid contaminants can be alleviated by precipitation by forming an aggregate with a poly-cationic macromolecule such as polyethyleneimine or protamine sulphate. Nucleic acid viscosity can also be reduced by digestion with endonucleases. Such additives may however be less attractive in an industrial process since they will have to be proven absent from the final product.
Particle content In all forms of chromatography, good resolution and maximum column life time depend on the sample being free from particulate matter. It is important that ‘‘dirty’’ samples are cleaned by filtration or centrifugation before being applied to the column. This requirement is particularly crucial when working with small particle media, e.g. 10 or 34 µm bead size. The filter required for sample preparation depends on the particle size of the HIC matrix which will be used. Samples to be separated on a 90 µm medium can be filtered using a 1 µm filter. For 34 µm and 10 µm media, samples should be filtered through a 0.45 µm filter. When sterile filtration or extra clean samples are required, a 0.22 µm filter is appropriate. Samples should be clear after filtration and free from visible contamination. If turbid solutions are injected onto the column, the column lifetime, resolution and capacity can be reduced. Centrifugation at 10 000 g for 15 minutes can also be used to prepare samples. This is not the ideal method of sample preparation but may be appropriate if samples are of very small volume or adsorb non-specifically to filters.
62
Sample application Sample reservoir (Fig. 25) Samples can be applied by connecting a sample reservoir (e.g. RK or R) to the valves LV-3 and LV-4 or SRV-3 and SRV-4. With this method, the sample is allowed to run onto the column by gravity. Small samples can be applied via a syringe using the valve as a syringe holder.
Sample applicators (Fig. 26) Sample applicators SA-5 and SA-50 are reservoirs which, when used in combination with a suitable valve e.g. SRV-4, allow the sample to be applied via a closed sample loop system using a pump. Sample can be introduced into the sample applicator as a layer below the eluent using a syringe and needle. As well as their large capacity (up to 5 ml for the SA-5 and 45 ml for the SA-50) the sample applicator offers the additional advantage of serving as a bubble trap.
Fig. 26. Sample application using a SA-5 in a sample loop system.
Fig. 25. Sample application using a reservoir.
RK 16/26
LV-3 From pump
XK 16/40
AK 16
63
Sample loops with valves LV-4 or SRV-4 (Fig. 27) This method is convenient for applying small samples. By using the same sample loop, very reproducible sample volumes can be applied, although exact knowledge of the applied volume requires calibration of the capillary tubing loop.
Sample loops or Superloop with valves V-7 or MV-7 (Fig. 28). This method is used for sample application when using high performance columns and other columns in FPLC System or BioPilot™ System. Superloop is a unique sample application device from which a sample of any volume up to the capacity of the Superloop™ (10, 50 or 150 ml) can be applied to a column without tailing. A movable seal separates the sample from the eluent. As eluent is pumped into the Superloop, the sample moves ahead of the seal and onto the column. When nearly all the sample has been applied, eluent flows round the seal to wash the remainder of the sample quantitatively onto the column. Superloop should be used for applying sample volumes larger than 1 ml. Fig. 27. Sample application with a sample loop and two SRV-4 valves.
Fig. 28. Seven-port valves, V-7 and MV-7 have three operating positions which make sample application and changing eluents particularly convenient.
64
Batch separation For an initial capturing step on a HIC medium in process scale, a batch separation procedure can sometimes be worthwhile considering instead of a more traditional column separation procedure. Although the resolution of batch separation is lower than in column chromatography, it may offer advantages in particular cases. When very large sample volumes with low protein concentration have to be processed, the sample application time on a column can be very long and filtration of such a large sample can also be rather difficult to perform. Binding the sample in batch mode will be much quicker and there will be no need to remove particulate matter. A batch procedure can also be an attractive approach if high sample viscosity generates high back pressure in a column procedure or if high back pressure is generated by contaminants such as lipids which may cause severe fouling and clogging of the column. When working with HIC in batch mode starting conditions should be selected in the same way as in column chromatography, i.e. to bind the substance of interest but to prevent as many contaminants as possible from binding. When starting conditions have been selected, the amount of adsorbent needed and the time to reach equilibrium should be determined at small scale in a beaker. Adsorbent is added to the sample and stirred until binding is complete. The gel slurry should not be stirred too rigorously since this will generate fines. Then the gel is allowed to settle and filtered by suction until the adsorbent is damp but not dry. The sedimented adsorbent is washed with buffer to remove non-adsorbed unwanted material. Then elution buffer is added (1–2 times the volume of the sedimented gel) and stirred until desorption is complete, which can take up to 30 minutes or more. Finally, suction is used to filter the buffer containing the desolved product of interest from the adsorbent. The gel can also be packed in a column after the washing step and be eluted stepwise in the same way as during normal column chromatography. Resolution will however be lower for such a combined batch and column procedure compared with a normal column procedure, since the sample is bound uniformly throughout the gel slurry and the subsequent chromatographic bed. At process scale, the complete procedure of adsorption, washing and desorption is most conveniently carried out in a batch application tank equipped with a stirrer and an outlet with a filter at the bottom of the tank.
Cleaning, sanitization and sterilization procedures Cleaning-in-place (CIP) is the removal from the purification system of very tightly bound, precipitated or denatured substances generated in previous purification cycles. In some applications, substances such as lipids or denatured proteins may remain in the column bed instead being eluted by the regeneration procedure. If such contaminants 65
accumulate on the column for a number of purification cycles, they may affect the chromatographic properties of the column. If the fouling is severe, it may also block the column, increasing back pressure and reducing flow rate. A specific CIP protocol should be designed according to the type of contaminants that are known to be present in the feed stream. NaOH is a very efficient cleaning agent that can be used for solubilizing irreversibly precipitated protein and lipid material and in HIC it can be effectively combined with solvent or detergent based cleaning methods. Sanitization is the inactivation of microbial populations. When a packed column is washed with a sanitizing agent, the risk of contaminating the purified product with viable microorganisms is reduced. The most commonly used sanitization method in chromatography today is to wash the column with NaOH. NaOH has a very good sanitizing effect and also has the additional advantage of cleaning the column. Sterilization, which is not synonymous with sanitization, is the destruction or elimination of all forms of microbial life in the system. Suggested protocols for cleaning-in-place (CIP), santization-in-place (SIP) and sterilization that can be applied to the full range of HIC products outlined in Chapter 3, ‘‘Product Guide’’, are summarized in Table 12. The CIP protocols should be used as guidelines to formulate a cleaning protocol specific for the raw material to be applied. The frequency of use will depend on the raw material applied to the column but it is recommended to use a CIP procedure at least every 5 cycles during normal use. Depending on the nature of the contaminants, different protocols may have to be used in combination. If fouling is severe the protocols may have to be further optimized. During CIP the flow direction through the column should be reversed. Table 12. Suggested CIP, SIP and sterilization protocols for HIC media from Amersham Pharmacia Biotech.
Purpose
Procedure
Removal of precipitated proteins
4 bed volumes of 0.5 –1.0 M NaOH at 40 cm/h followed by 2–3 bed volumes of water
Removal of strongly bound hydrophobic proteins, lipoproteins and lipids
4–10 bed volumes of up to 70% ethanol or 30% isopropanol followed by 3–4 bed volumes of water. (Removal of 20% ethanol from Phenyl Sepharose Fast Flow (high sub) is shown in Fig. 29) or 1–2 bed volumes of 0.5% non-ionic detergent (e.g. in 1 M acetic acid) followed by 5 bed volumes of 70% ethanol, to remove the detergent, and 3–4 bed volumes of water
Sanitization
0.5–1.0 M NaOH with a contact time of 30–60 min
Sterilization
autoclave the medium at 120oC for 20 min.
Note: Detergents should be used with care since they work as displacers and may sometimes bind so hard to the gel that it affects the binding capacity during subsequent purification cycles. 66
Fig. 29. Removal of 20% ethanol from Phenyl Sepharose 6 Fast Flow (high sub) in an HR 10/10 Column, bed volume 8 ml; mobile phase H2O; flow rate 1 ml/min. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
Ethanol conc. (ppm) 100 000
10 000 1 000
100 10
1 0
2
4
6
8
10
12
Column volumes
Storage of gels and columns Prevention of microbial growth Steps should always be taken to prevent bacterial growth in columns during storage. Microbial growth can seriously interfere with the chromatographic properties of the column and contaminate the purified product with microorganisms and endotoxins or other pyrogenic material. During storage, an antimicrobial agent should always be added to the chromatographic media. Antimicrobial agents may be eluted from columns before chromatographic runs or they may be present in the eluent during chromatography. Antimicrobial agents which interact with sample substances must be avoided if they are to be used in eluents, otherwise any agent which does not interact with the gel may be used. Some of the more commonly used antimicrobial agents are described below.
Antimicrobial agents Sodium hydroxide Sodium hydroxide, 0.01 M, is an effective bacteriostatic agent and is, besides 20% ethanol, the main recommendation for storage of HIC media from Amersham Pharmacia Biotech. At higher concentrations (0.5–1.0 M) it is an effective sanitizer for contaminated columns. For the most frequent contaminants in chromatographic systems, such as gram-negative bacteria, a good bactericidal effect is reached even at such low concentrations as 0.01 M NaOH.
67
NaOH is a widely accepted agent for maintaining chromatographic columns and systems since it not only gives efficient sanitization but also effectively destroys endotoxin (LPS) and solubilizes precipitated and denatured substances that have accumulated on the column. An additional advantage is the lack of toxicity as a contaminant in the end product.
Ethanol 20% Chromatography media from Amersham Pharmacia Biotech are supplied as a suspension containing 20% ethanol. 20% ethanol can also be used as an alternative to NaOH for storing chromatography media under bacteriostatic conditions.
Chlorhexidine ™
Chlorhexidine (e.g. Hibitane ) is a very efficient bacteriostatic agent that inhibits the growth of many bacteria at a concentration of 0.002%. The effect against fungi is less pronounced, but the growth of many types can be inhibited by concentrations between 0.01% and 0.1%. Hibitane is incompatible with only a very few substances. Precipitation may occur on storage of Hibitane in solutions with appreciable concentrations of chloride or sulphate ions.
Phenyl mercuric salts 1 Phenyl mercuric salts (acetate, nitrate, borate) are most efficient as bacteriostatics in weakly alkaline solutions. Concentrations recommended are from 0.001% to 0.01%.
Thimerosal 1 Thimerosal (ethylmercuric thiosalicylate e.g. Merthiolate™) is a bacteriostatic most efficient in weakly acidic solutions. Concentrations recommended are from 0.005% to 0.01%. It is bound to and inactivated by substances containing thiol groups.
Trichlorobutanol Trichlorobutanol (e.g. Chloretone™) is another bacteriostatic showing highest efficiency in weakly acidic solutions. Concentrations recommended are from 0.01% to 0.05%.
1
68
The use of mercury containing antimicrobial agents is on the decline because of their toxicity. When used in a manufacturing process they may have to be proved absent in the end product.
Sodium azide Sodium azide is a very widely used bacteriostatic agent giving a high bacteriostatic effect at a concentration of 0.02%–0.05%. Note: The use of sodium azide is discouraged in many countries since it forms explosive insoluble salts with heavy metals and it is believed to be a mutagen.
Storage of unused media Unused media should be stored in closed containers at a temperature of +4oC to +25oC. Note that it is important that the media are not allowed to freeze as the structure of the beads may be disrupted by ice crystals. This disruption will generate fines.
Storage of used media Used media should be stored at a temperature of +4oC to +8oC in the presence of a suitable bacteriostatic agent, e.g. 0.01 M NaOH or 20% ethanol. Note that it is important that the media are not allowed to freeze as the structure of the beads may be disrupted by ice crystals. This disruption will generate fines.
Storage of packed columns Packed columns should be stored at a temperature of +4oC to +8oC in the presence of a suitable bacterostatic agent, e.g. 0.01 M NaOH or 20% ethanol. For long-term storage, the packed column should be thoroughly cleaned (CIP) before equilibration with the storage solution. Recycling the storage solution through the column or flushing the column once a week with fresh storage solution is recommended to prevent bacterial growth.
69
Process considerations Selecting a column When a chromatographic step is being developed to be a part of a manufacturing process and the time has come for scaling-up, the next crucial step in ensuring a reliable product quality and maximum production economy is the decision about which column to use. Large scale columns offered by Amersham Pharmacia Biotech are described in the ‘‘Process Column Selection Guide’’, which is available upon request. Different demands are put on a column for production compared with one used for the inital R&D and scale-up experiments. Flexibility, which is needed in R&D and scale up, is achieved by using a column with a movable adaptor. In production, consistency in performance and safety of the end product are the main concerns. Here the column packing has to be reproducible, materials of construction have to be well characterised for leakage and the design mechanically stable. A number of criteria have to be considered. These criteria are more dependent on the scale of operation than on the media and are thus very similar in their importance for HIC, ion exchange, gel filtration and affinity chromatography. Their ranking and importance change when moving through a chromatographic process (Fig. 30).
Start material Purification stage
t
Capturing
t Intermediate purification
Demands High flow rate, Large volume, CIP
t t
Polishing
t
Low dead volume, Low flow rate, Resolution, CIP, SIP
t
Pure Product Fig. 30. In the initial capturing, handling large volumes at high flow rates is important. When moving towards the final steps, usually gel filtration, the demand for high resolution and thus low dead volume becomes more and more important. As noted earlier, HIC is mainly used for intermediate purification but can also be applied as an initial capturing step.
70
Aspects of column design Flow distribution system The single most important factor in process column construction is that the packed column will give a low and consistent HETP value of the same order as previously established in the small scale column during method development. To achieve this, the flow distribution system has to be designed to make flow distribution as even as possible at the column inlet and outlet. Technically, the construction can vary but all columns showing an even flow distribution have a radial pressure drop that is negligible in relation to the axial pressure drop at the inlet (Fig. 31). The simplest design to assist radial distribution consists of a course mesh net positioned between the column end piece and the finer mesh net retaining the bed. The course mesh net acts to provide channels for radial distribution. Single or multiple inlet/ /outlet ports are used depending on the column diameter. Depth filters have a disadvantage compared with nets since the relatively large filter surface can become blocked due to adherence of molecules in the feed to the filter material. In continuous production situations, this drawback of depth filters might create serious problems. Fig. 31. Radial and axial back pressure in a column distribution system.
71
Material resistance and durability Wetted components of the column must be constructed from materials having high chemical resistance towards harsh chemicals such as 1 M NaOH, which is frequently used in regular cleaning-in-place (CIP) and sanitization procedures. Very large columns have to be constructed from stainless steel. Occasionally, a normal stainless steel column might not be compatible with some chemicals used. For example, even common NaCl buffers at mildly acidic conditions can cause corrision problems. In this case a fluoroplastic coated stainless steel construction is recommended. When using a stainless steel column in a HIC step, it is exposed to high salt concentrations. The steel type ASTM 316 L (DIN 1.4435, SS 2353), which is normally used in stainless steel constructions, can stand 0.5 M NaCl but only if the pH is kept at pH 6 or above. Sanitary design The possibility of effectively cleaning and sanitizing a packed column also depends on the smoothness of the wetted surfaces. Smooth surfaces hinder bacterial attachment and facilitate cleaning. The total column design, including the absence of threaded fittings, is important in eliminating dead volume in the column. Minimizing dead volumes will minimize trapping and growth of microorganisms and thus facilitate cleaning and sanitization of all wetted parts of the column. Columns constructed from calibrated borosilicate glass allow the use of thin Orings in the adaptor end-plate, which gives a minimum of dead volume in the column. Borosilicate glass will also provide a smooth and durable surface, minimizing bacterial attachment and facilitating the cleaning of the column. A plastic column is usually less expensive, but most plastics do not meet pharmaceutical industry requirements for chemical resistance, hygienic design and in-line cleaning. They might, however, be well suited for scale-up experiments. Pressure vessel safety When working with HIC, the pressure is usually kept low i.e. about 1 bar, but the volumes handled and the size of a process column can mean that it should be regarded as a pressure vessel. The design has then to conform to local regulations to be approved for use. Also, to facilitate a final regulatory approval, the whole column has to be produced under strict documentation routines where materials used and modifications made can be traced. Ergonomics Finally, for easy handling of a process column, it becomes important to have a column which is constructed in a stable way, which is easy to pack and to keep clean. If the column has an adaptor, it should be easy to move and lock in its new position. Valves should be easy to reach and the whole column should be possible to take apart for cleaning. Keeping all the above factors in mind will facilitate choosing the correct column for the specified need. 72
Packing large scale columns Column configuration Process columns with a moveable adaptor are essentially packed in the same way as laboratory columns with adaptors. In essence, this means that the gel slurry is compressed by a flowing liquid until the bed height has stabilized, at which point the flow is stopped and the adaptor is lowered onto the gel surface and secured in place. Large scale columns are, however, frequently supplied with fixed end pieces. This calls for a different packing technique. Some kind of extension tube has to be fitted on top of the column as a reservoir for the gel slurry. When the bed has been packed and settled at the join between the extension tube and the column, the extension tube is removed and the top column lid is secured in place.
Pressurized systems (pressure packing) Columns with moveable adaptors are packed in a pressurized system with a constant packing flow rate or a constant packing pressure. If constant flow rate is used, the pressure drop over the column will increase during packing as result of increased flow restriction from the packed bed. If constant pressure is used, the flow rate will be high in the beginning but decrease during packing for the same reason as above. Moderately sized columns with fixed end pieces can also be packed in a pressurized system. For such columns, two column tubes are fitted together to store the complete slurry volume before packing is started. When the bed has settled at the join between the two tubes, the upper tube is emptied of liquid by suction through the packed bed. At this stage the system is no longer pressurized but the bed is still kept compressed in the lower column tube by the liquid flow during the suction phase. When the upper tube is emptied the flow is stopped, the tube is quickly removed and the top lid is put in place and secured.
Non-pressurized systems (suction packing) Columns with fixed end pieces, such as the BioProcess Stainless Steel Columns from Amersham Pharmacia Biotech, are packed in a non-pressurized system by sucking packing solution through the column. Pressure packing of such columns would require very heavy packing tubes, which would be impractical to work with. In suction packing, the pump is connected to the column outlet and the excess packing solution in the gel slurry is pumped out at a predetermined flow rate. Immediately after the last part of the slurry has been sucked into the packed bed (when the surface starts to be dry), the flow is stopped, the packing device is quickly removed and the column lid is put in place and secured. Very simple packing devices can be used to store the gel slurry since the system is not pressurized. More detailed packing instructions are to be found in the instruction manual accompanying each column.
73
Packing flow rate Irrespective of the packing technique, the most important parameter for an optimally packed bed is the linear packing flow rate (velocity of flow through the column). In general, the higher the flow rate the better the performance of the packed bed, as long as the flow rate does not cause extensive bed compression, which can lead to channelling and an irregular flow pattern through the bed. Modern rigid media such as Sepharose Fast Flow and Sepharose High Performance withstand very high flow rates. In such cases, the pressure specification of the column rather than the separation medium, often sets the upper flow rate limit. However, with less rigidly cross-linked media such as Sepharose and Sepharose CL, the bed is often compressed and maximum flow rate reached, before the pressure limit of the column is reached. Irrespective of gel type, bed compression is more pronounced in large diameter columns since support given by the inner column wall to the gel bed is reduced. Since the optimum packing flow rate and pressure is dependent on gel type, gel batch, gel quantity, temperature, packing solution and equipment, it must be determined empirically for each individual system by establishing a pressure/flow curve for each specific column/gel set up. A pressure/flow curve is established in the following way: 1) Prepare the column in exactly the same way as for column packing 2) Pump buffer through the column at a low flow rate (e.g. 30% of the expected maximum flow rate). Record the flow rate and pressure when the bed is packed and the pressure has stabilized. 3) Slowly increase the flow rate in small steps and record the flow rate and pressure at each step after the pressure has stabilized. 4) Continue to increase the flow rate like this until the flow rate levels off at a plateau, indicating bed compression, or until the pressure reaches the pressure specification of the column. 5) Plot pressure against flow rate as indicated in Fig. 32. The optimal packing flow rate is the maximum flow rate, i.e. where the flow rate starts levelling off on the pressure/ flow curve. If no plateau is reached, use the flow rate at the maximum pressure specification of the column. Alternatively, use a constant pressure packing technique where the packing pressure is the pressure where flow rate starts levelling off, or if no plateau is reached, the specified maximum pressure for the column used. The packed column should not be run at more than 70% of the final flow rate reached during packing. This precaution prevents further bed compression when, for instance, a viscous sample is applied.
74
Linear flow rate cm/h
Fig. 32. Establishing a pressure/flow rate curve.
700
Packing flow rate
600 500 400 300 200 100 1
2
3 Pressure bar
Packing buffer The composition of the packing buffer can sometimes be critical for the performance of the packed bed. A packing solution frequently used is 0.1 M NaCl. For HIC media supplied by Amersham Pharmacia Biotech, water is equally effective.
Packing Sepharose CL and Sepharose Fast Flow based media The first task when packing Sepharose CL and Sepharose Fast Flow based media in large scale columns is to determine the optimal packing flow rate (constant flow rate packing) or optimal packing pressure (constant pressure packing), by establishing a pressure/flow curve as outlined opposite. For constant flow rate packing, the bed is packed by pumping packing solution through the column at the predetermined flow rate. The flow rate is checked at regular intervals and adjusted continuously since the increase in flow resistance from the packed bed will continuously reduce flow rate. The back pressure should be recorded with a manometer connected between the pump and the column to assure that maximum pressure for the gel or the column is not exceeded. For a constant pressure packing technique, the packing solution is applied through the column at a constant pressure by using a pump and a manometer, or by using a pressure vessel, to deliver the flow through the column continuously at a preset back pressure. The packing technique will differ in detail depending on which type of column is used. Detailed packing instructions for each type of column are included in the instruction manuals for large scale columns supplied by Amersham Pharmacia Biotech. Packing Phenyl Sepharose High Performance in
75
BioProcess Glass Columns Packing Phenyl Sepharose High Performance in BioProcess Glass Columns (BPG™) is performed with a two-step technique similar to that recommended for laboratory columns. The gel is packed with a low flow rate in the first step and then compressed with a high constant back pressure in the second step. * STEP 1: Pack the gel at a constant flow rate of 20 cm/h for 60 minutes. STEP 2: Lower the adaptor to approximately 1 cm above the surface of the bed. Increase the flow rate until a pressure of 3.0 bar is reached. Maintain this pressure for 30 minutes. This packing technique has been developed to give maximum column efficiency and bed stability when packing Phenyl Sepharose High Performance in BPG Columns.
Scale-up Once scaleability has been considered from start and built into the process during the method development work (see Chapter 4, ‘‘Experimental design’’), scaling up a chromatographic step is usually a straight-forward process. One important aspect of scaleability is the physical stability of the chromatography media. Scaling up to a larger diameter column means that most of the bed support from the friction against the column wall is lost. This loss can give increased bed compression and poorer flow/pressure characteristics. Using a highly cross-linked, rigid matrix during the method design work will ensure that the large scale column can be run at the same linear flow rate as the small scale column, without problems with increased back-pressure. Another important aspect of scaleability is the bead size. If a small bead (e.g. 10 µm) has been used during method development work in small scale, it is usually necessary to switch to a larger bead when scaling up to optimize throughput and reduce operating costs. In such cases, some re-optimization work has to be performed at the laboratory scale before the process can be scaled up.
* The recommendation for the first step is for BPG 100 and BPG 200 columns. For BPG 300 columns, a constant pressure of 0.5 bar should be applied for 30 minutes.
76
Some general guide-lines for scaling-up are outlined in Table 13. Table 13. Scale up guidelines. Maintain
Increase
Check system factors
Bed height Linear flow rate Sample concentration Gradient volume/bed volume
Sample load Volumetric flow rate Column diameter
Distribution system Wall effects Extra column zone spreading
Increasing the bed volume by increasing the column diameter and increasing volumetric flow and sample load accordingly, will ensure the same cycle time as in the laboratory scale method development. The column bed height, linear flow rate, sample concentration and ratio of sample to gel, all optimized on a laboratory scale, will be kept the same. If a gradient is used for elution, the ratio of gradient volume to bed volume will remain constant and, therefore, the time required for the gradient to develop and the effect on resolution, will remain the same on the larger column. The same principle is applied for the volume of each step in a step gradient. Different system factors may affect performance after scale up. If the large scale column has a less efficient flow distribution system, peak broadening may occur due to increased axial dispersion in the bed and extra zone spreading in the end pieces. This will cause extra dilution of the product fraction or even loss of resolution. Depending on the rigidity of the media, the loss of wall support in a large scale column will have a smaller or greater impact on bed compression, with accompanying deterioration of the flow/pressure properties of the packed bed. The effect of bed compression can be checked by running a pressure/flow rate curve such as outlined under ‘‘Packing large scale columns’’. Zone spreading can also be caused by non-column factors such as increased internal volumes of pumps, valves and monitoring cells and different lengths and diameters of pipes or tubing. If all the above aspects of scaling up are taken into consideration, chromatographic variability is normally not a big issue when scaling-up. Non-chromatographic factors may have a more significant effect on performance. These factors include: changes in sample composition and concentration that often occur as the fermentation scale increases, precipitation in the biological feedstock due to longer holding times when large volumes must be handled, non-reproducibility of the buffer quality due to inadequate equipment for consistently preparing large quantities of buffer solutions, and microbial growth in feed-stock or buffers due to increased handling and longer holding times. The effects of these kinds of variabilities should be checked by challenging the chromatographic process during method development by running it under ‘‘worstcase’’ situations.
77
78
6 Applications Preparative and analytical HIC applications in the research laboratory HIC is widely used in protein purification in the research laboratory as a complement to other techniques that separate according to other parameters such as charge (ion exchange chromatography), size (gel filtration) or biospecific recognition (affinity chromatography). The outcome of a protein purification procedure is obviously dependent on the choice of separation equipment and techniques. The order in which the different techniques are combined is also of great importance. This chapter, emphasises different possibilities to combine HIC with other separation techniques in laboratory scale protein purification schemes. Analytical separations by HIC are also discussed.
HIC in combination with ammonium sulphate precipitation When ammonium sulphate precipitation has been used early in a protein purification procedure to precipitate out contaminants, HIC is ideal as the next step. The protein of interest is present in the supernatant at a high ammonium sulphate concentration, and the sample can thus be directly applied to the HIC column. Purification occurs concomitant with a reduction in volume.
Crude purification of human autotaxin HIC was used for initial purification of autotaxin, a human 125K protein which stimulates tumour cell motility (49). The supernatant from ammonium sulphate precipitation of concentrated cell culture medium was applied directly to a Phenyl Sepharose CL-4B column (Fig. 33). Elution was achieved with a double linear gradient with decreasing ammonium sulphate and increasing ethylene glycol. Autotaxin was then further purified to homogeneity using affinity chromatography, gel filtration and anion exchange chromatography.
79
Column: Sample:
Buffer A: Buffer B: Flow rate: Detection:
Fig. 33. HIC purification of human autotaxin from the supernatant from ammonium sulphate precipitation of conditioned melanoma cell culture medium (reproduced with permission, from ref. 49).
Phenyl Sepharose CL-4B, 200 ml Supernatant from ammonium sulphate precipitation (1.2 M) of concentrated conditioned media (corresponding to 200 l of conditioned media) from A2058 melanoma cells 50 mM Tris, pH 7.5, 5% (v/v) methanol, 1.2 M ammonium sulphate 50 mM Tris, pH 7.5, 5% (v/v) methanol, 50% (v/v) ethylene glycol 1 ml/min A280 (solid curve) and motility (circles).
Chemotaxis was quantitated with a 2202 Ultroscan laser densitometer.
30
2.0
100
50
15 10
OD280 (—)
75 20
Gradient (% B) (–––)
Motility (density units)
25
25 5 0 0
200
400
600
800
0 1000 1200 Time (min)
0
HIC in combination with ion exchange chromatography HIC is often an excellent choice subsequent to ion exchange in a protein purification procedure. Both techniques have an extremely broad applicability, and are complementary (i.e. separation according to hydrophobicity and charge, respectively). Furthermore, material eluted with a salt gradient in an ion exchange separation requires a minimum of sample treatment before application to a HIC column. Usually sample treatment is limited to the addition of salt.
Purification of recombinant HIV reverse transcriptase Recombinant HIV reverse transcriptase, expressed as a 66K/51K heterodimer in E. coli, was purified using a multi-step procedure involving ion exchange, ammonium sulphate precipitation and HIC (50). The second chromatography step was anion exchange with DEAE Sepharose CL-6B. Pooled active material was diluted with 3 M 80
Fig. 34. Purification of recombinant HIV reverse transcriptase, expressed in E. coli, using HIC (reproduced with permission, from ref. 50).
Column: Sample:
HiLoad 16/10 Phenyl Sepharose High Performance 400 ml (10 mg protein), obtained from ion exchange on DEAE Sepharose CL-6B, diluted to 600 ml with 3 M ammonium sulphate. Buffer A: 10 mM Tris-HCl, pH 8.0, 1 M ammonium sulphate, 10% glycerol, 1 mM DTT Buffer B: 10 mM Tris-HCl, pH 8.0, 10% glycerol, 1 mM DTT Flow rate: 3 ml/min Detection: A280 (solid line) and reverse transcriptase activity (black area). The broken line is the programmed gradient. A280 nm 0.5
217 650
233 700
250 750
267 (min) 800 (ml)
ammonium sulphate and applied to a column containing Phenyl Sepharose High Performance (Fig. 34). The HIC step was used both as a purification step and a concentration step and it reduced the volume 15 fold (from 600 to 40 ml). The final purification step was anion exchange with FPLC™ using a Mono Q™ column.
Purification of mammalian transcription factors Transcription factors are present at extremely low levels in mammalian cell nuclei. A purification scheme was developed for µg amounts of six different transcription factors from an extract of 1012 HeLa cells (51). The complementary selectivities of HIC and ion exchange are well illustrated in this scheme. Transcription factors IIF and IIH co-purified in anion exchange (two different DEAE columns) and cation exchange (Phosphocellulose and Mono™ S), but were excellently separated on Phenyl Superose HR 10/10 (Fig. 35) with FPLC System. Further purification of the factors involved other chromatography steps. Final micropurification of transcription factor IIE was done on Phenyl Superose™ PC 1.6/5 with SMART™ System. 81
Column: Sample:
Phenyl Superose HR 10/10 HeLa cell extract purified on phosphocellulose, 2 x DEAE columns, Mono S HR 10/10 Buffer A: 20 mM Tris-HCl, pH 7.9, 0.1 mM EDTA, 20% glycerol, 10 mM b-mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride, 1.4 M ammonium sulphate Buffer B: A without ammonium sulphate Detection: Triangles represent transcription factor IIF activity, and open circles represent transcription factor IIH activity in specific transcription
Fig. 35. HIC separation of mammalian transcription factors IIH and IIF (reproduced with permission, from ref. 51).
0.5
1,0
0.3
0,75
0.2
0,50
0,25
0.1
5
10 15 20 25 30 35 40 45 50 55 60 Fraction Number
Ammonium Sulphate – – –
1.0
0.4
α
1.5
Protein (mg/ml)
(α - 32P) -UMP Incorporated (pmol)
11 2.0
0
Micropurification of a GTPase activating protein Final micropurification of a GTPase activating protein, GAP-3, from bovine brain was done with micropreparative columns for HIC and anion exchange chromatography (52). Prior purification steps were anion exchange chromatography, dye affinity chromatography, ammonium sulphate precipitation, gel filtration, hydroxyapatite, HIC and anion exchange. GAP-3 containing fractions from the latter step (Mono Q HR 5/5) were applied to the Phenyl Superose PC 1.6/5 column (Fig. 36). Active material from HIC was then applied to a second micropreparative column (Mono Q PC 1.6/5), and subjected to N-terminal sequence analysis. The overall recovery was 50 µg GAP-3 from 1.6 kg of brain tissue, which corresponds to a purification factor of approximately 18000.
HIC in combination with gel filtration A major advantage with adsorption chromatography is the possibility to achieve a decrease in sample volume concomitant with an increase in purity. In a purification scheme, HIC and other adsorption chromatography techniques are therefore frequently used prior to gel filtration, in which sample volume is limited.
82
Phenyl Superose PC 1.6/5 Partly purified GAP-3 from bovine brain homogenate, active material from Mono Q HR 5/5 Buffer A: 25 mM Tris-HCl, pH 7.5, 1 mM DTT, 1 mM EDTA, 1.7 M ammonium sulphate Buffer B: 25 mM Tris-HCl, pH 7.5, 1 mM DTT, 1 mM EDTA Flow rate: 50 µl/min Detection: A280 (upper curve) and GAP-3 activity (32P-GTP hydrolysis; lower curve)
Absorbance (280 nm)
Column: Sample:
0.1 AU
POOL
CPM ( X 105 )
8
6
4
2
0
10
20
30
40
50
Retention time (min)
Fig. 36. Micropurification of GAP-3 (reproduced with permission, from ref. 52).
Human pituitary prolactin was purified on a Phenyl Sepharose CL-4B column (53) (Fig. 37). Elution was achieved stepwise, with 50% ethylene glycol. The sample volume was reduced in HIC from 300 ml to 45 ml, and the recovery of activity was 95%. The sample was applied to a gel filtration column (Sephadex G-100) for further purification.
HIC as a ‘‘single step’’ purification technique In general, ‘‘single step’’ purification of a protein to homogeneity from a complex biological sample requires the use of highly specific affinity techniques. If general techniques are chosen, e.g. HIC, ion exchange and gel filtration, they usually have to be combined to obtain a homogeneous product. In some instances, however, a single chromatography step with a general technique may be sufficient to give a pure product.
83
0.002 M glycine-NaOH, pH 9.8/50% ethylene-glycol
A280
10
0.2 M glycine-NaOH, pH 9.8
0.02 M glycine-NaOH, pH 9.8
20
15
Fig. 37. Chromatography on Phenyl Sepharose CL-4B of a prolactin preparation. The hatched area represents the prolactincontaining fractions. (reproduced with permission, from ref. 53.)
5
0
20
40
60
80
100
120
Fraction number
Column: Sample:
Alkyl Superose HR 5/5 100 µl mouse ascites containing monoclonal IgG1 (a) or IgG2a (b) + 100 µl buffer A, centrifuged and filtered Buffer A: 0.1 M phosphate, pH 7.0, 2.0 M amminium sulphate Buffer B: 0.1 M phosphate, pH 7.0 Detection: A280. Proteins were identified by SDS-PAGE with PhastSystem. The programmed gradient (FPLC System) is also shown. A280 nm
A280 nm
a)
b)
0.5
0.5
lgG1 lgG2a
Alb Trans
0
84
20
Alb Trans
40 60 Time (min)
0
20
40 60 Time (min)
Fig. 38. ‘‘Single step’’ HIC purification of monoclonal antibodies from ascites. (Work by Amersham Pharmacia Biotech).
Phenyl Sepharose High Performance, 5x10 mm. a) 60 µg methylamine treated, inactive (‘‘fast’’) a2-macroglobulin b) 60 µg active (‘‘slow’’) a2-macroglobulin c) a + b Buffer A: 20 mM sodium phosphate, pH 7.2, 1.0 M sodium sulphate Buffer B: 0.25 mM sodium phosphate, pH 7.2 Flow rate: 0.5 ml/min Detection: A280. The programmed gradient (FPLC System) is also shown. ”Slow” and ”fast” a2-macroglobulins were identified by native PAGE with PhastSystem. A280
a)
0.04 AU
‘‘fast’’
Column: Samples:
0
[Na2SO4]
A280
1.0 M
0.04 AU
[Na2SO4] 1.0 M
c)
0.0 0
20 min
0
10 ml
‘‘slow’’
b) 0.04 AU
1.0 M
0.0 0 0
20 min 10 ml
0
0.0 0 0
20 min 10 ml
Fig. 39. Separation of conformational isomers of a2-macroglobulin using HIC. (Work by Amersham Pharmacia Biotech).
Small scale purification of monoclonal antibodies Mouse monoclonal antibodies were purified from ascites on a milligram scale. IgG was the main protein in the sample and a single chromatography step with Alkyl Superose HR 5/5 was sufficient to obtain homogeneous IgG (Fig. 38). Purity was checked by SDS-PAGE and silver staining. Both IgG antibodies were well separated from the main contaminants albumin and transferrin. The two antibodies were eluted at clearly different positions (Fig. 38 a, b) in the gradient however, indicating that separation conditions may have to be modified for different antibodies. 85
20
10
1
5
0
0 0
5
10
1
Nonidet P - 40 (mM)
Protein (mg/ml)
15
2
Lauryl Maltoside (mM)
2
Fig. 40. Exchange of lauryl maltoside for protein-bound Nonidet P-40. (reproduced with permission, from ref. 54).
0
15
Fraction Number
Analysis of conformational changes with HIC A conformational change in a protein leads to a change in physico-chemical surface properties, e.g. hydrophobicity, of the molecule. Such changes can be exploited using HIC, offering exciting possibilities both in analytical and preparative applications.
Separation of conformational isomers of a2-macroglobulin with HIC
a2-macroglobulin, a tetrameric 720K plasma protein, undergoes a major, irreversible conformational change (without peptide bond cleavage) on treatment with methylamine. The two conformational isomers are referred to as ‘‘slow’’ and ‘‘fast’’ a2-macroglobulin, respectively, referring to their different mobilities in native PAGE. The two conformational isomers were clearly separated by HIC, using Phenyl Sepharose High Performance (Fig. 39). Ammonium sulphate was avoided, since ammonia mimicks the action of methylamine on the protein. Other HIC application areas in the research laboratory HIC using Phenyl Sepharose CL-4B has been used for exchange of protein-bound detergent (54) (Fig. 40). Octyl Sepharose CL-4B has been used for the separation of different forms of dermatan sulphate proteoglycans (55). HIC of nucleic acids, viruses and cells has also been described (17).
86
Preparative, large scale applications. When chromatographic techniques are developed to be part of a manufacturing process for a pharmaceutical or a diagnostic for commercial application, they have to comply with special requirements. As well as meeting demands for productivity and overall economy, the processes also have to fulfil different regulatory requirements regarding final product safety. Regulatory authority requirements are based on the concern that infectious, pyrogenic, immunogenic or tumourigenic agents may be present in the end product. This section shows some large scale applications that demonstrate how HIC can be integrated into a logical sequence of chromatographic steps intended for a large scale downstream process.
Purification of a monoclonal antibody for clinical studies of passive immunotherapy of HIV-1. In Sweden, scientists at the National Bacteriological Laboratory (SBL), Department of Virology, in collaboration with Amersham Pharmacia Biotech , have succeeded in developing a purification procedure for large scale production of a monoclonal IgG1 (anti-gp120) intended for intravenous use for clinical studies on AIDS (56). The specification for the purification was that the Mab could be used for in vivo therapy, which required steps to reduce endotoxins and DNA. Phenyl Sepharose High Performance was selected for the initial step in a three step procedure that gave a product purity of 99% and an overall yield of 61% (Fig. 41). Phenyl Sepharose High Performance is known to be a good choice for initial purification of monoclonal antibodies. In this case it was compared with an alternative technique consisting of desalting on Sephadex G-25 Super Fine followed by ion exchange chromatography on S Sepharose High Performance. The HIC technique gave superior resolution - no albumin was detected by SDS-PAGE. The second step on S Sepharose High Performance was included to reduce endotoxins by binding the Mab while allowing the endotoxins to pass unretarded through the column. In fact, it was the final gel filtration step on Superdex™ 200 prep grade that turned out to be the most efficient step for reduction of endotoxins in this case, but the cation step served as a concentration step, meeting the specification for protein concentration in the final product. The microbiological contamination as well as the DNA and endotoxin levels were all judged to be within the specifications for parenteral use in clinical trials. All chromatographic runs were performed on BioPilot System. The start material was hybridoma supernatant and the concentration of mouse IgG1(anti-gp 120), was 0.61 mg/ml. The method development work was performed on Pharmacia XK columns. Loading capacity for Phenyl Sepharose High Performance was tested by analysing the flow through fractions during sample application by SDS-PAGE and ELISA. 87
Start material 10 l supernatant Acusyst hollow fibre 10 l 0.61 mg/ml MAb
Fig. 41. Purification scheme for a large scale purification of mouse IgG1 anti-gp120. (Two cycles were run, i.e. a total of 20 l of Mab supernatant).
t Step 1
Phenyl Sepharose High Performance BPG 100/500 10 cm bed height
Process time: 3h
t
1.4 l
t
Dilution pH-adjustment pH 5.0 4.5 mS/cm 3.9 l
t
Step 2
S Sepharose High Performance BioPilot Column 60/100 10 cm bed height
Process time: 1.4 h
t
0.4 l
t Step 3
Superdex 200 prep grade BPG 100/950 60 cm bed height
Process time: 2h
t
0.72 l
Product: 3.7 g SDS page purity: 99% Overall yield: 61%
Dynamic binding capacity was 9.1 mg/ml separation medium at a flow rate of 90 cm/h. As a safety measure only 75% of maximum loading was used. The Mab was eluted with a single step of low salt buffer. The chromatogram and SDS-PAGE showed good resolution and high concentration of the Mab (Fig. 42 a). For large scale purification, 20 litres of supernatant were divided into 2 lots each containing an equal quantity of Mab. BioProcess Glass Columns were used for the first step on Phenyl Sepharose High Performance and for the final gel filtration step. A BioPilot Column was used for the intermediate step on S Sepharose High Performance. Both resolution and yield (Fig. 42b) were equally good as the small scale run.
88
Column: Gel: Sample: Sample volume: Sample load: Flow rate: Buffer A:
XK 16/20 Phenyl Sepharose High Performance, 10 cm bed height. Hybridoma cell culture supernatant; mouse IgG1 anti-gp120.
222 ml 6.8 mg Mab/ml gel 90 cm/h (3 ml/min) 10 mM potassium phosphate pH 7.0 + 0.5 M ammonium sulphate Buffer B: 10 mM potassium phosphate pH 7.0 Productivity: 2.32 mg Mab/ml gel . h
Column: Gel: Sample: Sample volume: Sample load: Flow rate: Buffer A:
2 x 10 l 7.77 mg Mab/ml gel 90 cm/ h (7.1 l/h) 10 mM potassium phosphate pH 7.0 + 0.5 M ammonium sulphate Buffer B: 10 mM potassium phosphate pH 7.0 Productivity: 3.34 mg Mab/ml gel . h
%
% a)
100
b)
50
50
0
0
0
BPG 100/500 Phenyl Sepharose High Performance, 10 cm bed height Hybridoma cell culture supernatant; mouse IgG1 anti-gp120.
50
100
Time (min)
0
50
100
150 Time (min)
Fig. 42. Laboratory and production scale purification of mouse IgG1 anti-gp120 on Phenyl Sepharose High Performance (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
Purification of recombinant human Epidermal Growth Factor (h-EGF) from yeast. A chromatographic downstream process has been developed for the purification of human Epidermal Growth Factor (h-EGF) expressed as an extracellular product by Saccharomyces cerevisiae (57). Phenyl Sepharose 6 Fast Flow (high sub) was selected for an initial capture step. This was followed by an intermediate anion exchange step on Q Sepharose High Performance and a final polishing gel filtration step on Superdex 75 prep grade. This three step procedure gave a product purity of 99% as determined by RPCHPLC, and an overall yield of 73% (Fig. 43). 89
Fig. 43. Purification scheme for large scale purification of h-EGF from yeast cell culture supernatant.
Process description Yeast cell culture supernatant
t
t
Centrifugation or 5 mm filtration Ammonium sulphate to 0.5 M
t
Phenyl Sepharose 6 Fast Flow (high sub)
t
Dilution 1/10 0.02 M Tris pH 7.6
t
Q Sepharose High Performance
t
Superdex 75 p.g.
HIC media scouting for initial step Media characteristics for EGF purification Phenyl Sepharose High Performance • Very high selectivity • Very high binding capacity • Higher backpressure than for Fast Flow media
Phenyl Sepharose 6 Fast Flow (low sub) • EGF comes in wash with binding buffer • Low selectivity for EGF
Phenyl Sepharose 6 Fast Flow (high sub) • Very high selectivity • High binding capacity • High throughput
Butyl Sepharose 4 Fast Flow • Was not possible to elute with low salt buffer • Binds too hard Fig. 44. HIC media screening experiments for the initial capture step. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
90
Initial media screening experiments for the capture step were performed on four different HIC media. Phenyl Sepharose 6 Fast Flow (high sub) was selected due to its high selectivity for EGF, high binding capacity and high throughput (Fig. 44). A cation exchanger (S Sepharose Fast Flow) was also evaluated during this screening phase but was found to have lower selectivity for EGF than Phenyl Sepharose 6 Fast Flow (high sub). A high resolution anion exchanger, Q Sepharose High Performance, was selected for intermediate purification in order to reach a high degree of purity in the second step (> 96%). To achieve a high final purity by separating polymers and unwanted buffer salts from the EGF product, gel filtration on Superdex 75 prep grade was selected for final polishing. The start material was clarified cell culture supernatant supplied by Chiron-Cetus Corp., Emeryville, USA. Concentration of EGF in the start material was 0.018 mg/ml and the overall protein content was 63 mg/ml. The small scale development work was performed on BioPilot System and XK columns. The product was eluted with a single step procedure which gave adequate purification and high product concentration (Fig. 45). The large scale purification work was performed on BioProcess System and BioProcess Glass Columns. For the capture step, 80 l of feed material was applied to
Column: Gel:
Sample: Sample volume: Sample load: Flow rate: Buffer A:
Buffer B:
XK 16/20 Phenyl Sepharose 6 Fast Flow (high sub), 10 cm bed height Yeast supernatant. Ammonium sulphate added to 0.5 M
A280 nm Buffer A
3.00
450 ml 0.41 mg h-EGF/ml media 300 cm/h; 10 ml/min (loading) 60 cm/h; 2 ml/min (elution) 20 mM sodium phosphate pH 7.0 + 0.5 M ammonium sulphate 20 mM sodium phosphate pH 7.0
Purification time: 1.5 h
2.00
1.00
Buffer B
0.00 0
50
Time (min)
Fig. 45. Laboratory scale purification of h-EGF on Phenyl Sepharose 6 Fast Flow (high sub). (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
91
Column: Gel:
BPG 300/500 Phenyl Sepharose 6 Fast Flow (high sub), 10 cm bed height Sample: Yeast supernatant. Ammonium sulphate added to 0.5 M Sample volume: 80 l Sample load: 0.36 mg h-EGF/ml media Flow rate: 300 cm/h; 212 l/h (loading) 60 cm/h; 42 l/h (elution) Buffer A: 20 mM sodium phosphate pH 7.0 + 0.5 M ammonium sulphate Buffer B: 20 mM sodium phosphate pH 7.0 Purification time: 1.5 h A280
Fig 46. Production scale purification of h-EGF on Phenyl Sepharose 6 Fast Flow (high sub). (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
ms/cm 100
3.0
2.0 50 1.0
0.0 50
100
Volume (liter)
a BPG 300/500 column with a bed volume of 7.1 l (Fig. 46). No dilution or recovery losses were seen when scaling up from XK columns on BioPilot System to BPG columns on BioProcess System.
Purification of a monoclonal antibody for in vitro diagnostic use. A single step purification technique for the large scale purification of a monoclonal antibody using HIC has been developed (58). Purification was performed on Phenyl Sepharose High Performance to a product purity of > 95% and a yield of 78%. If a gel filtration polishing step on Superdex 200 prep grade was added on to the HIC step, a final purity of >99% was achieved (Fig. 47). The start material, from a hollow fibre bioreactor, was mouse hybridoma cell culture supernatant containing monoclonal IgG1 anti-IgE. Mab concentration, determined by nephelometry, was 0.63 mg/ml.
92
Fig. 47. Purification scheme for the large scale purification of mouse IgG1, anti-IgE.
Process design Cell culture
t
Filtration Through filter paper Addition of (NH4)2SO4 to optimized concentration
t
Hydrophobic Interaction Chromatography Phenyl Sepharose High Performance
t
Concentration Membrane concentration or Ion exchange chromatography
t
Gel Filtration Chromatography Superdex 200 prep grade
The small scale development work was performed on a HiLoad 16/10 Phenyl Sepharose High Performance column (Fig. 48). The Mab bound very strongly to the gel while most of the fetal calf serum proteins passed through unretarded. Different salt concentrations in the start buffer were tested and 0.5 M ammonium sulphate was selected since this showed the highest binding selectivity for the Mab. At higher salt concentrations, the IgG fraction was slightly contaminated with serum albumin. Dynamic binding capacity was determined to be 4.5 mg Mab/ml gel.
Column:
HiLoad 16/10 Phenyl Sepharose High Performance, 10 cm bed height Sample: Hybridoma cell culture supernatant; mouse IgG1 anti-IgE. Ammonium sulphate added to 0.5 M. Sample volume: 130 ml Sample load: 4.5 mg Mab/ml gel Flow rate: 100 cm/h (3.3 ml/min) Buffer A: 20 mM potassium phosphate, pH 7.0 + 0.5 M ammonium sulphate Buffer B: 20 mM potassium phosphate, pH 7.0 Gradient: 0-100% B; 10 column volumes
A280 nm .40 .30 .20 .10 .00 50
50
100
150 Time (min)
Fig. 48. Laboratory scale purification of mouse IgG1, anti-IgE, on Phenyl Sepharose High Performance. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
93
Column: Gel:
BioPilot Column 35/100 Phenyl Sepharose High Performance, 10 cm bed height Sample: Hybridoma cell culture supernatant; mouse IgG1, anti-IgE. Ammonium sulphate added to 0.5 M. Sample volume: 735 ml Sample load: 4.5 mg Mab/ml gel Flow rate: 100 cm/h (16.7 ml/min) Buffer A: 20 mM potassium phosphate, pH 7.0 + 0.5 M ammonium sulphate Buffer B: 20 mM potassium phosphate pH 7.0 Gradient: 0–100 % B; 10 column volumes
Fig. 49. Production scale purification of mouse IgG1, anti-IgE, on Phenyl Sepharose High Performance. (Work from Amersham Pharmacia Biotech, Uppsala, Sweden).
A280 nm .50 .40 .30 .20 .10 .00 0
50
100 Time (min)
The large scale purification was performed on BioPilot System and BioPilot Column Phenyl Sepharose High Performance. The process was first scaled up to a BioPilot Column 35/100 with a total column volume of 100 ml (Fig. 49) and later to a BioPilot Column 60/100 with a total column volume of 300 ml. No difference in performance between the two columns was seen. An IgG preparation, highly homogeneous by electrophoretic criteria, was obtained in a single chromatographic step. One process cycle yielded over 1 g of IgG from 2.2 litres of culture medium. This corresponds to a capacity of 400 g per year, the productivity of the bioreactor being the limiting step.
Purification of a recombinant Pseudomonas aeruginosa exotoxin produced in E. coli. An optimized purification process for a recombinant Pseudomonas aeruginosa exotoxin produced in the periplasm of E. coli has been developed (59). The scheme resulted in high recovery of a homogeneous exotoxin with reduced levels of DNA, endotoxins, and other contaminants (Table 14). 94
Table 14.
Step
Medium
Column
Purity %
Sample
DNA content (pg)*
Endotoxin content (EU)*
12 000
1
DEAE Sepharose Fast Flow
XK 16/20 Bed height 10 cm
³25
1 500
2.4 x 106
2
Phenyl Sepharose Fast Flow (high sub)
XK 16/20 Bed height 15 cm
³65
118
1.2 x 106
3
Q Sepharose High Performance
XK 16/20 Bed height 10 cm
>99
8
24
Superdex 75 prep grade
XK 16/70 Bed height 60 cm
100
4
5
1
DEAE Sepharose Fast Flow
BPG 100/500 Bed height 10 cm
³25
820
2.4 x 106
2
Phenyl Sepharose Fast Flow (high sub)
BPG 100/500 Bed height 15 cm
³63
118
8.0 x 105
3
Q Sepharose High Performance
BPG 100/500 Bed height 10 cm
>99
6
10
Superdex 75 prep grade
XK 16/70 Bed height 60 cm
100
N. D.**
6
4
4
* = per mg of protein ** = Not Determined
The protein is a well characterized (60–63) cytotoxic agent that acts by irreversibly inhibiting protein synthesis (ADP ribosylation of elongation factor 2). By conjugating the exotoxin to the monoclonal antibody B3, which binds to a carbohydrate epitope present on the surface of many cancer cells (64), an immunotoxin is produced. This type of immunotoxin can then be used as a therapeutic agent for targeted treatment of cancer. LysPE38, a genetically modified P. aeruginosa exotoxin, was purified to support an Investigational New Drug filing with the FDA. The purification strategy involved the extraction of the toxin from the periplasm, followed by clarification and chromatographic purification. During the method development stages, both anion exchange and HIC were evaluated. By using HIC early in the process, the only sample pretreatment necessary was the addition of a suitable amount of solid ammonium sulphate for binding. Phenyl Sepharose Fast Flow (high sub) was a suitable medium as it demonstrated high selectivity for LysPE38 at a relatively low concentration of ammonium sulphate (0.5 M), an important economic consideration in large scale HIC applications.
95
Subsequent ion exchange and gel filtration steps were used, but the level of DNA in the purified exotoxin fraction remained high. To remove the DNA from the sample, a DEAE Sepharose Fast Flow anion exchange step was added prior to HIC. The goal was to capture as much DNA as possible at a conductivity high enough to prevent the protein from binding. The DEAE Sepharose Fast Flow was used to remove DNA at a high conductivity so that the subsequent Phenyl Sepharose Fast Flow (high sub) with higher selectivity for LysPE38 could be used as the capture step. The small scale development work was performed on XK columns. For the HIC step, the salt concentration in start buffer was 0.5 M ammonium sulphate. The column was first eluted with a 5 column volume gradient from 0.5 M ammonium sulphate to 0 M ammonium sulphate (buffer B). Another 5 column volumes of buffer B was used to elute the exotoxin (Fig. 50).
Column: Gel:
XK 16/20 Phenyl Sepharose Fast Flow (high sub), 15 cm bed height Sample: Flow-through from the DEAE Sepharose Fast Flow step. Ammonium sulphate added to 0.5 M Sample volume: 120 ml Flow rate: 60 cm/h (2 ml/min) Buffer A: 20 mM Tris™; 1 mM EDTA, pH 7.5 + 1 M ammonium sulphate Buffer B: 20 mM Tris; 1 mM EDTA, pH 7.5 Gradient: 50–100% B, 5 column volumes, followed by 5 column volumes of buffer B to elute the exotoxin %
40.0
30.0 Exotoxin 20.0
10.0
0.0 0.
96
100.
200.
min
Fig. 50. Laboratory scale purification of a recombinant Pseudomonas aeruginosa exotoxin on Phenyl Sepharose Fast Flow (high sub). (Work by National Institute of Health (NIH), Bethesda, U.S.A., in collaboration with Amersham Pharmacia Biotech, Uppsala, Sweden).
The process was scaled up to BioProcess Glass Columns (BPG 100/500), with the exception of the final gel filtration step. The HIC step was run under the same conditions as employed at small scale and no difference in performance was seen (Fig. 51). A highly homogeneous LysPE38 was obtained with very low content of DNA and endotoxin.
Fig. 51. Production scale purification of a recombinant Pseudomonas aeruginosa exotoxin on Phenyl Sepharose Fast Flow (high sub). (Work by National Institute of Health (NIH), Bethesda, U.S.A., in collaboration with Amersham Pharmacia Biotech, Uppsala, Sweden).
Column: Gel:
BPG 100/500 Phenyl Sepharose Fast Flow (high sub), 15 cm bed height Sample: Flow-through from DEAE Sepharose Fast Flow step. Ammonium sulphate added to 0.5 M Sample volume: 5.0 l Flow rate: 60 cm/h (4.7 l/h) Buffer A: 20 mM Tris; 1 mM EDTA, pH 7.5 + 1 M ammonium sulphate Buffer B: 20 mM Tris; 1 mM EDTA, pH 7.5 Gradient: 50–100% B, 5 column volumes, followed by 5 column volumes of buffer B to elute the exotoxin. %
50.0 40.0 Exotoxin 30.0 20.0 10.0 0.0 100.
200.
min
97
98
7 References 1.
Adsorption separation by salting out. Arkiv för Kemi, Mineralogi Geologi 26B (1948) 1–5, Tiselius, A.
2.
Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature 214 (1967) 1302–1304, Axén, R., Porath, J., Ernback, S.
3.
Preparation of adsorbents for biospecific affinity chromatography. I. Attachment of amino groupcontaining ligands to insoluble polymers by means of bifunctional oxiranes. J. Chromatog. 90 (1974) 87–98, Sundberg, L., Porath, J.
4.
Chromatography of lipophilic proteins on adsorbents containing mixed hydrophobic and ionic groups. Biochem. J. 126 (1972) 765–767, Yon, R.J.
5.
Hydrocarbon-coated Sepharoses. Use in the purification of glycogen phosphorylase. Biochem. Biophys. Res. Commun. 49 (1972) 383-390, Er-el, Z., Zaidenzaig, Y., Shaltiel, S.
6.
Hydrophobic affinity chromatography of proteins. Anal. Biochem. 52 (1973) 430–448, Hofstee, B.H.J.
7.
Hydrophobic chromatography: Use for purification of glycogen synthetase. Proc. Nat. Acad. Sci. USA 70 (1973) 778–781, Shaltiel, S., Er-el, Z.
8.
On the mode of adsorption of proteins to ”hydrophobic columns”. Biochem. Biophys. Res. Commun. 72 (1976) 108–113, Wilchek, M., Miron, T.
9.
Hydrophobic chromatography on homologous series of alkyl agaroses. A comparison of charged and electrically neutral column materials. J. Chromatog. 215 (1981) 211–228, Halperin, G., Breitenbach, M., Tauber-Finkelstein, M., Shaltiel, S.
10. Salting-out in amphiphilic gels as a new approach to hydrophobic adsorption. Nature 245 (1973) 465–466, Porath, J., Sundberg, L., Fornstedt, N., Olson, I. 11. Hydrophobic interaction chromatography. The synthesis and the use of some alkyl and aryl derivatives of agarose. J. Chromatog. 101 (1974) 281–288, Hjertén, S., Rosengren, J., Påhlman, S. 12. Hydrophobic interaction chromatography on Phenyl- and Octyl-Sepharose CL-4B. in: Chromatography of synthetic and biological macromolecules. Roger, E. Ed., Ellis Horwood Ltd., Chichester, England, 1978. Janson, J-C., Låås, T. 13. Hydrophobic interaction chromatography of serum proteins on Phenyl-Sepharose CL-4B. J. Chromatog. 242 (1982) 385–388, Hrkal, Z., Rejnkova, J. 14. Proteins of the kidney microvillar membrane. The amphipathic form of dipeptidyl peptidase IV. Biochem. J. 179 (1979) 379-395, McNair, R.D., Kenny, A.J.
99
15. Nuclear proteins. VI. Fractionation of chromosomal non-histone proteins using hydrophobic chromatography. Biochim. Biophys. Acta 563 (1979) 253–260, Comings, D.E., Miguel, A.G., Lesser, H.H. 16. Hydrophobic interaction chromatography as a tool in insulin receptor study. Proc. 2nd. Intl. Insulin Symp. (1980) 243–250, Kuehn, L., Meyer, H., Reinauer, H. 17. Hydrophobic interaction chromatography of proteins, nucleic acids, viruses and cells on non-charged amphiphilic gels, in: Methods of Biochemical Analysis (D. Glick, ed.), John Wiley & Sons, Inc., 1981, pp. 89–108. Hjertén, S. 18. Hydrophobic adsorbants for the isolation and purification of biosynthetic human growth hormone from crude fermentation mixtures. J. Chromatog. 361 (1986) 209–216, Lefort, S., Ferrara, P. 19. Purification of recombinant hepatitis B surface antigen produced by transformed Chinese hamster ovary (CHO) cell line grown in culture. Bioseparation 1 (1991) 397–408, Belew, M., Yafang, M., Bin, L., Berglöf, J., Janson, J-C. 20. Utilization of hydrophobic interaction for the formation of an enzyme reactor bed. Biotechnology & Bioengineering 17 (1975) 613–616, Caldwell, K.D., Axén, R., Porath, J. 21. Immobilization of phospholipid vesicles on alkyl derivatives of agarose gel beads. Biochim. Biophys. Acta 924 (1987) 185–192, Sandberg, M., Lundahl, P., Greijer, E., Belew, M. 22. The hydrophobic effect: formation of micelles and biological membranes. Tanfor, C., John Wiley & sons, New York, 1973. 23. Proteins, structure and molecular properties. Creighton, T.E., W.E. Freeman, New York, 1984. 24. Salt-promoted adsorption: recent developments. J. Chromatog. 376 (1986) 331–341, Porath, J. 25. Fractionation of proteins by hydrophobic interaction chromatography, with reference to serum proteins. Proceedings Intl. Workshop on Technology for Protein Separation & Improvement of Blood Plasma Fractionation. Reston, Virginia, 1977, 410–421, Hjertén, S. 26. Fractionation of proteins by fractional interfacial salting out on unsubstituted agarose gels. Biochem. Biophys. Res. Comm. 70 (1976) 1009–1013, von der Haar, F. 27. Salt effects on hydrophobic interactions in precipitation and chromatography of proteins: an interpretation of the lyotropic series. Arch. Biochem. Biophys. 183 (1977) 200–215, Melander, W., Horvath, C. 28. Solubility chromatography of serum proteins. II. Partial purification of the second component of guinea pig complement by solubility chromatography in concentrated ammonium sulphate solutions. J. Chromatog. 40 (1969) 53–61, Hoffmann, L.G., McGivern, P.W. 29. Role of physical forces in hydrophobic interaction chromatography. Separation & Purification Methods 9 (1980) 267–370, Srinivasan, R., Ruckenstein, E. 30. Non-ionic adsorption chromatography of proteins. J. Chromatog. 159 (1978) 57–69, Hofstee, B.H.J, Otillio, N.F. 31. General aspects of hydrophobic chromatography. Adsorption and elution characteristics of some skeletal muscle enzymes. Biochemistry 14 (1975) 754–760, Jennissen, H.P., Heilmeyer, I.M.G. 32. Hydrophobic interaction chromatography on non-charged Sepharose derivatives. Binding of a model protein, related to ionic strength, hydrophobicity of the substituent, and degree of substitution (determined by NMR). Biochim. Biophys. Acta 412 (1975) 51–61, Rosengren, J., Påhlman, S., Glad, M., Hjertén, S. 33. Agar derivatives for chromatography, electrophoresis & gel-bound enzymes. IV. Benzylated dibromopropanol cross-linked Sepharose as an amphophilic gel for hydrophobic salting out chromatography of enzymes with special emphasis on denaturing risks. J. Chromatog. 111 (1975) 373–387, Låås, T.
100
34. Multivalent interaction chromatography as exemplified by the adsorption and desorption of skeletal muscle enzymes on hydrophobic alkyl-ligands. J. Chromatog. 159 (1978) 71–83, Jennissen, H.P. 35. Synthesis of new hydrophobic adsorbents based on homologous series of uncharged alkyl sulphide agarose derivatives. J. Chromatog. 321 (1985) 305–317, Maisano, F., Belew, M., Porath, J. 36. Hydrophobic interaction chromatography on uncharged Sepharose derivatives. Effects of neutral salts on the adsorption of proteins. J. Chromatog. 131 (1977) 99–108, Påhlman, S., Rosengren, J., Hjertén, S. 37. Displacement of water and its control of biochemical reactions. Levin, S., Academic Press, New York, 1974. 38. Hydrophobic interaction chromatography of proteins on neutral adsorbents, in: Methods of protein separation, vol. 2. Catsimpoolas, N., Ed., Plenum Publishing Corporatin, New York, 1976. Hjertén, S. 39. Temperature-dependent van der Waals forces. Biophys. J. 10 (1970) 664–674, Parsegian, V.A., Ninham, B.W. 40. Separation of lipoamide dehydrogenase isoenzymes by affinity chromatography. Biochim. Biophys. Acta 384 (1975) 69–80, Visser, J., Strating, M. 41. Some general aspects of hydrophobic interaction chromatography. J. Chromatog. 87 (1973) 325– 331, Hjertén, S. 42. Gradient and isocratic High Performance Hydrophobic Interaction Chromatography of proteins on agarose columns. J. Chromatog. 359 (1986) 99–109, Hjertén, S., Yao, K., Eriksson, K.-O., Johansson, B. 43. Determination of the leakage from Phenyl Sepharose CL-4B, Phenyl Sepharose Fast Flow and Phenyl Superose in bulk and column experiments. J. Chromatog. 403 (1987) 85-98, Johansson, B.-L., Hellberg, U., Wennberg, O. 44. Comparison of molecular structures of proteins: Helix content; distribution of apolar residues. Arch. Biochem. Biophys. 138 (1970) 704–706, Klotz, I.M. 45. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55 (1971) 397–400, Lee, B., Richards, F.M. 46. Characterization of hydrophobic interaction and Hydrophobic Interaction Chromatography media by multivariate analysis. J. Chromatog. 599 (1992) 131–136, Kårsnäs, P., Lindblom, T. 47. Differences in retention behavior between small and large molecules in Ion Exchange Chromatography and Reversed Phase Chromatography. Anal. Biochem. 142 (1984) 134–139, Ekström, B., Jacobson, G. 48. Electron-donor-acceptor chromatography (EDAC) for biomolecules in aqueous solutions, in: Protein recognition of immobilized ligands, Alan R. Liss, Inc., (1989) pp. 101–122, Porath, J. 49. Identification, purification and partial sequence analysis of Autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 267 (1992) 2524–2529, Stracke, M.L., Krutzsch, H.C., Unsworth, E.J., Årestad, A., Cioce, V., Schiffmann, E., Liotta, L.A. 50. Expression, Purification and Crystallization of the HIV-1 Reverse Transeriptase (RT). AIDS Res. Hum. Retrovir. 6 (1990) 1297–1303, Unge, T., Ahola, H., Bhikhabhai, R., Bäckbro, K., Lövgren, S., Fenyö, E.M., Honigman, A., Panet, A., Gronowitz, G.S., Strandberg, B. 51. Factors involved in specific transcription by mammalian RNA polymerase II. Identification and characterization of Factor II H. J. Biol. Chem. 267 (1992) 2786–2793, Flores, O., Lu, H., Reinberg, D.
101
52. A multidimensional HPLC strategy for the purification of proteins and peptides for micro-sequence analysis: - The role of micropreparative ion exchange columns. Poster presented at the 10th International Symposium of Proteins, Peptides and Polynucleotides, Wiesbaden, Germany, October 1990, Nice, E., Fabri, L., Burgess, A., Simpson, R., Hellman, V., Andersson, K. 53. Isolation of Human Pituitary Prolactin. Biochim. Biophys. Acta 588 (1979) 368–379, Roos, P., Nyberg, F., Wide, L. 54. Phenyl-Sepharose-mediated Detergent-Exchange Chromatography: Its application to exchange of detergents bound to membrane proteins. Biochemistry 23 (1984) 6121–6126, Robinson, N.C., Wiginton, D., Talbert, L. 55. Characterization of the dermatan sulphate proteoglycans, DS-PGI and DS-PGII, from bovine articular cartilage and skin isolated by Octyl Sepharose chromatography. J. Biol. Chem. 264 (1989) 2876–2884, Choi, H.U., Johnson, T.L., Pal, S., Tang, L.-H., Rosenberg L., Neame, P.J. 56. Production and purification of murine monoclonal antibodies directed against HIV-1, for use in passive immunotherapy of HIV-1. Poster presented at Biotech 92; International Symposium; New Generation of Monoclonal Antibodies in Diagnosis and Therapy, Genoa, Italy, April 1992, Gilljam, G., Hinkula, J., Daniels, A.I., Wahren, B. 57. Development and a scale up study of a chromatographic downstream process for the purification of recombinant EGF. Poster presented at Ninth International Biotechnology Symposium, Crystal City, Virginia, USA, August 1992, Daniels, A.I., Pettersson, N.T. 58. Characterization of Phenyl Sepharose High Performance – a new 34 µm medium for Hydrophobic Interaction Chromatography. Poster presented at 32nd International Union of Pure and Applied Chemistry (IUPAC) Congress, Stockholm, Sweden, August 1989, Daniels, A.I., Weitman, A., Westin, G., Söderström, L. 59. Production of clinical grade recombinant Exotoxin A from E. Coli. Presented at Recovery of Biological Products VI, An Engineering Foundation Conference, Interlaken, Switzerland, September 1992, Tsai, A.M., Kaufman, J.B., Shiloach, J., Gallo, M., Fass, S. 60. Recombinant toxins for cancer treatment. Science 254 (1991) 1173–1177, Pastan, I., FitzGerald, D. 61. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Ångström resolution. Proc. Natl. Acad. Sci. USA 83 (1986) 1320–1324, Allured, V.S., Collier, R.J., Carroll, S.F., McKay, D.B. 62. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. Coli. Cell 48 (1987) 129–136, Hwang, J., FitzGerald, D.J., Adhya, S., Pastan, I. 63. Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin. J. Biol. Chem. 264 (1989) 14256–14261, Siegall, C.B., Chaudhary, V.K., FitzGerald, D.J., Pastan, I. 64. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA 88 (1991) 3358-3362, Pai, L.H., Batra, J.K., FitzGerald, D.J., Willingham, M.C., Pastan, I. 65. Solvent modulation in Hydrophobic Interaction Chromatography. Biotechnol. Appl. Biochem. 13 (1991) 151–172, Arakawa T., Narhi, L.O. 66. Hydrophobic Interaction Chromatography in alkaline pH. Anal. Biochem. 182 (1989) 266–270, Narhi, L.O., Kita, Y., Arakawa, T.
102
Ordering information
104
Product/Bulk media
Pack size
Phenyl Sepharose 6 Fast Flow (low sub)
200 ml 1l 5l
17-0965-05 17-0965 03 17-0965-04
Phenyl Sepharose 6 Fast Flow (high sub)
200 ml 1l 5l
17-0973-05 17-0973-03 17-0973-04
Butyl Sepharose 4 Fast Flow
200 ml 500 ml 5l
17-0980-01 17-0980-02 17-0980-04
Octyl Sepharose 4 Fast Flow
25 ml 200 ml 500 ml 1l 5l
17-0946-10 17-0946-02 17-0946-05 17-0946-03 17-0946-04
Phenyl Sepharose High Performance
75 ml 1l 5l
17-1082-01 17-1082-03 17-1082-04
Phenyl Sepharose CL-4B
50 ml 200 ml 10 l
17-0810-02 17-0810-01 17-0810-05
Octyl Sepharose CL-4B
50 ml 200 ml 10 l
17-0790-02 17-0790-01 17-0790-05
SOURCE™ 15ETH
50 ml 200 ml 1l
17-0146-01 17-0146-02 17-0146-04
SOURCE 15ISO
50 ml 200 ml 1l
17-0148-01 17-0148-02 17-0148-04
SOURCEPHE
50 ml 200 ml 1l 5l
17-0147-01 17-0147-02 17-0147-04 17-0147-05
Product/Prepacked columns
Bed volume
HiTrap™ HIC test kit HiLoad™ 16/10 Phenyl Sepharose HP HiLoad 26/10 Phenyl Sepharose HP Alkyl Superose HR 5/5 Alkyl Superose HR 10/10 Phenyl Superose HR 5/5 Phenyl Superose HR 10/10 Phenyl Superose PC 1.6/5 RESOURCE™ 15ETH RESOURCE 15ISO RESOURCE 15PHE RESOURCE HIC Test kit RESOURCE 15PHE PE 4.6/100
5 x 1 ml 20 ml 53 ml 1 ml 8 ml 1 ml 8 ml 0.1 ml 1 ml 1 ml 1 ml
Code No.
Code No. 17-1349-01 17-1085-01 17-1086-01 17-0586-01 17-0587-01 17-0519-01 17-0530-01 17-0772-01 17-1184-01 17-1185-01 17-1186-01 17-1187-01 17-1171-01
ISBN 91-970490-4-2
105
Production: RAK Design AB
Gel Filtration Handbook – Principles and Methods
Gel Filtration Principles and Methods
www.chromatography.amershambiosciences.com Back to Collection 18-1022-18 Edition AI
Handbooks from Amersham Biosciences
Antibody Purification ÄKTA, FPLC, PlusOne, HiLoad , HiTrap, HiPrep, Hybond, ECL, ECL Plus, BioProcess, MabSelect, Sephacryl, Sephadex, Superose, Sepharose, Superdex and Drop Design are trademarks of Amersham Biosciences Limited.
Handbook 18-1037-46
Amersham and Amersham Biosciences are trademarks of Amersham plc.
The Recombinant Protein Handbook
Gel Filtration
Coomassie is a trademark of ICI plc.
Protein Amplification and Simple Purification 18-1142-75
Principles and Methods 18-1022-18
MicroSpin is a trademark of Lida Manufacturing Corp. Triton is a registered trademark of Union Carbide Chemicals and Plastics Co.
Percoll
Tween is a registered trademark of ICI Americas, Inc.
Methodology and Applications 18-1115-69
Eppendorf and Multipipette are trademarks of Eppendorf-Netheler-Hinz GmbH.
Ficoll-Paque Plus
All goods and services are sold subject to the terms and conditions of sale of the company within the Amersham Biosciences group that supplies them. A copy of these terms and conditions is available on request. © Amersham Biosciences AB 2002 – All rights reserved.
Protein Purification
Reversed Phase Chromatography
Handbook 18-1132-29
Principles and Methods 18-1134-16
Ion Exchange Chromatography
Expanded Bed Adsorption
Principles and Methods 18-1114-21
Principles and Methods 18-1124-26
Affinity Chromatography
Chromatofocusing
Principles and Methods 18-1022-29
with Polybuffer and PBE 18-1009-07
Hydrophobic Interaction Chromatography
Microcarrier cell culture
using immobilized pH gradients
Principles and Methods 18-1020-90
Principles and Methods 18-1140-62
Principles and Methods 80-6429-60
For in vitro isolation of lymphocytes 18-1152-69
GST Gene Fusion System Handbook 18-1157-58
BIACORE is a trademark of Biacore AB.
Amersham Biosciences AB, Björkgatan 30, SE-751 84 Uppsala, Sweden Amersham Biosciences UK Limited, Amersham Place, Little Chalfont, Buckinghamshire HP7 9NA, England Biosciences Corp., 800 Centennial Avenue, PO Box 1327, Piscataway NJ 08855, USA Amersham Biosciences Europe GmbH, Munzinger Strasse 9, D-79111 Freiburg, Germany
2-D Electrophoresis
Amersham Biosciences K.K., Sanken Bldg. 3-25-1, Hyakunincho Amersham Shinjuku-ku, Tokyo 169-0073, Japan.
Gel filtration Principles and Methods
1
Contents Introduction ............................................................................................................. 5 Symbols ................................................................................................................................................... 6 Common abbreviations .............................................................................................................................. 7
Chapter 1 Gel filtration in practice ........................................................................................... 9 Introduction ................................................................................................................ 9 Separation by gel filtration ........................................................................................... 9 Resolution in gel filtration .......................................................................................... 13 Media selection ......................................................................................................... 16 Sample preparation ................................................................................................... 20 Buffer composition and preparation ............................................................................. 21 Denaturing (chaotropic) agents and detergents ........................................................................................... 22
Column and media preparation ................................................................................... 23 Sample application .................................................................................................... 23 Elution and flow rates ................................................................................................ 24 Method development for high resolution fractionation ................................................... 26 Care of gel filtration media ......................................................................................... 27 Equipment selection .................................................................................................. 27 Scaling up ................................................................................................................ 27 BioProcess Media for large-scale production ................................................................ 29 Troubleshooting ......................................................................................................... 29
Chapter 2 Gel filtration media ................................................................................................ 35 Components of gel filtration media .............................................................................. 35 Superdex: first choice for high resolution, short run times and high recovery .................... 36 Separation options ................................................................................................................................... 38 Separation examples ................................................................................................................................ 39 Performing a separation ............................................................................................................................ 42 Cleaning ................................................................................................................................................. 43 Media characteristics ............................................................................................................................... 44 Chemical stability .................................................................................................................................... 44 Storage ................................................................................................................................................... 44
Sephacryl: fast, high recovery separations at laboratory and industrial scale .................... 45 Separation options ................................................................................................................................... 48 Separation examples ................................................................................................................................ 48 Performing a separation ............................................................................................................................ 49 Cleaning ................................................................................................................................................. 50 Media characteristics ............................................................................................................................... 51 Chemical stability .................................................................................................................................... 51 Storage ................................................................................................................................................... 51
Superose: broad fractionation range, but not suitable for industrial scale separations ....... 52
2
Separation options ................................................................................................................................... 53 Separation examples ................................................................................................................................ 54 Performing a separation ............................................................................................................................ 54 Cleaning ................................................................................................................................................. 55 Media characteristics ............................................................................................................................... 56 Chemical stability .................................................................................................................................... 56 Storage ................................................................................................................................................... 56
Sephadex: rapid group separation of high and low molecular weight substances, such as desalting, buffer exchange and sample clean up ............................................... 57 Separation options ................................................................................................................................... 59 Separation examples ................................................................................................................................ 61 Performing a separation ............................................................................................................................ 61 Scale up and processing large sample volumes ........................................................................................... 66 Media characteristics ............................................................................................................................... 68 Column Packing ...................................................................................................................................... 68 Cleaning ................................................................................................................................................. 68 Chemical stability .................................................................................................................................... 68 Storage ................................................................................................................................................... 69
Chapter 3 Gel filtration in theory ............................................................................................ 71 Defining the process .................................................................................................. 71 Selectivity curves and media selection ......................................................................... 74 Resolution ................................................................................................................ 75
Chapter 4 Molecular weight determination and molecular weight distribution analysis ............. 79 Chapter 5 Sephadex LH-20 .................................................................................................... 81 Separation options ................................................................................................................................... 82 Separation examples ................................................................................................................................ 82 Packing a column .................................................................................................................................... 83 Performing a separation ............................................................................................................................ 84 Cleaning ................................................................................................................................................. 84 Medium characteristics ............................................................................................................................ 84 Chemical stability .................................................................................................................................... 85 Storage ................................................................................................................................................... 85 Transferring Sephadex LH-20 between organic solvents ............................................................................... 85
Chapter 6 Gel filtration in a Purification Strategy (CIPP) ........................................................... 87 Applying CIPP ............................................................................................................ 87 Selection and combination of purification techniques ................................................... 88 Gel filtration as a polishing step ................................................................................................................ 91
3
Appendix 1 Column packing and preparation ............................................................................ 93 Columns for packing gel filtration media ...................................................................... 93 Checking column efficiency ........................................................................................ 95 Column packing for high resolution fractionation using Superdex prep grade and Sephacryl High Resolution ......................................................................................... 95 Column packing for group separations using Sephadex .................................................. 98
Appendix 2 Sephadex and Darcy's law .................................................................................... 102 Appendix 3 Sample preparation .............................................................................................. 103 Sample stability ..................................................................................................................................... 103 Sample clarification ............................................................................................................................... 104
Specific sample preparation steps ............................................................................. 105 Removal of lipoproteins ............................................................................................ 108 Removal of phenol red ............................................................................................. 108 Removal of low molecular weight contaminants .......................................................... 108
Appendix 4 Selection of purification equipment ...................................................................... 109 Appendix 5 Converting from linear flow (cm/hour) to volumetric flow rates (ml/min) and vice versa ........................................................................ 110 Appendix 6 Conversion data: proteins, column pressures ........................................................ 111 Appendix 7 Table of amino acids ............................................................................................ 112 Appendix 8 Analytical assays during purification .................................................................... 114 Appendix 9 Storage of biological samples .............................................................................. 116 Additional reading and reference material ............................................................ 117 Ordering information ............................................................................................ 118
4
Introduction Biomolecules are purified using chromatography techniques that separate them according to differences in their specific properties, as shown in Figure 1. Property
Technique
Size
Gel filtration (GF), also called size exclusion
Charge
Ion exchange chromatography (IEX)
Hydrophobicity
Hydrophobic interaction chromatography (HIC) Reversed phase chromatography (RPC)
Biorecognition (ligand specificity)
Affinity chromatography (AC)
Gel filtration
Hydrophobic interaction
Ion exchange
Affinity
Reversed phase
Fig. 1. Separation principles in chromatography purification.
For more than forty years since the introduction of Sephadex™, gel filtration has played a key role in the purification of enzymes, polysaccharides, nucleic acids, proteins and other biological macromolecules. Gel filtration is the simplest and mildest of all the chromatography techniques and separates molecules on the basis of differences in size. The technique can be applied in two distinct ways: 1. Group separations: the components of a sample are separated into two major groups according to size range. A group separation can be used to remove high or low molecular weight contaminants (such as phenol red from culture fluids) or to desalt and exchange buffers. 2. High resolution fractionation of biomolecules: the components of a sample are separated according to differences in their molecular size. High resolution fractionation can be used to isolate one or more components, to separate monomers from aggregates, to determine molecular weight or to perform a molecular weight distribution analysis. Gel filtration can also be used to facilitate the refolding of denatured proteins by careful control of changing buffer conditions.
5
Gel filtration is a robust technique that is well suited to handling biomolecules that are sensitive to changes in pH, concentration of metal ions or co-factors and harsh environmental conditions. Separations can be performed in the presence of essential ions or cofactors, detergents, urea, guanidine hydrochloride, at high or low ionic strength, at 37 °C or in the cold room according to the requirements of the experiment. This handbook describes the use of gel filtration for the purification and separation of biomolecules, with a focus on practical information for obtaining the best results. The media available, selection criteria and examples with detailed instructions for the most common applications are included, as well as the theoretical principles behind the technique. The first step towards a successful separation is to select the correct medium and this handbook focuses on the most up-to-date gel filtration media and prepacked columns. The biocompatibility, stability and utility of gel filtration media from Amersham Biosciences have made these products the standard choice in practically every laboratory using the technique. A wide variety of prepacked columns and ready to use media is available. The illustration on the inside cover shows the range of handbooks from Amersham Biosciences that have been produced to ensure that chromatography and other separation techniques are used easily and effectively at any scale, in any laboratory and for any application.
Symbols this symbol indicates general advice which can improve procedures or provide recommendations for action under specific situations. this symbol denotes advice which should be regarded as mandatory and gives a warning when special care should be taken. this symbol highlights troubleshooting advice to help analyse and resolve difficulties that may occur. chemicals, buffers and equipment. experimental protocol.
6
Common abbreviations In chromatography GF: gel filtration (sometimes referred to as SEC: size exclusion chromatography) IEX: ion exchange chromatography (also seen as IEC) AC: affinity chromatography RPC: reverse phase chromatography HIC: hydrophobic interaction chromatography CIPP: Capture, Intermediate Purification and Polishing MPa: megapascals psi: pounds per square inch SDS: sodium dodecyl sulphate CIP: cleaning in place A280nm, A214nm: UV absorbance at specified wavelength Mr: relative molecular weight N: column efficiency expressed as theoretical plates per meter Ve: elution volume is measured from the chromatogram and relates to the molecular size of the molecule. Vo: void volume is the elution volume of molecules that are excluded from the gel filtration medium because they are larger than the largest pores in the matrix and pass straight through the packed bed Vt: total column volume is equivalent to the volume of the packed bed (also referred to as CV) Rs: resolution, the degree of separation between peaks Kav and logMr: partition coefficient and log molecular weight, terms used when defining the selectivity of a gel filtration medium In product names HMW: high molecular weight LMW: low molecular weight HR: high resolution pg: prep grade PC: precision column SR: solvent resistant
7
8
Chapter 1 Gel filtration in practice Introduction Gel filtration separates molecules according to differences in size as they pass through a gel filtration medium packed in a column. Unlike ion exchange or affinity chromatography, molecules do not bind to the chromatography medium so buffer composition does not directly affect resolution (the degree of separation between peaks). Consequently, a significant advantage of gel filtration is that conditions can be varied to suit the type of sample or the requirements for further purification, analysis or storage without altering the separation. Gel filtration is well suited for biomolecules that may be sensitive to changes in pH, concentration of metal ions or co-factors and harsh environmental conditions. Separations can be performed in the presence of essential ions or cofactors, detergents, urea, guanidine hydrochloride, at high or low ionic strength, at 37 °C or in the cold room according to the requirements of the experiment. Purified proteins can be collected in any chosen buffer. This chapter provides general guidelines applicable to any gel filtration separation. A key step towards successful separation is to select the correct medium, so selection guides for the most up-to-date gel filtration media and prepacked columns are included. Other application examples and product-specific information are found in Chapter 2.
Separation by gel filtration
Interacting with medium
Low molecular weight
Sample injection
High molecular weight
Absorbance
Intermediate molecular weight
To perform a separation, gel filtration medium is packed into a column to form a packed bed. The medium is a porous matrix in the form of spherical particles that have been chosen for their chemical and physical stability, and inertness (lack of reactivity and adsorptive properties). The packed bed is equilibrated with buffer which fills the pores of the matrix and the space in between the particles. The liquid inside the pores is sometimes referred to as the stationary phase and this liquid is in equilibrium with the liquid outside the particles, referred to as the mobile phase. It should be noted that samples are eluted isocratically, i.e. there is no need to use different buffers during the separation. However, a wash step using the running buffer is usually included at the end of a separation to facilitate the removal of any molecules that may have been retained on the column and to prepare the column for a new run. Figure 2 shows the most common terms used to describe the separation and Figure 3 illustrates the separation process of gel filtration.
Vt
Vo Ve
Void volume Vo
Total column volume Vt
Vt – Vo
Vt – Vo
Fig. 2. Common terms in gel filtration.
9
1. Spherical particles of gel filtration medium are packed into a column.
2. Sample is applied to the column.
3. Buffer (mobile phase) and sample move through the column. Molecules diffuse in and out of the pores of the matrix (also described as partitioning of the sample between the mobile phase and the stationary phase). Smaller molecules move further into the matrix and so stay longer on the column.
4. As buffer passes continuously through the column, molecules that are larger than the pores of the matrix are unable to diffuse into the pores and pass through the column. Smaller molecules diffuse into the pores and are delayed in their passage down the column.
Diffusion Diffusion out of the pores Buffer
Buffer
Ve Vt – Vo
10
Interacting with medium Vt
Vo
Fig. 3. Process of gel filtration.
Low molecular weight
Sample injection
5. Large molecules leave the column first followed by smaller molecules in order of their size. The entire separation process takes place as one total column volume (equivalent to the volume of the packed bed) of buffer passes through the gel filtration medium.
High molecular weight
Absorbance
Intermediate molecular weight
Diffusion into the pores
Group separation Gel filtration is used in group separation mode to remove small molecules from a group of larger molecules and as a fast, simple solution for buffer exchange. Small molecules such as excess salt (desalting) or free labels are easily separated. Samples can be prepared for storage or for other chromatography techniques and assays. Gel filtration in group separation mode is often used in protein purification schemes for desalting and buffer exchange. For further details refer to Chapter 2, page 57 and the Protein Purification Handbook from Amersham Biosciences. Sephadex G-10, G-25 and G-50 are used for group separations. Large sample volumes up to 30% of the total column volume (packed bed) can be applied at high flow rates using broad, short columns. Figure 4 shows the elution profile (chromatogram) of a typical group separation. Large molecules are eluted in or just after the void volume, Vo as they pass through the column at the same speed as the flow of buffer. For a well packed column the void volume is equivalent to approximately 30% of the total column volume. Small molecules such as salts that have full access to the pores move down the column, but do not separate from each other. These molecules usually elute just before one total column volume, Vt, of buffer has passed through the column. In this case the proteins are detected by monitoring their UV absorbance, usually at A280nm, and the salts are detected by monitoring the conductivity of the buffer. A 280 nm UV 280 nm Conductivity 0.15 (His)6 protein
Sample:
0.10
Column: Buffer:
Salt
0.05
(His)6 protein eluted from HiTrap™ Chelating HP with sodium phosphate 20 mM, sodium chloride 0.5 M, imidazole 0.5 M, pH 7.4 HiTrap Desalting 5 ml Sodium phosphate 20 mM, sodium chloride 0.15 M, pH 7.0
void volume Vo, total column volume Vt Inject Vt
Vo 0 0
1
2 min
Fig. 4. Typical chromatogram of a group separation. The UV (protein) and conductivity (salt) traces enable pooling of the desalted fractions and facilitate optimization of the separation.
Refer to Chapter 2, page 57 for detailed information on group separation of high and low molecular weight substances, i.e. desalting, buffer exchange and sample clean up using Sephadex. Refer to Chapter 3 for detailed information on the theory of gel filtration.
11
High resolution fractionation Gel filtration is used in fractionation mode to separate multiple components in a sample on the basis of differences in their size. The goal may be to isolate one or more of the components, to determine molecular weight, or to analyze the molecular weight distribution in the sample (refer to Chapter 4 for details of molecular weight determination and distribution analysis). The best results for high resolution fractionation will be achieved with samples that originally contain few components or with samples that have been partially purified by other chromatography techniques (in order to eliminate proteins of similar size that are not of interest). High resolution fractionation by gel filtration is well suited for the final polishing step in a purification scheme. Monomers can be separated from aggregates (difficult to achieve by any other technique) and samples can be transferred to a suitable buffer for assay or storage. Gel filtration can be used directly after any of the chromatography techniques such as ion exchange, chromatofocusing, hydrophobic interaction or affinity since the components from any elution buffer will not affect the final separation. For further details on using gel filtration in a purification strategy, refer to Chapter 6 and the Protein Purification Handbook from Amersham Biosciences. Figure 5 shows the theoretical elution profile (chromatogram) of a high resolution fractionation. Molecules that do not enter the matrix are eluted in the void volume, Vo as they pass directly through the column at the same speed as the flow of buffer. For a well packed column the void volume is equivalent to approximately 30% of the total column volume (packed bed). Molecules with partial access to the pores of the matrix elute from the column in order of decreasing size. Small molecules such as salts that have full access to the pores move down the column, but do not separate from each other. These molecules usually elute just before one total column volume, Vt, of buffer has passed through the column. high molecular weight
Absorbance
low molecular weight
sample injection volume
void volume Vo total column volume Vt
intermediate molecular weight equilibration Vt
Vo
1 cv Column Volumes (cv)
Fig. 5. Theoretical chromatogram of a high resolution fractionation (UV absorbance).
12
Resolution in gel filtration Many factors influence the final resolution (the degree of separation between peaks of a gel filtration separation): sample volume, the ratio of sample volume to column volume, column dimensions, particle size, particle size distribution, packing density, pore size of the particles, flow rate, and viscosity of the sample and buffer. The molecular weight range over which a gel filtration medium can separate molecules is referred to as the selectivity of the medium (see selection guide for gel giltration media on page 18). Resolution is a function of the selectivity of the medium and the efficiency of that medium to produce narrow peaks (minimal peak broadening), as illustrated in Figure 6. The success of gel filtration depends primarily on choosing conditions that give sufficient selectivity and counteract peak broadening effects during the separation.
high efficiency
low efficiency
Fig. 6. Dependence of resolution on selectivity and the counteraction of peak broadening.
After selecting a gel filtration medium with the correct selectivity, sample volume and column dimensions become two of the most critical parameters that will affect the resolution of the separation.
13
Sample volume and column dimensions Sample volumes are expressed as a percentage of the total column volume (packed bed). Using smaller sample volumes helps to avoid overlap if closely spaced peaks are eluted. Figure 7 illustrates how sample volume can influence a high resolution fractionation. 1)
25 µl,1.0 ml/min (76 cm/h) A 280 nm 0.25
Vo
Vt
0.20 0.15 0.10 0.05
0.00 0.0
5.0
10.0
15.0
20.0
25.0 min
250 µl,1.0 ml/min (76 cm/h)
2)
Column: Superdex™ 200 HR 10/30 (Vt: 24 ml) Sample: Mr Conc. (mg/ml) Thyroglobulin 669 000 3 Ferritin 440 000 0.7 IgG 150 000 3 Transferrin 81 000 3 Ovalbumin 43 000 3 Myoglobin 17 600 2 Vitamin B12 1 355 0.5 Sample concentration: 15.2 mg/ml Sample volumes: 1) 25 µl (0.1% × Vt) 2) 250 µl (1% × Vt) 3) 1000 µl (4.2% × Vt) Buffer: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.0 Flow: 1.0 ml/min (76.4 cm/h)
A 280 nm Vo
Vt
0.15
0.10
0.05
0.00 0.0
3)
5.0
10.0
15.0
20.0
25.0 min
1 000 µl,1.0 ml/min (76 cm/h) A 280 nm Vo
Vt
0.10
0.05
0.00 0.0
5.0
10.0
15.0
20.0
25.0 min
Fig. 7. Influence of sample volume on resolution.
For group separations sample volumes up to 30% of the total column volume can be applied. For high resolution fractionation a sample volume from 0.5–4% of the total column volume is recommended, depending on the type of medium used. For most applications the sample volume should not exceed 2% to achieve maximum resolution. Depending on the nature of the specific sample, it may be possible to load larger sample volumes, particularly if the peaks of interest are well resolved. This can only be determined by experimentation. 14
For analytical separations and separations of complex samples, start with a sample volume of 0.5% of the total column volume. Sample volumes less than 0.5% do not normally improve resolution. To increase the capacity of a gel filtration separation samples can be concentrated. Avoid concentrations above 70 mg/ml protein as viscosity effects may interfere with the separation. Sample dilution is inevitable because diffusion occurs as sample passes through the column. In order to minimize sample dilution use a maximum sample volume that gives the resolution required between the peaks of interest.
Resolution, R s
The ratio of sample volume to column volume influences resolution, as shown in Figures 8a and 8b, where higher sample volume to column volume ratios give lower resolution. Column volumes are normally selected according to the sample volumes to be processed. However, since larger sample volumes may require significantly larger column volumes, there may be occasions when it is more beneficial to repeat the separation several times on a smaller column and pool the fractions of interest or to concentrate the sample (see Appendix 3 on sample preparation).
1.5
Column: Buffer: Sample:
1.0
Sample concentration: Flow:
HiLoad™ 16/60 Superdex 200 prep grade 50 mM NaPO 4, 0.1 M NaCl, pH 7.2 Solution of transferrin (Mr 81 000) and IgG (Mr 160 000) by equal weight 8 mg/ml 1 ml/min (30 cm/h)
0.5
0 0
4 5 2 3 Sample volume (% of column volume)
1
Fig. 8a. Influence of sample volume on the resolution of transferrin and IgG on prepacked HiLoad 16/60 Superdex 200 prep grade.
HiPrepTM 16/60 16
Columns:
HiPrep 16/60 Sephacryl™ S-100 HR HiPrep 16/60 Sephacryl S-200 HR HiPrep 16/60 Sephacryl S-300 HR Buffer: 50 mM NaPO 4, 0.15 M NaCl, 0.02% NaN3, pH 7.0 Sample: Ovalbumin Flow: 0.66 ml/min (20 cm/h) Protein load: 8 mg
14 S-300
Resolution, R s
12 10
S-200 8 6
S-100
4 2 0 0
1
2
3
4 5 Sample volume, ml
Fig. 8b. Influence of sample volume on the resolution of ovalbumin and IgG on different prepacked columns of HiPrep 16/60 Sephacryl High Resolution.
15
The height of the packed bed affects both resolution and the time taken for elution. The resolution in gel filtration increases as the square root of bed height. Doubling the bed height gives an increase in resolution equivalent to È2 = 1.4 (40%). For high resolution fractionation long columns will give the best results and a bed height between 30–60 cm should be satisfactory. Sufficient bed height together with a low flow rate allows time for all 'intermediate' molecules to diffuse in and out of the matrix pores and give sufficient resolution. If a very long column is judged to be necessary, the effective bed height can be increased by using columns, containing the same media, coupled in series. Refer to Chapter 3 for detailed information on the theory of gel filtration.
Media selection Chromatography media for gel filtration are made from porous matrices chosen for their inertness and chemical and physical stability. The size of the pores within a particle and the particle size distribution are carefully controlled to produce a variety of media with different selectivities. Today's gel filtration media cover a molecular weight range from 100 to 80 000 000, from peptides to very large proteins and protein complexes. The selectivity of a gel filtration medium depends solely on its pore size distribution and is described by a selectivity curve. Gel filtration media are supplied with information on their selectivity, as shown for Superdex in Figure 9. The curve has been obtained by plotting a partition coefficient Kav against the log of the molecular weight for a set of standard proteins (see Chapter 3 Gel filtration in theory for calculation of Kav). K av 1.00
Superdex peptide 0.75 Superdex 75 Superdex 200 Superdex 30 prep grade Superdex 75 prep grade
0.50
Superdex 200 prep grade
Fig. 9. Selectivity curves for Superdex.
16
1000000
100000
10000
1000
100
10
0.25
Log Mr
Selectivity curves are usually quite linear over the range Kav = 0.1 to Kav = 0.7 and it is this part of the curve that is used to determine the fractionation range of a gel filtration medium (Figure 10).
1.0
0.7
Kav
Exclusion limit 0.1 Log Mr Fractionation range
Fig. 10. Defining fractionation range and exclusion limit from a selectivity curve.
The fractionation range defines the range of molecular weights that have partial access to the pores of the matrix, i.e. molecules within this range should be separable by high resolution fractionation. The exclusion limit for a gel filtration medium, also determined from the selectivity curve, indicates the size of the molecules that are excluded from the pores of the matrix and therefore elute in the void volume. The steeper the selectivity curve, the higher the resolution that can be achieved. When choosing an appropriate medium, consider two main factors: 1. The aim of the experiment (high resolution fractionation or group separation). 2. The molecular weights of the target proteins and contaminants to be separated. The final scale of purification should also be considered. Figure 11 on the next page gives a step by step guide to media selection.
17
Superdex Upper - medium pressure systems High recovery High stability High selectivity
High selectivity (0.1–600 kD) Wide Mr range ( 1–5 000 kD)
Preparative (0.5–5 000 kD)
Preparative & analytical (0.1–5 000 kD) Preparative /Macro fractionation (1–500 000 kD)
2 11 3
4
5
6
1 2
4 5
High selectivity (0.5–600 kD) Wide M r range ( 1–5 000 kD)
7
14 13 12
7
6
3
200
10
9
75
8
Peptide 10 6
10 5
10 4
10 3
Superose TM
Analytical (0.1–5 000 kD)
1. Thyroglobulin 2. Ferritin 3. Aldolase 4. Albumin 5. Ovalbumin 6. Chymotrypsinogen A 7. Ribonuclease A 8. Cytochrome C 9. Aprotinin 10. Gastrin I 11. Substance P 12. (Gly) 6 13. (Gly)3 14. Gly
1
10 2 Mr (approx)
1. Thyroglobulin 2. Ferritin 3. Aldolase 4. Albumin 5. Ovalbumin 6. Chymotrypsinogen A 7. Ribonuclease A
1 2
Medium pressure systems High recovery Wide M r fractionation range
4 3
5 6 7
2
1
3 4
6 7 5
Superose 6 Superose 12
10 6
10 5
10 4 Mr (approx)
Sephacryl 1 2
Lower - medium pressure systems Macromolecule separation Product line covering wide fractionation range
1
2 5 34
1 2
3
3
1. Thyroglobulin 2. Ferritin 3. Aldolase 4. Albumin 5. Ovalbumin 6. Chymotrypsinogen A 7. Ribonuclease A
67
45
S - 300
6 4 5
6
S - 200
7
S - 100 10 6
10 5
10 4
Mr (approx)
Fractionation NaCl
Group separation Desalting
Sephadex
BSA
Desalting <70% organic solvents
Group separation
0
10
20
30
>70% organic solvents
40
50
Time (seconds)
O
1
2
1.
Sephadex LH
CH 3
O
C O
Sta
250 mg
2. CH 3 C HN
254mg
re he
C O
Separation in (nonpolar) organic solvents
rt
C OH NH
68
Time (h)
Fig. 11. Gel filtration media selection guide.
Superdex is the first choice for high resolution, short run times and high recovery. Sephacryl is suitable for fast, high recovery separations at laboratory and industrial scale. Superose offers a broad fractionation range, but is not suitable for large scale or industrial scale separations. After deciding upon Superdex, Sephacryl or Superose, select the medium with the fractionation range that covers the molecular weight values of interest in your sample. In cases where two media have a similar fractionation range: select the medium with the steepest selectivity curve for best resolution of all components in the sample. When you are interested in a specific component, select the medium where the log molecular weight of the target component falls in the middle of the selectivity curve. Sephadex is ideal for rapid group separations such as desalting and buffer exchange. Sephadex is used at laboratory and production scale, before, between or after other chromatography purification steps. 18
OH
Fractionation range (globular proteins) Peptides Semi-preparative
Small proteins
Analytical separation
Polynucleotides Proteins DNA-fragment
Preparative separation
Semi-preparative Analytical separation Preparative separation
Superdex 75 prep grade Superdex 200 prep grade
Large proteins
Macro molecules
10
6
10
7
10
8
Superose 12 prep grade
Sephacryl S-100 HR Sephacryl S-200 HR Sephacryl S-300 HR
Sephacryl S-500 HR
Small particles Virus
Sephacryl S-1000 SF
Low molecular steroids
5
Superose 6 prep grade
Sephacryl S-400 HR
Proteins
10
Superose 12
Purification of macromolecules
Small peptides
4
Superose 6
Fractionation of macromolecules
Peptides/small proteins
10
Superdex 200
Proteins DNA-fragment
Proteins
3
High resolution
Superdex 30 prep grade
Intermediate fractionation range Wide fractionation range Intermediate fractionation range
10
Superdex 75
Small proteins Polynucleotides
Wide fractionation range
2
Superdex Peptide
Peptides
Small proteins Proteins
10
Sephadex Sephadex Sephadex Sephadex Sephadex
G-10 G-25 G-25 G-25 G-50
Exclusion limit SF F M F
Exclusion limit Exclusion limit
Sephadex LH-20
Terpenoids, lipids and peptides
• Sephadex G-25 is recommended for the majority of group separations involving globular proteins. This medium is excellent for removing salt and other small contaminants away from molecules that are greater than Mr 5 000. • Sephadex G-10 is well suited for the separation of biomolecules such as peptides (Mr >700) from smaller molecules (Mr >100). • Sephadex G-50 is suitable for the separation of molecules Mr >30 000 from molecules Mr <1 500 such as labeled protein or DNA from free label. For group separations select gel filtration media so that high molecular weight molecules are eluted at the void volume, with minimum peak broadening or dilution and minimum time on the column. The lowest molecular weight substances should appear by the time one column volume of buffer has passed through the column.
19
Sample preparation Correct sample preparation is extremely important for gel filtration. Simple steps to clarify a sample before applying it to a column will avoid the risk of blockage, reduce the need for stringent washing procedures and extend the life of the packed chromatography medium. Samples must be clear and free from particulate matter, particularly when working with bead sizes of 34 µm or less. Appendix 3 contains an overview of sample preparation techniques. For small sample volumes a syringe-tip filter of cellulose acetate or PVDF can be sufficient. Sample buffer composition The pH, ionic strength and composition of the sample buffer will not significantly affect resolution as long as these parameters do not alter the size or stability of the proteins to be separated and are not outside the stability range of the gel filtration medium. The sample does not have to be in exactly the same buffer as that used to equilibrate and run through the column. Sample is exchanged into the running buffer during the separation, an added benefit of gel filtration. Sample concentration and viscosity Gel filtration is independent of sample mass, and hence sample concentration, as can be seen in Figure 12. Hence high resolution can be maintained despite high sample concentration and, with the appropriate medium, high flow rates.
Medium: Column: Column volume: Sample: Sample volume: Buffer: Flow:
Superdex 200 prep grade XK 16/70 140 ml Solution of transferrin (Mr 81 000) and IgG (Mr 160 000) by equal weight 0.8% × Vt 0.05 sodium phosphate, 0.1 M sodium chloride, pH 7.2 1 ml/min (30 cm/h)
0
24
48
72
96
120
155
mg/ml sample
0.0
0.2
0.4
0.6
0.8
1.0
1.2
mg sample/ml packed bed
Resolution, R S
1.5
1.0
0.5
0.0
Fig. 12. Influence of sample concentration on the resolution of transferrin and IgG on Superdex 200 prep grade.
20
However, the solubility or the viscosity of the sample may limit the concentration that can be used. A critical variable is the viscosity of the sample relative to the running buffer, as shown by the change in elution profiles of haemoglobin and NaCl at different sample viscosities in Figure 13.
Concentration
Too high sample viscosity causes instability of the separation and an irregular flow pattern. This leads to very broad and skewed peaks and back pressure can increase.
A
B
C
Elution Volume
Fig. 13. Elution diagrams obtained when haemoglobin (blue) and NaCl (red) were separated. Experimental conditions were identical except that the viscosities were altered by the addition of increasing amounts of dextran. A deterioration of the separation becomes apparent. (A lower flow rate will not improve the separation.)
Samples should generally not exceed 70 mg/ml protein. Dilute viscous samples, but note sample volume (refer to page 14 for more information on the importance of sample volume). Remember that viscosity varies with temperature. Sample volume Sample volume is one of the most important parameters in gel filtration. Refer to page 14 for more information.
Buffer composition and preparation Buffer composition does not directly influence the resolution obtained in gel filtration since the separation should depend only on the sizes of the different molecules. The most important consideration is the effect of buffer composition on the shape or biological activity of the molecules of interest. For example, the pH and ionic strength of the buffer and the presence of denaturing agents or detergents can cause conformational changes, dissociation of proteins into subunits, dissociation of enzymes and cofactors, or dissociation of hormones and carrier proteins. Select a buffer and pH that are compatible with protein stability and activity and in which the product of interest should be collected. Use a buffer concentration that is sufficient to 21
maintain buffering capacity and constant pH. Use up to 0.15 M NaCl to avoid non-specific ionic interactions with the matrix (shown by delays in peak elution). Note that some proteins may precipitate in low ionic strength solutions. Use volatile buffers such as ammonium acetate, ammonium bicarbonate or ethylenediamine acetate if the separated product is to be lyophilized. Use high quality water and chemicals. Solutions should be filtered through 0.45 µm or 0.22 µm filters. It is essential to degas buffers before any gel filtration separation as air bubbles can significantly affect performance. Buffers will be degassed if they are filtered under vacuum. When working with a new sample try these conditions first: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.0 or select the buffer into which the product should be eluted for the next step such as further purification, analysis or storage. Avoid extreme changes in pH or other conditions that may cause inactivation or even precipitation. If the sample precipitates in a gel filtration column, the column will be blocked, possibly irreversibly, and the sample may be lost.
Denaturing (chaotropic) agents and detergents Denaturing agents such as guanidine hydrochloride or urea can be used for initial solubilization of a sample and in gel filtration buffers in order to maintain solubility of the sample. However, because they will denature the protein, they should be avoided unless denaturation is required. Modern media such as Superdex, Sephacryl and Superose are in general more suitable than classical media such as Sepharose™ or Sephadex for working under dissociating or denaturing conditions or at extreme pH values. Detergents are useful as solubilizing agents for proteins with low aqueous solubility such as membrane components and will not affect the separation. If denaturing agents or detergents are necessary to maintain the solubility of the sample, they should be present in both the running buffer and the sample buffer. Note that high concentrations of detergent will increase the viscosity of the buffer so that lower flow rates may be necessary to avoid over-pressuring the column packing. If proteins that have been solubilized in a denaturant or detergent are seen to precipitate, elute later than expected or be poorly resolved during gel filtration, add a suitable concentration of the denaturing agent or detergent to the running buffer. Urea or guanidine hydrochloride are very useful for molecular weight determination. The presence of these denaturing agents in the running buffer maintains proteins and polypeptides in an extended configuration. For accurate molecular weight determination the calibration standards must also be run in the same buffer. Note that selectivity curves are usually determined using globular proteins so they do not reflect the behavior of denatured samples. Gel filtration can be used to exchange a protein solubilized initially in, for example SDS, into a more gentle detergent such as Triton™ X-100 without losing solubility. 22
Column and media preparation To perform a separation, gel filtration medium is packed into a column 30–60 cm in height for high resolution fractionation and up to 10 cm in height for group separations. The volume of the packed bed is determined by the sample volumes that will be applied. Efficient column packing is essential, particularly for high resolution fractionation. The efficiency of a packed column defines its ability to produce narrow symmetrical peaks during elution. Column efficiency is particularly important in gel filtration in which separation takes place as only a single column volume of buffer passes through the column. The uniformity of the packed bed and the particles influences the uniformity of the flow through the column and hence affects the shape and eventual peak width. Gel filtration media with high uniformity (lower particle size distribution) facilitate the elution of molecules in narrow peaks. Refer to Chapter 3 Gel filtration in theory and Appendix 1 for further information on column efficiency and column packing. Efficiency can be improved by decreasing the particle size of a medium. However, using a smaller particle size may increase back pressure so that flow rate needs to be decreased, lengthening the run time. Using prepacked columns is highly recommended to ensure the best performance and reproducible results. An evenly packed column ensures that, as the sample passes down the column, the component peaks are not unnecessarily broadened. Uneven packing causes peak broadening and high resolution results become impossible. Allow buffers, media or prepacked columns to reach the same temperature before beginning preparation. Rapid changes in temperature, for example removing packed columns from a cold room and applying buffer at room temperature, can cause air bubbles in the packing and affect the separation. Storage solutions and preservatives should be washed away thoroughly before using any gel filtration medium. Equilibrate the column with 1–2 column volumes of buffer before starting a separation.
Sample application The choice of sample application method depends largely on the volume to be applied and on the equipment available. Ensure that the sample is not diluted on the way to the column and that the top of the column bed is not disturbed during sample application. Samples can be applied automatically or manually. Apply samples directly to the column via a chromatography system, a peristaltic pump or a syringe. The choice of equipment depends largely on the size of column, the type of gel filtration medium and the sample volume. For example, a chromatography system will be required for a Superdex column whereas a syringe can be used with small prepacked columns such as HiTrap Desalting. Note that samples are applied by gravity feed to prepacked columns such as PD-10 Desalting.
23
Elution and flow rates Samples are eluted isocratically from a gel filtration column, using a single buffer system. After sample application the entire separation takes place as one column volume of buffer (equivalent to the volume of the packed bed) passes through the column. Use flow rates that allow time for molecules to diffuse in and out of the matrix (partitioning between the mobile phase and the stationary phase) in order to achieve a separation. The goal for any separation is to achieve the highest possible resolution in the shortest possible time. Figures 14a, 14b and 14c show that resolution decreases as flow rate increases and each separation must be optimized to provide the best balance between these two parameters. Put simply, maximum resolution is obtained with a long column and a low flow rate whereas the fastest run is obtained with a short column and a high flow rate. Suitable flow rates for high resolution fractionation or group separation are usually supplied with each product. The advantage of a higher flow rate (and consequently a faster separation) may outweigh the loss of resolution in the separation. Column: Superdex 200 HR 10/30 (Vt: 24 ml) Sample: Mr Conc. (mg/ml) Thyroglobulin 669 000 3 Ferritin 440 000 0.7 IgG 150 000 3 Transferrin 81 000 3 Ovalbumin 43 000 3 Myoglobin 17 600 2 Vitamin B12 1 355 0.5 Total sample concentration: 15.2 mg/ml Buffer: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.0 Flow: 1) 0.25 ml/min (19.1 cm/h) 2) 1.0 ml/min (76.4 cm/h)
1)
A 280 nm
2)
25 µl, 0.25 ml/min (19 cm/h)
0.30
Vo
Vt
A 280 nm
25 µl, 1.0 ml/min (76 cm/h) Vo
0.25
Vt
0.25 0.20 0.20 0.15 0.15 0.10
0.10
0.05
0.05 0.00 0.0
25.0
50.0
75.0
Fig. 14a. Influence of flow rate on resolution.
24
100.0 min
0.00 0.0
5.0
10.0
15.0
20.0
25.0 min
2.0
1.5 Resolution, R s
a b
1.0
Column: Buffer: Sample : Sample volume: Sample concentration:
HiLoad 16/60 Superdex 30 prep grade 50 mM sodium acetate, 0.1 M NaCl, pH 5.0 IGF-1 containing monomers and dimers 1 ml (0.8% × Vt) a) 1.25 mg/ml b) 5 mg/ml
0.5
0 0
20
40
60
80 Flow, cm/h
Fig. 14b. Resolution between two different concentrations of IGF-1 containing monomers and dimers at different flow rates.
HiPrep 16/60
3
Resolution, R s
Columns:
HiPrep 16/10 Sephacryl S-100 HR HiPrep 16/10 Sephacryl S-200 HR HiPrep 16/10 Sephacryl S-300 HR Buffer: 50 mM NaPO4, 0.15 M NaCl, 0.02% NaN3, pH 7.0 Sample: IgG, ovalbumin, cytochrome C, 1:2:1 Sample volume: 2.4 ml (2% × Vt) Total sample load: 8 mg
2 S-100 S-200 1
S-300
0 0.0
0.2
0.4
0.6
0.8
1.0 1.2 Flow, ml/min
Fig. 14c. Resolution between IgG, ovalbumin and cytochrome C at different flow rates.
If peaks are well separated at a low flow rate, increase the flow rate or shorten the column to save time. Alternatively, increase the sample volume and benefit from a higher capacity without significant loss of resolution. For group separations such as desalting, monitor the elution of protein at A280 and follow the elution of the salt peak using a conductivity monitor. Adjust flow rate and sample volume to balance speed of separation against an acceptable level of salt in the final sample. Recommended flow rates are given in the instructions supplied with each product. Flow rate is measured in simple volume terms, e.g. ml/min, but when comparing results between columns of different sizes it is useful to use the linear flow, cm/hour (see Appendix 5). Results obtained at the same linear flow on different size columns will be comparable as far as the effects of flow rate are concerned. Selecting a smaller particle size of the same medium (if available) can also help to achieve the the correct balance between flow rate and resolution. Smaller particles of the same medium can increase column efficiency, improve resolution and may allow the use of higher flow rates. However, smaller particles can also result in increased back pressure and this factor may become restrictive if the intention is to scale up the separation. 25
Include a wash step at the end of a run to facilitate the removal of any molecules that may have been retained on the column, to prevent cross-contamination and to prepare the column for a new separation. Controlling flow Accurate, reproducible control of the flow rate is not only essential for good resolution, but also for reliability in routine preparative work and repeated experiments. A pump is used to control liquid flow for most gel filtration separations, although gravity feed has been used in the past (see Appendix 1). Use a pump within a chromatography system (rather than a peristaltic pump or gravity feed) to fully utilize the high rigidity and excellent flow properties of Sephacryl, Superose or Superdex for high resolution fractionation. Always pump the buffer onto a column (rather than drawing the buffer through the column with the pump below). This reduces the risk of bubble formation as a result of suction. If you have packed the column yourself, always use a flow rate for separation that is less than the flow rate used for column packing. Use a syringe or pump with small prepacked columns such as HiTrap Desalting or gravity feed with PD-10 Desalting for group separations of small sample volumes. Gel filtration columns must not run dry. Ensure that there is sufficient buffer for long, unattended runs or that the pump is programmed to stop the flow after a suitable time. Columns that run dry must be repacked since the packed bed has been destroyed. Reversing flow through a gel filtration column should only be considered under cases of severe contamination. There is a risk that reversing the flow may cause channeling through the packed bed leading to poor resolution, loss of efficiency and the need to repack the column. Professionally packed columns are less likely to be affected, but extreme care must be taken.
Method development for high resolution fractionation Steps are given in order of priority. 1. Select the medium that will give the best resolution of the target protein(s), see media selection guide, page 18. 2. To ensure reproducibility and high resolution, select a prepacked column that is best suited to the volume of sample that needs to be processed (see Chapter 2 for details of prepacked columns containing Superdex, Sephacryl or Superose). 3. Select the highest flow rate that maintains resolution and minimizes separation time. Check recommended flow rates supplied in the instructions for the specific medium and column. 4. Determine the maximum sample volume that can be loaded without reducing resolution. Higher flow rates and viscous buffers yield higher operating pressures (remember that buffer viscosity increases when running at +4 °C). Check the maximum operating pressure of the packed column and set the upper pressure limit on the chromatography system accordingly.
26
If greater resolution is required, increase the bed height by connecting two columns containing the same medium in series. Alternatively, try a medium with the same or similar fractionation range, but with a smaller particle size. To process larger sample volumes, see scaling up on this page.
Care of gel filtration media When a gel filtration medium has been in use for some time, it may be necessary to remove precipitated proteins or other contaminants that can build up. The need for cleaning may show itself as the appearance of a colored band at top of the column, as a space between the upper adaptor and the bed surface, as a loss in resolution or as a significant increase in back pressure. Detailed cleaning procedures for each gel filtration medium are given in Chapter 2. In all cases, prevention is better than cure and routine cleaning is recommended. If an increase in back pressure is observed, either on the pressure monitor or by seeing the surface of the medium move downwards, check that the problem is actually caused by the column before starting the cleaning procedure. Disconnect one piece of equipment at a time (starting at the fraction collector), start the pump and check the pressure after each piece is disconnected. A dirty on-line filter is a common cause of increased back pressure. Check back pressure at the same stage during each run, since the value can vary within a run during sample injection or when changing to a different buffer. • Always use filtered buffers and samples to reduce the need for additional column maintenance. See Appendix 3 for further details on sample preparation. • Always use well degassed buffers to avoid the formation of air bubbles in the packed column during a run. • Buffers, prepacked columns and samples should be kept at the same temperature to prevent air bubbles forming in the column. • Filter cleaning solutions before use and always re-equilibrate the column with 2–3 column volumes of buffer before the next separation.
Equipment selection Appendix 4 provides a guide to the selection of systems recommended for gel filtration separation.
Scaling up After establishing a high resolution or group separation on a small column, it may be preferred to pack a larger column in order to process larger sample volumes in a single step. General guidelines for scaling up are shown below. Maintain
Increase
Bed height
Column diameter
Linear flow rate
Volumetric flow rate
Sample composition
Sample volume
27
When scaling up a gel filtration column, follow the points below: 1. Optimize the separation at small scale (see method development page 26). 2. Maintain the sample volume: column volume ratio and the sample concentration. 3. Increase the column volume by increasing the cross sectional area of the column. 4. Maintain the bed height. 5. Run the separation at the same linear flow rate as used on the smaller column (see Appendix 5). Refer to Appendix 1 for column selection and column packing. Different equipment factors may affect performance after scale-up. If the large scale column has a less efficient flow distribution system, or the large scale system introduces large dead volumes, peak broadening may occur. This will cause extra dilution of the product fraction or even loss of resolution if the application is sensitive to variations in efficiency. For certain media, e.g. Superdex, Superose or Sephadex, it is usually recommended to select a larger particle size. For high resolution fractionation, pack a small column containing the larger particles and repeat the separation to facilitate any optimization that may be needed to achieve the same resolution on the larger column. Scaling up on Sephadex G-25, even to production scale, is a straightforward and wellestablished process. Well known examples of commercial applications include buffer exchange in processes for removing endotoxins from albumin, and preparative steps during the production of vaccines. Figure 15 shows an example of a large scale buffer exchange step used during the production of albumin and IgG from human plasma. Column: Sample:
Eluent: Flow:
1 2
1 2
1 2
1 2
BPSS 400/600, 75 l 10 l human plasma 1: sample application 2: eluent application 0.025 M sodium acetate 240 l/h
1 2 A 280 Conductivity
Elution volume
Fig. 15. Chromatogram of the buffer exchange step on Sephadex G-25 Coarse during production of albumin and IgG from human plasma.
28
BioProcess Media for large-scale production Specific BioProcess™ Media have been designed for each chromatography stage in a process from Capture to Polishing. Large capacity production integrated with clear ordering and delivery routines ensure that BioProcess media are available in the right quantity, at the right place and at the right time. Amersham Biosciences can assure future supplies of BioProcess Media, making them a safe investment for long-term production. The media are produced following validated methods and tested under strict control to fulfill high performance specifications. A certificate of analysis is available with each order. Regulatory Support Files (RSF) contain details of performance, stability, extractable compounds and analytical methods. The essential information in these files gives an invaluable starting point for process validation, as well as providing support for submissions to regulatory authorities. Using BioProcess Media for every stage results in an easily validated process. High flow rate, high capacity and high recovery contribute to the overall economy of an industrial process. All BioProcess Media have chemical stability to allow efficient cleaning and sanitization procedures. Packing methods are established for a wide range of scales and compatible large-scale columns and equipment are available.
Troubleshooting This section focuses on practical problems that may occur when running a chromatography column. The diagrams indicate how a chromatogram may deviate from ideal behavior during a gel filtration separation. The following pages contain suggestions of possible causes and their remedies. Highly acidic or basic substances at low ionic strength or aromatic materials may behave differently during gel filtration, interacting with the matrix. For some applications this can be an advantage. For example aromatic peptides and other substances that differ only slightly in molecular weight can be separated on Sephadex. However this is not a true gel filtration separation.
29
Satisfactory separation Well resolved, symmetrical peaks.
Vo
Vt
Poor resolution Review factors affecting resolution (see page 13), including media selection, particle size, sample volume: column volume and flow rate.
Vo
Vt
Leading peaks Asymmetric peaks: sample elutes before void volume indicates channelling in column bed. Leading peaks can also be due to overpacking of column (packed at too high pressure or flow rate). Column may need to be repacked. Vo
Tailing peaks Asymmetric peaks: sample application uneven. Check top of column if possible. Ensure medium is evenly packed and that sample is applied without disturbing the packed bed. Tailing peaks can also be due to underpacking of column (packed at too low pressure or flow rate). Vo
Vo
30
Vt
Late elution Peaks seen after one column volume of buffer has passed through the column. Always include a wash step between runs to ensure removal of late eluting molecules. Molecules may be binding non-specifically to gel filtration medium. If the interaction is ionic in nature, increasing the concentration of sodium chloride (up to 150 mM) may help. If the interaction is hydrophobic in nature, reducing salt concentration, increasing pH or adding a detergent or organic solvent may help.
Situation
Cause
Remedy
Peak of interest is poorly resolved from other major peaks.
Sample volume is too high or sample has been incorrectly applied.
Decrease sample volume and apply carefully. Check bed surface and top filter for possible contamination.
Sample is too viscous.
Dilute with buffer, but check maximum sample volume. Maintain protein concentration below 70 mg/ml.
Sample filtered incorrectly.
Reequilibrate column, filter sample and repeat.
Column not mounted vertically.
Adjust column position. Column may need to be repacked.
Column is poorly packed.
Check column efficiency (see Appendix 1). Repack if needed. Use prepacked columns.
Column is dirty.
Clean and reequilibrate.
Incorrect medium.
Check selectivity curve. Check for adsorption effects. Consider effects of denaturing agents or detergents if present.
Large dead volumes.
Minimize dead volumes in tubings and connections.
Column too short.
See Appendix 1 for recommended bed heights.
Flow rate too high.
Check recommended flow rates. Reduce flow.
Uneven temperature.
Use a column with a water jacket.
Sample volume is different from previous runs.
Keep sample volume constant. Resolution is dependent on sample volume.
Ionic interactions between protein and matrix.
Maintain ionic strength of buffers above 0.05 M (preferably include 0.15 M NaCl).
Hydrophobic interactions between protein and matrix.
Reduce salt concentration to minimize hydrophobic interaction. Increase pH. Add suitable detergent or organic solvent, e.g. 5% isopropanol.
Sample has not been filtered properly.
Clean the column, filter the sample and repeat.
Sample has changed during storage.
Prepare fresh samples.
Column is not equilibrated sufficiently.
Repeat or prolong the equilibration step.
Proteins or lipids have precipitated on the column.
Clean the column or use a new column.
Column is overloaded with sample.
Decrease the sample load.
Microbial growth has occurred in the column.
Microbial growth rarely occurs in columns during use. To prevent infection of packed columns, store in 20% ethanol when possible.
Protein has changed during storage.
Prepare fresh samples.
Ionic interactions between protein and matrix.
Maintain ionic strength of buffers above 0.05 M (preferably include 0.15 M NaCl).
Hydrophobic interactions between protein and matrix.
Reduce salt concentration to minimize hydrophobic interaction. Add suitable detergent or organic solvent, e.g. 5% isopropanol.
Precipitation of protein in the column filter and/ or at the top of the bed.
If possible, clean the column, exchange or clean the filter or use a new column.
Protein elutes later than expected or even after running a total column volume.
Hydrophobic and/or ionic interactions between protein and matrix.
Reduce salt concentration to minimize hydrophobic interaction. Increase pH. Add suitable detergent or organic solvent e.g. 5% isopropanol. Increase salt concentration (up to 150 mM) to minimize ionic interaction.
Peaks elute late and are very broad.
Column is dirty.
Clean and reequilibrate.
Protein elutes earlier than expected (before the void volume)
Channelling in the column.
Repack column using a thinner slurry of medium. Avoid introduction of air bubbles.
Protein does not elute as expected.
Molecular weight or shape is not as expected.
31
Situation
Cause
Remedy
Leading or very rounded peaks in chromatogram.
Column overloaded.
Decrease sample load and repeat.
Tailing peaks.
Column is 'under' packed.
Check column efficiency (see Appendix 1). Repack using a higher flow rate. Use prepacked columns.
Leading peaks.
Column is 'over' packed.
Check column efficiency (see Appendix 1). Repack using a slower flow rate. Use prepacked columns.
Medium/beads appears in eluent.
Bed support end piece is loose or broken.
Replace or tighten.
Column operated at too high pressure.
Do not exceed recommended operating pressure for medium or column.
Protein may be unstable or inactive in the buffer.
Determine the pH and salt stability of the protein.
Enzyme separated from co-factor or similar.
Test by pooling aliquots from the fractions and repeating the assay.
Protein may have been degraded by proteases.
Add protease inhibitors to the sample and buffers to prevent proteolytic digestion. Run sample through a medium such as Benzamidine 4 Fast Flow (high sub) to remove trypsin-like serine proteases.
Adsorption to filter during sample preparation.
Use another type of filter.
Sample precipitates.
May be caused by removal of salts or unsuitable buffer conditions.
Hydrophobic proteins.
Use denaturing agents, polarity reducing agents or detergents.
Non-specific adsorption.
Reduce salt concentration to minimize hydrophobic interaction. Increase pH. Add suitable detergent or organic solvent e.g. 5% isopropanol. If necessary, add 10% ethylene glycol to running buffer.
Sample absorbs poorly at chosen wavelength.
Check absorbance range on monitor. If possible, use a different wavelength, e.g. 214 nm instead of 280 nm.
Low recovery of activity, but normal recovery of protein.
Lower yield than expected.
Peaks too small.
Excessive band broadening.
Check column packing. Repack if necessary.
More sample is recovered than expected.
Protein is co-eluting with other substances.
Optimize conditions to improve resolution. Check buffer conditions used for assay before and after the run. Check selection of medium.
More activity is recovered than was applied to the column.
Different assay conditions have been used before and after the chromatography step.
Use the same assay conditions for all the assays in the purification scheme.
Removal of inhibitors during separation. Reduced or poor flow through the column.
32
Presence of lipoproteins or protein aggregates.
Remove lipoproteins and aggregates during sample preparation (see Appendix 3).
Protein precipitation in the column caused by removal of stabilizing agents during separation.
Modify the eluent to maintain stability.
Blocked column filter.
If possible, replace the filter or use a new column. Always filter samples and buffer before use.
Blocked end-piece or adaptor or tubing.
If possible, remove and clean or use a new column.
Precipitated proteins.
Clean the column using recommended methods or use a new column.
Bed compressed.
If possible repack the column or use a new column.
Microbial growth.
Microbial growth rarely occurs in columns during use, but, to prevent infection of packed columns, store in 20% ethanol when possible.
Medium not fully swollen (Sephadex).
See Appendix 1 for reswelling conditions.
Situation
Back pressure increases during a run or during successive runs.
Air bubbles in the bed.
Cause
Remedy
Fines (Sephadex).
Decant fines before column packing. Avoid using magnetic stirrers that can break the particles.
Turbid sample.
Improve sample preparation (see Appendix 3). Improve sample solubility by the addition of ethylene glycol, detergents or organic solvents.
Precipitation of protein in the column filter and/or at the top of the bed.
Clean using recommended methods. If possible, exchange or clean filter or use a new column. Include any additives that were used for initial sample solubilization in the running buffer.
Column packed or stored at cool temperature and then warmed up.
Remove small bubbles by passing degassed buffer through the column. Take special care if buffers are used after storage in a fridge or cold-room. Do not allow column to warm up due to sunshine or heating system. Repack column, if possible (see Appendix 1).
Buffers not properly degassed.
Buffers must be degassed thoroughly.
Cracks in the bed.
Large air leak in column.
Check all connections for leaks. Repack the column if possible (see Appendix 1).
Distorted bands as sample runs into the bed.
Air bubble at the top of the column or in the inlet adaptor.
If possible, re-install the adaptor taking care to avoid air bubbles.
Particles in buffer or sample.
Filter or centrifuge the sample. Protect buffers from dust.
Blocked or damaged net in upper adaptor.
If possible, dismantle the adaptor, clean or replace the net. Keep particles out of samples and eluents.
Column poorly packed.
Suspension too thick or too thin. Bed packed at a temperature different from run. Bed insufficiently packed (too low packing pressure, too short equilibration). Column packed at too high pressure.
Distorted bands as sample passes down the bed.
33
Fig. 16. Time-line for a gel filtration separation on Sephadex G-200 compared to the latest Superdex 200 prep grade (which has replaced Sephadex G-200) and a prepacked HiLoad 16/60 Superdex prep grade column.
34
Packing Degas
4 5
10
Packing with adaptor
15
2 3
Result after: 3.3 h
Result Sample application Equilibration (1.5 × Vt )
0
Time (hours)
HiLoad 16/60 Superdex 200 prep grade
Packing
Washing gel slurry
Result Sample application Check the packed bed Equilibration (1.5 × Vt ) Packing with adaptor
21
Equilibration (1.5 × Vt )
Result after: 6.3 h
Superdex 200 prep grade XK 16/60 1.5 5 Time 0.5 4 (hours) 0 2 6
Swelling
0
Sephadex G-200 XK 16/60 30
Check the packed bed
36
40
Sample application
46
50
Time (hours)
Result after: 56 h
Result
56
Chapter 2 Gel filtration media Components of gel filtration media The development of gel filtration media has been driven by the need to achieve the highest flow rates while retaining the highest resolution. As a sample passes through a gel filtration column the separation or resolution of the different components is affected by several parameters: flow rate, particle size, particle size distribution, packing density, porosity of the particle and viscosity of the mobile phase. Attempts to optimize each parameter has led to the development of a series of gel filtration media. The earliest gel filtration matrices were formed by cross-linking polymers to form a threedimensional network, for example Sephadex is formed by cross-linking dextran. Controlling the degree of cross-linking and particle size made it possible to produce a broad range of media, each one having a high selectivity over a narrow range of molecular weight values. However, to increase the speed of a separation the medium must withstand higher flow rates and so alternative polymers such as agarose were investigated. This resulted in gel filtration media based on Sepharose and, later, the more highly cross-linked Superose. Matrices based on agarose are, in general, more porous than those based on dextran so that, although the speed of a separation could be increased there was less selectivity when compared to Sephadex. The porosity of Sepharose makes it highly suitable for binding techniques such as affinity chromatography where the high porosity facilitates a high binding capacity. A major advance in gel filtration technology occurred when composite gels could be prepared by grafting a second polymer onto a pre-formed matrix, for example Sephacryl (cross-linking allyl dextran with N,N'-methylene bisacrylamide) and the most recent, Superdex. In the case of Superdex, with the dextran chains covalently bonded to a highly cross-linked agarose matrix, it has been possible to create a range of media with the same high selectivity as Sephadex, but with the mechanical strength of a highly cross-linked agarose-based matrix. The selectivity curves and pressure-flow relationship curves shown for Superose, Sephacryl and Superdex in the following sections show how the performance of gel filtration media has developed. Figure 16 clearly illustrates the significant increase in speed without loss of performance that has been achieved with the development of Superdex. For Superose and Superdex, manipulation of the particle size (Superose prep grade or Superdex prep grade) is also used to allow higher flow rates when running larger columns.
35
Superdex: first choice for high resolution, short run times and high recovery 10 2
10 3
10 4
10 5
Superdex Peptide Superdex 75 Superdex 200 Superdex 30 prep grade Superdex 75 prep grade Superdex 200 prep grade
Fig. 17. Fractionation ranges for Superdex.
Fig. 18. Prepacked HiLoad Superdex prep grade columns.
From laboratory to process scale applications, Superdex is the first choice for a high resolution fractionation with short run times and good recovery. The success of Superdex is clearly demonstrated by the hundreds of scientific publications in which the use of Superdex has been described. Reference lists highlighting the use of the prepacked columns HiLoad Superdex 200 prep grade, HiLoad Superdex 75 prep grade and HiLoad Superdex 30 prep grade are available at www.chromatography.amershambiosciences.com. Selectivity curves and pressure-flow relationship curves for Superdex are shown in Figures 19a and 19b. A typical linear flow is up to 75 cm/h. K av 1.00
Superdex peptide 0.75 Superdex 75 Superdex 200 Superdex 30 prep grade Superdex 75 prep grade
0.50
Superdex 200 prep grade
1000000
100000
10000
1000
100
10
0.25
Log Mr
Fig. 19a. Selectivity curves for Superdex (13 µm) and Superdex prep grade (34 µm) media.
36
Pressure (bar)
4
3
0 /6 26
0
/6
16
2
1
20
40
60
80
100 120 140 Flow rate (cm/h)
Fig. 19b. Pressure drop as a function of flow rate for HiLoad columns packed with Superdex prep grade. Bed height approximately 60 cm in distilled water at +25 °C. To calculate volumetric flow rate, multiply linear flow by crosssectional area of column (2 cm2 for XK 16, 5.3 cm2 for XK 26).See Appendix 5 for more information about flow rate calculations.
Superdex is a composite medium based on highly cross-linked porous agarose particles to which dextran has been covalently bonded, as illustrated in Figure 20. The result is media with high physical and chemical stability, due mainly to the highly cross-linked agarose matrix, and excellent gel filtration properties determined mainly by the dextran chains. The mechanical rigidity of Superdex allows even relatively viscous eluents, such as 8 M urea, to be run at practical flow rates. The media can withstand high flow rates during equilibration or cleaning thereby shortening overall cycle times. This stability makes Superdex prep grade very suitable for use in industrial processes where high flow rates and fast, effective cleaningin-place protocols are required. Under normal chromatography conditions non-specific interactions between proteins and Superdex are negligible when using buffers with ionic strengths in the range 0.15 M to 1.5 M.
Crosslinked Agarose Dextran
Fig. 20. In Superdex the dextran chains are covalently linked to a highly cross-linked agarose matrix. The figure shows a schematic of a section through a Superdex particle.
37
Separation options Superdex is produced in two different mean particle sizes (13 µm and 34 µm) and four different selectivities (Superdex Peptide, Superdex 30, Superdex 75 and Superdex 200). • Use the 13 µm particles of Superdex Peptide, Superdex 75 and Superdex 200 in prepacked columns for highest resolution analytical separations with smaller sample volumes. • Use the 34 µm particles of Superdex prep grade (available in prepacked columns or as loose media) for larger scale applications. Product †
Fractionation range, Mr (globular proteins)
Sample loading capacity
Superdex Peptide PC 3.2/30
1×102–7×103
25–250 µl
1.8 MPa, 18 bar, 260 psi
<0.15 ml/min
Superdex Peptide HR 10/30
1×102–7×103
25–250 µl
1.8 MPa, 18 bar, 260 psi
<1.2 ml/min
HiLoad 16/60 Superdex 30 pg*
<1×104
<5 ml
0.3 MPa, 3 bar, 42 psi
<1.6 ml/min
HiLoad 26/60 Superdex 30 pg*
<1×104
<13 ml
0.3 MPa, 3 bar, 42 psi
<4.4 ml/min
Superdex 30 pg*
<1×104
0.5–4% of total column volume
0.5 MPa, 5 bar, 70 psi
10–50 cm/h
Superdex 75 PC 3.2/30
3×103–7×104
<50 µl
2.4 MPa, 24 bar, 350 psi
<0.1 ml/min
Superdex 75 HR 10/30
3×103–7×104
25–250 µl
1.8 MPa, 18 bar, 260 psi
<1.5 ml/min
HiLoad 16/60 Superdex 75 pg*
3×103–7×104
<5 ml
0.3 MPa, 3 bar, 42 psi
<1.6 ml/min
HiLoad 26/60 Superdex 75 pg*
3×103–7×104
<13 ml
0.3 MPa, 3 bar, 42 psi
<4.4 ml/min
Superdex 75 pg*
3×103–7×104
0.5–4% of total column volume
0.5 MPa, 5 bar, 70 psi
10–50 cm/h
Superdex 200 PC 3.2/30
1×104–6×105
<50 µl
1.5 MPa, 15 bar, 220 psi
<0.1 ml/min
Superdex 200 HR 10/30
1×104–6×105
25–250 µl
1.5 MPa, 15 bar, 220 psi
0.25–0.75 ml/min
HiLoad 16/60 Superdex 200 pg* 1×104–6×105
<5 ml
0.3 MPa, 3 bar, 42 psi
<1.6 ml/min
HiLoad 26/60 Superdex 200 pg* 1×104–6×105
<13 ml
0.3 MPa, 3 bar, 42 psi
<4.4 ml/min
0.5–4% of total column volume
0.5 MPa, 5 bar, 70 psi
10–50 cm/h
Superdex 200 pg*
1×104–6×105
Maximum operating back pressure ‡
Recommended operating flow ¶
* prep grade. †
HR and PC columns are packed with Superdex and HiLoad columns are packed with Superdex prep grade.
For maximum resolution apply as small a sample volume as possible, but note that sample volumes less than 0.5% do not normally improve resolution.
‡
¶
See Appendix 5 to convert linear flow (cm/hour) to volumetric flow rates (ml/min) and vice versa.
Start with Superdex 200 when the molecular weight of the protein of interest is unknown. Superdex 200 or Superdex 200 prep grade (pg) are especially suitable for the separation of monoclonal antibodies from dimers and from contaminants of lower molecular weight, for example albumin and transferrin. Start with Superdex Peptide or Superdex 30 prep grade for separations of peptides, oligonucleotides and small proteins below Mr 10 000. Exposure to temperatures outside the range +4 °C to +40 °C will destroy the efficiency of the packed bed and the column will need to be re-packed.
38
Separation examples The figures below illustrate examples of separations performed on Superdex Peptide, Superdex 75 and Superdex 200. a)
Sample:
b) mV
A 214 nm 0.12
5000
Sample volume: Column:
4000
Eluent:
Mr 4
1 2 3 4 5 6 7
0.10 2
3
0.08
Cytochrome C Aprotinin Gastrin I Substance P (Gly) 6 (Gly) 3 Gly
12 500 6 500 2 126 1 348 360 189 75
Flow: 3000
1 7 5
100 µl Two Superdex Peptide HR 10/30 in series, effective bed height 60 cm 30% acetonitrile, 0.1% TFA in water 0.6 ml/min
A - Tetramer B - Trimer C - Dimer D - Monomer
6
0.06
Synthetic cyclic peptide (polymers)
2000
0.04
1000
0.02
V0
Vt
0 0
5
10
15
1
20 25 Volume (ml)
5
30 A
45 B
60
C D
75 90 Time (min)
Fig. 21. a) Separation of standard peptides on Superdex Peptide HR 10/30. b) Separation of peptide polymers (monomer Mr ~1 000). The fractions indicated were analyzed by off-line mass spectrometry. Courtesy of K. Walhagen, Ferring Research Institute, Sweden.
2
A 280 nm
7
Column: Sample:
0.30 Vt
Vo
0.20 1
3
Superdex 200 HR 10/30 1. Thyroglobulin (Mr 669 000), 3.0 mg/ml 2. Ferritin (M r 440 000), 0.7 mg/ml 3. Human IgG (M r 150 000), 3.0 mg/ml 4. Human transferrin (Mr 81 000), 3.0 mg/ml 5. Ovalbumin (M r 43 000), 3.0 mg/ml 6. Myoglobin (Mr 17 600), 2.0 mg/ml 7. Vitamin B12 (M r 1 355), 0.5 mg/ml
Total sample amount: 0.38 mg Sample volume: 25 ml Buffer: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.0 Flow: 0.25 ml/min (19 cm/h)
4 5 6
0.10
0 0
5.0
10.0
15.0
20.0
25.0 Volume (ml)
Fig. 22. Separation of standard proteins on Superdex 200 HR 10/30.
39
A 280 nm Monomer
0.05
Column: Sample:
Superdex 75 HR 10/30 A specially prepared sample of rhGH in distilled water Concentration: 1.5 mg/ml Sample volume: 50 µl (75 µg rhGH) Buffer: 0.05 M sodium phosphate, 0.1 M Na2SO4, pH 7.3 Flow: 1 ml/min (76 cm/h)
0.025
Oligomer
Dimer 10
20
Time (min)
VO
Vt
Fig. 23. Separation of growth hormone oligomers on Superdex 75 HR 10/30.
b)
a) A 280 nm
A 280 nm
Vt
Vo
Vo
Vt
Column: a) Superdex 200 HR 10/30 b) HiLoad 16/60 Superdex 200 prep grade Bed volumes: a) 24 ml b) 122 ml Sample: Mouse monoclonal IgG1 10 × concentrated cell culture supernatant Sample volume: a) 200 µl, 0.8% × Vt b) 1.0 ml, 0.8% × Vt Buffer: 50 mM NaH2PO4, 0.15 M NaCl, pH 7.0 Flow: a) 1.0 ml/min (76 cm/h) b) 0.5 ml/min (15 cm/h)
0.60 0.60
IgG1 0.40
IgG 1
0.40
0.20
0.20
5.0
15.0
25.0
ml
50
150
250
ml
Fig. 24. Scale up (five times) of a mouse monoclonal IgG1 purification from Superdex 200 HR 10/30 (a) onto HiLoad 16/60 Superdex 200 prep grade (b).
Absorbance 0.005
TFA
Column: HiLoad 16/60 Superdex 30 prep grade Sample: 50 ml mix of five synthetic peptides in 1% TFA 1. Mr 3 894 2. Mr 3 134 3. Mr 2 365 4. Mr 1 596 5. Mr 827 Buffer: 20 mM Tris-HCl, 0.25 M NaCI, pH 8.5 Flow: 1 ml/min (30 cm/h)
1 2 3 4
0
80
160
240
5
320 Volume (ml)
Fig. 25. Separation of test substances on HiLoad 16/60 Superdex 30 prep grade.
40
Columns:
a) HiLoad 16/60 Superdex 75 prep grade b) HiLoad 16/60 Superdex 200 prep grade 1. Myoglobin 1.5 mg/ml, Mr 17 000 2. Ovalbumin 4 mg/ml, Mr 43 000 3. Albumin 5 mg/ml, Mr 67 000 4. IgG 0.2 mg/ml, Mr 158 000 5. Ferritin 0.24 mg/ml, Mr 440 000 Sample volume: 0.5 ml Buffer: 0.05 M phosphate buffer, 0.15 M NaCl, 0.01% sodium azide, pH 7.0 Flow: 1.5 ml/min (45 cm/h)
Sample:
b)
a) A 280 nm
A 280 nm
HiLoad 16/60 Superdex 75 prep grade
4 and 5
0.2
3
HiLoad 16/60 Superdex 200 prep grade
0.2
2 3
2
0.1
0.1
5
1
1 Vo
4
0
0 0
10
20
30
40
50
0
60 70 Time (min)
10
20
30
40
50
60 70 Time (min)
Fig. 26. Comparison of the selectivity of Superdex 75 prep grade and Superdex 200 prep grade for model proteins. Superdex 75 prep grade (a) gives excellent resolution of the three proteins in the Mr range 17 000 to 67 000 while the two largest proteins elute together in the void volume. Superdex 200 prep grade (b) resolves the two largest proteins completely. The three smaller proteins are not resolved quite as well as the larger ones or as in (a). The void volume (Vo) peak at 28 minutes in (b) is caused by protein aggregates.
Columns: Column volumes, Vt:
HiLoad Superdex 200 prep grade
a) ≈ 120 ml (16/60) b) ≈ 320 ml (26/60) Sample: Mouse monoclonal cell supernatant, IgG2b incl. 1% Fetal Calf Serum Sample Concentration ≈ 40× pretreatment: Sample volume: a) 1.2 ml (1% × Vt) b) 3.2 ml (1% × Vt) Buffer: 50 mM NaH2PO4, 0.15 NaCI, pH 7.0 Flow: a) 1.6 ml/min (50 cm/h) b) 4.4 ml/min (50 cm/h) (max recommended flow rates) b)
a)
A 280 nm
A 280 nm
HiLoad 16/60 Superdex 200 prep grade
0.60
IgG2b
IgG2b
0.40
0.40
0.20
0.20
0.00
0.00 0
20.0
40.0
HiLoad 26/60 Superdex 200 prep grade
0.60
60.0
80.0 Time (min)
0
20.0
40.0
60.0
80.0 Time (min)
Fig. 27. Purification of mouse monoclonal IgG2b from cell supernatant using a) HiLoad 16/60 Superdex 200 prep grade, column volume 120 ml and b) HiLoad 26/60 Superdex 200 prep grade, column volume 320 ml. Almost identical separations are the result, even using prepacked columns of different sizes.
41
Protein refolding After solubilization, recombinant proteins must be properly refolded to regain function. Denaturing agents must be removed to allow refolding of the protein and formation of the correct intramolecular associations. Critical parameters during refolding include pH, presence of thiol reagents, the speed of denaturant removal, and the relative concentrations of host proteins and recombinant protein. The table below compares the advantages and disadvantages of the alternative methods for refolding of recombinant proteins. Different proteins require different conditions for successful refolding. Gel filtration provides an alternative method that can be tried if on-column refolding during affinity purification is not possible. For further details about on-column refolding using affinity chromatography refer to The Recombinant Protein Handbook, Amplification and Simple Purification, available from Amersham Biosciences and Febs Letters 345 (1994) 125–130. Refolding technique
Advantages/Disadvantages
Step dialysis
Takes several days. Uses large volumes of buffer.
Dilution into near neutral pH
Dilutes the protein of interest.
On-column gel filtration
Slower than on-column refolding by affinity chromatography. Requires a second column to be run. Only small volumes can be processed per column.
On-column affinity chromatography
Fast and simple. No sample volume limitations.
Performing a separation Buffer: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7 or select the buffer in which the sample should be stored or solubilized for the next step.
Use 0.15 M NaCl, or a buffer with equivalent ionic strength, to avoid pH dependent nonionic interactions with the matrix. At very low ionic strength, the presence of a small number of negatively charged groups on the medium may cause retardation of basic proteins. The sample should be fully dissolved. Centrifuge or filter to remove particulate material (see Appendix 3). Always use degassed buffers and maintain a constant temperature during the run to avoid introducing air into the column. Set an appropriate pressure limit on the chromatography system to avoid damage to the column packing. 1. For first time use, or after long term storage, equilibrate the column with 1 column volume of buffer, but containing 0.05 M NaCl at 30 cm/h (0.4 ml/min for HR 10/30, 1 ml/min for XK 16/60 or 2.6 ml/min for XK 26/60). 2. Equilibrate with 2 column volumes of buffer containing 0.15 M NaCl at 50 cm/h (0.65 ml/min for HR 10/30, 1.6 ml/min for XK 16/60 or 4.3 ml/min for XK 26/60). 3. Reduce linear flow to 30 cm/h. Apply a sample volume equivalent to 0.5–4% of the column volume (up to 0.25 ml for HR 10/30, 1.2 ml for XK 16/60 or 3.2 ml for XK 26/60). Note that the smaller the sample volume the better the resolution. 4. Elute with 1 column volume of buffer. 5. Before applying a new sample, re-equilibrate column with 1 column volume of buffer at 50 cm/h and until the baseline monitored at A280 is stable.
42
Column performance should be checked at regular intervals by determining the theoretical plate number per meter and peak symmetry. Prepacked columns are supplied with recommended values. See page 95 for how to check column efficiency. See page 26 for advice on optimizing the separation. Exposure to temperatures outside the range +4 °C to +40 °C will destroy the efficiency of a packed bed and the column will need to be re-packed.
Cleaning 1. Wash with 1 column volume of 0.5 M NaOH at a flow of 25 cm/h (0.33 ml/min for HR 10/30, 0.8 ml/min for XK 16/60 or 2.2 ml/min for XK 26/60) to remove most non-specifically adsorbed proteins. 2. Wash with 1 column volume of distilled water at 25 cm/hr. 3. Re-equilibrate with 2 column volumes of buffer at a flow of 50 cm/hr (0.4 ml/min for HR 10/30, 1.6 ml/min XK 16/60 or 4.3 ml/min for XK 26/60) or until the baseline monitored at A280 and the pH of the eluent are stable. Further equilibration may be necessary if the buffer contains detergent.
Routine cleaning after every 10–20 separations is recommended, but the frequency of cleaning will also depend on the nature of the samples being applied. To remove severe contamination 1. Reverse the flow and wash at a linear flow of 25 cm/h at room temperature. 2. Wash with 4 column volumes of 1 M NaOH (to remove hydrophobic proteins or lipoproteins) followed by 4 column volumes of distilled water. 3. Wash with 0.5 column volume of 30% isopropanol (to remove lipids and very hydrophobic proteins), followed by 2 column volumes of distilled water. 4. Equilibrate the column with at least 5 column volumes of buffer, or until the baseline monitored at A280 and the pH of the eluent are stable, before beginning a new separation. For extreme cases of contamination, check the instructions supplied with the product.
Reversing flow through a gel filtration column should only be considered under cases of severe contamination. There is a risk that reversing the flow may cause channeling through the packed bed leading to poor resolution, loss of efficiency and the need to repack the column. Professionally packed columns are less likely to be affected, but extreme care must be taken.
43
Media characteristics Composition: Superdex is formed from dextran bound covalently to highly cross-linked agarose. Product
Efficiency: theoretical plates per meter (prepacked columns only)
pH stability*
Particle size
Mean particle size
Superdex Peptide
>30 000 m-1
Long term: 1–14 Short term: 1–14
13–15 µm
13 µm
Superdex 75
>30 000 m-1
Long term: 3–12 Short term: 1–14
13–15 µm
13 µm
Superdex 200
>30 000 m-1
Long term: 3–12 Short term: 1–14
13–15 µm
13 µm
Superdex 30 prep grade
>13 000 m-1
Long term: 3–12 Short term: 1–14
22–44 µm
34 µm
Superdex 75 prep grade
>13 000 m-1
Long term: 3–12 Short term: 1–14
22–44 µm
34 µm
Superdex 200 prep grade
>13 000 m-1
Long term: 3–12 Short term: 1–14
22–44 µm
34 µm
*Long term pH stability refers to the pH interval where the medium is stable over a long period of time without adverse side effects on its chromatography performance. Short term pH stability refers to the pH interval for regeneration, cleaning-in-place and sanitization procedures. All ranges are estimates based on the experience and knowledge within Amersham Biosciences.
Chemical stability Superdex is stable in all commonly used aqueous buffers, pH 3–12, and additives such as detergents (1% SDS), denaturing agents (8 M urea or 6 M guanidine hydrochloride). The following solutions can be used for cleaning: up to 30% acetonitrile, up to 1 M sodium hydroxide, up to 70% ethanol (Superdex 30 prep grade), up to 24% ethanol (Superdex 75 prep grade and Superdex 200 prep grade), up to 1 M acetic acid, up to 30% isopropanol or up to 0.1 M HCl (Superdex 30 prep grade).
Storage Store unused media +4 °C to +25 °C in 20% ethanol. Do not freeze. Columns can be left connected to a chromatography system with a low flow rate (0.01 ml/min) of buffer passing through the column to prevent bacterial growth or the introduction of air into the column which would destroy the packing. For long term storage, wash with 4 column volumes of distilled water followed by 4 column volumes of 20% ethanol. Store at +4 °C to +25 °C. Degas the ethanol/water mixture thoroughly and use a low flow rate, checking the back pressure as the column equilibrates. Avoid changes in temperature which may cause air bubbles in the packing.
44
Sephacryl: fast, high recovery separations at laboratory and industrial scale Sephacryl High Resolution (HR) media provide a useful alternative to Superdex prep grade for applications that require a slightly broader fractionation range, as shown in Figure 28. High chemical stability and tolerance of high flow rates make Sephacryl well suited for industrial use. 10
2
10
3
10
4
10
5
10
6
10
7
10
8
Sephacryl S-100 HR Sephacryl S-200 HR Sephacryl S-300 HR Sephacryl S-400 HR Sephacryl S-500 HR Sephacryl S-1000 SF
Fig. 28. Fractionation ranges for Sephacryl High Resolution (HR).
Fig. 29. Sephacryl is available as loose media and in prepacked columns.
Reference lists highlighting the use of HiPrep Sephacryl S-300 HR, HiPrep Sephacryl S-200 HR and HiPrep Sephacryl S-300 HR are available at www.chromatography.amershambiosciences.com.
45
Figure 30 shows a comparison of the different selectivities of Sephacryl High Resolution. Typical selectivity and pressure-flow relationship curves for Sephacryl are shown in Figures 31a and 31b. A 280 nm
a) HiPrep 16/60 Sephacryl S-100 HR
0.3
BSA IgG
Cytochrome C
0.2
Cytidine b-lactoglobulin
0.1
20 A 280 nm
40
60
80
100
Column: a) HiPrep 16/60 Sephacryl S-100 HR b) HiPrep 16/60 Sephacryl S-200 HR c) HiPrep 16/60 Sephacryl S-300 HR Sample: 500 µl of a mixture containing IgG (Mr 160 000), BSA (Mr 67 000), b-lactoglobulin (M r 35 000), cytochrome C (Mr 12 400) and cytidine (Mr 240) Buffer: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.0 Flow: 0.8 ml/min (24 cm/h)
120 Vol (ml)
b) HiPrep 16/60 Sephacryl S-200 HR
0.3 BSA 0.2
Cytochrome C
IgG
Cytidine b-lactoglobulin
0.1
20 A 280 nm
40
60
80
100
120 Vol (ml)
c) HiPrep 16/60 Sephacryl S-300 HR BSA
0.2
Cytochrome C
Cytidine b-lactoglobulin
IgG 0.1
20
40
60
80
100
120 Vol (ml)
Fig. 30. Comparison of the selectivity of HiPrep 16/60 Sephacryl S-100 HR, HiPrep 16/60 Sephacryl S-200 HR, and HiPrep 16/60 Sephacryl S-300 HR columns.
K av
Globular proteins*
K av
0.8
0.8
0
50
S-
0.8
Dextran standards*
Proteins**
K av
00
0.6
HR
5
6
10 10 10 Molecular weight, M r
0.4
0.4
0.2
0.2
4
5
6
10 10 10 Molecular weight, M r
* In 0.05 M phosphate buffer, 0.15 M NaCl, pH 7.0. ** In 6 M guanidine hydrochloride.
Fig. 31a. Selectivity curves for Sephacryl High Resolution media.
46
HR
HR
0.2
4
00
0
4 S-
40 0.6
HR
S-4
S-
HR 00 HR 00 S-2 HR 00 S-1
0.4
S-3
0.6
4
5
6
10 10 10 Molecular weight, Mr
a)
b) MPa*
MPa*
Column diameter 1.6 cm
0.3
Column diameter 2.6 cm
0.3
R
0H
0.2
0 S-2
S-3
0
0.2
R 0H
S-
S-1
S-500
00
S-3
HR 00
HR
S-1
R 00 H
0.1
2
00
0.1
HR
HR
HR S-400 0 HR S-50
S-400 HR 25
75
50
100
25
75
50
Linear flow rate cm.h -1
100
Linear flow rate cm.h -1 *0.1 MPa = 100 cm H20 = 1 bar = 14.2 psi
Fig. 31b. Pressure drop as a function of flow rate for Sephacryl High Resolution. Bed height approximately 60 cm, distilled water, temperature +25 °C. To calculate the volumetric flow rate, multiply the linear flow by the cross-sectional area of the column (2 cm2 for XK 16 or 5.3 cm2 for XK 26).
Sephacryl High Resolution (HR) is a composite medium prepared by covalently cross-linking allyl dextran with N,N'-methylene bisacrylamide to form a hydrophilic matrix of high mechanical strength, illustrated in Figure 32. The porosity of the medium, determined by the dextran component, has been controlled to yield five different selectivities. The mechanical rigidity of Sephacryl HR allows even relatively viscous eluents, such as 8 M urea, to be run at practical flow rates. Under normal chromatography conditions (A280, 0.05 M phosphate, 0.15 M NaCl, pH 7.0) Sephacryl S-100 HR gave yields of at least 96% of the following substances: Blue Dextran 2000, ferritin, catalase, aldolase, BSA, ovalbumin, b-lactoglobulin A+B, chymotrypsinogen A, myoglobin, lysozyme, ribonuclease A and cytochrome C. An ionic strength of at least 0.15 M is recommended for best results. CH2 NH
CH
C=O CH2
n
O
CH2
CH
OH
O
CH
2
H
O=C CH2
O
HN
CH OH
C=O
O
CH
NH
2
O
OH
O
H
CH2 NH
O O
C=O CH2
CH2
CH
CH2 CH
CH2
HO
OH
CH2
O
HO
OH
O
CH2
OH
O
O
O
O
2
OH
OH
CH O H
CH
OH
O CH2
O
HO
OH
O CH2
O
Fig. 32. Partial structure of Sephacryl High Resolution.
47
Separation options Product †
Fractionation range, Mr (globular proteins)
Sample loading capacity
Maximum operating back pressure
HiPrep 16/60 Sephacryl S-100 HR*
1×103–1×105
<5 ml
0.15 MPa, 5 bar, 21 psi
0.5 ml/min
HiPrep 26/60 Sephacryl S-100 HR*
1×103–1×105
<13 ml
0.15 MPa, 5 bar, 21 psi
1.3 ml/min
Sephacryl S-100 HR*
1×103–1×105
0.5–4% of total column volume
0.2 MPa, 2 bar, 28 psi
10–35 cm/h
HiPrep 16/60 Sephacryl S-200 HR*
5×103–2.5×105
<5 ml
0.15 MPa, 5 bar, 21 psi
0.5 ml/min
HiPrep 26/60 Sephacryl S-200 HR*
5×103–2.5×105
<13 ml
0.15 MPa, 5 bar, 21 psi
1.3 ml/min
Sephacryl S-200 HR*
5×103–2.5×105
0.5–4% of total column volume
0.2 MPa, 2 bar, 28 psi
10–35 cm/h
HiPrep 16/60 Sephacryl S-300 HR*
1×104–1.5×106
<5 ml
0.15 MPa, 5 bar, 21 psi
0.5 ml/min
HiPrep 26/60 Sephacryl S-300 HR*
1×104–1.5×106
<13 ml
0.15 MPa, 5 bar, 21 psi
1.3 ml/min
Sephacryl S-300 HR*
1×104–1.5×106
0.5–4% of total column volume
0.2 MPa, 2 bar, 28 psi
10–35 cm/h
Sephacryl S-400 HR*
2×104–8×106
0.5–4% of total column volume
0.2 MPa, 2 bar, 28 psi
10–35 cm/h
Sephacryl S-500 HR*
–
0.5–4% of total column volume
0.2 MPa, 2 bar, 28 psi
10–35 cm/h
Sephacryl S-1000 SF (Superfine)
–
0.5–4% of total column volume
not determined
2–30 cm/h
†
Recommended operating flow ‡
* High Resolution. For maximum resolution apply as small a sample volume as possible, but note that sample volumes less than 0.5% do not normally improve resolution.
†
‡
See Appendix 5 to convert linear flow (cm/hour) to volumetric flow rates (ml/min) and vice versa.
Separation examples A 280 nm
Column: HiPrep 26/60 Sephacryl S-100 HR Sample: 1 ml of a mixture containing bovine insulin chain A (Mr 2 532) and chain B (Mr 3 496), 0.5 mg/ml of each Buffer: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.0 Flow: 2.0 ml/min (22 cm/h)
0.03 Chain A 0.02 Chain B 0.01
0.00
0
40
80
120
160
200
240 Vol. (ml)
Fig. 33. Separation of insulin chains on HiPrep 26/60 Sephacryl S-100 HR.
48
A 280 nm
1
2
Immunoglobulin
Sample: IgG fraction from previous ion exchange step (sample volume equivalent to 1% of Vt. (V t =column volume) Column: BP 113/120 containing Sephacryl S-200 HR, bed height 100 cm Buffer: 0.05 M Tris-HCl, 0.15 NaCl, pH 7.5 Flow: 7.5 cm/h
Elution volume
Fig. 34. Purification of monoclonal antibodies on Sephacryl S-200 HR. Inset shows analysis by gradient SDS-PAGE of the immunoglobulin pool. Lane 1, native sample; lane 2, sample reduced with 2-mercaptoethanol.
A 280 nm 1. Large phospoholipid vesicles (LPLV) 2. Small phospholipid vesicles (SPLV) 0.6
1 2
0.4
0.2
50
100
150
Medium: Sephacryl S-400 HR Sample: Integral membrane proteins prepared from human erythrocytes solubilized in 0.1 M phosphate, 100 mM SDS, 1 mM EDTA, 1 mM DTE, pH 7.4 Sample volume: 2 ml (2 mg/ml) Column: K 26/70, packed bed 2.6 x 61 cm Buffer: 0.1 M phosphate, 50 mM SDS, 1 mM EDTA, 1 mM DTE, pH 7.4 Flow: 1 ml/min (11 cm/h)
200 250 Elution volume (ml)
Fig. 35. Gel filtration on Sephacryl S-400 HR quickly separates phospholipid vesicles (liposomes) into large (LPLV) and small (SPLV) phospholipid vesicles. (Data provided by E. Greijer and P. Lundahl, Dept. of Biochemistry, Biomedical Centre, University of Uppsala, Sweden.)
Performing a separation Buffer: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.2 or select the buffer in which the sample should be stored or solubilized for the next step.
Use 0.15 M NaCl, or a buffer with equivalent ionic strength, to avoid pH dependent nonionic interactions with the matrix. At very low ionic strength, the presence of a small number of negatively charged groups may cause retardation of basic proteins and exclusion of acidic proteins. The sample should be fully dissolved. Centrifuge or filter to remove particulate material (see Appendix 3). Always use degassed buffers and maintain a constant temperature during the run to avoid introducing air into the column. Set an appropriate pressure limit on the chromatography system to avoid damage to the column packing.
49
1. For first time use, or after long term storage, equilibrate the column with at least 0.5 column volume of distilled water at 15 cm/h (0.5 ml/min for 16/60 column or 1.3 ml/min for 26/60). 2. Equilibrate with 2 column volumes of buffer at 30 cm/h (1.0 ml/min for 16/60 column or 2.6 ml/min for 26/60). 3. Reduce flow to 15 cm/h and, for best resolution, apply a sample volume equivalent to 1% of the column volume (1.2 ml for 16/60 column or 3.2 ml for 26/60). Sample volumes between 0.5–4% can be applied. 4. Elute with 1 column volume of buffer. 5. Before applying a new sample re-equilibrate column with 1 column volume of buffer at 30 cm/h until the baseline monitored at A280 is stable.
Column performance should be checked at regular intervals by determining the theoretical plate number per meter and peak symmetry. Prepacked columns are supplied with recommended values. See page 95 on how to check column efficiency. See page 26 for advice on optimizing the separation. Exposure to temperatures outside the range +4 °C to +40 °C will destroy the efficiency of a packed bed and the column will need to be re-packed.
Cleaning 1. Wash with 0.5 column volume of 0.2 M NaOH at a flow of 15 cm/h (0.5 ml/min for column 16/60 or 1.3 ml/min for 26/60) to remove most non-specifically adsorbed proteins. 2. Re-equilibrate immediately with 2 column volumes of buffer or until the baseline monitored at A280 and the pH of the eluent are stable. Further equilibration may be necessary if the buffer contains detergent.
Routine cleaning after every 10–20 separations is recommended, but the frequency of cleaning will also depend on the nature of the samples being applied. If required Sephacryl High Resolution may be autoclaved repeatedly at +121 °C, pH 7 for 30 minutes without significantly affecting its chromatography properties. The medium must be removed from a column before autoclaving as certain column components cannot tolerate such high temperatures. To remove severe contamination Reverse the flow and wash at a flow rate of 10 cm/h (0.3 ml/min for column 16/60 or 0.8 ml/min for 26/60) at room temperature using the following solutions: 1. Wash with 0.25 column volumes of 0.5 M NaOH (to remove hydrophobic proteins or lipoproteins) followed by 4 column volumes of distilled water. 2. Wash with 0.5 column volume of 30% isopropanol (to remove lipids and very hydrophobic proteins), followed by 2 column volumes of distilled water. For extreme cases of contamination, check the instructions supplied with the product.
Reversing flow through a gel filtration column should only be considered under cases of severe contamination. There is a risk that reversing the flow may cause channeling through the packed bed leading to poor resolution, loss of efficiency and the need to repack the column. Professionally packed columns are less likely to be affected, but extreme care must be taken.
50
Media characteristics Composition: Sephacryl is a composite medium prepared by covalently cross-linking allyl dextran with N,N'-methylene bisacrylamide to form a hydrophilic matrix of high mechanical strength. The porosity of the medium is determined by the dextran component. Product
Efficiency: theoretical plates per meter (prepacked columns only)
pH stability
Sephacryl S-100 HR*
>5 000 m-1
Sephacryl S-200 HR*
†
Particle size
Mean particle size
Long term: 3–11 Short term: 2–13
25–75 µm
47 µm
>5 000 m-1
Long term: 3–11 Short term: 2–13
25–75 µm
47 µm
Sephacryl S-300 HR*
>5 000 m-1
Long term: 3–11 Short term: 2–13
25–75 µm
47 µm
Sephacryl S-400 HR*
‡
Long term: 3–11 Short term: 2–13
25–75 µm
47 µm
Sephacryl S-500 HR*
‡
Long term: 3–11 Short term: 2–13
25–75 µm
47 µm
Sephacryl S-1000 SF (Superfine)
‡
Long term: 3–11 Short term: 2–13
40–105 µm
65 µm
* High Resolution. † Long term pH stability refers to the pH interval where the medium is stable over a long period of time without adverse side effects on its chromatography performance. Short term pH stability refers to the pH interval for regeneration, cleaning-in-place and sanitization procedures. All ranges are estimates based on the experience and knowledge within Amersham Biosciences. ‡
Efficiencies of 9 000 m-1 have been achieved, but depend significantly on how well the column is packed.
Chemical stability Sephacryl High Resolution is stable in all commonly used aqueous buffers and additives such as detergents (1% SDS), denaturing agents (8 M urea or 6 M guanidine hydrochloride). The medium is also stable in 30% acetonitrile, 0.5 M sodium hydroxide, up to 24% ethanol, up to 1 M acetic acid and up to 30% isopropanol.
Storage Store unused media +4 °C to +25 °C in 20% ethanol. Do not freeze. Columns can be left connected to a chromatography system with a low flow rate (0.01 ml/min) of buffer passing through the column to prevent bacterial growth or the introduction of air into the column which would destroy the packing. For long term storage, wash with 4 column volumes of distilled water followed by 4 column volumes of 20% ethanol. Store at +4 °C to +25 °C. Degas the ethanol/water mixture thoroughly and use a low flow rate, checking the back pressure as the column equilibrates. Avoid changes in temperature which may cause air bubbles in the packing.
51
Superose: broad fractionation range, but not suitable for industrial scale separations 10 2
10 3
10 4
10 5
10 6
Superose 6 Superose 12 Superose 6 prep grade Superose 12 prep grade
Fig. 36. Fractionation ranges of Superose.
Superose is a medium with high physical and chemical stability based on highly cross-linked porous agarose particles. Typical fractionation ranges for Superose are shown in Figure 36. The mechanical rigidity of Superose allows even relatively viscous eluents, such as 8 M urea, to be run at practical flow rates. Under normal chromatography conditions non-specific interactions between proteins and Superose are negligible when using buffers with ionic strengths in the range 0.15 M to 1.5 M. Some hydrophobic interactions have been noted, particularly for compounds such as smaller hydrophobic and/or aromatic peptides, membrane proteins and/or lipoproteins which may elute later than predicted. However, in some applications, these interactions can be an advantage for increasing the resolution of the separation. Typical selectivity curves for Superose are shown in Figure 37.
Kav 1.0
Superose 6 prep grade 0.8
0.6
Superose 12 0.4
Superose 6
0.2
Superose 12 prep grade 0 10
3
10
4
10
Fig. 37. Selectivity curves of Superose for globular proteins.
52
5
10
6
Mr
Figure 38 gives a comparison of the different selectivities of Superose 6 and Superose 12 prepacked columns. Column: Superose 6 HR 10/30 Sample: 100 µl solution containing: 1. Thyroglobulin (Mr 669 000), 5 mg/ml 2. Ferritin (M r 440 000), 0.3 mg/ml 3. Bovine serum albumin (Mr 67 000), 8 mg/ml 4. Ribonuclease A (M r 13 700), 5 mg/ml 5. Glycyl tyrosin (Mr 238), 0.6 mg/ml Buffer: 0.05 M phosphate buffer, 0.15 M NaCl, pH 7.0 Flow: 0.4 ml/min
Column: Superose 12 HR 10/30 Sample: 100 µl solution containing: 1. IgG (Mr 160 000), 2.5 mg/ml 2. BSA (Mr 67 000), 8 mg/ml 3. b-lactoglobulin (Mr 35 000), 2.5 mg/ml 4. Cytochrome C (Mr 12 400), 1 mg/ml 5. Vitamin B12 (Mr 1 355), 0.1 mg/ml 6. Cytidine (Mr 243), 0.1 mg/ml Buffer: 0.05 M phosphate buffer, 0.15 M NaCl, pH 7.0 Flow: 0.4 ml/min
a)
b)
A 280 nm
A 280 nm 3
0.5
0.5
2 6 1
1
3
5
4
4
5
2 0.25
0.25
30
60 Time (min)
30
60 Time (min)
Fig. 38. a) Standard proteins separated on Superose 6 HR 10/30, Mr range: 5 000–5 000 000. b) Standard proteins separated on Superose 12 HR 10/30, Mr range: 1 000–300 000.
Separation options Superose is produced in different particle sizes (11 µm, 13 µm and 30 µm) and with two different selectivities (Superose 6 and Superose 12). Use 11 µm or 13 µm particles for analytical separations and 30 µm particles for preparative separations. Product*
Fractionation range, Mr (globular proteins)
Sample loading capacity*
Maximum operating back pressure
Recommended operating flow †
Superose 6 PC 3.2/30
5×103–5×106
Superose 6 HR 10/30
5×103–5×106
200 µl
1.2 MPa, 12 bar, 175 psi
<0.1 ml/min
25–250 µl
1.5 MPa,15 bar, 220 psi
Superose 6 prep grade
0.3–0.5 ml/min
5×103–5×106
0.5–4% of total column volume
0.4 MPa, 4 bar, 58 psi
<40 cm/h
Superose 12 PC 3.2/30
1×103–3×106
200 µl
2.4 MPa,24 bar, 350 psi
<0.1 ml/min
Superose 12 HR 10/30
1×103–3×106
25–250 µl
3 MPa, 30 bar, 435 psi
0.5–1.0 ml/min
Superose 12 prep grade
1×103–3×106
0.5–4% of total column volume
0.7 MPa, 7 bar, 101 psi
<40 cm/h
* For maximum resolution apply as small a sample volume as possible, but note that sample volumes less than 0.5% do not normally improve resolution. †
See Appendix 5 to convert linear flow (cm/hour) to volumetric flow rates (ml/min) and vice versa.
53
Separation examples A 280 nm 0.025
Column: Sample: Buffer: Flow:
0.020
Superose 12 PC 3.2/30 0.75 µl human tears 0.02 M sodium phosphate, 0.5 M NaCl, pH 5.3 40 µl/min
0.015 0.010 0.005 0.000 0
20
40
60
Time (min)
Fig. 39. Microfractionation of 0.75 µl of human tears.
Column: 2× Superose 6 HR 10/30 in series Sample: 10 µg Hae III cleaved pBR 322 Buffer: 0.05 M Tris-HCl, 1 mM EDTA, pH 8.0 Flow: 0.1 ml/min
Column: Sample: Buffer: Flow:
A 254 nm
A 254 nm 0.05
Superose 6 HR 10/30 fX-174 RF DNA-Hae III digest, 10 µg 0.05 M Tris-HCl, pH 8.0 0.4 ml/min
0.05
434 458 504 540 587
1353 1078 872 603
267 192 184 234 213
310 281 271
123 124
234 104 89 80 64 57
194 51 21 18
118 11 7
2
3
4
5
Time (h)
30
72
60 Time (min)
Fig. 40. Separation of DNA fragments on Superose 6 HR 10/30. Peak figures correspond to number of base pairs.
Performing a separation Buffer: 0.05 M sodium phosphate, 0.15 M NaCl, pH 7 or select the buffer in which the sample should be stored or solubilized for the next step.
Use 0.15 M NaCl, or a buffer with equivalent ionic strength, to avoid pH dependent nonionic interactions with the matrix. At very low ionic strength, the presence of a small number of negatively charged groups may cause retardation of basic proteins and exclusion of acidic proteins.
54
The sample should be fully dissolved. Centrifuge or filter to remove particulate material (see Appendix 3). Always use degassed buffers and maintain a constant temperature during the run to avoid introducing air into the column. Set an appropriate pressure limit on the chromatography system to avoid damage to the column packing. Column performance should be checked at regular intervals by determining the theoretical plate number per meter and peak symmetry. Prepacked columns are supplied with recommended values. See page 96 for how to check column efficiency. See page 26 for advice on optimizing the separation. Exposure to temperatures outside the range +4 °C to +40 °C will destroy the efficiency of a packed bed and the column will need to be re-packed.
Cleaning 1. Wash with 1 column volume 0.5 M NaOH at 40 cm/h (0.5 ml/min for HR 10/30 columns). 2. Rinse immediately with 1 column volume of distilled water or buffer at 40 cm/h. 3. Continue to re-equilibrate with 2 column volumes of buffer or until the baseline and the eluent pH are stable. For extreme cases of contamination, check the instructions supplied with the product.
In special cases only, it may be necessary to change the bottom filter or to remove and discard the top 2–3 mm of the gel. These operations must be carried out extremely carefully to avoid serious loss of resolution. Reversing flow through a gel filtration column should only be considered under cases of severe contamination. There is a risk that reversing the flow may cause channeling through the packed bed leading to poor resolution, loss of efficiency and the need to repack the column. Professionally packed columns are less likely to be affected, but extreme care must be taken. Superose prep grade may be autoclaved repeatedly at +121 °C, pH 7 for 30 minutes without significantly affecting its chromatography properties. The medium must be removed from a column before autoclaving as certain column components cannot tolerate such high temperatures.
55
Media characteristics Composition: Superose is formed from highly cross-linked agarose. Superose prep grade shows less tendency towards hydrophobic interactions than Superose in prepacked columns. Superose 6 shows less tendency towards hydrophobic interactions than Superose 12. Product
Efficiency: theoretical plates per meter* (prepacked columns only)
pH stability
Superose 6
>30 000 m-1
Superose 6 prep grade
†
Particle size
Mean particle size
Long term: 3–12 Short term: 1–14
11–15 µm
13 µm
*
Long term: 3–12 Short term: 1–14
20–40 µm
30 µm
Superose 12
>40 000 m-1
Long term: 3–12 Short term: 1–14
9–13 µm
11 µm
Superose 12 prep grade
*
Long term: 3–12 Short term: 1–14
20–40 µm
30 µm
* A minimum column efficiency of 10 000 m-1 should be expected for a well packed column. Long term pH stability refers to the pH interval where the medium is stable over a long period of time without adverse side effects on its chromatography performance. Short term pH stability refers to the pH interval for regeneration, cleaning-in-place and sanitization procedures. All ranges are estimates based on the experience and knowledge within Amersham Biosciences.
†
Chemical stability Stable in all commonly used aqueous buffers and additives such as detergents (1% SDS), denaturing agents (8 M urea or 6 M guanidine hydrochloride) and 30% acetonitrile.
Storage Store unused media +4 °C to +25 °C in 20% ethanol. Do not freeze. Columns can be left connected to a chromatography system with a low flow rate (0.01 ml/min) of buffer passing through the column to prevent bacterial growth or the introduction of air into the column which would destroy the packing. For long term storage, wash with 2 column volumes of distilled water followed by 2 column volumes of 20% ethanol. Store at +4 °C to +25 °C. Degas the ethanol/water mixture thoroughly and use a low flow rate, checking the back pressure as the column equilibrates. Avoid changes in temperature which may cause air bubbles in the packing.
56
Sephadex: rapid group separation of high and low molecular weight substances, such as desalting, buffer exchange and sample clean up Sephadex is prepared by cross-linking dextran with epichlorohydrin, illustrated in Figure 41. CH2 HC H O H C OH H C O CH2 C HC OH C H O H H OH C OH H C O CH2 C HC H HO C O H H C OH O H C O C OH C CH 2
HC
H
OH
OH
CH2 H O
CH2
HO C H C OH C O C H
HC H HC O H C OH H C O CH2 C O C H OH CH2 HC
O
O
CH2
H C H O H C OH H C O C HO C H
OH
OH
CH2 OH
Fig. 41. Partial structure of Sephadex.
The different types of Sephadex vary in their degree of cross-linking and hence in their degree of swelling and selectivity for specific molecular sizes, as shown later on page 68 Media characteristics. • Sephadex G-10 is well suited for the separation of biomolecules such as peptides (Mr >700) from smaller molecules (Mr <100). • Sephadex G-50 is suitable for the separation of molecules Mr >30 000 from molecules Mr <1 500 such as labeled protein or DNA from unconjugated dyes. The medium is often used to remove small nucleotides from longer chain nucleic acids. • Sephadex G-25 is recommended for the majority of group separations involving globular proteins. These media are excellent for removing salt and other small contaminants away from molecules that are greater than Mr 5 000. Using different particle sizes enables columns to be packed according to application requirements, see below. The particle size determines the flow rates and the maximum sample volumes that can be applied. For example, smaller particles give higher column efficiency (narrow, symmetrical peaks), but may need to be run more slowly as they create higher operating pressures. Sephadex G-25
Application
Superfine
For highest column efficiency (highest resolution), but operating pressures increase
Fine
For laboratory scale separations
Coarse and Medium
Use when a high flow rate at a low operating pressure is essential, e.g. large scale
Coarse
For batch procedures
57
b
a
Fig. 42. Prepacked columns: a) HiPrep 26/10 Desalting, b) HiTrap Desalting 5 ml.
Dialysis is frequently mentioned in the literature as a technique to remove salt or other small molecules and to change the buffer composition of a sample. However, dialysis is generally a very slow technique, requiring large volumes of buffer. During handling or as a result of proteolytic breakdown or non-specific binding to the dialysis membranes, there is a risk of losing material. A simpler and much faster technique is to use a desalting column, packed with Sephadex G-25, for group separation between high and low molecular weight substances. Proteins are separated from salts and other small molecules. In a fast, single step, the sample is desalted, transferred into a new buffer and low molecular weight materials are removed. The high speed and high volume capacity of the separation enables even large sample volumes to be processed rapidly and efficiently. Sample volumes up to 30% of the total volume of the desalting column can be applied and separated at much higher flow rates than those used for high resolution fractionation, as illustrated in Figure 43. a)
RS
HiPrep 26/10 Desalting Flow: 9 ml/min (100 cm/h)
3.5
b)
RS
HiPrep 26/10 Desalting Sample volume: 15 ml
3.5
3
3
2.5
2.5
2
2
1.5
1.5
1
1
0.5
0.5
0
0
0
2
4
6
8
10
12 14 16 18 Sample volume (ml)
0
5
10
15
20
Fig. 43. a) Influence of sample volume on resolution. b) Influence of flow rate on resolution.
58
25
30 35 Flow (ml/min)
Desalting columns are used not only to remove low molecular weight contaminants such as salt, but also for buffer exchange before and after different chromatography techniques and for the rapid removal of reagents to terminate a reaction. Examples of group separations include: • removal of phenol red from culture fluids prior to anion exchange chromatography or nucleic acid preparations • removal of unincorporated nucleotides during DNA sequencing • removal of free low molecular weight labels • termination of reactions between macromolecules and low molecular weight reactants • removal of products, cofactors or inhibitors from enzymes • removal of unreacted radiolabels such as [a-32P] ATP from nucleic acid labeling reactions
Separation options For group separations the medium should be selected so that the high molecular weight molecules are eluted at the void volume with minimum peak broadening or dilution and minimum time on the column. The lowest molecular weight substances should appear by the time one column volume of buffer has passed through the column. Product
Exclusion limit
HiTrap Desalting 5 ml >5×103 (Sephadex G-25 Superfine) HiPrep 26/10 Desalting (Sephadex G-25 Fine)
Sample loading capacity
Sample elution volume (for maximum sample loading)
Maximum operating back pressure (MPa, bar, psi)
Recommended operating flow
0.25–1.5 ml
1.0–2.0 ml
0.3 MPa, 3 bar, 42 psi
1–10 ml/min
>5×103
2.5–15 ml
7.5–20 ml
0.15 MPa, 1.5 bar, 22 psi
9–31 ml/min
PD-10 >5×103 (Sephadex G-25 Medium)
1.5–2.5 ml
2.5–3.5 ml
Run under gravity
Run under gravity Run under gravity
NICK*
>3×104
<0.1 ml
0.4 ml
Run under gravity
MicroSpin™ G-25†
>5×103
10–100 µl
–
Centrifuge
Centrifuge
NAP-5*
>5×103
<0.5 ml
1.0 ml
Run under gravity
Run under gravity
NAP-10*
>5×103
<1.0 ml
1.5 ml
Run under gravity
Run under gravity
NAP-25*
>5×103
<2.5 ml
3.5 ml
Run under gravity
Run under gravity
Sephadex G-25 Superfine
>5×103
n.a.
n.a.
Darcy's law applies‡ applies‡
Darcy's law
Sephadex G-25 Fine
>5×103
n.a.
n.a.
Darcy's law applies‡
Darcy's law applies‡
Sephadex G-25 Medium
>5×103
n.a.
n.a.
Darcy's law applies‡
Darcy's law applies‡
‡
Darcy's law applies‡
Sephadex G-25 Coarse
>5×10
3
n.a.
n.a.
Darcy's law applies
Sephadex G-50 Fine
>3×104
n.a.
n.a.
Darcy's law applies‡
Darcy's law applies‡
Sephadex G-10
>700
n.a.
n.a.
Darcy's law applies‡
Darcy's law applies‡
* NICK columns are packed with Sephadex G-50 Fine DNA Grade and NAP columns are packed with Sephadex G-25 Medium DNA Grade. † A range of MicroSpin columns is available for desalting of proteins and purification of labeled DNA fragments and PCR products. Refer to the BioDirectory catalogue from Amersham Biosciences for further details. ‡ In practice this means that the pressure/flow considerations that must be made when using other gel filtration media do not apply to Sephadex. Doubling the flow rate doubles the column pressure. See Appendix 2 for an explanation of Darcy's law.
59
For convenience and reliable performance, use prepacked Sephadex columns such as HiTrap Desalting 5 ml and HiPrep 26/10 Desalting. Reference lists highlighting the use of HiPrep 26/10 Desalting and HiTrap Desalting are available at www.chromatography.amershambiosciences.com. Always use disposable columns if there is a risk of biological or radioactive contamination or when any possibility of carryover between samples is unacceptable. The type of equipment available and the sample volume to be processed also govern the choice of prepacked column, as shown in Figure 44.
Fig. 44. Selecting prepacked columns for desalting and buffer exchange.
60
Separation examples A 280 nm
Sample: UV 280 nm Conductivity
Column: Buffer:
0.15 (His)6 protein
(His)6 protein eluted from HiTrap Chelating HP with sodium phosphate 20 mM, sodium chloride 0.5 M, imidazole 0.5 M, pH 7.4 HiTrap Desalting 5 ml Sodium phosphate 20 mM, sodium chloride 0.15 M, pH 7.0
0.10
Salt
0.05 Inject Vo
Vt
0 0
1
2 min
Fig. 45. Desalting a (His)6 fusion protein using HiTrap Desalting 5 ml on ÄKTA™prime. The UV (protein) and conductivity (salt) traces enable pooling of the desalted fractions and facilitate optimization of the separation.
A 280 nm
NHS
Column: Sample:
HiPrep 26/10 Desalting 2 mg/ml BSA, 0.07 mg/ml N-Hydroxysuccinimide (NHS) in 50 mM sodium phosphate, 0.15 M NaCl, pH 7.0. Filtered through a 0.45 µm filter Sample volume: 13 ml Buffer: 50 mM sodium phosphate, 0.15 M NaCl, pH 7.0 Flow: 31 ml/min (350 cm/h)
BSA
0.0
1.0
2.0
Time (min)
Fig. 46. Reproducible removal of N-Hydroxysuccinimide from bovine serum albumin.
Performing a separation Desalting and buffer exchange can take less than 5 minutes per sample with greater than 95% recovery for most proteins. To prevent possible ionic interactions the presence of a low salt concentration (25 mM NaCl) is recommended during desalting and in the final sample buffer. Volatile buffers such as 100 mM ammonium acetate or 100 mM ammonium hydrogen carbonate can be used if it is necessary to avoid the presence of NaCl. The sample should be fully dissolved. Centrifuge or filter to remove particulate material (see Appendix 3). Always use degassed buffers to avoid introducing air into the column. Sample concentration up to 70 mg/ml protein should not influence the separation when using normal aqueous buffers.
61
If possible use a chromatography system with a UV and a conductivity monitor to facilitate optimization of the sample loading. The elution of the protein peak at A280 and the appearance of the salt peak can be followed exactly and different separations can be easily compared, as shown in Figure 47. If conductivity cannot be monitored and recovery of completely desalted sample is the major requirement, apply sample volumes of between 15 and 20% of the total column volume.
A 280 nm
Conductivity (mS/cm)
0.25
A 280
Conductivity
0.20
10.0
0.15 0.10 5.0 0.05 0.00 0.0
1.0
2.0
Fig. 47. Buffer exchange of mouse plasma on HiPrep 26/10 Desalting.
62
Time (min)
Alternative 1: Using a HiTrap column with a syringe The maximum recommended sample volume is 1.5 ml. The table below shows the effect of reducing the sample volume applied to the column. Table 1. Recommended sample and elution volumes using a syringe or Multipipette™ with HiTrap Desalting 5 ml Sample load
Add buffer
Elute and collect
Yield %
0.25 ml
1.25 ml
1.0 ml
> 95
0.0
4.0
0.50 ml
1.0 ml
1.5 ml
> 95
< 0.1
3.0
1.00 ml
0.5 ml
2.0 ml
> 95
< 0.2
2.0
1.50 ml
0 ml
2.0 ml
> 95
< 0.2
1.3
Step 3
Step 4
Remaining salt %
Dilution factor
Step 6
1. Fill the syringe with buffer. Unscrew the stop plug at the top of the column. To avoid introducing air into the column, connect the column "drop to drop" to the syringe (via the adapter provided). 2. Remove the twist-off end. 3. Wash the column with 25 ml buffer at 5 ml/min to completely remove the 20% ethanol (supplied as storage buffer). If air is trapped in the column, wash with degassed buffer until the air disappears. Air bubbles introduced onto the column by accident during sample application do not influence the separation. 4. Apply the sample using a 2–5 ml syringe at a flow rate between 1–10 ml/min. Discard the liquid eluted from the column. 5. If the sample volume is less than 1.5 ml, change to buffer and proceed with the injection until a total of 1.5 ml has been eluted. Discard the eluted liquid. 6. Elute the protein with the appropriate volume selected from Table 1. Collect the desalted protein in the volume indicated.
Note: 5 ml/min corresponds to approximately 120 drops/min when using a HiTrap 5 ml column.
A simple peristaltic pump can also be used to apply sample and buffers.
63
Alternative 2: Simple desalting with ÄKTAprime ÄKTAprime contains pre-programmed templates for individual HiTrap Desalting 5 ml and HiPrep 26/10 Desalting columns.
Buffer Preparation Prepare at least 500 ml of the required buffer 1. Follow the instructions supplied on the ÄKTAprime cue card to connect the column and load the system with buffer. 2. Select the Application Template. 3. Start the method. 4. Enter the sample volume and press OK.
Alternative 3: Desalting on a gravity-feed PD-10 column Buffer Preparation 1. Remove top cap and pour off the excess liquid. 2. Cut off the bottom tip. 3. Place column in the Desalting Workmate supplied onto the plastic tray and equilibrate with 25 ml buffer. Discard the eluent. 4. Add a total sample volume of 2.5 ml. If the sample volume is less than 2.5 ml, add buffer to reach a final volume of 2.5 ml. Discard the eluent. 5. Add 3.5 ml buffer to elute high molecular weight components and collect the eluent.
Using the standard procedure described above protein yield is typically greater than 95% with less than 4% salt (low molecular weight) contamination. The dilution factor is 1:4. Sephadex G-10 can be packed into empty PD-10 columns and run in the same manner as PD-10 Desalting columns. Optimization of desalting 1. When possible select a prepacked column that is best suited to the volume of sample that needs to be desalted (see Separation Options). For the majority of separations the instructions supplied ensure satisfactory results and very little optimization should be necessary. 2. Ensure that buffer conditions are optimal for the separation. 3. Select the highest flow rate recommended. Figure 48 shows an example of the influence of flow rate on group separation. 4. Determine the maximum sample volume that can be loaded. Figure 49 shows an example of the influence of sample volume on group separation.
64
Column: Sample: Buffer: Sample volume: Flow:
HiTrap Desalting 5 ml Bovine serum albumin, 2 mg/ml in 0.5 M NaCl, 0.05 M sodium phosphate, pH 7.0 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.0 0.8 ml 1.7, 3.3, 6.7, 10.0, 13.3, 16.7, 20.0 ml/min
A 280 nm 3.3 ml/min
0.30
6.7 10.0 13.3
Conductivity (mS/cm) 75 1.2 1.0 Relative resolution
0.40
0.20
0.8 0.6 0.4 0.2
0.10
0.0
BSA
10 ml/min
0
NaCl
20
0
0.00 0
2
4
8 ml
6
Fig. 48. Influence of flow rate on separation using a HiTrap Desalting column.
Column: Sample: Buffer: Sample volume: Flow:
HiTrap Desalting 5 ml Bovine serum albumin, 2 mg/ml in 0.5 M NaCl, 0.05 M sodium phosphate, pH 7.0 0.05 M sodium phosphate, 0.15 M NaCl, pH 7.0 0.8, 1.3, 1.7, 2.2 ml 5 ml/min Volume collected: 1.5 + × ml
A 280 nm 0.40
Conductivity (mS/cm) 75
% NaCl contamination
2.2 ml 0.30 1.7 ml 1.3 ml
0.20
0.8 ml
0.8 ml sample
30
1.3 ml sample 1.7 ml sample 2.2 ml sample
20
10
0.10 2.0
2.5 3.0 Volume collected: 1.5 + × ml
3.0
0
0.00 0
2
4
6
8
ml
Fig. 49. Influence of sample volume on separation using a HiTrap Desalting column.
As the sample volume increases (up to a maximum of 30% of the total column volume) the dilution factor decreases and there may be a slight increase in the amount of salt remaining in the sample after elution. Table 1 on page 63 illustrates this effect when using a HiTrap Desalting 5 ml column. Sample volumes up to 30% of the total column volume give a separation with minimal sample dilution. Larger sample volumes can be applied, but resolution will be reduced.
65
Scale up and processing large sample volumes Connecting columns in series increases the effective column volume and so increases sample loading capacity. Table 2 shows the sample loading capacities and dilution factors when using prepacked desalting columns alone or in series, see also Figure 50 for HiTrap application examples. Table 2. Selection guide for desalting/buffer exchange columns Column
Loaded volume (ml)
Eluted volume (ml)
Dilution factor
Operation
HiPrep 26/10 Desalting
10 15 (max)
10–15 15–20
1–1.5 1–1.3
pump pump
2 x HiPrep 26/10 Desalting
30 (max)
30–40
1–1.3
pump
3 x HiPrep 26/10 Desalting
45 (max)
45–55
1–1.2
pump
4 x HiPrep 26/10 Desalting
60 (max)
60–70
1–1.2
HiTrap Desalting
0.25 0.5 1.0 1.5 (max)
1.0 1.5 2.0 2.0
4 3 2 1.3
pump syringe/pump syringe/pump syringe/pump syringe/pump
2 x HiTrap Desalting
3.0
4–5
1.3–1.7
syringe/pump
3 x HiTrap Desalting
4.5 (max)
6–7
1.3–1.7
syringe/pump
PD-10 Desalting columns
1.5 2.0 2.5 (max)
3.5 3.5 3.5
2.3 1.7 1.4
gravity gravity gravity
Increasing sample loading capacity from 1.5 ml up to 7.5 ml HiTrap Desalting 1 × 5 ml
Column: Sample:
HiTrap Desalting, 1 × 5 ml, 3 × 5 ml, 5 × 5 ml 2 mg/ml BSA in 50 mM sodium phosphate, 0.5 M sodium chloride, pH 7.0
A 280 nm
Conductivity (mS/cm) BSA
A
NaCl
0.40
Sample volume: Buffer:
28% × Vt (1.4, 4.3 and 7.1 ml respectively) 50 mM sodium phosphate, 0.15 M sodium chloride, pH 7.0 5 ml/min
Flow:
50
0.30 40 0.20 30 0.10 20
0.00 0
2.0
HiTrap Desalting 3 × 5 ml in series A 280 nm B
6.0
ml
HiTrap Desalting 5 × 5 ml in series
Conductivity (mS/cm) BSA
4.0
Conductivity (mS/cm)
A 280 nm BSA
NaCl
NaCl
C
0.40
50
0.30
0.40
50
0.30 40
0.20
40 0.20
30 0.10 20
0.00 0
5.0
10.0
15.0
20.0
ml
Fig. 50. Scale up using HiTrap columns connected in series.
66
30 0.10 20
0.00 0
10.0
20.0
30.0
ml
Increasing sample loading capacity from 15 ml up to 60 ml Connect HiPrep 26/10 Desalting columns in series, e.g. 2 columns: sample volume 30 ml, 4 columns: sample volume 60 ml, as shown in Figure 51. Even with four columns in series, high flow rates can be maintained without causing back pressure difficulties so that up to 60 ml of sample can be processed in 20–30 minutes.
Fig. 51. Four HiPrep 26/10 Desalting columns connected in series.
For sample volumes greater than 60 ml Select a suitable particle size of Sephadex G-25, rehydrate and pack into a short, wide column to facilitate high flow rates and rapid recovery of desalted materials. See Appendix 1 for details on column packing. The particle size determines the flow rates and sample volumes that can be applied, as shown in Figure 52. 100
200
cm/h flow velocity (linear flow rate)
% of column volume
maximum flow rate
maximum sample volume
Superfine
Fine
Medium
Coarse
increasing particle size
Fig. 52. Sephadex G-25: recommended sample volumes and flow rates vary with particle size.
• Use Superfine grade with a bed height of approximately 15 cm when requiring the highest efficiencies. • Use Fine grade with an approximate bed height of 15 cm for laboratory scale separations. • Use Coarse and Medium grades for preparative processes where a high flow rate at a low operating pressure is essential. Pack in a column less than 50 cm in bed height. The Coarse grade is suitable for batch procedures.
67
Media characteristics Sephadex is prepared by cross-linking dextran with epichlorohydrin. Variations in the degree of cross linking create the different Sephadex media and influence their degree of swelling and their selectivity for specific molecular sizes. Product
Fractionation range, Mr (globular proteins)
pH stability*
Bed volume ml/g dry Sephadex
Maximum operating flow
Particle size, wet
Sephadex G-10
<7×102
Long term: 2–13 Short term: 2–13
Sephadex G-25 Coarse
1×103–5×103
Long term: 2–13 Short term: 2–13
2–3
Darcy's law†
55–165 µm
4–6
Darcy's law†
170–520 µm
Sephadex G-25 Medium
1×103–5×103
Long term: 2–13 Short term: 2–13
4–6
Darcy's law†
85–260 µm
Sephadex G-25 Fine
1×103–5×103
Long term: 2–13 Short term: 2–13
4–6
Darcy's law†
35–140 µm
Sephadex G-25 Superfine
1×103–5×103
Long term: 2–13 Short term: 2–13
4–6
Darcy's law†
17–70 µm
Sephadex G-50 Fine
1×103–3×104
Long term: 2–10 Short term: 2–13
9–11
Darcy's law†
40–160 µm
* Long term pH stability refers to the pH interval where the medium is stable over a long period of time without adverse side effects on its chromatography performance. Short term pH stability refers to the pH interval for regeneration, cleaning-in-place and sanitization procedures. All ranges are estimates based on the experience and knowledge within Amersham Biosciences. In practice this means that the pressure/flow considerations that must be made when using other gel filtration media do not apply to Sephadex. Doubling flow rate will double column pressure. See Appendix 2 for an explanation of Darcy's Law.
†
Column Packing See Appendix 1.
Cleaning PD-10, NAP, NICK and HiTrap Desalting columns are disposable, but, depending on the type of sample and if cross-contamination is not a concern, they can be re-used a few times. For HiPrep 26/10 Desalting columns proceed as follows: 1. Wash the column with 2 column volumes of 0.2 M sodium hydroxide or a solution of a non ionic detergent (typically 0.1–0.5% Triton X-100 dissolved in distilled water or 0.1 M acetic acid) at a flow rate of 10 ml/min. Ensure that the pressure drop does not exceed 0.15 MPa (1.5 bar, 22 psi). 2. Wash the column with 5 column volumes of distilled water at a flow rate of 15 ml/min. 3. Before use, re-equilibrate the column with at least 5 column volumes of buffer until the UV base line and pH are stable.
To remove precipitated proteins and peptides, fill the column with 1 mg pepsin/ml in 0.1 M acetic acid, 0.5 M NaCl and leave at room temperature overnight or 1 hour at +37 ºC. Repeat the normal cleaning procedure above.
Chemical stability Sephadex is stable in all commonly used aqueous buffers and additives such as ionic and non-ionic detergents, denaturing agents (8 M urea or 6 M guanidine hydrochloride). The media are stable in short chain alcohols such as ethanol, methanol and propanol, but concentrations above 25% should not normally be used. Note that Sephadex shrinks in alcohol solutions. 68
Storage Store unused media +4 °C to +25 °C in 20% ethanol. Do not freeze. Wash used media with 2 column volumes of distilled water followed by 2 column volumes of 20% ethanol. Store at +4 °C to +25 °C. Alternatively, wash with 2 column volumes of distilled water followed by 2 column volumes 0.01 M NaOH. Sodium hydroxide solution is bacteriostatic, easily disposed of and does not shrink the medium. Degas the ethanol/water mixture thoroughly and use a low flow rate, checking the back pressure as the column equilibrates. Avoid changes in temperature which may cause air bubbles in the packing.
69
70
Chapter 3 Gel filtration in theory Defining the process Results from gel filtration are usually expressed as an elution profile or chromatogram that shows the variation in concentration (typically in terms of UV absorbance at A280nm) of sample components as they elute from the column in order of their molecular size (Figure 53). Molecules that do not enter the matrix are eluted in the void volume, Vo as they pass directly through the column at the same speed as the flow of buffer. Molecules with partial access to the pores of the matrix elute from the column in order of decreasing size. Molecules with full access to the pores move down the column, but do not separate from each other. These molecules usually elute just before one total column volume, Vt, of buffer has passed through the column.
high molecular weight
Absorbance
low molecular weight
sample injection volume
void volume Vo total column volume Vt
intermediate molecular weight equilibration Vt
Vo
1 cv Column Volumes (cv)
Fig. 53. Theoretical chromatogram of a high resolution fractionation.
The behavior of each component can be expressed in terms of its elution volume, Ve, determined by direct measurement from the chromatogram. As shown in Figure 54 there are three different ways of measuring Ve, dependent on the volume of sample applied to the column. A. When very small samples are applied (small enough to be neglected compared to the elution volume), take the position of the peak maximum in the elution diagram as Ve. B. If the sample volume cannot be neglected compared with the elution volume, measure the elution volume from half the sample volume to the position of the peak maximum. C. When very large sample volumes are used (giving a plateau region in the elution curve), take the volume eluted from the start of sample application to the inflexion point (or half height) of the rising part of the elution peak as Ve.
71
A 280 nm A
A. Sample size negligible compared with volume of packed bed.
Ve B
B. Sample size not negligible compared with volume of packed bed.
Ve C
C. Sample giving plateau elution curve. inflexion point
Ve
Elution volume
Fig. 54. Measurement of elution volume, Ve.
Since symmetrical peaks are common in gel filtration, elution volumes are easily determined. However, Ve does not completely define the behavior of the sample since Ve will vary with the total volume of the packed bed (Vt) and the way in which the column has been packed. The elution of a sample is best characterized by a distribution coefficient (Kd) derived as follows: The volume of the mobile phase (buffer) is equal to the void volume, Vo, i.e. the elution volume of molecules that remain in the buffer because they are larger than the largest pores in the matrix and pass straight through the packed bed. In a well packed column the void volume is approximately 30% of the total column. The volume of the stationary phase, Vs, is equal to Vi, the volume of buffer inside the matrix which is available to very small molecules, i.e. the elution volume of molecules that distribute freely between the mobile and stationary phases minus the void volume. Since, in practice, Vs or Vi are difficult to determine, it is more convenient to substitute the term (Vt – Vo). The estimated volume of the stationary phase will therefore include the volume of solid material which forms the matrix. Kd represents the fraction of the stationary phase that is available for diffusion of a given molecular species. The stationary phase Vs can be can be substituted by the term (Vt – Vo) in order to obtain a value Kav. Kav = (Ve – Vo)/(Vt – Vo)
72
Void volume Vo
Total column volume Vt
Vt – Vo
Fig. 55. Diagrammatic representation of Vt and Vo. Note that Vt – Vo will include the volume of the solid material which forms the matrix (Fischer, L. Laboratory Techniques in Biochemistry and Molecular Biology. Vol. 1 part II. An Introduction to Gel Chromatography. North Holland Publishing Company, Amsterdam. Reproduced by kind permission of the author and publisher).
Low molecular weight
Intermediate molecular weight
Sample injection
High molecular weight
Absorbance
Interacting with medium
Since (Vt – Vo) includes the volume of the matrix that is inaccessible to all solute molecules, Kav is not a true partition coefficient. However, for a given medium there is a constant ratio of Kav:Kd which is independent of the nature of the molecule or its concentration. Kav is easily determined and, like Kd, defines sample behavior independently of the column dimensions and packing. Other methods of normalizing data give values which vary depending upon how well the column is packed. The approximate relationships between some of these terms are shown in Figure 56.
Vt
Vo Ve
Kav =
Ve– Vo Vt – Vo
Kd =
Ve– Vo = Vt – Vo – Vgel matrix
Vt – Vo Vi 0.5
1.0
1
2
3
0
0.5
1.0
0
0.5
1.0
Ve– Vo Vi
Ve / Vt
Kav Kd
Fig. 56. Relationship between several expressions used for normalizing elution behavior.
73
Selectivity curves and media selection The partition coefficient Kav is related to the size of a molecule. Molecules of similar shape and density demonstrate a sigmoidal relationship between their Kav values and the logarithms of their molecular weights (Mr). Over a considerable range there is a linear relationship between Kav and log Mr. The selectivity of a gel filtration medium depends solely on its pore size distribution and is described by a selectivity curve. By plotting Kav against the log of the molecular weight for a set of standard proteins, selectivity curves are created for each gel filtration medium, as shown in Figure 57.
K av 0.8
Superdex 75 prep grade and Superdex 200 prep grade
0.6
Dextrans
Superdex 30 prep grade
0.4
g 0p 20 pg 75
K av 0.7 0.6
0.2 0.5
PEG Peptides
0.4
10 0.3
K av 0.8
0.2
10
5
10
7
Mr
10
7
Mr
Globular proteins 0
0.4
pg
75
10 000 Mr
6
20
1000
10
Superdex 75 prep grade and Superdex 200 prep grade
0.6
0.1
300
4
pg
0.2
10
4
10
5
10
6
Fig. 57. Selectivity curves for Superdex 30 prep grade, Superdex 75 prep grade and Superdex 200 prep grade.
Gel filtration media should be selected so that the high molecular weight molecules are eluted at the void volume (Kav = 0) with minimum peak broadening or dilution and minimum time on the column. The lowest molecular weight substances should be eluted near Vt (Kav = 1). Under ideal conditions, no molecules can be eluted with a Kav greater than 1 or less than 0. If the Kav is greater than 1, molecules have bound non-specifically to the medium. If Kav is less than 0 after calibration then there is channeling in the chromatography bed and the column must be repacked.
74
Resolution Final resolution, the degree of separation between peaks, is influenced by many factors: the ratio of sample volume to column volume, flow rate, column dimensions, particle size, particle size distribution, packing density, porosity of the particle and viscosity of the mobile phase. The success of gel filtration depends primarily on choosing conditions that give sufficient selectivity and counteract peak broadening effects during the separation. Resolution (Rs) is defined by the following expression: Rs =
Vr2 – Vr1 (W1 + W2) 2
Vr1 and Vr2 are the elution volumes for two adjacent peaks measured at the center of the peak. W1 and W2 are the respective peak widths.
(Vr2 – Vr1) represents the distance between the peaks and 1/2 (W1 + W2) the mean peak width of the two peaks as shown in Figure 58. ( Vr2 – Vr1 )
W1
W2
Fig. 58. Parameters used to define resolution (Rs).
Resolution is a function of the selectivity of the medium and the efficiency of that medium to produce narrow peaks (minimal peak broadening) as illustrated in Figure 59.
high efficiency
low efficiency
Fig. 59. Dependence of resolution on selectivity and the counteraction of peak broadening.
75
The efficiency of a packed column defines its ability to produce narrow symmetrical peaks during elution. Refer to Appendix 1 for column packing and preparation and determination of column efficiency. Efficiency is particularly important in gel filtration in which separation takes place as only a single column volume of buffer passes through the column. Efficiency is defined in terms of theoretical plates per meter (N): N = 5.54 (Ve/W1/2)2 × 1000/L where Ve = peak elution (retention) volume W1/2 = peak width at half peak height L = bed height (mm) Ve and W1/2 are in same units Efficiency can be improved by decreasing the particle size of the medium. However, using a smaller particle size may create an increase in back pressure so that flow rate needs to be decreased, lengthening the run time. The uniformity of the packed bed and the particles influences the uniformity of the flow through the column and hence affects the shape and eventual peak width. Gel filtration media with high uniformity (lower particle size distribution) facilitate the elution of molecules in narrow peaks. Gel filtration media with smaller particle sizes facilitate diffusion of sample molecules in and out of the particles by reducing the time to achieve equilibrium between mobile and stationary phases and so improve resolution by reducing peak width. Sample dilution is inevitable because sample passes through the column and diffusion occurs. In order to minimize sample dilution a maximum sample volume is used within the limits set by the separation distance i.e. the resolution required between the peaks of interest. The sample can be regarded as a zone passing down the column. Figure 60 shows how, if no zone broadening occurs, the maximum sample volume could be as great as the separation volume (VSep): VSep = VeB – VeA However, due to eddy diffusion, non-equilibrium between the stationary phase and the buffer, and longitudinal diffusion in the bed, the zones will always be broadened. Therefore the sample volume must always be smaller than the separation volume.
76
Concentration
A
A
B
Ve
B Ve
Elution volume
Vsep
Fig. 60. Elution curves for different sample sizes. The top diagram corresponds to the application of a small sample. The center diagram corresponds to the maximum sample volume that gives complete separation if there is no zone broadening. The bottom diagram corresponds to the maximum sample volume to obtain complete separation in the conditions of the experiment. The shaded areas correspond to the elution profiles that would be obtained if there was no zone broadening.
77
78
Chapter 4 Molecular weight determination and molecular weight distribution analysis Unlike electrophoretic techniques, gel filtration provides a means of determining the molecular weight or size (Stokes radius) of native or denatured proteins under a wide variety of conditions of pH, ionic strength and temperature, free from the constraints imposed by the charge state of the molecules. In order to understand and follow the procedures outlined, it is important to have read Chapter 3 Gel filtration in theory. For molecular weight determination, several theoretical models have been proposed to describe the behavior of solutes during gel filtration. Most models assume that the partition of solute molecules between the particles and surrounding liquid is an entirely steric effect. However, in practice a homologous series of compounds demonstrate a sigmodial relationship between their various elution volume parameters and the logarithm of their molecular weights. Thus molecular weight determination by gel filtration can be made by comparing an elution volume parameter, such as Kav of the substance of interest, with the values obtained for several known calibration standards. A calibration curve is prepared by measuring the elution volumes of several standards, calculating their corresponding Kav values (or similar parameter), and plotting their Kav values versus the logarithm of their molecular weight. The molecular weight of an unknown substance can be determined from the calibration curve once its Kav value is calculated from its measured elution volume. Various elution parameters, such as Ve, Ve/Vo, Kd, and Kav have been used in the literature for the preparation of calibration curves but the use of Kav is recommended since: 1) it is less sensitive to errors which may be introduced as a result of variations in column preparation and column dimensions, 2) it does not require the unreliable determination of the internal volume (Vi) as is required with Kd. For accurate determination of molecular weight, the calibration standards must have the same relationship between molecular weight and molecular size as the substance of interest. Calibration Kits from Amersham Biosciences provide well-characterized, globular protein standards for protein molecular weight determination. The Low Molecular Weight Gel Filtration Calibration Kit contains 4 individually lyophilized proteins with molecular weights in the range 13 700–67 000 and Blue Dextran 2000. The High Molecular Weight Gel Filtration Calibration Kit contains 4 individually lyophilized proteins with molecular weights in the range 158 000–669 000 and Blue Dextran 2000. Many of the parameters important for a successful molecular weight determination are the same as for any high resolution fractionation: Use a medium with the correct fractionation range for the molecules of interest. The expected molecular weight values should fall in the linear part of the selectivity curve (see gel filtration selection guide page 18). Use a prepacked column whenever possible. Homemade columns must be packed very carefully (see Appendix 1).
79
Use freshly prepared calibration standards, selected so that the expected molecular weight values are covered by the entire calibration range. Always filter Blue Dextran before use. Apply samples in a volume less than 2% of the total column volume. Use the same buffer for the separation of calibrants and sample, for example 50 mM sodium phosphate, 0.15 M NaCl, pH 7. Use the recommended flow rate for the prepacked column or medium selected. If the molecular weight is unknown, use a medium with a wide fractionation range such as Sephacryl HR. This is also recommended for molecular weight distribution analysis and for polymeric materials such as dextrans and polyethylene glycols. Performing a molecular weight determination in the presence of urea, guanidine hydrochloride or SDS transforms polypeptides and proteins to a random coil configuration and so reduces structural differences. Differences will be seen in the resulting molecular weight values when compared to values acquired under non-denaturing conditions. Deviation from a Kav:log Mr calibration curve may occur if the molecule of interest does not have the same molecular shape as the standards. Performing a molecular weight determination 1. If using a self-packed column, prepare a fresh, filtered solution of Blue Dextran 2000 (1.0 mg/ml) in the running buffer. Apply Blue Dextran to the column, using a volume <2% of the total column volume (Vt) to determine the void volume (Vo), and to check the column packing. 2. Dissolve the selected calibration proteins in the running buffer (at concentrations recommended by the manufacturer). Allow a few minutes for dissolution, stirring gently. Do not heat or mix vigorously. If necessary, filter the calibration solution. 3. Apply the calibration solution to the column, in a volume <2% of the total column volume (Vt). 4. Determine the elution volumes (Ve) for the standards by measuring the volume of the eluent from the point of application to the centre of the elution peak. 5. Calculate the Kav values for the standards and prepare a calibration curve of Kav versus the logarithm of their molecular weights, as follows: Kav =
Ve – Vo Vt – Vo
where Ve = elution volume for the protein Vo = column void volume = elution volume for Blue Dextran 2000 Vt = total bed volume On semilogarithmic graph paper, plot the Kav value for each protein standard (on the linear scale) against the corresponding molecular weight (on the logarithmic scale). Draw the straight line which best fits the points on the graph. Alternatively, use a statistics package to calculate the regression line. 6. Apply the sample in a volume <2% of the total column volume (Vt) and determine the elution volume (Ve) of the molecule of interest. 7. Calculate the corresponding Kav for the component of interest and determine its molecular weight from the calibration curve.
A calibrated column can be used for extended periods as long as the column is kept in good condition and not allowed to dry out, eliminating the need to set up a separate experiment for each determination.
80
Chapter 5 Sephadex LH-20 Sephadex LH-20 is specifically designed for the separation and purification of natural products that require the presence of organic solvents to maintain their solubility, including molecules such as steroids, terpenoids, lipids and low molecular weight peptides (up to 35 amino acid residues). Compounds are usually separated by a form of liquid/liquid partitioning or absorption chromatography. Sephadex LH-20 can have a very high selectivity for aromatic compounds in certain solvents and can be used at analytical or industrial scale for the preparation of closely related species. Sephadex LH-20 is made from hydroxypropylated dextran beads that have been crosslinked to yield a polysaccharide network. The medium can be swollen in water and organic solvents. The partial structure of Sephadex LH-20 is shown in Figure 61.
O O HO
HO
O O O
HO O HO O HO HO
O
O O O
O
O OH
O O
HO O HO
O
O HO
HO
O
O O
HO
O O
Fig. 61. Partial structure of Sephadex LH-20.
Sephadex LH-20 is suitable for an initial purification before polishing by ion exchange or reversed phase chromatography, or for a final polishing step, for example during the preparation of diastereoisomers. Depending upon the chosen solvents, Sephadex LH-20 can also separate components by partitioning between the matrix and the organic solvent. Sephadex LH-20 exhibits both hydrophilic and hydrophobic properties, the combination of which can offer unique chromatography selectivity for certain applications. For more detailed information on gel filtration in organic solvents refer to Preparative Gel Chromatography on Sephadex LH-20 by H. Henke, available from Amersham Biosciences. Sephadex has been used for gel filtration in organic solvents, for example dimethylformamide may be used with Sephadex G-10 and mixtures of water with the shorter chain alcohols may be used with Sephadex G-10, G-25 and G-50. 81
Separation options Product
Fractionation range (globular proteins)
Sample loading capacity*
Maximum operating back pressure
Maximum operating flow
Sephadex LH-20
< 5 × 103 (exclusion limit will depend on the solvent)
2% of column volume
Solvent dependent
12 cm/min (720 cm/hr) (bed height 14 cm, 15 MPa back pressure)
* If Sephadex LH-20 is used in adsorption mode then the sample volume is unlimited until reaching the point of column saturation.
Separation examples An HIV-1 reverse transcriptase inhibitor has been isolated from Phyllanthus niruri, a natural medicine that has been used for many years to combat edema and jaundice. The active component that inhibits HIV-1 reverse transcriptase has been identified as repandusinic acid A monosodium salt, a small tannin-like molecule. The structure of the free acid is shown in Figure 62. HO
OH HO
HO
HO
OH O
OH
6
O
O O
5
O HOOC 4'
H
5'
OH 1
3
OH
2
OH O HO
7'
6'
O O
O
4
6''
5''
OH
3'
4''
H
1''
OH
2'
H
HOOC
2''
1'
3''
O O
Fig. 62. Structure of free acid form of repandusinic acid A.
Table 3 shows the recovery of active inhibitor from an analytical separation on Sephadex LH-20. Table 3. Summary of data for the isolation of repandusinic acid A from P. niruri Purification step
Yield (mg)
ID50* (µg/ml)
Specific activity (×102 IU/mg)
Total activity (×103 IU) †
H2O extract
6 600
50
4
2 640
MeOH insoluble
2 500
20
10
2 500
Sephadex LH-20 Fr. 4–11‡
247
3.0–3.6
56–67
1 616
Cellulose Fr. 1 Fr. 2 Fr. 3 Fr. 4 Fr. 5
189 24 18 9 14
7.8 5.0 2.4 3.4 1.8
26 40 83 58 111
484 96 150 52 156
RA (pure substance)
5.9
0.3
668
394
* ID50 indicates the effectiveness of inhibitors expressed as concentrations which cause 50% inhibition of HIV-1-RT. Crude HIV-1-RT was used in this experiment. IU are arbitrary inhibitory activity units obtained by dividing the total weight of the fraction at each step by the weight of each fraction required to achieve 50% inhibition of [3H]dTTP incorporation into the polymer in the HIV-1-RT assay.
†
‡
82
Fractions 4–10 and Fraction 11 were combined because both fractions had the inhibitory activity.
Figure 63 shows Sephadex LH-20 used at a preparative scale for the separation of 2-acetamidobenzoic acid and 4-acetamidobenzoic acid. In this separation the hydrophilicity and hydrophobicity of the medium provide a unique chromatography selectivity resulting in high resolution of closely related species. The molecules differ only by the position of the acetamide moiety on the benzene ring. RI
1
2 O
1.
C
NH
OH
C
Column: Sample: Eluent: Flow rate: Detection: Yield:
CH 3
Sephadex LH-20, 2.5 × 200 cm Mixture of 2- and 4-acetamidobenzoic acid Acetone 8 ml/min Refractive Index 250 mg 2-acetamidobenzoic acid 254 mg 4-acetamidobenzoic acid
O
CH 3
6
C O
254 mg
250 mg
2.
8
HN
C
OH
O
Time (h)
Fig. 63. Separation of 2- and 4-acetamidobenzoic acid on Sephadex LH-20.
Packing a column Sephadex LH-20 should be packed in a solvent resistant column selected from Table 4 according to the column volume required for the separation. Table 4. Solvent resistant columns (*SR 10/50J includes a borosilicate glass jacket. Jackets are not available for other SR columns. All SR columns are supplied with two adaptors for top and bottom assembly) Column
Volume (ml)
Bed height (cm)
SR 10/50
16–39
20–50
SR 10/50J*
16–39
20–50
SR 25/45
73–220
15–45
SR 25/100
343–490
70–100
Simple steps to clarify a sample before applying it to a column will avoid the risk of blockage, reduce the need for stringent washing procedures and extend the life of the chromatography medium. Filter or centrifuge all solvents and samples before use. 1. Refer to Table 5, page 85, to calculate the amount of dry medium required as the extent of swelling depends upon the solvent system. Swell Sephadex LH-20 for at least 3 hours at room temperature in the solvent to be used for the separation. 2. Prepare a slurry 75:25 settled medium:solvent and decant any fine particles of medium. 3. Equilibrate all materials to room temperature. 4. Resuspend and pour the slurry into the column in one continuous step (using a glass rod will help to eliminate air bubbles). 5. Fill the column reservoir to the top with solvent. Seal, attach to a pump and open the column outlet. 6. Pack at 300 cm/h until the bed has reached a constant height. Stop the flow, empty and remove the packing reservoir.
83
7. Carefully fill the column with solvent and insert a wetted adaptor into the column. Ensure no air bubbles are trapped under the net and adjust the adaptor O-ring to give a sliding seal against the column wall. 8. Connect all tubings, ensuring that there are no air bubbles in the flow path. 9. Slowly slide down the adaptor so that any air in the tubings is displaced by solvent and lock the adaptor into position on the surface of the medium. 10. Open the column outlet and continue packing until the packed bed is stable and a final adjustment of the top adaptor can be made.
In solvents such as chloroform Sephadex LH-20 is less dense than the solvent and the medium will float. Pour the medium into the column and drain until the second adaptor can be inserted. Lock the adaptor in position at the surface of the medium and direct the flow of chloroform upwards. The bed will be packed against the top adaptor and the lower adaptor can be pushed slowly upwards towards the lower surface of the medium. Close the column outlet when moving the adaptor to avoid compressing the bed.
Performing a separation Start at a linear flow of 1 cm/h to check resolution. The lower the flow, the better the resolution. 1. Equilibrate the column with at least 2 column volumes of the solvent until a stable baseline is achieved. 2. Apply a sample volume equivalent to 1–2% of the total column volume. 3. Elute in 1 column volume. Re-equilibration is not needed between runs with the same solvent.
Cleaning Wash the column with 2–3 column volumes of the solvent, followed by re-equilibration in a new solvent if changing the separation conditions.
Medium characteristics Sephadex LH-20
pH stability
Bed volume ml/g dry Sephadex LH-20
Particle size
Working: 2–11 *Short term: 2–13
Depends on solvent, see table 5
Dry: 18–111 µm Wet: depends on solvent
* Short term pH stability refers to the pH interval for regeneration, cleaning-in-place and sanitization procedures. All ranges are estimates based on the experience and knowledge within Amersham Biosciences.
The wet particle size for Sephadex LH-20 varies according to the solvent used for swelling, as shown in Table 5.
84
Table 5. Approximate values for packed bed volumes of Sephadex LH-20 swollen in different solvents Solvent
Approx. bed volume (ml/g dry Sephadex LH-20)
Dimethyl sulfoxide
4.4–4.6
Pyridine
4.2–4.4
Water
4.0–4.4
Dimethylformamide
4.0–4.4
Methanol
3.9–4.3
Saline
3.8–4.2
Ethylene dichloride
3.8–4.1
Chloroform *
3.8–4.1
Propanol
3.7–4.0
†
3.6 –3.9
Ethanol
Isobutanol
3.6–3.9
Formamide
3.6–3.9
Methylene dichloride
3.6–3.9
Butanol
3.5–3.8
Isopropanol
3.3–3.6
Tetrahydrofuran
3.3–3.6
Dioxane
3.2–3.5
Acetone
2.4–2.6
Acetonitrile ‡
2.2–2.4
Carbon tetrachloride Benzene
‡
Ethyl acetate Toluene
‡
1.8–2.2 1.6–2.0
‡
‡
1.6–1.8 1.5 –1.6
* Containing 1% ethanol. †
Containing 1% benzene.
‡
Solvents that give a bed volume of less than 2.5 ml/g dry Sephadex LH-20 are not generally useful.
Chemical stability Sephadex LH-20 is stable in most aqueous and organic solvent systems. The medium is not stable below pH 2.0 or in strong oxidizing agents.
Storage Store dry at +4 °C to +25 °C. Store packed columns and used medium at +4 °C to +8 °C in the presence of a bacteriostatic agent.
Transferring Sephadex LH-20 between organic solvents Transfer Sephadex LH-20 from an aqueous solution to the organic solvent by moving through a graded series of solvent mixtures. This will ensure efficient replacement of the water by the required solvent. To transfer from aqueous solution or organic solvent (100% A) to a new organic solvent (100% B), proceed as follows: transfer to 70% A:30% B then to 30% A:70% B and finally to 100% B. If A and B are not mutually miscible, make the transfer via an intermediate solvent, for example from water to chloroform via acetone, as shown in Figure 64.
85
Water
Ethanol Dimethylformamide Dioxane Dimethyl sulfoxide
Acetone
Chloroform, dichloroethane, dichloromethane, tetrahydrofuran, n-heptane, ethyl acetate, toluene Fig. 64. Suggested routes for changing to organic solvents. 1. Transfer the required amount of medium to a sintered glass Buchner funnel and remove the excess aqueous solution by gentle suction. 2. Add the next solvent and resuspend the medium by stirring gently. 3. Suck off the excess solvent and resuspend in the same solvent. 4. Repeat the process with the next solvent in the series. Perform at least two resuspensions for each change of solvent conditions until the final solvent composition is reached. 5. Pack the medium into solvent resistant SR 10/50, SR 25/45 or SR 25/100 columns.
86
Chapter 6 Gel filtration in a Purification Strategy (CIPP) For a high degree of purity, or when a suitable ligand is unavailable for a single step affinity purification, an efficient multi-step process must be developed using the purification strategy of Capture, Intermediate Purification and Polishing (CIPP). CIPP is used in both the pharmaceutical industry and in the research laboratory to ensure faster method development, a shorter time to pure product and good economy. This chapter gives a brief overview of this approach, which is recommended for any multi-step protein purification. The Protein Purification Handbook from Amersham Biosciences is an ideal guide for planning efficient and effective protein purification strategies and for the selection of the correct medium for each step and scale of purification. As shown in Figure 65, an important first step for any purification is correct sample preparation and this is covered in more detail in Appendix 3. Gel filtration is often used for desalting and buffer exchange during sample preparation (using Sephadex G-25), when samples volumes up to 30% of the total column volume can be applied.
Purity
In high resolution mode, gel filtration is ideal for the final polishing steps in a purification when sample volumes have been reduced (sample volume significantly influences speed and resolution in gel filtration). Samples are eluted isocratically (single buffer, no gradient) and buffer conditions can be varied to suit the sample type or the requirements for subsequent purification, analysis or storage, since buffer composition does not directly affect resolution.
Polishing Achieve final high level purity
Intermediate purification Capture Preparation, extraction, clarification
Remove bulk impurities
Isolate, concentrate and stabilize
Step Fig. 65. Preparation and CIPP.
Applying CIPP Imagine the purification has three phases: Capture, Intermediate Purification and Polishing. Assign a specific objective to each step within the purification process. The purification problem associated with a particular step will depend greatly upon the properties of the starting material. Thus, the objective of a purification step will vary according to its position in the process.
87
In the capture phase the objectives are to isolate, concentrate and stabilize the target product. The product should be concentrated and transferred to an environment that will conserve potency/activity. During the intermediate purification phase the objectives are to remove most of the bulk impurities, such as other proteins and nucleic acids, endotoxins and viruses. In the polishing phase most impurities have already been removed except for trace amounts or closely related substances. The objective is to achieve final purity by removing any remaining trace impurities or closely related substances. The optimal selection and combination of purification techniques for Capture, Intermediate Purification and Polishing is crucial for an efficient purification.
Selection and combination of purification techniques Proteins are purified using purification techniques that separate according to differences in specific properties, as shown in Table 6. Table 6. Protein properties used during purification Protein property
Technique
Size
Gel filtration (GF)
Charge
Ion exchange (IEX)
Hydrophobicity
Hydrophobic interaction (HIC), Reversed phase (RPC)
Biorecognition (ligand specificity)
Affinity (AC)
Resolution
Recovery
Speed
Capacity
Every technique offers a balance between resolution, capacity, speed and recovery. Capacity, in the simple model shown, refers to the amount of target protein loaded during purification. In some cases the amount of sample that can be loaded will be limited by volume (as in gel filtration) or by large amounts of contaminants rather than the amount of the target protein. Speed is most important at the beginning of purification where contaminants, such as proteases, must be removed as quickly as possible. Recovery becomes increasingly important as the purification proceeds because of the increased value of the purified product. Recovery is influenced by destructive processes in the sample and by unfavourable conditions on the column.
88
Resolution is achieved by the selectivity of the technique and the efficiency of the chromatography matrix in producing narrow peaks. In general, resolution is most difficult to achieve in the final stages of purification when impurities and target protein are likely to have very similar properties. Select a technique to meet the objectives for the purification step. Choose logical combinations of purification techniques based on the main benefits of the technique and the condition of the sample at the beginning or end of each step. A guide to the suitability of each purification technique for the stages in CIPP is shown in Table 7. Table 7. Suitability of purification techniques for CIPP
Technique Main features
Sample start condition
Sample end condition
high resolution high capacity high speed
low ionic strength sample volume not limiting
high ionic strength or pH change
good resolution good capacity high speed
high ionic strength sample volume not limiting
high resolution high capacity high speed
specific binding conditions sample volume not limiting
GF
high resolution using Superdex media
limited sample volume (<5% total column volume) and flow rate range
buffer exchanged (if required) diluted sample
RPC
high resolution
sample volume usually not limiting additives may be required
in organic solvent, risk loss of biological activity
IEX
HIC
AC
Capture
Intermediate
Polishing
concentrated sample low ionic strength
concentrated sample specific elution conditions
concentrated sample
Minimize sample handling between purification steps by combining techniques to avoid the need for sample conditioning. The product should be eluted from the first column in conditions suitable for the start conditions of the next column (see Table 7). Ammonium sulfate, often used for sample clarification and concentration (see Appendix 3), leaves the sample in a high salt environment. Consequently HIC, which requires high salt to enhance binding to the media, becomes the ideal choice as the capture step. The salt concentration and the total sample volume will be significantly reduced after elution from the HIC column. Dilution of the fractionated sample or rapid buffer exchange using a desalting column will prepare it for the next IEX or AC step. Gel filtration is a non-binding technique unaffected by buffer conditions, but with limited volume capacity. GF is well suited for use after any of the concentrating techniques (IEX, HIC, AC) since the target protein will be eluted in a reduced volume and the components from the buffer will not affect the gel filtration process. Selection of the final strategy will always depend upon specific sample properties and the required level of purification. Logical combinations of techniques are shown in Figure 66.
89
Proteins with low solubility SDS extraction
GF (in non-ionic detergent)
SDS extraction
Solubilizing agents (urea, ethylene glycol non-ionic detergents)
HIC
HIC
GF
GF
Crude sample or sample in high salt concentration Sample clarification
Capture
GF GF desalt mode desalt mode
AC
IEX
Intermediate Purification Polishing
GF or RPC
GF or RPC
GF desalt mode
HIC IEX dilution may be needed
IEX
HIC
GF
GF
Clear or very dilute samples Capture
AC
IEX
Intermediate Purification Polishing
GF or RPC
GF or RPC
IEX
Precipitation (e.g. in high ionic strength)
HIC
Resolubilize
GF
Treat as for sample in high salt concentration
Fig. 66. Logical combinations of chromatography techniques.
For any capture step, select the technique showing the most effective binding to the target protein while binding as few of the contaminants as possible, i.e. the technique with the highest selectivity and/or capacity for the target protein. A sample is purified using a combination of techniques and alternative selectivities. For example, in an IEX-HIC-GF strategy, the capture step selects according to differences in charge (IEX), the intermediate purification step according to differences in hydrophobicity (HIC) and the final polishing step according to differences in size (GF). If nothing is known about the target protein use IEX-HIC-GF. This combination of techniques can be regarded as a standard protocol. IEX is a technique which offers different selectivities using either anion or cation exchangers. The pH of the purification can be modified to alter the charge characteristics of the sample components. It is therefore possible to use IEX more than once in a purification strategy, for capture, intermediate purification or polishing. IEX can be used effectively in the same purification scheme for rapid purification in low resolution mode during capture and in high resolution mode during polishing. Consider the use of both anion and cation exchange chromatography to give different selectivities within the same purification strategy.
90
Gel filtration as a polishing step Most commonly, separations by charge, hydrophobicity or affinity will have been used in earlier stages of a purification strategy so that high resolution gel filtration is ideal for the final polishing step. The product can be purified and transferred into the required buffer in one step and dimers and aggregates can be removed, as shown in Figure 67. Gel filtration is also the slowest of the chromatography techniques and the size of the column determines the volume of sample that can be applied. It is therefore most logical to use gel filtration after techniques that reduce sample volume so that smaller columns can be used.
A 280 nm
Column: Sample: Sample load: Buffer: Flow:
monomeric ZZ-Brain IGF
0.01
XK 16/60 packed with Superdex 75 prep grade Partly purified ZZ-brain IGF 1.0 ml 0.3 M ammonium acetate, pH 6.0 0.5 ml/min (15 cm/h)
0.005
Vo
Fraction 1
0
1
Vt
2
3
4
2
5
6
3
4 Time (h)
Fig. 67. Final polishing step: separation of dimers and multimers on Superdex 75 prep grade.
Media for polishing steps should offer highest possible resolution. Superdex is the first choice at laboratory scale and Superdex prep grade for large scale applications. RPC can also be considered for a polishing step, provided that the target protein can withstand the run conditions. Reversed phase chromatography (RPC) separates proteins and peptides on the basis of hydrophobicity. RPC is a high selectivity (high resolution) technique, usually requiring the use of organic solvents. The technique is widely used for purity check analyses when recovery of activity and tertiary structure are not essential. Since many proteins are denatured by organic solvents, RPC is not generally recommended for protein purification because recovery of activity and return to a correct tertiary structure may be compromised. However, in the polishing phase, when the majority of protein impurities have been removed, RPC can be an excellent technique, particularly for small target proteins that are not often denatured by organic solvents. CIPP does not mean that there must always be three purification steps. For example, capture and intermediate purification may be achievable in a single step, as may intermediate purification and polishing. Similarly, purity demands may be so low that a rapid capture step is sufficient to achieve the desired result. For purification of therapeutic proteins, a fourth or fifth purification step may be required to fulfill the highest purity and safety demands. The number of steps used will always depend upon the purity requirements and intended use for the protein.
91
Purification of humanised IgG4 monoclonal antibody A humanized IgG4 monoclonal antibody was expressed in a myeloma cell culture and purified by a combination of affinity chromatography and gel filtration. The antibody was captured by affinity chromatography using MabSelect™. Gel filtration on Superdex 200 prep grade was then used to separate the monomer from the dimer and larger polymers. Capture by affinity chromatography
Purification of the monomer (polishing step)
Sample:
Sample:
1282 ml myeloma cell culture containing humanized IgG4 (~0.33 mg/ml) Column: MabSelect (18 ml), XK 16/20 column Binding buffer: 20 mM sodium phosphate, 0.15 M NaCl, pH 7.4 Elution buffer: 100 mM sodium citrate, pH 3.0 Flow: 220 cm/h (7.4 ml/min) System: ÄKTAexplorer Operation: Equilibration: 5 column volumes (CV) binding buffer Sample application: 1 282 ml. Wash: 10 CV binding buffer. Elution: step gradient 100% 5 CV elution buffer
Column: Buffer: Flow: System: Operation:
7.5 ml of the pooled fractions from MabSelect column HiLoad 26/60 Superdex 200 prep grade 50 mM sodium phosphate, 0.15 M NaCl, pH 7.0 22.6 cm/h (2 ml/min) ÄKTAexplorer Equilibration 2 CV Sample application Isocratic elution 1 CV
CV = total column volume = Vt A 280nm (mAU)
A 280nm (mAU)
5000 600
Purified IgG 4 4000
500 Monomer 400
3000
300
2000 Dimer/multimer
200
1000
100
0
13579121620
0
400
800
1200
0
Waste
1600 ml
1 2 3 4 56 7 8 910 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50 52 54 56 58 60 62 64 66 68 70
0
100
200
Analysis: SDS-PAGE, silver staining Unreduced sample Lane 1: LMW Marker Lane 2: Crude sample from myeloma cell culture Lane 3: Pooled eluted sample from capture step Lane 4: Fraction 4–9 from polishing step Lane 5: Fraction 10–12 from polishing step Lane 6: Fraction 14–18 from polishing step 1
2
3
4
5
6
Reduced sample Lane 1: LMW Marker Lane 2: Pooled eluted sample from capture step Lane 3: Fraction 4–9 from polishing step Lane 4: Fraction 10–12 from polishing step Lane 5: Fraction 14–18 from polishing step 1
2
3
4
5
Mr 97 000 66 000
H - chain
45 000 30 000 20 100 14 400
Fig. 68. Two step purification of humanized IgG4.
92
L - chain
300
400 ml
Appendix 1 Column packing and preparation A well-packed column is essential for a high resolution fractionation on any gel filtration medium. Prepacked columns from Amersham Biosciences will ensure reproducible results and the highest performance. If the column volume or medium you require is not available as a prepacked column, contact you local Amersham Biosciences sales representative to inquire about our column packing services. Packing a column is a very critical stage in any gel filtration experiment. A poorly packed column will give rise to uneven flow, peak broadening, loss of resolution and can also affect achievable flow rates. If you decide to pack a gel filtration column yourself then the guidelines in this appendix will apply at any scale of operation. A Column Packing Video is available to demonstrate how to produce a well-packed column (see Ordering information). The video focuses particularly on the importance of column packing for gel filtration. Gel filtration is simple to perform once a well-packed column has been obtained. Providing that a column is used and maintained carefully it can be expected to give reproducible, high resolution results for a long time. Ensure that there is sufficient buffer for long, unattended runs or that the pump is programmed to stop the flow after a suitable time. Gel filtration columns that run dry must be repacked.
Columns for packing gel filtration media XK columns are fully compatible with the high flow rates achievable with modern media and a broad range of column dimensions is available. Ordering information for XK columns and main accessories can be found at the back of this handbook. For a complete listing of all spare parts refer to the Amersham Biosciences BioDirectory catalogue or web catalogue (www.chromatography.amershambiosciences.com).
93
Table 8. XK columns for packing gel filtration media Column
Column volume (ml) with one adaptor
XK 16/20
2 –34
XK 16/40
42 –74
XK 16/70
102 –135
XK 16/100
163 –195
XK 26/20
0 –80
XK 26/40
122 –196
XK 26/70
281 –356
XK 26/100
440 –315
XK 50/20
0 –275
XK 50/30
330 –510
XK 50/60
785 –1099
XK 50/100
1570 –1884
Adaptors are adjustable column end pieces that help to eliminate any disturbances to the surface of the packed medium as sample is applied and to prevent insoluble particles from entering and blocking the column. All XK columns are delivered with one AK adaptor, but a second adaptor can be used instead of a column end piece if a shorter bed height is required. TEFZEL tubing with M6 connectors, a thermostatic jacket, snap-on support net rings, dismantling tool and instructions are supplied with the XK column. Longer XK 50 columns can be difficult to pack under normal laboratory conditions. As alternatives, use our column packing services or connect two or more shorter XK columns (20 or 30 cm bed height) in series to achieve the required bed height.
94
Checking column efficiency Column performance should be checked at regular intervals by determining the theoretical plate number and peak symmetry. Prepacked columns are supplied with recommended values. Typical values for column performance: Superdex: Efficiency N>10 000, Peak symmetry As = 0.70–1.30 Sephacryl HR: Efficiency N>9 000, Peak symmetry As = 0.80–1.50 1. Equilibrate the packed column in distilled water at a linear flow of 60 cm/h. 2. Inject acetone (10 mg/ml in water) in a volume equivalent to 0.2% of the total packed column volume. 3. Monitor UV absorbance 280 nm from the time of injection until the acetone peak has eluted and the signal has returned to baseline. 4. Calculate column efficiency i.e. the number of theoretical plates (N): N = 5.54 (Ve / W1/2)2 × 1000/L
Absorbance
where Ve = peak elution (retention) volume W1/2 = peak width at half peak height L = bed height (mm) Ve and W1/2 are in same units Calculate the symmetry factor (As): w1/2
As = b/a
where a = first half peak width at 10% peak height b = second half peak width at 10% peak height
a
b
Ve
Volume
Column packing for high resolution fractionation using Superdex prep grade and Sephacryl High Resolution Superdex prep grade and Sephacryl High Resolution should be packed and equilibrated at a high flow rate using a column from the XK-series. XK columns are optimally designed for gel filtration with a bed design that ensures a uniform liquid flow and a dead space at the column outlet of less than 0.1% of the column volume in order to minimize dilution and to prevent remixing of separated peaks. XK columns are manufactured from materials which do not interfere with labile biological substances. They are easy to dismantle and reassemble for thorough cleaning, particularly important when handling biological samples. Ensure that the column and all components are clean and in good condition. It is particularly importance that the nets, net fasteners and glass tube are not damaged. Use well degassed buffers and equilibrate all materials to the temperature at which the separation will be performed. Avoid simple columns with large dead volumes as this will affect resolution.
95
For high resolution fractionation, use bed heights between 30–60 cm. Apply sample volumes equivalent to 1–2% of the column volume. The sample volume can be increased up to 4% if good resolution can be maintained. The settled medium should have a volume of 1.15 times that of the required packed column volume, see Table 8 for examples. 1. Sephacryl HR and Superdex prep grade are supplied swollen in a suspension containing 20% ethanol as a preservative. Suspend the medium by shaking gently and pour a sufficient quantity into a graduated glass cylinder or beaker. Avoid using magnetic stirrers, spatulas or glass rods since they may damage the matrix. 2. Wash the medium with 5–10 column volumes of distilled water on a glass filter and resuspend in distilled water to a final concentration of 50% settled medium. The medium must be thoroughly washed to remove the 20% ethanol storage solution. Residual ethanol may interfere with subsequent procedures.
To produce a more evenly dispersed slurry of Superdex prep grade, Tween™ 20 (250 ml per 500 ml washed slurry) can be added in order to reduce surface tension. 3. Wet the bottom filter by injecting distilled water through the effluent tubing. Close the end piece outlet. Mount filter and bottom end piece onto the column. 4. Attach the packing reservoir tightly to the column.
For XK 16 and XK 26 columns using a second column instead of a packing reservoir makes it easier to obtain a well-packed column. The second column is used with Packing Connector XK 16 or XK 26 as appropriate. 5. Mount the column and packing reservoir vertically on a laboratory stand. 6. Fill the column with distilled water to a height of 2 cm above the column end piece. Avoid air bubbles. 7. Degas the suspended medium under vacuum and carefully pour the suspended medium down the wall of the column using a glass rod. Avoid introducing air bubbles. Pour everything in a single operation and fill the reservoir to the top with distilled water. 8. Connect the pump outlet to the inlet on the packing reservoir. Open the column outlet and start the flow of buffer, see Table 9 for flow recommendations.
To achieve satisfactory column efficiency, Superdex prep grade must be packed in two steps: Step 1 for 2 hours or until the bed has reached a constant height and Step 2 for 60 minutes. Table 9 shows the flow rates for each step. Sephacryl HR can usually be packed satisfactorily using only the higher flow rate given in Step 2 of Table 9. Use the two step process if the column efficiency was unsatisfactory after the first attempt. 9. Stop the pump and remove the packing reservoir. Carefully fill the column with distilled water to form an upward meniscus at the top and insert the adaptor. Adjust the adapter to the surface of the packed bed. 10. Continue packing the column at the flow rate used in Step 2 for approximately 10 minutes. If the recommended flow rate cannot be obtained, use the maximum flow rate the pump can deliver.Mark the position of the top of the packed medium, stop the pump, close the column outlet, move the adaptor down onto to the surface of the medium and then push the adaptor a further 3 mm into the medium. The column is now ready to use. See Table 9 for maximum recommended flow rate and operating pressure for Sephacryl HR and Superdex prep grade media.
Maximum pressures (Sephacryl HR 0.3 MPa, 0.3 bar and Superdex prep grade 5 MPa, 5 bar) should not be exceeded during packing.
96
Always check the specific storage instructions supplied with the product. Table 9. Recommended flow rates for packing Sephacryl HR and Superdex prep grade Column
Bed height cm
Step 1 Sephacryl HR ml/min
Step 2 Sephacryl HR ml/min
Step 1 Superdex prep grade ml/min
Step 2 Superdex prep grade ml/min
XK 16/40
35
2
12–14
2
10–12
XK 16/70
65
2
12–14
2
10–12
XK16/100
95
2
12–14
2
10–12
XK 26/40
35
4
6–8
4
12
XK 26/70
65
4
6–8
4
12
XK 26/100
95
4
6–8
4
12
XK 50/20
10–15
9
12
10
20
XK 50/30
20–25
9
12
10
20
XK 50/60
55
9
12
10
20
XK 50/100
95
9
12
10
20
Controlling flow The safest and easiest way in which to control flow during column packing and chromatography separation is to use a pump controlled within an ÄKTAdesign chromatography system. Accurate and reproducible flow control is particularly important for efficient column packing and when repeating experiments or performing routine preparative work. The maximum flow rate achievable will depend on column diameter and buffer viscosity. Narrow columns allow a higher pressure and higher linear flow (cm/h) than wide columns. Always connect a pump so that buffer is pumped onto the column (rather than connecting the pump after the column and drawing buffer through the column). This reduces the risk of bubble formation due to suction effects. Do not exceed the maximum recommended values for pressure or linear flow for the medium (see Chapter 2). Exceeding these values may cause the medium to compress and reduce the flow rate and resolution during the separation. Do not exceed 75% of the packing flow rate during any separation. A peristaltic pump cannot achieve the highest flow rates or back pressures tolerated by Superdex and Sephacryl and so is not recommended for column packing or running high resolution fractionation on larger columns.
97
Column packing for group separations using Sephadex Sephadex is supplied as a dry powder and must be allowed to swell in excess buffer before use. After swelling adjust with buffer to form a thick slurry from which air bubbles are removed under vacuum. Approximately 75% settled medium is suitable. Fine particles can be decanted. Accelerate the swelling process by using a boiling water bath (Table 10). This also serves to degas the suspension. Allow the suspension to cool before use. Table 10. Bed volume and swelling times for Sephadex Medium
Approx. bed volume (ml/g)
Swelling time (h) +20 °C
Swelling time (h) +90 °C
Sephadex G-10
2–3
3
1
Sephadex G-25 (all grades)
4–6
3
1
Sephadex G-50 Fine
9–11
3
1
Ensure that the column and all components are clean and in good condition. It is particularly important that the nets, net fasteners and glass tube are not damaged. Use well degassed buffers and equilibrate all materials to the temperature at which the separation will be performed. Keep a packed column away from locations that are exposed to drafts or direct sunlight that can cause temperature changes and the formation of bubbles. For group separations, use up to 10 cm bed height. Sample volumes can be up to 30% of the column volume. Pack a quantity of medium up to 5 times the volume of the sample to be desalted. Note: These instructions assume that a column with two adaptors is used for packing. 1. Weigh out the correct amount of dry Sephadex and allow the medium to swell according to the instructions above. Avoid using magnetic stirrers, spatulas or glass rods since they may damage the matrix. 2. Wet the bottom filter by injecting distilled water through the effluent tubing. Close the end piece outlet. Mount filter and bottom end piece onto the column.
For XK 16 and XK 26 columns using a second column instead of a packing reservoir makes it easier to obtain a well-packed column. The second column is used with Packing Connector XK 16 or XK 26 as appropriate. 3. If the slurry volume is greater than the volume of the column, attach a packing reservoir to the column (Figure 69). 4. Mount the column and packing reservoir vertically on a laboratory stand. 5. Fill the column with distilled water or buffer to a height of approximately 2 cm above the column end piece. Avoid air bubbles. 6. Pour the well-mixed and well-degassed suspension in a single operation down the inside wall using a glass rod. Avoid introducing air bubbles. 7. Connect the pump outlet to the inlet of the packing reservoir. Open the column outlet and start the flow of buffer. Pass 2–3 column volumes of buffer through the column in order to stabilize the bed and equilibrate completely. Use a slightly higher flow rate than the flow rate to be used during separations. 8. Maintain the packing flow rate for at least 3 column volumes after a constant bed height is obtained. 9. Mark the bed height on the column and close the column outlet. Remove the packing reservoir. 10. Add buffer carefully to fill the column and form an upward meniscus (Figure 70).
98
11. Connect all tubings. Slacken the adaptor tightening mechanism and insert the adaptor at an angle into the column so that no air is trapped under the net. Slide the adaptor slowly down the column until the mark is reached. Note that the outlet of the adaptor should be open and the column outlet should be closed. 12. Adjust the tightening mechanism to give a sliding seal between the column wall and O-ring. Screw the adaptor onto the column. 13. Continue packing the column for approximately 10 minutes. Stop the pump, close the column outlet and move the top adaptor down onto the surface of the medium. Push the adaptor a further 3 mm into the medium. The column is now ready for equilibration.
1
2
3
2
3
Fig. 69. Using a packing reservoir. 1
Fig. 70. Adding the top adaptor.
Sephadex G-10, G-25 and G-50 obey Darcy's law, for example if the flow rate is doubled then the column pressure will double, hence maximum values for flow or operating pressures do not need to be considered (see Appendix 2 for an explanation of Darcy's law). Controlling flow The safest and easiest way in which to control flow during column packing and chromatography separation is to use a pump controlled within an ÄKTAdesign chromatography system. Accurate and reproducible flow control is particularly important for efficient column packing and when repeating experiments or performing routine preparative work. A peristaltic pump can be used with Sephadex packed in smaller columns. Always connect a pump so that buffer is pumped onto the column (rather than connecting the pump after the column and drawing buffer through the column). This reduces the risk of bubble formation due to suction effects. Always use a flow rate for column packing that is higher than the flow rate used for separation. 99
Packing under gravity Sephadex can be packed using a gravity feed system in which flow rates are controlled by differences in hydrostatic pressure, that is the operating pressure created by the difference between the free surface of the buffer in the buffer container and the column outlet. Use a safety loop as shown in Figure 71 to prevent air from entering the column. A
B AK 26 Operating pressure
XK 26/70
XK 26/70
Fig. 71a. Definition of operating pressure A and B. Pressure (cm water) is measured as the distance between the free surface in the column or reservoir and the end of the outlet tubing. A
B
Fig. 71b. Alternative safety loop arrangements: A. Place the safety loop after the column and place the end of the outlet tubing above the column. The flow stops when the buffer in the inlet tubing reaches the level of the outlet. B. Place the safety loop before the column with the column outlet tubing in any position above the lower loop on the inlet side. The flow stops when the buffer in the inlet tubing reaches the level of the outlet.
Temperature influences the viscosity of the buffer. For a given pressure head, lower flow rates will be reached in a cold room than at room temperature.
100
Custom Designed Products The Custom Products (CP) Group at Amersham Biosciences supplies prepacked columns, made according to the client's choice from our range of columns and media. Custom Designed Media (CDM) can be produced for specific industrial process separations when suitable media are not available from the standard range. The CDM group at Amersham Biosciences works in close collaboration with the user to design, manufacture, test and deliver media for specialized separation requirements. When a chromatography step is developed to be an integral part of a manufacturing process, the choice of column is important to ensure consistent performance and reliable operation. Amersham Biosciences provides a wide range of columns that ensures the highest performance from all our purification media and meets the demands of modern pharmaceutical manufacturing. Please ask your local representative for further details of CP and CDM products or services.
101
Appendix 2 Sephadex and Darcy's law Sephadex G-10, G-25 and G-50 may be assumed to behave as rigid spheres in gel filtration and therefore obey Darcy's Law: U = K DP L-1 (1) U = linear flow rate expressed in cm/h (see Appendix 5). DP = pressure drop over bed expressed in cm H2O L = bed height expressed in cm K = constant of proportionality depending on the properties of the bed material and the buffer. Assuming a buffer with viscosity of 1 cP: U = Ko DP L-1 (2) Ko = the "specific permeability" depending on the particle size of the medium and the water regain. Note that flow is proportional to the pressure drop over the bed and, assuming a constant pressure head, inversely proportional to the bed height. In practice this means that the pressure/flow considerations that must be made when using other gel filtration media do not apply to Sephadex and that a doubling of flow rate leads to a doubling in column pressure. To a good approximation, flow rate is independent of the column diameter. Flow at viscosities greater than 1 cP can be obtained by using the relationship: flow rate is inversely proportional to viscosity. High buffer viscosities can be compensated for by increasing the operating pressure and so maintaining high flow rate. Theoretical flow (not maximum) can be calculated from equation (2) by inserting values for DP and L. Specific permeabilities (K) are given in Table 11. Table 11. Specific permeabilities of Sephadex Sephadex type
Permeability K
Sephadex G-10
19
Sephadex G-25 Superfine Sephadex G-25 Fine Sephadex G-25 Medium Sephadex G-25 Coarse Sephadex G-50 Fine
102
9 30 80 290 36
Appendix 3 Sample preparation Samples for chromatographic purification should be clear and free from particulate matter. Simple steps to clarify a sample before beginning purification will avoid clogging the column, may reduce the need for stringent washing procedures and can extend the life of the chromatographic medium. Sample extraction procedures and the selection of buffers, additives and detergents are determined largely by the source of the material, the stability of the target molecule, the chromatographic techniques that will be employed and the intended use of the product. These subjects are dealt with in general terms in the Protein Purification Handbook and more specifically according to target molecule in the Recombinant Protein Handbook, Protein Amplification and Simple Purification and Antibody Purification Handbook, available from Amersham Biosciences.
Sample stability In the majority of cases, biological activity needs to be retained after purification. Retaining the activity of the target molecule is also an advantage when following the progress of the purification, since detection of the target molecule often relies on its biological activity. Denaturation of sample components often leads to precipitation or enhanced non-specific adsorption, both of which will impair column function. Hence there are many advantages to checking the stability limits of the sample and working within these limits during purification. Proteins generally contain a high degree of tertiary structure, kept together by van der Waals' forces, ionic and hydrophobic interactions and hydrogen bonding. Any conditions capable of destabilizing these forces may cause denaturation and/or precipitation. By contrast, peptides contain a low degree of tertiary structure. Their native state is dominated by secondary structures, stabilized mainly by hydrogen bonding. For this reason, peptides tolerate a much wider range of conditions than proteins. This basic difference in native structures is also reflected in that proteins are not easily renatured, while peptides often renature spontaneously. It is advisable to perform stability tests before beginning to develop a purification protocol. The list below may be used as a basis for such testing: • Test the stability and occurrence of proteolytic activity by leaving an aliquot of the sample at room temperature overnight. Centrifuge each sample and measure activity and UV absorbance at 280 nm in the supernatant. • Test pH stability in steps of one pH unit between pH 2 and pH 9. • Test salt stability with 0–2 M NaCl and 0–2 M (NH4)2SO4 in steps of 0.5 M. • Test the stability towards acetonitrile and methanol in 10% steps between 0 and 50%. • Test the temperature stability in +10 °C steps from +4 to +40 °C.
103
Sample clarification Centrifugation and filtration are standard laboratory techniques for sample clarification and are used routinely when handling small samples. It is highly recommended to centrifuge and filter any sample immediately before chromatographic purification. Centrifugation Centrifugation removes lipids and particulate matter, such as cell debris. If the sample is still not clear after centrifugation, use filter paper or a 5 µm filter as a first step and one of the filters below as a second step filter. • For small sample volumes or proteins that adsorb to filters, centrifuge at 10 000 g for 15 minutes. • For cell lysates, centrifuge at 40 000–50 000 g for 30 minutes. • Serum samples can be filtered through glass wool after centrifugation to remove any remaining lipids. Filtration Filtration removes particulate matter. Membrane filters that give the least amount of nonspecific binding of proteins are composed of cellulose acetate or PVDF. For sample preparation before chromatography, select a filter pore size in relation to the bead size of the chromatographic medium. Nominal pore size of filter 1 µm
Particle size of chromatographic medium 90 µm and upwards
0.45 µm
34 µm
0.22 µm
3, 10, 15 µm or when extra clean samples or sterile filtration is required
Check the recovery of the target protein in a test run. Some proteins may adsorb nonspecifically to filter surfaces. Desalting Desalting columns are suitable for any sample volume and will rapidly remove low molecular weight contaminants in a single step at the same time as transferring the sample into the correct buffer conditions. Centrifugation and/or filtration of the sample before desalting is still recommended. Detailed procedures for buffer exchange and desalting are given in Chapter 2, page 57. At laboratory scale, when samples are reasonably clean after filtration or centrifugation, the buffer exchange and desalting step can be avoided. For affinity chromatography or hydrophobic interaction chromatography, it may be sufficient to adjust the pH of the sample and, if necessary, dilute to reduce the ionic strength of the solution. Rapidly process small or large sample volumes. Use before and/or between purification steps, if needed (remember that each extra step can reduce yield and desalting also dilutes the sample).
104
Remove salts from proteins with molecular weight Mr >5 000. Use 100 mM ammonium acetate or 100 mM ammonium hydrogen carbonate if volatile buffers are required.
Specific sample preparation steps Specific sample preparation steps may be required if the crude sample is known to contain contamininants such as lipids, lipoproteins or phenol red that may build up on a column or if certain gross impurities, such as bulk protein, should be removed before any chromatographic step. Fractional precipitation Fractional precipitation is frequently used at laboratory scale to remove gross impurities from small sample volumes, and occasionally used in small-scale commercial production. Precipitation techniques separate fractions by the principle of differential solubility. Because protein species differ in their degree of hydrophobicity, increased salt concentrations can enhance hydrophobic interactions between the proteins and cause precipitation. Fractional precipitation can be applied to remove gross impurities in three different ways, as shown in Figure 72.
Clarification Bulk proteins and particulate matter precipitated
Supernatant
Extraction Clarification Concentration Target protein precipitated with proteins of similar solubility
Redissolve pellet*
Extraction Clarification Bulk proteins and particulate matter precipitated
Concentration Target protein precipitated
Chromatography
Redissolve pellet*
Remember: if precipitating agent is incompatible with next purification step, use Sephadex G-25 for desalting and buffer exchange e.g. HiTrap Desalting or PD-10 columns
*Remember: not all proteins are easy to redissolve, yield may be reduced
Fig. 72. Three ways to use precipitation.
105
Examples of precipitation agents are reviewed in Table 12. The most common precipitation method using ammonium sulfate is described in more detail. Table 12. Examples of precipitation techniques Precipitation agent
Typical conditions for use
Sample type
Comment
Ammonium sulfate
As described below.
>1 mg/ml proteins especially immunoglobulins.
Stabilizes proteins, no denaturation, supernatant can go directly to HIC.
Dextran sulfate
Add 0.04 ml 10% dextran sulfate and 1 ml 1 M CaCl2 per ml sample, mix 15 min, centrifuge 10 000 g, discard pellet.
Samples with high levels of lipoprotein e.g ascites.
Precipitates lipoprotein.
Polyvinylpyrrolidine
Add 3% (w/v), stir 4 hours, centrifuge 17 000 g, discard pellet.
Samples with high levels of lipoprotein e.g ascites.
Alternative to dextran sulfate.
Polyethylene glycol (PEG, Mr > 4 000)
Up to 20% w/v
Plasma proteins.
No denaturation, supernatant goes directly to IEX or AC, complete removal may be difficult.
Acetone (cold)
Up to 80% v/v at +0 °C. Collect pellet after centrifugation at full speed in an Eppendorf™ centrifuge.
May denature protein irreversibly. Useful for peptide precipitation or concentration of sample for electrophoresis.
Polyethyleneimine
0.1% w/v
Precipitates aggregated nucleoproteins.
Protamine sulfate
1% w/v
Precipitates aggregated nucleoproteins.
Streptomycin sulfate
1% w/v
Caprylic acid
(X/15) g where X = volume of sample.
Precipitation of nucleic acids. Antibody concentration should be >1 mg/ml.
Precipitates bulk of proteins from sera or ascites, leaving immunoglobulins in solution.
Details taken from: Scopes R.K., Protein Purification, Principles and Practice, Springer, (1994), J.C. Janson and L. Rydén, Protein Purification, Principles, High Resolution Methods and Applications, 2nd ed. Wiley Inc, (1998). Personal communications.
Ammonium sulfate precipitation Some proteins may be damaged by ammonium sulfate. Take care when adding crystalline ammonium sulfate: high local concentrations may cause contamination of the precipitate with unwanted proteins. For routine, reproducible purification, precipitation with ammonium sulfate should be avoided in favour of chromatography. In general, precipitation is rarely effective for protein concentrations below 1 mg/ml. Solutions needed for precipitation: Saturated ammonium sulfate solution (add 100 g ammonium sulfate to 100 ml distilled water, stir to dissolve). 1 M Tris-HCl, pH 8.0. Buffer for first purification step.
106
1. Filter (0.45 µm) or centrifuge the sample (10 000 g at +4 °C). 2. Add 1 part 1 M Tris-HCl, pH 8.0 to 10 parts sample volume to maintain pH. 3. Stir gently. Add ammonium sulfate solution, drop by drop. Add up to 50% saturation*. Stir for 1 hour. 4. Centrifuge 20 minutes at 10 000 g. 5. Remove supernatant. Wash the pellet twice by resuspension in an equal volume of ammonium sulfate solution of the same concentration (i.e. a solution that will not redissolve the precipitated protein or cause further precipitation). Centrifuge again. 6. Dissolve pellet in a small volume of the buffer to be used for the next step. 7. Ammonium sulfate is removed during clarification/buffer exchange steps with Sephadex G-25, using desalting columns (see Chapter 2, page 57). *The % saturation can be adjusted either to precipitate a target molecule or to precipitate contaminants.
The quantity of ammonium sulfate required to reach a given degree of saturation varies according to temperature. Table 13 shows the quantities required at +20 °C. Table 13. Quantities of ammonium sulfate required to reach given degrees of saturation at +20 °C Final percent saturation to be obtained 20
25
Starting percent saturation
30
35
40
45
50
55
60
65
70
75
80
85
90
95 100
Amount of ammonium sulfate to add (grams) per litre of solution at +20 °C
0
113 144 176 208 242 277 314 351 390 430 472 516 561 608 657 708 761
5
85 115 146 179 212 246 282 319 358 397 439 481 526 572 621 671 723
10
57
15
28
58
88 119 151 185 219 255 293 331 371 413 456 501 548 596 647
20
0
29
59
89 121 154 188 223 260 298 337 378 421 465 511 559 609
0
29
60
0
30
61
92 125 160 195 232 270 309 351 393 438 485 533
0
30
62
94 128 163 199 236 275 316 358 402 447 495
0
31
63
96 130 166 202 241 281 322 365 410 457
0
31
64
0
32
65
99 135 172 210 250 292 335 381
0
33
66 101 138 175 215 256 298 343
25 30 35 40
86 117 149 182 216 251 287 325 364 405 447 491 537 584 634 685
91 123 157 191 228 265 304 344 386 429 475 522 571
45 50 55 60 65 70 75 80 85 90 95
98 132 169 206 245 286 329 373 419
0
33 0
67 103 140 179 219 261 305 34 0
69 105 143 183 224 267 34 0
70 107 146 186 228 35 0
72 110 149 190 36 0
73 112 152 37 0
75 114 37
76
0
38
Resolubilization of protein precipitates Many proteins are easily resolubilized in a small amount of the buffer to be used in the next chromatographic step. However, a denaturing agent may be required for less soluble proteins. Specific conditions will depend upon the specific protein. These agents must always be removed to allow complete refolding of the protein and to maximize recovery of mass and activity. A chromatographic step often removes a denaturant during purification. Table 14 gives examples of common denaturing agents.
107
Table 14. Denaturing agent
Typical conditions for use
Removal/comment
Urea
2 M–8 M
Remove using Sephadex G-25.
Guanidine hydrochloride
3 M–6 M
Remove using Sephadex G-25 or during IEX.
2%
Remove using Sephadex G-25 or during IEX.
1.5%
Remove using Sephadex G-25 or during IEX.
Triton X-100 Sarcosyl N-octyl glucoside Sodium dodecyl sulfate Alkaline pH
2% 0.1%–0.5% >pH 9, NaOH
Remove using Sephadex G-25 or during IEX. Exchange for non-ionic detergent during first chromatographic step, avoid anion exchange chromatography. May need to adjust pH during chromatography to maintain solubility.
Details taken from: Scopes R.K., Protein Purification, Principles and Practice, Springer, (1994), J.C. Janson and L. Rydén, Protein Purification, Principles, High Resolution Methods and Applications, 2nd ed. Wiley Inc, (1998) and other sources.
See Chapter 2, page 57.
Removal of lipoproteins Lipoproteins and other lipid material can rapidly clog chromatography columns and it is advisable to remove them before beginning purification. Precipitation agents such as dextran sulfate and polyvinylpyrrolidine, described under Fractional precipitation, are recommended to remove high levels of lipoproteins from samples such as ascitic fluid. Centrifuge samples to avoid the risk of non-specific binding of the target molecule to a filter. Samples such as serum can be filtered through glass wool to remove remaining lipids.
Removal of phenol red Phenol red is frequently used at laboratory scale as a pH indicator in cell culture. Although not directly interfering with purification, phenol red may bind to certain purification media and should be removed as early as possible to avoid the risk of contamination. It is known to bind to anion exchange media at pH >7. Use a desalting column to simultaneously remove phenol red (a low molecular weight molecule) and transfer sample to the correct buffer conditions for further purification, as described in Chapter 2, page 57.
Removal of low molecular weight contaminants If samples contain a high level of low molecular weight contaminants, use a desalting column before the first chromatographic purification step, as described in Chapter 2, page 57.
108
Appendix 4 Selection of purification equipment Simple buffer exchange and desalting steps can be performed using a syringe or peristaltic together with prepacked HiTrap columns. A chromatography system is needed to deliver accurately controlled flow rates for high resolution separations. Standard ÄKTAdesign configurations Explorer 100
Purifier 10
FPLC
Prime
Syringe or peristaltic pump + HiTrap Desalting column
Gravity–fed columns
Simple, one step desalting, buffer exchange
ü
ü
ü
ü
ü
ü
Reproducible performance for routine separation
ü
ü
ü
ü
Optimization of one step separation to increase purity
ü
ü
ü
ü
System control and data handling for regulatory requirements, e.g. GLP
ü
ü
ü
Automatic method development and optimization
ü
ü
ü
Automatic buffer preparation
ü
ü
Automatic pH scouting
ü
ü
Automatic media or column scouting
ü
Automatic multi-step purification
ü
Scale up, process development and transfer to production
ü
Way of working
ÄKTAprime
ÄKTAFPLC™
ÄKTAexplorer ÄKTApurifier
109
Appendix 5 Converting from linear flow (cm/hour) to volumetric flow rates (ml/min) and vice versa It is convenient when comparing results for columns of different sizes to express flow as linear flow (cm/hour). However, flow is usually measured in volumetric flow rate (ml/min). To convert between linear flow and volumetric flow rate use one of the formulae below.
From linear flow (cm/hour) to volumetric flow rate (ml/min) Volumetric flow rate (ml/min) = =
Linear flow (cm/h) x column cross sectional area (cm2) 60 Y p x d2 x 60 4
where Y = linear flow in cm/h d = column inner diameter in cm
Example: What is the volumetric flow rate in an XK 16/70 column (i.d. 1.6 cm) when the linear flow is 150 cm/hour? Y = linear flow = 150 cm/h d = inner diameter of the column = 1.6 cm Volumetric flow rate =
150 x p x 1.6 x 1.6 ml/min 60 x 4
= 5.03 ml/min
From volumetric flow rate (ml/min) to linear flow (cm/hour) Linear flow (cm/h) =
Volumetric flow rate (ml/min) x 60 column cross sectional area (cm2)
= Z x 60 x
4 p x d2
where Z = volumetric flow rate in ml/min d = column inner diameter in cm
Example: What is the linear flow in an HR 5/5 column (i.d. 0.5 cm) when the volumetric flow rate is 1 ml/min? Z = Volumetric flow rate = 1 ml/min d = column inner diameter = 0.5 cm Linear flow = 1 x 60 x
4 p x 0.5 x 0.5
cm/h
= 305.6 cm/h
From ml/min to using a syringe 1 ml/min = approximately 30 drops/min on a HiTrap 1 ml column 5 ml/min = approximately 120 drops/min on a HiTrap 5 ml column
110
Appendix 6 Conversion data: proteins, column pressures Mass (g/mol)
1 µg
1 nmol
Protein
A280 for 1 mg/ml
10 000
100 pmol; 6 x 10
13
molecules
10 µg
IgG
50 000
20 pmol; 1.2 x 10
13
molecules
50 µg
IgM
1.20
100 000
10 pmol; 6.0 x 10
12
molecules
100 µg
IgA
1.30
150 000
6.7 pmol; 4.0 x 10
12
molecules
150 µg
Protein A
0.17
1 kb of DNA
= 333 amino acids of coding capacity
270 bp DNA
= 10 000 g/mol
1.35
Avidin
1.50
Streptavidin
3.40
Bovine Serum Albumin
0.70
= 37 000 g/mol 1.35 kb DNA
= 50 000 g/mol
2.70 kb DNA
= 100 000 g/mol
Average molecular weight of an amino acid = 120 g/mol.
Column pressures The maximum operating back pressure refers to the pressure above which the column contents may begin to compress. Pressure units may be expressed in megaPascals, bar or pounds per square inch and can be converted as follows: 1MPa = 10 bar = 145 psi
111
Appendix 7 Table of amino acids Three-letter code
Single-letter code
Alanine
Ala
A
Arginine
Arg
R
Amino acid
Structure HOOC CH3 H 2N NH2
HOOC CH2CH2CH2NHC H 2N
NH
HOOC
Asparagine
Asn
N
Aspartic Acid
Asp
D
CH2CONH2 H 2N HOOC CH2COOH H 2N HOOC
Cysteine
Cys
CH2SH
C H 2N HOOC
Glutamic Acid
Glu
CH2CH2COOH
E H 2N HOOC
Glutamine
Gln
Q
Glycine
Gly
G
Histidine
His
H
Isoleucine
Ile
I
CH2CH2CONH2 H 2N HOOC H H 2N HOOC
N CH2
NH
H 2N HOOC
CH(CH3)CH2CH3 H 2N HOOC
Leucine
Leu
L
CH3 CH2CH CH3
H 2N HOOC
Lysine
Lys
K
Methionine
Met
M
CH2CH2CH2CH2NH2 H 2N HOOC CH2CH2SCH3 H 2N HOOC
Phenylalanine
Phe
F
Proline
Pro
P
CH2 H 2N HOOC H 2N
NH
HOOC
Serine
Ser
S
Threonine
Thr
T
CH2OH H 2N HOOC CHCH3 H 2N
OH
HOOC
Tryptophan
Trp
W
CH2 H 2N
NH
HOOC
Tyrosine
Tyr
CH2
Y H 2N HOOC
Valine
Val
CH(CH3)2
V H 2N
112
OH
Formula
Mr
Middle unit residue (-H20) Formula Mr
C3H7NO2
89.1
C3H5NO
C6H14N4O2
174.2
C 4H 8N 2O 3
Charge at pH 6.0–7.0
Hydrophobic (non-polar)
Uncharged (polar)
71.1
Neutral
n
C6H12N4O
156.2
Basic (+ve)
132.1
C 4H 6N 2O 2
114.1
Neutral
C4H7NO4
133.1
C4H5NO3
115.1
Acidic(-ve)
C3H7NO2S
121.2
C3H5NOS
103.2
Neutral
C5H9NO4
147.1
C5H7NO3
129.1
Acidic (-ve)
C5H10N2O3
146.1
C 5H 8N 2O 2
128.1
Neutral
n
C2H5NO2
75.1
C2H3NO
57.1
Neutral
n
C 6H 9N 3O 2
155.2
C6H 7N3O
137.2
Basic (+ve)
C6H13NO2
131.2
C6H11NO
113.2
Neutral
n
C6H13NO2
131.2
C6H11NO
113.2
Neutral
n
C6H14N2O2
146.2
C6H12N2O
128.2
Basic(+ve)
C5H11NO2S
149.2
C5H9NOS
131.2
Neutral
n
C9H11NO2
165.2
C9H9NO
147.2
Neutral
n
C5H9NO2
115.1
C5H7NO
97.1
Neutral
n
C3H7NO3
105.1
C3H5NO2
87.1
Neutral
n
C4H9NO3
119.1
C4H7NO2
101.1
Neutral
n
C11H12N2O2
204.2
C11H10N2O
186.2
Neutral
C9H11NO3
181.2
C9H9NO2
163.2
Neutral
C5H11NO2
117.1
C5H9NO
99.1
Neutral
Hydrophilic (polar)
n n n n n
n
n
n n n
113
Appendix 8 Analytical assays during purification Analytical assays are essential to follow the progress of purification. They are used to assess the effectiveness of each step in terms of yield, biological activity, recovery and to help during optimization of experimental conditions. The importance of a reliable assay for the target molecule cannot be over-emphasized. When testing chromatographic fractions, ensure that the buffers used for purification do not interfere with the assay. Total protein determination Lowry or Bradford assays are used most frequently to determine the total protein content. The Bradford assay is particularly suited to samples where there is a high lipid content that may interfere with the Lowry assay. Purity determination Purity is most often estimated by SDS-PAGE. Alternatively, isoelectric focusing, capillary electrophoresis, reversed phase chromatography or mass spectrometry may be used. SDS-PAGE Analysis Reagents Required 6X SDS loading buffer: 0.35 M Tris-HCl (pH 6.8), 10.28% (w/v) SDS, 36% (v/v) glycerol, 0.6 M dithiothreitol (or 5% 2-mercaptoethanol), 0.012% (w/v) bromophenol blue. Store in 0.5 ml aliquots at -80 °C.
1. Add 2 µl of 6X SDS loading buffer to 5–10 µl of supernatant from crude extracts, cell lysates or purified fractions as appropriate. 2. Vortex briefly and heat for 5 minutes at +90 to +100 °C. 3. Load the samples onto an SDS-polyacrylamide gel. 4. Run the gel and stain with Coomassie™ Blue (Coomassie Blue R Tablets) or silver (PlusOne™ Silver Staining Kit, Protein).
The percentage of acrylamide in the SDS-gel should be selected according to the expected molecular weight of the protein of interest (see Table 15). Table 15. % Acrylamide in resolving gel
Separation size range
Single percentage: 5%
36 000–200 000
7.5%
24 000–200 000
10%
14 000–200 000
12.5%
14 000–100 000
15%
14 000–60 0001
5–15%
14 000–200 000
Gradient:
1
114
5–20%
10 000–200 000
10–20%
10 000–150 000
The larger proteins fail to move significantly into the gel.
Functional assays Immunospecific interactions have enabled the development of many alternative assay systems for the assessment of active concentration of target molecules. • Western blot analysis is used when the sensitivity of SDS-PAGE with Coomassie Blue or silver staining is insufficient. 1. Separate the protein samples by SDS-PAGE. 2. Transfer the separated proteins from the gel to an appropriate membrane, such as Hybond™ ECL™ (for subsequent ECL detection) or Hybond P (for subsequent ECL Plus™ detection). 3. Develop the membrane with the appropriate specified reagents.
Electrophoresis and protein transfer may be accomplished using a variety of equipment and reagents. For further details, refer to the Protein Electrophoresis Technical Manual and Hybond ECL instruction manual, both from Amersham Biosciences. • ELISAs are most commonly used as activity assays. • Functional assays using the phenomenon of surface plasmon resonance to detect immunospecific interactions (e.g. using BIACORE™ systems) enable the determination of active concentration, epitope mapping and studies of reaction kinetics. Detection and assay of tagged proteins SDS-PAGE, Western blotting and ELISAs can also be applied to the detection and assay of genetically engineered molecules to which a specific tag has been attached. In some cases, an assay based on the properties associated with the tag itself can be developed, e.g. the GST Detection Module for enzymatic detection and quantification of GST tagged proteins. Further details on the detection and quantification of GST and (His)6 tagged proteins are available in The Recombinant Protein Handbook: Protein Amplification and Simple Purification and GST Gene Fusion System Handbook from Amersham Biosciences.
115
Appendix 9 Storage of biological samples The advice given here is of a general nature and cannot be applied to every biological sample. Always consider the properties of the specific sample and its intended use before following any of these recommendations. General recommendations • Add stabilizing agents, if essential. Stabilizing agents are often required for storage of purified proteins. • Serum, culture supernatants and ascitic fluid should be kept frozen at -20 °C or -70 °C, in small aliquots. • Avoid repeated freeze/thawing or freeze drying/re-dissolving that may reduce biological activity. • Avoid conditions close to stability limits for example pH or salt concentrations, reducing or chelating agents. • Keep refrigerated at +4 °C in a closed vessel to minimize bacterial growth and protease activity. Above 24 hours at +4 °C, add a preserving agent if possible (e.g. merthiolate 0.01%). Sodium azide can interfere with many coupling methods and some biological assays and can be a health hazard. It can be removed by using a desalting column (see Chapter 2, page 57). General recommendations for purified proteins • Store as a precipitate in high concentration of ammonium sulfate, for example 4.0 M. • Freeze in 50% glycerol, especially suitable for enzymes. • Avoid the use of preserving agents if the product is to be used for a biological assay. Preserving agents should not be added if in vivo experiments are to be performed. Instead store samples in small aliquots and keep frozen. • Sterile filter to prolong storage time. • Add stabilizing agents, e.g. glycerol (5–20%), serum albumin (10 mg/ml), ligand (concentration is selected based on concentration of active protein) to help to maintain biological activity. Remember that any additive will reduce the purity of the protein and may need to be removed at a later stage. • Avoid repeated freeze/thawing or freeze drying/re-dissolving that may reduce biological activity. Sodium azide can interfere with many coupling methods and some biological assays. It can be removed by using a desalting column (see Chapter 2, page 57). Cryoproteins are a group of proteins, including some mouse antibodies of the IgG3 subclass, that should not be stored at +4 °C as they precipitate at this temperature. Keep at room temperature in the presence of a preserving agent.
116
Additional reading and reference material Code No.
Purification Antibody Purification Handbook
18-1037-46
Protein Purification Handbook
18-1132-29
Recombinant Protein Handbook: Protein Amplification and Simple Purification
18-1142-75
GST Gene Fusion System Handbook
18-1157-58
Affinity Chromatography Handbook: Principles and Methods
18-1022-29
Ion Exchange Chromatography Handbook: Principles and Methods
18-1114-21
Hydrophobic Interaction Chromatography Handbook: Principles and Methods
18-1020-90
Reversed Phase Chromatography Handbook: Principles and Methods
18-1112-93
Expanded Bed Adsorption Handbook: Principles and Methods
18-1124-26
Protein and Peptide Purification Technique Selection
18-1128-63
Fast Desalting and Buffer Exchange of Proteins and Peptides
18-1128-62
Gel Filtration Columns and Media Selection Guide
18-1124-19
Ion Exchange Columns and Media Selection Guide
18-1127-31
Chromatofocusing with Polybuffer and PBE, Handbook
18-1009-07
HIC Columns and Media Product Profile
18-1100-98
Affinity Columns and Media Product Profile
18-1121-86
Convenient Protein Purification, HiTrap Column Guide
18-1128-81
ÄKTAdesign Brochure
18-1158-77
ÄKTA 3D Kit Brochure
18-1160-45
GST Fusion System Brochure
18-1159-30
Protein Purifier Software
18-1155-49
Protein Purification: Principles, High Resolution Methods and Applications, J-C. Jansson and L.Rydén
18-1128-68
Sephadex LH-20: chromatography in organic solvents
18-1009-74
Preparative Gel chromatography on Sephadex-LH-20, H. Henke
18-1113-89
Column Packing Video (PAL)
17-0893-01
Column Packing Video (NTSC)
17-0894-01
Reference list HiTrap Desalting
18-1156-70*
Reference list HiPrep 26/10 Desalting
18-1156-89*
Reference list HiPrep Sephacryl S-100 HR
18-1156-86*
Reference list HiPrep Sephacryl S-200 HR
18-1156-87*
Reference list HiPrep Sephacryl S-300 HR
18-1156-88*
Reference list HiLoad Superdex 30 prep grade
18-1156-94*
Reference list HiLoad Superdex 75 prep grade
18-1156-95*
Reference list HiLoad Superdex 200 prep grade
18-1156-96*
Analysis Protein analysis–using the power of 2-D electrophoresis
18-1124-82
2D Electrophoresis Handbook
80-6429-60
Protein Electrophoresis Technical Manual
80-6013-88
ECL Western and ECL Plus Western Blotting Application Note
18-1139-13
The reference lists are only available at www.chromatography.amershambiosciences.com and many of the above items can also be downloaded.
117
Ordering information Product
Quantity
Code No.
Superdex Peptide PC 3.2/30
1 × 2.4 ml column
17-1458-01
Superdex 75 PC 3.2/30
1 × 2.4 ml column
17-0771-01
Superdex 200 PC 3.2/30
1 × 2.4 ml column
17-1089-01
Superdex Peptide HR 10/30
1 × 24 ml column
17-1453-01
Superdex 75 HR 10/30
1 × 24 ml column
17-1047-01
Superdex 200 HR 10/30
1 × 24 ml column
17-1088-01
HiLoad 16/60 Superdex 30 prep grade
1 × 120 ml column
17-1139-01
HiLoad 26/60 Superdex 30 prep grade
1 × 320 ml column
17-1140-01
HiLoad 16/60 Superdex 75 prep grade
1 × 120 ml column
17-1068-01
HiLoad 26/60 Superdex 75 prep grade
1 × 320 ml column
17-1070-01
HiLoad 16/60 Superdex 200 prep grade
1 × 120 ml column
17-1069-01
HiLoad 26/60 Superdex 200 prep grade
1 × 320 ml column
17-1071-01
Superdex 30 prep grade
25 ml
17-0905-10
Superdex 30 prep grade
150 ml
17-0905-01
Superdex 75 prep grade
25 ml
17-1044-10
Superdex 75 prep grade
150 ml
17-1044-01
High Resolution Fractionation Superdex
Superdex 200 prep grade
25 ml
17-1043-10
Superdex 200 prep grade
150 ml
17-1043-01
Superose 6 PC 3.2/30
1 × 2.4 ml column
17-0673-01
Superose 12 PC 3.2/30
1 × 2.4 ml column
17-0674-01
Superose 6 HR 10/30
1 × 24 ml column
17-0537-01
Superose 12 HR 10/30
1 × 24 ml column
17-0538-01
Superose 6 prep grade
125 ml
17-0489-01
Superose 12 prep grade
125 ml
17-0536-01
Superose
Sephacryl
118
HiPrep 16/60 Sephacryl S-100 HR
1 × 120 ml column
17-1165-01
HiPrep 26/60 Sephacryl S-100 HR
1 × 320 ml column
17-1194-01
HiPrep 16/60 Sephacryl S-200 HR
1 × 120 ml column
17-1166-01
HiPrep 26/60 Sephacryl S-200 HR
1 × 320 ml column
17-1195-01
HiPrep 16/60 Sephacryl S-300 HR
1 × 120 ml column
17-1167-01
HiPrep 26/60 Sephacryl S-300 HR
1 × 320 ml column
17-1196-01
Sephacryl S-100 HR
150 ml
17-0612-10
Sephacryl S-100 HR
750 ml
17-0612-01
Sephacryl S-200 HR
150 ml
17-0584-10
Sephacryl S-200 HR
750 ml
17-0584-01
Sephacryl S-300 HR
150 ml
17-0599-10
Sephacryl S-300 HR
750 ml
17-0599-01
Sephacryl S-400 HR
150 ml
17-0609-10
Sephacryl S-400 HR
750 ml
17-0609-01
Sephacryl S-500 HR
150 ml
17-0613-10
Sephacryl S-500 HR
750 ml
17-0613-01
Sephacryl S-1000 SF
750 ml
17-0476-01
Product
Quantity
Code No.
Desalting and Group Separations HiTrap Desalting
5 × 5 ml columns
17-1408-01
HiPrep 26/10 Desalting
1 × 53 ml column
17-5087-01
PD-10 Desalting Column
30 gravity-fed columns
17-0851-01
Empty PD-10 Desalting Column
50 gravity-fed empty columns
17-0435-01
NICK columns
20 gravity-fed columns
17-0855-01*
NICK columns
50 gravity-fed columns
17-0855-02*
NAP-5 columns
20 gravity-fed columns
17-0853-01*
NAP-5 columns
50 gravity-fed columns
17-0853-02*
NAP-10 columns
20 gravity-fed columns
17-0854-01*
NAP-10 columns
50 gravity-fed columns
17-0854-02*
NAP-25 columns
20 gravity-fed columns
17-0852-01*
NAP-25 columns
50 gravity-fed columns
17-0852-02*
Sephadex G-10
100 g
17-0010-01
Sephadex G-10
500 g
17-0010-02
Sephadex G-25 Coarse
100 g
17-0034-01
Sephadex G-25 Coarse
500 g
17-0034-02
Sephadex G-25 Fine
100 g
17-0032-01
Sephadex G-25 Fine
500 g
17-0032-02
Sephadex G-25 Medium
100 g
17-0033-01
Sephadex G-25 Medium
500 g
17-0033-02 17-0031-01
Sephadex G-25 Superfine
100 g
Sephadex G-25 Superfine
500 g
17-0031-02
Sephadex G-50 Fine
100 g
17-0042-01
Sephadex G-50 Fine
500 g
17-0042-02
Sephadex LH-20
25 g
17-0090-10
Sephadex LH-20
100 g
17-0090-01
Sephadex LH-20
500 g
17-0090-02
Gel Filtration LMW Calibration Kit Includes: Ribonuclease A (13 700), chymotrypsinogen A (25 000), ovalbumin (43 000), bovine serum albumin (67 000), Blue Dextran 2000
1 kit
17-0442-01
Gel Filtration HMW Calibration Kit Includes: Aldolase (158 000), catalase (232 000), ferritin (440 000), thyroglobulin (669 000), Blue Dextran 2000
1 kit
17-0441-01
Blue Dextran 2000
10 g
17-0360-01
Separation in organic solvents
Calibration Kits
*Prepacked columns suitable for desalting of oligonucleotides, DNA and proteins.
119
Product
Quantity
Code No.
XK 16/20 column
1
18-8773-01
XK 16/40 column
1
18-8774-01
XK 16/70 column
1
18-8775-01
XK 16/100 column
1
18-8776-01
XK 26/20 column
1
18-1000-72
XK 26/40 column
1
18-8768-01
XK 26/70 column
1
18-8769-01
XK 26/100 column
1
18-8770-01
XK 50/20 column
1
18-1000-71
XK 50/30 column
1
18-8751-01
XK 50/60 column
1
18-8752-01
XK 50/100 column
1
18-8753-01
Columns
All XK columns are delivered with one AK adaptor, TEFZEL tubing (0.8 mm i.d. for XK 16 and XK 26 columns, 1.2 mm i.d. for XK 50 columns, with M6 connectors, thermostatic jacket, support snap-on net rings, dismantling tool (XK 16 and XK 26 only), and instructions.
Accessories and spare parts Packing Connector XK 16
1
18-1153-44
Packing Connector XK 26
1
18-1153-45
SR 10/50 column
1
19-2638-01
SR 10/50J column*
1
19-1734-01
SR 25/45 column
1
19-0879-01
SR 25/100 column
1
19-0880-01
Solvent resistant columns
All SR columns are delivered complete with two SRA adaptors, PTFE tubing (2 × 50 cm), spare bed supports, tubing end fittings, flanging tool and instructions. *SR 10/50J includes a borosilicate glass jacket. Jackets are not available for other SR columns.
Accessories SRE 10 packing reservoir
1
For a complete lisiting refer to Amersham Biosciences BioDirectory or www.chromatography.amershambiosciences.com
120
19-2097-01
Handbooks from Amersham Biosciences
Antibody Purification ÄKTA, FPLC, PlusOne, HiLoad , HiTrap, HiPrep, Hybond, ECL, ECL Plus, BioProcess, MabSelect, Sephacryl, Sephadex, Superose, Sepharose, Superdex and Drop Design are trademarks of Amersham Biosciences Limited.
Handbook 18-1037-46
Amersham and Amersham Biosciences are trademarks of Amersham plc.
The Recombinant Protein Handbook
Gel Filtration
Coomassie is a trademark of ICI plc.
Protein Amplification and Simple Purification 18-1142-75
Principles and Methods 18-1022-18
MicroSpin is a trademark of Lida Manufacturing Corp. Triton is a registered trademark of Union Carbide Chemicals and Plastics Co.
Percoll
Tween is a registered trademark of ICI Americas, Inc.
Methodology and Applications 18-1115-69
Eppendorf and Multipipette are trademarks of Eppendorf-Netheler-Hinz GmbH.
Ficoll-Paque Plus
All goods and services are sold subject to the terms and conditions of sale of the company within the Amersham Biosciences group that supplies them. A copy of these terms and conditions is available on request. © Amersham Biosciences AB 2002 – All rights reserved.
Protein Purification
Reversed Phase Chromatography
Handbook 18-1132-29
Principles and Methods 18-1134-16
Ion Exchange Chromatography
Expanded Bed Adsorption
Principles and Methods 18-1114-21
Principles and Methods 18-1124-26
Affinity Chromatography
Chromatofocusing
Principles and Methods 18-1022-29
with Polybuffer and PBE 18-1009-07
Hydrophobic Interaction Chromatography
Microcarrier cell culture
using immobilized pH gradients
Principles and Methods 18-1020-90
Principles and Methods 18-1140-62
Principles and Methods 80-6429-60
For in vitro isolation of lymphocytes 18-1152-69
GST Gene Fusion System Handbook 18-1157-58
BIACORE is a trademark of Biacore AB.
Amersham Biosciences AB, Björkgatan 30, SE-751 84 Uppsala, Sweden Amersham Biosciences UK Limited, Amersham Place, Little Chalfont, Buckinghamshire HP7 9NA, England Biosciences Corp., 800 Centennial Avenue, PO Box 1327, Piscataway NJ 08855, USA Amersham Biosciences Europe GmbH, Munzinger Strasse 9, D-79111 Freiburg, Germany
2-D Electrophoresis
Amersham Biosciences K.K., Sanken Bldg. 3-25-1, Hyakunincho Amersham Shinjuku-ku, Tokyo 169-0073, Japan.
Production: RAK Design AB
Gel Filtration Handbook – Principles and Methods
Gel Filtration Principles and Methods
www.chromatography.amershambiosciences.com
18-1022-18 Edition AI
Affinity Chromatography Principles and Methods
Back to Collection 18-1022-29 Edition AC
Handbooks from Amersham Pharmacia Biotech
Antibody Purification Handbook 18-1037-46
The Recombinant Protein Handbook Protein Amplification and Simple Purification 18-1142-75
Protein Purification Handbook 18-1132-29
Ion Exchange Chromatography
Reversed Phase Chromatography
Principles and Methods 18-1114-21
Principles and Methods 18-1134-16
Affinity Chromatography
Expanded Bed Adsorption
Principles and Methods 18-1022-29
Principles and Methods 18-1124-26
Hydrophobic Interaction Chromatography
Chromatofocusing
Principles and Methods 18-1020-90
with Polybuffer and PBE 50-01-022PB
Gel Filtration
Microcarrier cell culture
Principles and Methods 18-1022-18
Principles and Methods 18-1140-62
Affinity Chromatography Principles and Methods
1
Content Introduction ............................................................................................................. 7 Symbols and abbreviations ......................................................................................................................... 8
Chapter 1 Affinity chromatography in brief ................................................................................ 9 BioProcess Media for large-scale production ................................................................. 12 Custom Designed Media and Columns ......................................................................... 12 Common terms in affinity chromatography ................................................................... 13
Chapter 2 Affinity chromatography in practice ......................................................................... 15 Purification steps ..................................................................................................................................... 15 Media selection ....................................................................................................................................... 16 Preparation of media and buffers ............................................................................................................... 16 Sample preparation and application ........................................................................................................... 17 Elution ................................................................................................................................................... 18 Flow rates ............................................................................................................................................... 21 Analysis of results and further steps ........................................................................................................... 21 Equipment selection ................................................................................................................................ 21 Troubleshooting ....................................................................................................................................... 22
Chapter 3 Purification of specific groups of molecules ............................................................ 25 Immunoglobulins ....................................................................................................... 25 IgG, IgG fragments and subclasses .............................................................................. 26 HiTrap Protein G HP, Protein G Sepharose 4 Fast Flow, MAbTrap Kit ............................................................. 28 HiTrap Protein A HP, Protein A Sepharose 4 Fast Flow, HiTrap rProtein A FF, rProtein A Sepharose 4 Fast Flow .............................................................................................................. 33
Monoclonal IgM from hybridoma cell culture ................................................................ 38 HiTrap IgM Purification HP ....................................................................................................................... 38
Avian IgY from egg yolk .............................................................................................. 40 HiTrap IgY Purification HP ........................................................................................................................ 40
Recombinant fusion proteins ...................................................................................... 42 GST fusion proteins ................................................................................................... 42 GST MicroSpin Purification Module, GSTrap FF, Glutathione Sepharose 4 Fast Flow, Glutathione Sepharose 4B ........................................................................................................................ 42
Poly (His) fusion proteins ........................................................................................... 46 His MicroSpin Purification Module, HisTrap Kit, HiTrap Chelating HP, Chelating Sepharose Fast Flow .................................................................................................................. 46
Protein A fusion proteins ............................................................................................ 51 IgG Sepharose 6 Fast Flow ........................................................................................................................ 51
Purification or removal of serine proteases, e.g. thrombin and trypsin, and zymogens ..................................................................... 53 HiTrap Benzamidine FF (high sub), Benzamidine Sepharose 4 Fast Flow (high sub) ........................................ 53
2
Serine proteases and zymogens with an affinity for arginine ........................................... 57 Arginine Sepharose 4B ............................................................................................................................. 57
DNA binding proteins ................................................................................................. 59 HiTrap Heparin HP, HiPrep 16/10 Heparin FF, Heparin Sepharose 6 Fast Flow ............................................... 59
Coagulation factors .................................................................................................... 64 HiTrap Heparin HP, HiPrep 16/10 Heparin FF, Heparin Sepharose 6 Fast Flow ............................................... 64
Biotin and biotinylated substances .............................................................................. 65 HiTrap Streptavidin HP, Streptavidin Sepharose High Performance ................................................................ 65
Purification or removal of fibronectin ........................................................................... 68 Gelatin Sepharose 4B ............................................................................................................................... 68
Purification or removal of albumin ............................................................................... 69 HiTrap Blue HP, Blue Sepharose 6 Fast Flow .............................................................................................. 69
NAD+-dependent dehydrogenases and ATP-dependent kinases ....................................... 72 5' AMP Sepharose 4B, HiTrap Blue HP, Blue Sepharose 6 Fast Flow ............................................................. 72
NADP+-dependent dehydrogenases and other enzymes with affinity for NADP+ ............... 74 2'5' ADP Sepharose 4B, Red Sepharose CL-6B ........................................................................................... 74
Glycoproteins or polysaccharides ................................................................................. 79 Con A Sepharose 4B, Lentil Lectin Sepharose 4B, Agarose Wheat Germ Lectin ............................................... 79 Con A for binding of branched mannoses, carbohydrates with terminal mannose or glucose (aMan > aGlc > GlcNAc) .......................................................................................................... 79 Lentil lectin for binding of branched mannoses with fucose linked a(1,6) to the N-acetyl-glucosamine, (aMan > aGlc > GlcNAc) N-acetylglucosamine binding lectins ......................................................................................................................................... 82 Wheat germ lectin for binding of chitobiose core of N-linked oligosaccharides, [GlcNAc(b1,4GlcNAc)1-2 > b GlcNAc] ......................................................................................................... 83
Calmodulin binding proteins: ATPases, adenylate cyclases, protein kinases, phosphodiesterases, neurotransmitters ................................................. 85 Calmodulin Sepharose 4B ......................................................................................................................... 85
Proteins and peptides with exposed amino acids: His, Cys, Trp, and/or with affinity for metal ions (also known as IMAC, immobilized metal chelate affinity chromatography) ...................................................... 87 HiTrap Chelating HP, Chelating Sepharose Fast Flow, His MicroSpin Purification Module, HisTrap Kit ........................................................................................... 87
Thiol-containing substances (purification by covalent chromatography) ........................... 91 Activated Thiol Sepharose 4B, Thiopropyl Sepharose 6B .............................................................................. 91
Chapter 4 Components of an affinity medium ........................................................................... 96 The matrix ............................................................................................................................................... 96 The ligand ............................................................................................................................................... 97 Spacer arms ............................................................................................................................................ 98 Ligand coupling ....................................................................................................................................... 99 Ligand specificity ..................................................................................................................................... 99
3
Chapter 5 Designing affinity media using pre-activated matrices ............................................ 100 Choosing the matrix ............................................................................................................................... 100 Choosing the ligand and spacer arm ......................................................................................................... 100 Choosing the coupling method ................................................................................................................. 100 Coupling the ligand ................................................................................................................................ 102 Binding capacity, ligand density and coupling efficiency ............................................................................ 103 Binding and elution conditions ................................................................................................................ 104
Coupling through the primary amine of a ligand .......................................................... 105 HiTrap NHS-activated HP, NHS-activated Sepharose 4 Fast Flow ................................................................ 105 CNBr-activated Sepharose ....................................................................................................................... 108 Immunoaffinity chromatography .............................................................................................................. 112
Coupling small ligands through amino or carboxyl groups via a spacer arm ...................................................................................................... 113 EAH Sepharose 4B and ECH Sepharose 4B .............................................................................................. 113
Coupling through hydroxy, amino or thiol groups via a 12-carbon spacer arm ...................................................................................... 116 Epoxy-activated Sepharose 6B ................................................................................................................. 116
Coupling through a thiol group .................................................................................. 120 Thiopropyl Sepharose 6B ........................................................................................................................ 120
Coupling other functional groups ............................................................................... 121
Chapter 6 Affinity chromatography and CIPP ........................................................................... 123 Applying CIPP .......................................................................................................... 124 Selection and combination of purification techniques .................................................. 124
Appendix 1 .......................................................................................................... 129 Sample preparation ................................................................................................. 129 Sample stability ..................................................................................................................................... 129 Sample clarification ............................................................................................................................... 130
Specific sample preparation steps ............................................................................. 131 Resolubilization of protein precipitates ..................................................................................................... 133
Buffer exchange and desalting .................................................................................. 134 Removal of lipoproteins ............................................................................................ 137 Removal of phenol red ............................................................................................. 137 Removal of low molecular weight contaminants .......................................................... 137
Appendix 2 .......................................................................................................... 139 Selection of purification equipment ........................................................................... 139
Appendix 3 .......................................................................................................... 140 Column packing and preparation ............................................................................... 140
Appendix 4 .......................................................................................................... 142 Converting from linear flow (cm/hour) to volumetric flow rates (ml/min) and vice versa ............................................................................. 142
Appendix 5 .......................................................................................................... 143 Conversion data: proteins, column pressures .............................................................. 143 Column pressures .................................................................................................................................. 143
Appendix 6 .......................................................................................................... 144 Table of amino acids ................................................................................................ 144
Appendix 7 .......................................................................................................... 146 Kinetics in affinity chromatography ........................................................................... 146
Appendix 8 .......................................................................................................... 151 Analytical assays during purification .......................................................................... 151
Appendix 9 .......................................................................................................... 153 Storage of biological samples .................................................................................... 153
Additional reading and reference material ............................................................. 154 Ordering information ............................................................................................ 155
Introduction Biomolecules are purified using purification techniques that separate according to differences in specific properties, as shown in Figure 1. Property
Technique*
Biorecognition (ligand specificity)
Affinity chromatography
Charge
Ion exchange chromatography
Size
Gel filtration (sometimes called size exclusion)
Hydrophobicity
Hydrophobic interaction chromatography Reversed phase chromatography
*Expanded bed adsorption is a technique used for large-scale purification. Proteins can be purified from crude sample without the need for separate clarification, concentration and initial purification to remove particulate matter. The STREAMLINE™ adsorbents, used for expanded bed adsorption, capture the target molecules using the same principles as affinity, ion exchange or hydrophobic interaction chromatography.
Gel filtration
Hydrophobic interaction
Ion exchange
Affinity
Reversed phase
Fig. 1. Separation principles in chromatographic purification.
Affinity chromatography separates proteins on the basis of a reversible interaction between a protein (or group of proteins) and a specific ligand coupled to a chromatographic matrix. The technique offers high selectivity, hence high resolution, and usually high capacity for the protein(s) of interest. Purification can be in the order of several thousand-fold and recoveries of active material are generally very high. Affinity chromatography is unique in purification technology since it is the only technique that enables the purification of a biomolecule on the basis of its biological function or individual chemical structure. Purification that would otherwise be time-consuming, difficult or even impossible using other techniques can often be easily achieved with affinity chromatography. The technique can be used to separate active biomolecules from denatured or functionally different forms, to isolate pure substances present at low concentration in large volumes of crude sample and also to remove specific contaminants. Amersham Pharmacia Biotech offers a wide variety of prepacked columns, ready to use media, and pre-activated media for ligand coupling.
7
This handbook describes the role of affinity chromatography in the purification of biomolecules, the principle of the technique, the media available and how to select them, application examples and detailed instructions for the most commonly performed procedures. Practical information is given as a guide towards obtaining the best results. The illustration on the inside cover shows the range of handbooks that have been produced by Amersham Pharmacia Biotech to ensure that purification with any chromatographic technique becomes a simple and efficient procedure at any scale and in any laboratory.
Symbols and abbreviations this symbol indicates general advice which can improve procedures or provide recommendations for action under specific situations. this symbol denotes advice which should be regarded as mandatory and gives a warning when special care should be taken. this symbol highlights troubleshooting advice to help analyse and resolve difficulties that may occur. chemicals, buffers and equipment. experimental protocol. PBS
8
phosphate buffered saline (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4).
Chapter 1 Affinity chromatography in brief Affinity chromatography separates proteins on the basis of a reversible interaction between a protein (or group of proteins) and a specific ligand coupled to a chromatographic matrix. The technique is ideal for a capture or intermediate step in a purification protocol and can be used whenever a suitable ligand is available for the protein(s) of interest. With high selectivity, hence high resolution, and high capacity for the protein(s) of interest, purification levels in the order of several thousand-fold with high recovery of active material are achievable. Target protein(s) is collected in a purified, concentrated form. Biological interactions between ligand and target molecule can be a result of electrostatic or hydrophobic interactions, van der Waals' forces and/or hydrogen bonding. To elute the target molecule from the affinity medium the interaction can be reversed, either specifically using a competitive ligand, or non-specifically, by changing the pH, ionic strength or polarity. In a single step, affinity purification can offer immense time-saving over less selective multistep procedures. The concentrating effect enables large volumes to be processed. Target molecules can be purified from complex biological mixtures, native forms can be separated from denatured forms of the same substance and small amounts of biological material can be purified from high levels of contaminating substances. For an even higher degree of purity, or when there is no suitable ligand for affinity purification, an efficient multi-step process must be developed using the purification strategy of Capture, Intermediate Purification and Polishing (CIPP). When applying this strategy affinity chromatography offers an ideal capture or intermediate step in any purification protocol and can be used whenever a suitable ligand is available for the protein of interest. Successful affinity purification requires a biospecific ligand that can be covalently attached to a chromatographic matrix. The coupled ligand must retain its specific binding affinity for the target molecules and, after washing away unbound material, the binding between the ligand and target molecule must be reversible to allow the target molecules to be removed in an active form. Any component can be used as a ligand to purify its respective binding partner. Some typical biological interactions, frequently used in affinity chromatography, are listed below: • Enzyme ! substrate analogue, inhibitor, cofactor. • Antibody ! antigen, virus, cell. • Lectin ! polysaccharide, glycoprotein, cell surface receptor, cell. • Nucleic acid ! complementary base sequence, histones, nucleic acid polymerase, nucleic acid binding protein. • Hormone, vitamin ! receptor, carrier protein. • Glutathione ! glutathione-S-transferase or GST fusion proteins. • Metal ions ! Poly (His) fusion proteins, native proteins with histidine, cysteine and/or tryptophan residues on their surfaces.
9
Affinity chromatography is also used to remove specific contaminants, for example Benzamidine Sepharose™ 6 Fast Flow can remove serine proteases, such as thrombin and Factor Xa. Figure 2 shows the key stages in an affinity purification.
1. Affinity medium is equilibrated in binding buffer.
2. Sample is applied under conditions that favour specific binding of the target molecule(s) to a complementary binding substance (the ligand). Target substances bind specifically, but reversibly, to the ligand and unbound material washes through the column.
3. Target protein is recovered by changing conditions to favour elution of the bound molecules. Elution is performed specifically, using a competitive ligand, or non-specifically, by changing the pH, ionic strength or polarity.Target protein is collected in a purified, concentrated form.
4. Affinity medium is re-equilibrated with binding buffer.
Absorbance
equilibration
adsorption of sample and elution of unbound material
begin sample application
1-2 cv
wash away unbound material
elute bound protein(s)
change to elution buffer
x cv
1-2 cv Column Volumes (cv)
Fig. 2. Typical affinity purification.
10
re-equilibration
>1 cv
1-2 cv
The high selectivity of affinity chromatography enables many separations to be achieved in one simple step, including, for example, common operations such as the purification of monoclonal antibodies or fusion proteins. A wide variety of prepacked columns, ready to use media, and pre-activated media for ligand coupling through different functional groups, makes affinity chromatography readily available for a broad range of applications. To save time, the HiTrap™ column range (Table 1) is excellent for routine laboratory scale applications in which the risk of cross-contamination between samples must be eliminated, for purification from crude samples or for fast method development before scaling up purification. HiTrap columns can be operated with a syringe, a peristaltic pump or any ÄKTA™design chromatography system. Several HiTrap columns can be connected in series to increase purification capacity and all columns are supplied with detailed protocols for use.
Table 1. HiTrap and HiPrep™ affinity columns for laboratory scale purification. Application
HiTrap and HiPrep columns
Isolation of human immunoglobulins IgG, fragments and subclasses
HiTrap rProtein A FF, 1 ml and 5 ml
IgG, fragments and subclasses
HiTrap Protein A HP, 1 ml and 5 ml
IgG, fragments and subclasses including human IgG3 strong affinity for monoclonal mouse IgG1 and rat IgG
HiTrap Protein G HP, 1 ml and 5 ml MAbTrap™ Kit
Avian IgY from egg yolk
HiTrap IgY Purification HP, 5 ml
Mouse and human IgM
HiTrap IgM Purification HP, 1 ml
Purification of fusion proteins (His)6 fusion proteins
HisTrap™ Kit HiTrap Chelating HP, 1 ml and 5 ml
GST fusion proteins
GSTrap™ FF, 1 ml and 5 ml
Other Group Specific Media Albumin and nucleotide-requiring enzymes
HiTrap Blue HP, 1 ml and 5 ml
Proteins and peptides with exposed His, Cys or Trp
HiTrap Chelating HP, 1 ml and 5 ml
Biotinylated substances
HiTrap Streptavidin HP, 1 ml
DNA binding proteins and coagulation factors
HiTrap Heparin HP, 1 ml and 5 ml HiPrep 16/10 Heparin FF, 20 ml
Trypsin-like serine proteases including Factor Xa, thrombin and trypsin
HiTrap Benzamidine FF (high sub), 1 ml and 5 ml
Matrix for preparation of affinity media. Coupling via primary amines
HiTrap NHS-activated HP, 1 ml and 5 ml
11
BioProcess Media for large-scale production Specific BioProcess™ Media have been designed for each chromatographic stage in a process from Capture to Polishing. Large capacity production integrated with clear ordering and delivery routines ensure that BioProcess Media are available in the right quantity, at the right place, at the right time. Amersham Pharmacia Biotech can assure future supplies of BioProcess Media, making them a safe investment for long-term production. The media are produced following validated methods and tested under strict control to fulfil high performance specifications. A certificate of analysis is available with each order. Regulatory Support Files contain details of performance, stability, extractable compounds and analytical methods. The essential information in these files gives an invaluable starting point for process validation, as well as providing support for submissions to regulatory authorities. Using BioProcess Media for every stage results in an easily validated process. High flow rate, high capacity and high recovery contribute to the overall economy of an industrial process. All BioProcess Media have chemical stability to allow efficient cleaning and sanitization procedures. Packing methods are established for a wide range of scales and compatible large-scale columns and equipment are available. Please refer to the latest BioProcess Products Catalogue from Amersham Pharmacia Biotech for further details of our products and services for large-scale production.
Custom Designed Media and Columns Prepacked columns, made according to the client's choice from the Amersham Pharmacia Biotech range of columns and media, can be supplied by the Custom Products Group. Custom Designed Media (CDM) can be produced for specific industrial process separations when suitable media are not available from the standard range. The CDM group at Amersham Pharmacia Biotech works in close collaboration with the user to design, manufacture, test and deliver media for specialized separation requirements. When a chromatographic step is developed to be an integral part of a manufacturing process, the choice of column is important to ensure consistent performance and reliable operation. Amersham Pharmacia Biotech provides a wide range of columns that ensures the highest performance from all our purification media and meets the demands of modern pharmaceutical manufacturing. Please ask your local representative for further details of CDM products and services.
12
Common terms in affinity chromatography
Matrix: for ligand attachment. Matrix should be chemically and physically inert.
Spacer arm: used to improve binding between ligand and target molecule by overcoming any effects of steric hindrance.
Ligand: molecule that binds reversibly to a specific target molecule or group of target molecules.
Binding: buffer conditions are optimized to ensure that the target molecules interact effectively with the ligand and are retained by the affinity medium as all other molecules wash through the column. Elution: buffer conditions are changed to reverse (weaken) the interaction between the target molecules and the ligand so that the target molecules can be eluted from the column. Wash: buffer conditions that wash unbound substances from the column without eluting the target molecules or that re-equilibrate the column back to the starting conditions (in most cases the binding buffer is used as a wash buffer). Ligand coupling: covalent attachment of a ligand to a suitable pre-activated matrix to create an affinity medium. Pre-activated matrices: matrices which have been chemically modified to facilitate the coupling of specific types of ligand.
13
14
Chapter 2 Affinity chromatography in practice This chapter provides guidance and advice that is generally applicable to any affinity purification. The first step towards a successful purification is to determine the availability of a suitable ligand that interacts reversibly with the target molecule or group of molecules. Ready to use affinity media, often supplied with complete separation protocols, already exist for many applications. The contents section of this handbook lists the full range of affinity media from Amersham Pharmacia Biotech according to the specific molecule or group of molecules to be purified. Application- and product-specific information and advice for these media are supplied in other sections of this handbook. Practical information specific to the use of pre-activated matrices for the preparation of affinity medium is covered in Chapter 5.
Purification steps 1. Affinity medium is equilibrated in binding buffer.
2. Sample is applied under conditions that favour specific binding of the target molecule(s) to a complementary binding substance (the ligand). Target substances bind specifically, but reversibly, to the ligand and unbound material washes through the column.
3. Target protein is recovered by changing conditions to favour elution of the bound molecules. Elution is performed specifically, using a competitive ligand, or non-specifically, by changing the pH, ionic strength or polarity. Target protein is collected in a purified, concentrated form.
4. Affinity medium is re-equilibrated with binding buffer.
Absorbance
equilibration
adsorption of sample and elution of unbound material
begin sample application
1-2 cv
wash away unbound material
elute bound protein(s)
re-equilibration
change to elution buffer
x cv
1-2 cv
>1 cv
1-2 cv
Column Volumes (cv)
Fig. 3. Typical affinity purification.
15
Figure 4 shows the simple procedure used to perform affinity purification on prepacked HiTrap columns. Equilibrate column with binding buffer
3 min
Apply sample Wash with binding buffer
5-15 min
Waste
Elute with elution buffer
2 min
Collect
Collect fractions
Fig. 4.
HiTrap columns may be used with a syringe, a peristaltic pump or a liquid chromatography system (see Selection of Purification Equipment, Appendix 2) and are supplied with a detailed protocol to ensure optimum results.
Media selection A ligand already coupled to a matrix is the simplest solution. Selecting prepacked columns such as HiTrap or HiPrep will not only be more convenient, but will also save time in method optimization as these columns are supplied with detailed instructions for optimum performance. If a ligand is available, but needs to be coupled to a pre-activated matrix, refer to Chapter 5. If no suitable ligand is available, decide whether it is worth the time and effort involved to obtain a ligand and to develop a specific affinity medium. In many cases, it may be more convenient to use alternative purification techniques such as ion exchange or hydrophobic interaction chromatography.
Preparation of media and buffers Storage solutions and preservatives should be washed away thoroughly before using any affinity medium. Re-swell affinity media supplied as freeze-dried powders in the correct buffer as recommended by the manufacturer. Use high quality water and chemicals. Solutions should be filtered through 0.45 µm or 0.22 µm filters. Reuse of affinity media depends on the nature of the sample and should only be performed with identical samples to prevent cross-contamination. If an affinity medium is to be used routinely, care must be taken to ensure that any contaminants from the crude sample can be removed by procedures that do not damage the ligand. Binding and elution buffers are specific for each affinity medium since it is their influence on the interaction between the target molecule and the ligand that facilitates the affinitybased separation. Some affinity media may also require a specific buffer in order to make the medium ready for use again.
16
Avoid using magnetic stirrers as they may damage the matrix. Use mild rotation or end-over-end stirring.
Sample preparation and application Samples should be clear and free from particulate matter. Simple steps to clarify a sample before beginning purification will avoid clogging the column, may reduce the need for stringent washing procedures and can extend the life of the chromatographic medium. Appendix 1 contains an overview of sample preparation techniques. If possible, test the affinity of the ligand: target molecule interaction. Too low affinity will result in poor yields since the target protein may wash through or leak from the column during sample application. Too high affinity will result in low yields since the target molecule may not dissociate from the ligand during elution. Binding of the target protein may be made more efficient by adjusting the sample to the composition and pH of the binding buffer: perform a buffer exchange using a desalting column or dilute in binding buffer (see page 134). Sample preparation techniques should ensure that components known to interfere with binding (the interaction between the target molecule and the ligand) are removed. Since affinity chromatography is a binding technique, the sample volume does not affect the separation as long as conditions are chosen to ensure that the target protein binds strongly to the ligand. It may be necessary to test for a flow rate that gives the most efficient binding during sample application since this parameter can vary according to the specific interaction between the target protein and the ligand and their concentrations. The column must be pre-equilibrated in binding buffer before beginning sample application. For interactions with strong affinity between the ligand and the target molecule that quickly reach equilibrium, samples can be applied at a high flow rate. However, for interactions with weak affinity and/or slow equilibrium, a lower flow rate should be used. The optimal flow rate to achieve efficient binding may vary according to the specific interaction and should be determined when necessary. Further details on the kinetics involved in binding and elution from affinity media are covered in Appendix 7. When working with very weak affinity interactions that are slow to reach equilibrium, it may be useful to stop the flow after applying the sample to allow more time for the interaction to take place before continuing to wash the column. In some cases, applying the sample in aliquots may be beneficial. Do not begin elution of target substances until all unbound material has been washed through the column by the binding buffer (determined by UV absorbance at 280 nm). This will improve the purity of the eluted target substance.
17
Elution There is no generally applicable elution scheme for all affinity media. Reference to manufacturer's instructions, the scientific literature and a few simple rules should result in an effective elution method that elutes the target protein in a concentrated form. Elution methods may be either selective or non-selective, as shown in Figure 5.
Method 1 The simplest case. A change of buffer composition elutes the bound substance without harming either it or the ligand. Method 2 Extremes of pH or high concentrations of chaotropic agents are required for elution, but these may cause permanent or temporary damage. Methods 3 and 4 Specific elution by addition of a substance that competes for binding. These methods can enhance the specificity of media that use group-specific ligands.
Fig. 5. Elution methods.
When substances are very tightly bound to the affinity medium, it may be useful to stop the flow for some time after applying eluent (10 min. to 2 h is commonly used) before continuing elution. This gives more time for dissociation to take place and thus helps to improve recoveries of bound substances. Selective elution methods are applied in combination with group-specific ligands whereas non-selective elution methods are used in combination with highly specific ligands. Forces that maintain the complex include electrostatic interactions, hydrophobic effects and hydrogen bonding. Agents that weaken these interactions may be expected to function as efficient eluting agents. The optimal flow rate to achieve efficient elution may vary according to the specific interaction and should be determined when necessary. Further details on the kinetics involved in binding and elution of target molecules from affinity media are covered in Appendix 7. A compromise may have to be made between the harshness of the eluent required for elution and the risk of denaturing the eluted material or damaging the ligand on the affinity medium. Ready to use affinity media from Amersham Pharmacia Biotech are supplied with recommendations for the most suitable elution buffer to reverse the interaction between the ligand and target protein of the specific interaction. Each of these recommendations will be based on one of the following elution methods:
18
pH elution A change in pH alters the degree of ionization of charged groups on the ligand and/or the bound protein. This change may affect the binding sites directly, reducing their affinity, or cause indirect changes in affinity by alterations in conformation. A step decrease in pH is the most common way to elute bound substances. The chemical stability of the matrix, ligand and target protein determines the limit of pH that may be used. If low pH must be used, collect fractions into neutralization buffer such as 1 M Tris-HCl, pH 9 (60–200 µl per ml eluted fraction) to return the fraction to a neutral pH. The column should also be re-equilibrated to neutral pH immediately. Ionic strength elution The exact mechanism for elution by changes in ionic strength will depend upon the specific interaction between the ligand and target protein. This is a mild elution using a buffer with increased ionic strength (usually NaCl), applied as a linear gradient or in steps. Enzymes usually elute at a concentration of 1 M NaCl or less. Competitive elution Selective eluents are often used to separate substances on a group specific medium or when the binding affinity of the ligand/target protein interaction is relatively high. The eluting agent competes either for binding to the target protein or for binding to the ligand. Substances may be eluted either by a concentration gradient of a single eluent or by pulse elution, see page 22. When working with competitive elution the concentration of competing compound should be similar to the concentration of the coupled ligand. However, if the free competing compound binds more weakly than the ligand to the target molecule, use a concentration ten-fold higher than that of the ligand. Reduced polarity of eluent Conditions are used to lower the polarity of the eluent promote elution without inactivating the eluted substances. Dioxane (up to 10%) or ethylene glycol (up to 50%) are typical of this type of eluent. Chaotropic eluents If other elution methods fail, deforming buffers, which alter the structure of proteins, can be used, e.g. chaotropic agents such as guanidine hydrochloride or urea. Chaotropes should be avoided whenever possible since they are likely to denature the eluted protein.
19
Gradient and step elution Figure 6 shows examples of step and gradient elution conditions. For prepacked affinity HiTrap columns, supplied with predefined elution conditions, a step elution using a simple syringe can be used. HiTrap columns can also be used with a chromatography system such as ÄKTAprime. The use of a chromatography system is essential when gradient elution is required.
A 280
A 280 Elution conditions
Linear change in elution conditions Binding conditions
Binding conditions
Time/vol.
Time/vol.
Fig. 6a. Step elution.
Fig. 6b. Gradient elution.
During development and optimization of affinity purification, use a gradient elution to scan for the optimal binding or elution conditions, as shown in Figure 7 and Figure 8.
A 280 nm
UV 280 nm Programmed elution buffer conc.
0.3
Imidazole (M) 0.5
Column: 0.4
0.2
Sample:
Binding buffer:
Elution buffer:
(His)6 fusion protein
0.3
0.2
Flow: System:
Clarified homogenate of E. coli expressing His fusion protein HiTrap Chelating HP 1 ml column charged with Ni2+ 20 mM sodium phosphate, 0.5 M sodium chloride, 10 mM imidazole, pH 7.4 20 mM sodium phosphate, 0.5 M sodium chloride, 0.5 M imidazole, pH 7.4 1 ml/min ÄKTAprime
0.1 0.1
1 2
0 0
45
0
65 min
Fig. 7. Gradient elution of a (His)6 fusion protein.
20
1: selected imidazole concentration for elution of impurities 2: selected imidazole concentration for elution of pure (His) 6 fusion protein
pH
A 280 nm
Sample:
0.6
7.0
pH selected for elution in a step gradient
6.0
0.4
Column: Binding buffer:
A 280
0.2
5.0
Elution buffer:
4.0
Flow: System:
pH
0
Cell culture supernatant containing monoclonal IgG1, 90 ml HiTrap rProtein A FF, 1 ml 100 mM sodium phosphate, 100 mM sodium citrate, 2.5 M sodium chloride, pH 7.4 100 mM sodium phosphate, 100 mM sodium citrate, pH-gradient from 7.4 to 3.0 1 ml/min ÄKTAFPLC™
3.0 150
200
250
ml
Fig. 8. Scouting for optimal elution pH of a monoclonal IgG1 from HiTrap rProtein A FF, using a pH gradient.
Flow rates It is not possible to specify a single optimal flow rate in affinity chromatography because dissociation rates of ligand/target molecule interactions vary widely. For ready to use affinity media follow the manufacturer's instructions and optimize further if required: -determine the optimal flow rate to achieve efficient binding -determine the optimal flow rate for elution to maximize recovery -determine the maximum flow rate for column re-equilibration to minimize total run times To obtain sharp elution curves and maximum recovery with minimum dilution of separated molecules, use the lowest acceptable flow rate.
Analysis of results and further steps The analysis of results from the first separation can indicate if the purification needs to be improved to increase the yield, achieve higher purity, speed up the separation or increase the amount of sample that can be processed in a single run. Commonly used assays are outlined in Appendix 8. It is generally recommended to follow any affinity step with a second technique, such as a high resolution gel filtration to remove any aggregates, or ligands that may have leached from the medium. For example, Superdex™ can be used to separate molecules, according to differences in size, and to transfer the sample into storage buffer, removing excess salt and other small molecules. The chromatogram will also give an indication of the homogeneity of the purified sample. Alternatively, a desalting column that gives low resolution, but high sample capacity, can be used to quickly transfer the sample into storage buffer and remove excess salt (see page 134).
Equipment selection Appendix 2 provides a guide to the selection of purification systems.
21
Troubleshooting This section focuses on practical problems that may occur when running a chromatography column. The diagrams below give an indication of how a chromatogram may deviate from the ideal during affinity purification and what measures can be taken to improve the results. Target elutes as a sharp peak. Satisfactory result A 280
Flow through (unbound material)
Eluted target
Elution buffer Binding buffer
ml
• If it is difficult or impossible to retain biological activity when achieving this result, either new elution conditions or a new ligand must be found. • If using low pH for elution, collect the fractions in neutralization buffer (60–200 µl 1 M Tris-HCl, pH 9.0 per ml eluted fraction).
Target is a broad, low peak that elutes while binding buffer is being applied A 280
Flow through (unbound material)
• Find better binding conditions.
Eluted target
Binding buffer
ml
Target elutes in a broad, low peak A 280
Flow through (unbound material) Elution buffer Eluted target
Binding buffer
ml
A 280
Flow through (unbound material) Elution buffer Binding buffer
Wait Eluted target
ml
• Try different elution conditions. • If using competitive elution, increase the concentration of the competitor in the elution buffer. • Stop flow intermittently during elution to allow time for the target molecule to elute and so collect the target protein in pulses (see second figure beneath). Note: This result may also be seen if the target protein has denatured and aggregated on the column or if there is non-specific binding.
Some of the target molecule elutes as a broad, low peak while still under binding conditions A 280
Flow through (unbound material)
Elution buffer Eluted target
Binding buffer
ml Flow through (unbound material)
A 280
Elution buffer Binding buffer
Eluted target
ml
22
• Allow time for the sample to bind and/or apply sample in aliquots, stopping the flow for a few minutes between each sample application (see second figure beneath).
Situation
Cause
Protein does not bind or elute as expected.
Sample has not been filtered properly. Clean the column, filter the sample and repeat.
Low recovery of activity, but normal recovery of protein.
Remedy
Sample has altered during storage.
Prepare fresh samples.
Sample has wrong pH or buffer conditions are incorrect.
Use a desalting column to transfer sample into the correct buffer (see page 134).
Solutions have wrong pH.
Calibrate pH meter, prepare new solutions and try again.
The column is not equilibrated sufficiently in the buffer.
Repeat or prolong the equilibration step.
Proteins or lipids have precipitated on the column.
Clean and regenerate the column or use a new column.
Column is overloaded with sample.
Decrease the sample load.
Microbial growth has occurred in the column.
Microbial growth rarely occurs in columns during use, but, to prevent infection of packed columns, store in 20% ethanol when possible.
Precipitation of protein in the column filter and/ or at the top of the bed.
Clean the column, exchange or clean the filter or use a new column.
Protein may be unstable or inactive in the elution buffer.
Determine the pH and salt stability of the protein. Collect fractions into neutralization buffer such as 1 M Tris-HCl, pH 9 (60–200 µl per fraction).
Lower yield than expected.
More activity is recovered than was applied to the column.
Enzyme separated from co-factor or similar.
Test by pooling aliquots from the fractions and repeating the assay.
Protein may have been degraded by proteases.
Add protease inhibitors to the sample and buffers to prevent proteolytic digestion. Run sample through a medium such as Benzamidine 4 Fast Flow (high sub) to remove serine proteases.
Adsorption to filter during sample preparation.
Use another type of filter.
Sample precipitates.
May be caused by removal of salts or unsuitable buffer conditions.
Hydrophobic proteins. Protein is still attached to ligand.
Use chaotropic agents, polarity reducing agents or detergents.
Different assay conditions have been used before and after the chromatographic step.
Use the same assay conditions for all the assays in the purification scheme.
Removal of inhibitors during separation. Reduced or poor flow through the column.
Presence of lipoproteins or protein aggregates.
Remove lipoproteins and aggregrates during sample preparation (see Appendix 1).
Protein precipitation in the column caused by removal of stabilizing agents during fractionation.
Modify the eluent to maintain stability.
Clogged column filter.
Replace the filter or use a new column. Always filter samples and buffer before use.
Clogged end-piece or adaptor or tubing.
Remove and clean or use a new column.
Precipitated proteins.
Clean the column using recommended methods or use a new column.
Bed compressed.
Repack the column, if possible, or use a new column.
Microbial growth.
Microbial growth rarely occurs in columns during use, but, to prevent infection of packed columns, store in 20% ethanol when possible.
23
Situation
Cause
Remedy
Back pressure increases during a run or during successive runs.
Turbid sample.
Improve sample preparation (see Appendix 1). Improve sample solubility by the addition of ethylene glycol, detergents or organic solvents.
Precipitation of protein in the column filter and/or at the top of the bed.
Clean using recommended methods. Exchange or clean filter or use a new column. Include any additives that were used for initial sample solubilization in the solutions used for chromatography.
Bubbles in the bed.
Column packed or stored at cool temperature and then warmed up.
Buffers not properly de-gassed.
De-gas buffers thoroughly.
Cracks in the bed.
Large air leak in column.
Check all connections for leaks. Repack the column if possible (see Appendix 3).
Distorted bands as sample runs into the bed.
Air bubble at the top of the column or in the inlet adaptor.
Re-install the adaptor taking care to avoid air bubbles.
Particles in buffer or sample.
Filter or centrifuge the sample. Protect buffers from dust.
Clogged or damaged net in upper adaptor.
Dismantle the adaptor, clean or replace the net. Keep particles out of samples and eluents.
Column poorly packed.
Suspension too thick or too thin. Bed packed at a temperature different from run. Bed insufficiently packed (too low packing pressure, too short equilibration). Column packed at too high pressure.
Distorted bands as sample passes down the bed.
24
Remove small bubbles by passing de-gassed buffer upwards through the column. Take special care if buffers are used after storage in a fridge or cold-room. Do not allow column to warm up due to sunshine or heating system. Repack column, if possible, (see Appendix 3).
Chapter 3 Purification of specific groups of molecules A group specific medium has an affinity for a group of related substances rather than for a single type of molecule. The same general ligand can be used to purify several substances (for example members of a class of enzymes) without the need to prepare a new medium for each different substance in the group. Within each group there is either structural or functional similarity. The specificity of the affinity medium derives from the selectivity of the ligand and the use of selective elution conditions.
Immunoglobulins The diversity of antibody-antigen interactions has created many uses for antibodies and antibody fragments. They are used for therapeutic and diagnostic applications as well as for immunochemical techniques within general research. The use of recombinant technology has greatly expanded our ability to manipulate the characteristics of these molecules to our advantage. The potential exists to create an infinite number of combinations between immunoglobulins and immunoglobulin fragments with tags and other selected proteins. A significant advantage for the purification of antibodies and their fragments is that a great deal of information is available about the properties of the target molecule and the major contaminants, no matter whether the molecule is in its a native state or has been genetically engineered and no matter what the source material. The Antibody Purification Handbook from Amersham Pharmacia Biotech presents the most effective and frequently used strategies for sample preparation and purification of the many different forms of antibodies and antibody fragments used in the laboratory. The handbook also includes more detailed information on antibody structure and classification, illustrated briefly here in Figures 9 and 10.
Fig. 9. H2L2 structure of a typical immunoglobulin.
25
Antibody classes Characteristic Heavy chain Light chain
IgG
IgM
IgA
IgE
IgD
g k or l
m k or l
a
e
k or l
k or l
d k or l
Y structure
Fig. 10. Antibody classes.
IgG, IgG fragments and subclasses The basis for purification of IgG, IgG fragments and subclasses is the high affinity of protein A and protein G for the Fc region of polyclonal and monoclonal IgG-type antibodies, see Figure 9. Protein A and protein G are bacterial proteins (from Staphylococcus aureus and Streptococcus, respectively) which, when coupled to Sepharose, create extremely useful, easy to use media for many routine applications. Examples include the purification of monoclonal IgG-type antibodies, purification of polyclonal IgG subclasses, and the adsorption and purification of immune complexes involving IgG. IgG subclasses can be isolated from ascites fluid, cell culture supernatants and serum. Table 2 shows a comparison of the relative binding strengths of protein A and protein G to different immunoglobulins compiled from various publications. A useful reference on this subject is also: Structure of the IgG-binding regions of streptococcal Protein G, EMBO J., 5, 1567–1575 (1986). Binding strengths are tested with free protein A or protein G and can be used as a guide to predict the binding behaviour to a protein A or protein G purification medium. However, when coupled to an affinity matrix, the interaction may be altered. For example, rat IgG1 does not bind to protein A, but does bind to Protein A Sepharose.
26
Table 2. Relative binding strengths of protein A and protein G to various immunoglobulins. No binding: -, relative strength of binding: +, ++, +++, ++++. Species
Subclass
Human
IgA IgD IgE IgG1 IgG2 IgG3 IgG4 A IgM IgY IgYB
Chicken Avian egg yolk Cow Dog Goat Guinea pig Hamster Horse Koala Llama Monkey (rhesus) Mouse
Pig Rabbit Rat
IgG1 IgG2
IgG1 IgG2a IgG2b IgG3 IgMA no distinction IgG1 IgG2a IgG2b IgG3
Sheep
Protein A binding
Protein G binding
variable -
-
++++ ++++ ++++ variable ++ ++ ++++ ++++ + ++ ++++ + ++++ +++ ++ variable +++ ++++ + +/-
++++ ++++ ++++ ++++ ++++ + ++ ++ ++ ++ ++++ + + ++++ ++++ ++++ +++ +++ +++ +++ + ++++ ++ ++ ++
A
Purify using HiTrap IgM Purification HP columns. B Purify using HiTrap IgY Purification HP columns.
Single step purification based on Fc region specificity will co-purify host IgG and may even bind trace amounts of serum proteins. For any preparation that must be free of even trace amounts of contaminating IgG, immunospecific affinity using anti-host IgG antibodies as the ligand to remove host IgG or using target specific antigen to avoid binding host IgG, ion exchange and/or hydrophobic interaction chromatography may be better alternatives (see Chapter 6). Both protein A and a recombinant protein A are available, with similar specificities for the Fc region of IgG. The recombinant protein A has been engineered to include a C-terminal cysteine that enables a single-point coupling to Sepharose. Single point coupling often results in an enhanced binding capacity. Genetically engineered antibodies and antibody fragments can have altered biological properties and also altered properties to facilitate their purification. For example, tags can be introduced into target molecules for which no affinity media were previously available thus creating a fusion protein that can be effectively purified by affinity chromatography. Details for the purification of tagged proteins are covered in the section Recombinant Fusion Proteins on page 42 of this handbook. For information on the purification of 27
recombinant proteins in general, refer to The Recombinant Protein Handbook: Protein Amplification and Simple Purification from Amersham Pharmacia Biotech.
HiTrap Protein G HP, Protein G Sepharose 4 Fast Flow, MAbTrap Kit Protein G, a cell surface protein from Group G streptococci, is a type III Fc-receptor. Protein G binds through a non-immune mechanism. Like protein A, it binds specifically to the Fc region of IgG, but it binds more strongly to several polyclonal IgGs (Table 2) and to human IgG3. Under standard buffer conditions, protein G binds to all human subclasses and all mouse IgG subclasses, including mouse IgG1. Protein G also binds rat IgG2a and IgG2b, which either do not bind or bind weakly to protein A. Amersham Pharmacia Biotech offers a recombinant form of protein G from which the albumin-binding region of the native molecule has been deleted genetically, thereby avoiding undesirable reactions with albumin. Recombinant protein G contains two Fc binding regions. Protein G Sepharose is a better choice for general purpose capture of antibodies since it binds a broader range of IgG from eukaryotic species and binds more classes of IgG. Usually protein G has a greater affinity than protein A for IgG and exhibits minimal binding to albumin, resulting in cleaner preparations and greater yields. The binding strength of protein G for IgG depends on the source species and subclass of the immunoglobulin. The dynamic binding capacity depends on the binding strength and also on several other factors, such as flow rate during sample application. Many antibodies also interact via the Fab region with a low affinity site on protein G. Protein G does not appear to bind human myeloma IgM, IgA or IgE, although some do bind weakly to protein A. Leakage of ligands from an affinity medium is always a possibility, especially if harsh elution conditions are used. The multi-point attachment of protein G to Sepharose results in very low leakage levels over a wide range of elution conditions. Purification options Binding capacity
Maximum operating flow
Comments
HiTrap Protein G HP
Human IgG, > 25 mg/column Human IgG, >125 mg/column
4 ml/min (1 ml column) 20 ml/min (5 ml column)
Purification of IgG, fragments and . subclasses, including human IgG3 Strong affinity for monoclonal mouse IgG1 and rat IgG. Prepacked columns.
MAbTrap Kit
Human IgG, > 25 mg/column
4 ml/min
Purification of IgG, fragments and subclasses, including human IgG3. Strong affinity for monoclonal mouse IgG1 and rat IgG. Complete kit contains HiTrap Protein G HP (1 x 1 ml), accessories, pre-made buffers for 10 purifications and detailed experimental protocols.
Protein G Sepharose 4 Fast Flow
Human IgG, > 20 mg/ml medium Cow IgG, 23 mg/ml medium Goat IgG, 19 mg/ml medium G